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Dendritic  cells  (DCs)  are  professional  antigen  presenting  cells  whose  function  is  to 
initiate and shape an appropriate adaptive immune response. This requires an ability to 
distinguish  differences  between  whole  pathogens,  in  order  to  orchestrate  effective 
downstream  immunological  outcomes.  However,  cellular  re-programming  of  DC 
functions during these events are not well understood.
A paradigm of dendritic cell biology is that DCs have two modes of function that relate 
to  their  differentiation  states.  An  immature  DC  functions  as  an  immune  sentinel,  to 
monitor and  interrogate  its  surroundings  for  pathogens.  Encounter  with  such  stimuli 
results in a process termed “maturation”, where DCs acquire the properties of effective 
antigen  presenting  cells.  However,  this  process  of differentiation  is  complex.  In  this 
thesis, gene expression profiling of DCs exposed to pathogen components has revealed 
three distinct phases of maturation, with statistically significant expression of subsets of 
genes characterising these phases. Transcriptional regulation of the signalling pathways 
involving  p38  and  ERK  MAP  kinases  important  to  DC  function  were  identified. 
Specific inhibitors of p38 and ERK confirmed their differential role in DC maturation, 
with  p38  activity  being  necessary  for  the  initiation  of DC  maturation,  whilst  ERK 
activity persists to maintain DC survival.
Concurrent with the core maturation process is the DCs’ ability to differentially respond 
to pathogens. Gene expression analysis of DCs exposed to whole viruses supports the 
model  of  DC  plasticity  to  different  pathogenic  stimuli.  Using  exploratory  cluster 
analysis and a novel vector algebra method, core and pathogen-specific gene expression 
programmes were  identified.  The  programmes  involving the  differential  regulation  of 
cytokines were confirmed at the transcript level and at the protein level.
Together these data show that DCs mature to effective antigen presenting cells via an 
orchestrated pattern of at least three gene expression programmes. Superimposed on this 
core maturation response are pathogen-specific transcriptional programmes. Therefore, 
we  conclude  that  DCs  can  translate  different  pathogenic  stimuli  into  core  DC 
maturation and pathogen-specific responses that together shape an appropriate adaptive 
immune response.
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TAP1 Transporter 1, ATP-binding cassette, subfamily B (MDR/TAP)
TBK TRAF family member-associated NF-kB activator (TANK) binding 
kinase
TESS Transcription element search software
TGF(3 Transforming growth factor b
TH T helper cell
TICAM-1 TIR domain-containing adaptor molecule-1
TICAM-2 TIR domain-containing adaptor molecule-2
TIMP Tissue inhibitor of metalloproteinases
TIR Toll/IL-1  receptor
TIRAP TIR domain-containing adapter protein
TLR Toll-like receptor
TMB tetramethylbenzidine
TNFa Tumour necrosis factor alpha
TNFAIP Tumour necrosis factor alpha induced protein
TNFR Tumour necrosis factor receptor-associated factor
TNFRSF Tumour necrosis factor receptor superfamily
TNFSF Tumour necrosis factor (ligand) superfamily
TOR1B Torsin family 1, member B
TRADD TNFRSFIA-associated via death domain
TRAF Tumour necrosis factor receptor-associated factor
TRAM TRIF-related adaptor molecule
TRANSFAC The Transcription Factor Database
TRIF TIR domain-containing adapter inducing IFN-b
TRIKA TRAF6-regulated IKK activator
UBE Ubiquitin conjugating enzyme
UV Ultra-violet
VAK Virus-associated kinase
VEGF Vascular endothelial growth factor
VSV Vesicular stomatitis virus
VZV Varicella zoster virus
WASP Wiskott-Aldrich syndrome protein
wnt wingless-type MMTV integration site family
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Chapter 1 
Introduction
The  vertebrate  immune  response  to  microbial  pathogens  relies  on  both  innate  and 
adaptive components. The innate response is immediate, providing a first line defence 
against many common microorganisms.  Effector cells of the  innate  immune response 
comprise of neutrophils, basophils, eosinophils, monocytes, macrophages and dendritic 
cells  that  coordinate  additional  host  responses  by  synthesising  a  wide  range  of 
inflammatory  modulators.  Adaptive  immune  components,  comprising  of  T  and  B 
lymphocytes, have evolved a more antigen-specific means of defense that also provides 
increased  level  of protection  from  a subsequent  re-infection  with  the  same  pathogen. 
The  cells  of the  innate  system  play  a  crucial  part  in  the  initiation  and  subsequent 
direction of the adaptive immune response. Moreover, because there is a delay of 4 to7 
days  before  the  initial  adaptive  immune  response takes  effect,  the  innate  response  is 
crucial for controlling infections during this period.
The key role of dendritic cells (DCs) is to function as a bridge between the  innate and 
adaptive  immune response.  Dendritic  cells  are  an  integral  part  of the  innate  immune 
system.  As  immune  sentinels,  dendritic  cells  survey  their  surroundings  for  potential 
pathogenic  and  inflammatory  stimuli.  Upon  receipt  of  the  right  stimulation,  DCs 
undergo a complex process of “maturation”, with the end result of presenting antigen to 
T cells to  initiate and shape the downstream adaptive  immune response. Their role at 
the interface of innate and adaptive immunity make studies of dendritic cells crucial to 
the  understanding  of how  immune  responses  to  a  variety  of pathogenic  stimuli  are 
generated.
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1.11nnate immunity
Only vertebrates have developed a highly specific immune response that is based on the 
selection of somatically recombined B  and  T cell  receptors.  Other animals and plants 
lack this adaptive immune system, and instead rely on a relatively sophisticated system 
of  innate  immune  defences.  Even  vertebrates  rely  totally  on  this  innate  immune 
response for the week it takes to develop a specific adaptive immune response. Similar 
to the adaptive immune response, a primary challenge to the  innate immune system is 
how  to  discriminate  the  large  numbers  of potential  pathogens  from  self  cells  and 
proteins, in order to mount an effective response.
The challenge of recognition of a large number of potential microorganisms  is met by 
the  use  of pattern  recognition  receptors  (PRRs)  that  recognise  surface  determinants 
conserved  among  microbes  but  absent  in  the  host.  Such  patterns  include 
Iipopolysaccharides  (LPS),  peptidoglycans  (PGs),  mannans  and  other  proteins  and 
lipids specific to pathogens. PRRs activate the innate immune response by multiple and 
complex  signalling  cascades that  ultimately  regulate  the transcription  of target  genes 
encoding effector molecules. The molecular signatures of pathogens have been termed 
“pathogen-associated molecular patterns” (PAMPs).
1.1.1  Pattern recognition receptors
Much  of  what  is  now  known  about  innate  immunity  has  come  from  studies  in 
Drosophila  (Brennan  and  Anderson,  2004).  Drosophila  is  devoid  of  an  adaptive 
immune  system  and  relies  on  innate  immune  reactions  for  its  defence.  Genetic  and 
molecular approaches have shown that Drosophila is a powerful model system to study 
innate  immunity,  as  innate  immunity  seems to  be remarkably conserved  from  flies to 
mammals (Hoffmann and Reichhart, 2002).
Drosophila  innate immune responses comprise a humoral and cellular response that is 
distinct  from  the  vertebrate  adaptive  immune  system.  Drosophila  cellular  defences 
consist essentially of phagocytosis, and the humoral response consists of the synthesis 
of antimicrobial  peptides  (AMPs).  Drosophila  produces  nine  distinct  antimicrobial 
peptides with activity directed against various fungi, Gram-positive and Gram-negative 
bacteria  (Brennan  and  Anderson,  2004).  The  promoters  of the  genes  encoding  these
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peptides  contain  sequence  motifs  relating  to  mammalian  NF-kB  response  elements 
(Hetru et al., 2003). Induction of antimicrobial peptides are a result of activation of two 
immune  signalling pathways,  namely Toll  and  immune  deficiency  (Imd). Drosophila 
Toll  was  originally  identified  as  a  transmembrane  receptor  required  for  the 
establishment  of the  dorsal-ventral  axis  in  the  developing  embryo  (Anderson  et  al., 
1985).  The Toll  pathway  is activated  mainly by Gram-positive bacteria and  fungi.  In 
contrast,  the  Imd  pathway  modulates  immune  responses  to  Gram-negative  bacteria. 
However, most AMP genes can be regulated by either pathway, depending on the type 
of infection. The selective activation of Toll and Imd by different classes of pathogens 
does however lead to specific AMP gene expression programmes (De Gregorio et al., 
2002). The components of the Drosophila Toll and Imd pathways are shown in Figure 
1 .1 .
The  signalling  pathway  of  Drosophila  Toll  show  remarkable  similarity  to  the 
mammalian  interleukin-1   (IL-1)  pathway,  which  leads  to  activation  of  NF-kB,  a 
transcription  factor  responsible  for  many  aspects  of the  inflammatory  and  immune 
responses (Lemaitre et al.,  1996). The cytoplasmic domains of Drosophila Toll and IL- 
1   receptor  are  highly  conserved  and  are  referred  to  as  the  Toll/IL-1  receptor  (TIR) 
domain.  This  TIR  domain  in  Drosophila  Toll  interacts  with  adaptor  proteins 
DmMyD88,  Tube  and  Pelle,  that  have  a  death  domain  (DD)  region  (Homg  and 
Medzhitov,  2001;  Letsou  et  al.,  1991;  Shelton  and  Wasserman,  1993;  Tauszig- 
Delamasure et al., 2002). Fly mutants of each adaptor proteins do not mount a normal 
protective  antifungal  response  when  challenged  (Lemaitre  et  al.,  1996;  Tauszig- 
Delamasure et al., 2002). Upon activation, the Toll receptor-adaptor complex signals to 
dissociate  Cactus,  the  ankyrin-repeat  inhibitor  protein,  from  the  Rel  protein  by 
phosphorylation. There are three Rel proteins in Drosophila: Dorsal (Nusslein-Volhard 
et al.,  1980; Steward,  1987), Dorsal-related immunity factor (DIF) (Ip et al.,  1993), and 
Relish  (Dushay  et  al.,  1996).  Toll  is  activated  by  the  polypeptide  Spatzle,  which  is 
cleaved  to  its  active  form  as the  end  result  of a  proteolytic  cascade  (LeMosy  et  al., 
1999). Therefore, in Drosophila, rather than a direct recognition of microbial structures 
by  Toll,  fungal  and  Gram-positive  infectious  agents  probably  trigger  a  proteolytic 
cascade that leads to the processing of Spatzle, which in turn activates Toll. In support 
of this,  mutations  of a  gene  encoding  a  peptidoglycan-recognition  protein  (PGRP) 
PGRP-SA and a serine protease Persephone result in compromised anti-Gram-positive
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bacteria and antifungal responses (Michel et al., 2001). This also indicates the existence 
of distinct extracellular pathways for activation of Toll by Gram-positive bacteria and 
fungi,  involving  PGRP-SA  and  Persephone,  respectively.  Most  likely  molecules 
upstream of Persephone detects fungal  infection, and a serine protease downstream of 
PGRP-SA triggers the proteolytic cascade to activate Spatzle.
The Imd pathway governs defense reactions against Gram-negative bacteria. As for the 
Toll pathway, the immune induction of the relevant AMPs relies on  a member of the 
Rel  family,  Relish.  Relish  is  not  inhibited  by  Cactus,  but  carries  its  own  inhibitory 
sequences  in  the  form  of several  carboxy-terminally  located  ankyrin  repeat  domains 
(Dushay et al.,  1996). The mechanism of proteolytic cleavage of Relish  is not known. 
Another  peptidoglycan  recognition  protein,  PGRP-LC,  has  been  shown  to  mediate 
signals from bacterial LPS, and has been demonstrated to be crucial  for activating the 
Imd/Relish pathway (Choe et al., 2002).
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Figure 1.1 Drosophila Toll and Imd pathways of innate immunity
Fungus and Gram-positive bacteria are recognised by Persephone and PGRP-SA respectively, 
which activate Spatzle. Spatzle is the natural ligand for Drosophila (Dm)Toll,  and the activation 
of  DmToll  leads  to  downstream  signalling  events  resulting  in  the  activation  and  nuclear 
translocation of Dif.  Gram-negative bacteria are recognised  by  PGRP-LC,  which  activates the 
Imd  pathway.  Similar  downstream  signalling  events  leads  to  the  activation  and  nuclear 
translocation  of a  Relish,  another homolog  of human  NF-kB.  The activation of Dif and  Relish 
leads to the transcription of genes encoding antimicrobial peptides (AMPs) that are specific for 
the type of incoming pathogen  (fungus,  Gram-positive or Gram-negative bacteria).  Drosophila 
with mutant Toll or Imd have impaired antifungal and antibacterial responses.
(Figure adapted from Brennan and Anderson, 2004)
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1.1.2  Toll-like receptor family
A  year  after  the  discovery  of the  role  of the  Drosophila  Toll  in  host  defence,  a 
mammalian  homologue  of Drosophila  Toll  was  identified  (Medzhitov  et  al.,  1997). 
Toll-like  receptors  (TLR)  are  a  family  of  pattern  recognition  receptors  that  have 
important functions in innate immune defence. There are now currently  11  members in 
the TLR family in humans (Figure  1.2A). TLRs function as “taste receptors” to detect 
signatures of pathogens, and have evolved to recognise a range of microbial proteins, 
lipids, and nucleic acids (Table 1.1).
TLR  family  members  are  characterised  structurally  by  the  presence  of leucine-rich 
repeat (LRR) domains in their amino-terminal extracellular domain, and a TIR domain 
in  their  carboxy-terminal  intracellular  domain.  TLR4  was  the  first  mammalian  TLR 
identified,  and  ectopic  overexpression  was  shown  to  cause  induction  of genes  for 
several inflammatory cytokines and costimulatory molecules (Medzhitov et al.,  1997).
So far, the TLR members  1-10 have been divided into five subfamilies based on their 
amino acid  sequence and  genomic  structure (Takeda et  al.,  2003)  (Figure  1.2B).  The 
TLR2 subfamily is composed of TLR 1, TLR2, TLR6, and TLR 10; the TLR9 subfamily 
is  composed  of TLR7,  TLR8,  and  TLR9.  TLR3,  TLR4,  and  TLR5,  form  their  own 
subfamilies.
TLRs are  differentially  expressed  within  the  cell.  TLR4,  TLR5,  and  members  of the 
TLR2  subfamily are  expressed  on the  cell  surface;  TLR3  and members  of the TLR9 
subfamily  are  expressed  intracellularly  in  the  endosomal-lysosomal  compartments 
(Ahmad-Nejad  et  al.,  2002;  Latz  et  al.,  2004;  Nishiya  and  DeFranco,  2004).  It  is 
tempting to speculate that cell surface-expressed TLRs rapidly sense bacterial infections 
by  recognising  extracellular  bacterial  cell  wall  or  virus  envelope  constituents. 
Analogous  to this,  TLR3  and  members  of the TLR9  subfamily  that  are expressed  in 
endosome compartments most likely recognise nucleic  acids and other components of 
intracellular  bacteria  and  viruses  when  these  are  present  in  phagosome-endosome 
compartments.  Together,  this  may  help  optimise  recognition  of ligands,  through  the 
distribution of receptors to where their ligands are most likely encountered.
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Figure 1.2 Human Toll-like receptor family
A  Differential  cellular  localisation  of the  members  of the  human  Toll-like  receptor family.  Cell 
surface TLRs include TLRs 1, 2, and 6, which may heterodimerise and recognise a broad range 
of bacterial lipoproteins; TLR4 which specifically recognises a wide range of molecular patterns 
on  pathogens;  TLR5  which  recognises  flagellin  of  Gram-negative  bacteria;  TLR11  which 
recognises forms of uropathogenic bacteria; and TLR10 whose natural  ligand has not yet been 
discovered. TLRs 3, 7, 8,  9 are involved in recognising nucleic acids from viruses and bacteria, 
and  are  localised  intracellularly  in  lysosomes.  (Figure  adapted  from  Boehme  and  Compton, 
2004)
B  Phylogenetic  tree  of  the  first  10  members  of  the  human  toll-like  receptor  family.  The 
phylogenetic tree was  derived  from  alignment of the  amino  acid  sequences for human  TLRs. 
(Figure adapted from Takeda, 2003)
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Toll-like receptor 4
Toll-like  receptor  4  (TLR4)  was  the  first  human  TLR  to  be  discovered  in  1997 
(Medzhitov et al.,  1997).  Ectopic overexpression of this receptor caused the induction 
of the genes for several inflammatory cytokines and costimulatory molecules, including 
interleukin  (IL)-l,  CXCL-8  (formerly known as IL-8),  IL-6,  and CD80.  In  1998, two 
groups identified the gene responsible for the hyporesponsiveness to bacterial endotoxin 
in two mouse  strains,  C3H/HeJ and C57BL10/ScCr (Poltorak et al.,  1998;  Qureshi  et 
al.,  1999).  Mutation  in the  tlr4 gene was responsible  for hyporesponsiveness to LPS, 
and TLR4-deficient mice generated by gene targeting are also hyporesponsive to LPS, 
confirming that TLR4 is an essential receptor for the recognition of LPS (Hoshino et al., 
1999).
Recognition of LPS requires other molecules in addition to TLR4. LPS is recognised by 
CD 14  expressed  preferentially  on  the  surface  of  monocytes,  macrophages  and 
neutrophils (da Silva Correia et al., 2001; Moreno et al., 2004). The binding of LPS may 
also be potentiated by LPS-binding protein (LBP) present in the serum (Hailman et al., 
1994). MD-2 has been found to be essential for the transport of TLR4 from the Golgi 
apparatus to the cell  surface (Nagai et al., 2002), and associates with the extracellular 
portion of TLR4 to enhance LPS-responsiveness (Akashi et al.,  2000;  Shimazu et al., 
1999). Mutations in MD-2 result in hyporesponsiveness to LPS and resistance to LPS- 
induced  endotoxin  shock  (Nagai  et  al.,  2002;  Schromm  et  al.,  2001).  Another  cell 
surface protein  RP105  is also  involved  in the recognition  of LPS  by associating with 
TLR4 (Ogata et al., 2000). RP105 contains LRR domains that is structurally related to 
those found in the extracellular portion of the TLRs, and is preferentially expressed on 
the surface of B cells (Miyake et al.,  1994). Together, this suggests that the extracellular 
components  that  lead  to  TLR4-mediated  signalling  in  human  is  as  complex  as  in 
Drosophila.
In  addition  to  LPS,  TLR4  also  recognises  glycoproteins  present  in  virus  envelopes. 
Viral ligands that trigger TLR4 include the fusion protein of Respiratory Syncytial virus 
(RSV) (Kurt-Jones et al., 2000), envelope proteins of Mouse Mammary Tumour virus 
(MMTV)  (Burzyn  et  al.,  2004),  and  the  core  protein  of  hepatitis  C  virus  (HCV) 
(Duesberg et al., 2002).
26Introduction
TLR4 also recognises endogenous ligands, particularly heat shock proteins (HSPs). The 
functions of HSPs include helping proteins achieve their native conformation, to reach 
their correct cellular destination, and resist protein denaturation due to cellular stressors. 
In  normal  conditions,  HSPs  are  abundant  and  intracellular.  Tissue  damage  and  cell 
death results in the release of HSPs into the extracellular milieu, which are recognised 
by  macrophages,  dendritic  cells,  neutrophils  and  monocytes  through  HSP  receptors, 
including  TLR4.  A  wide  variety  of stress  conditions  such  as  heat  shock,  ultraviolet 
(UV) radiation, and infections induce the increased synthesis of heat shock proteins, and 
their detection by  innate immune cells are a potent signal for the presence of danger, 
stress and infectious agents. Recent evidence also point to HSPs as potent activators of 
pro-inflammatory and innate immune responses (Tsan and Gao, 2004). HSP60, HSP70 
and HSP90 are recognised by TLR4, alone or in combination with TLR2 (Ohashi et al., 
2000;  Triantafilou  and  Triantafilou,  2004;  Vabulas et  al.,  2001).  Triggering  of TLRs 
singly  or  in  combination  may  contribute  to  additional  specificity  of the  downstream 
immune response.
Toll-like receptor 2
Toll-like receptor 2 (TLR2) recognises a variety of microbial components (Table  1.1), 
ranging from components of Gram  positive and Gram negative bacteria, mycoplasma, 
and  parasites.  Analysis  of TLR2-deficient  mice  showed  that  TLR2  is  critical  to  the 
recognition of peptidoglycan and  lipoproteins (Schwandner et al.,  1999). Accordingly, 
TLR2-deficient  mice  showed  higher  susceptibility  to  infection  by  Staphylococcus 
aureus  than  wild-type  mice  (Takeuchi  et  al.,  2000).  Furthermore,  TLR2  recognises 
several  atypical  types  of  LPS  from  Leptospira  interrogans  and  Porphyromonas 
gingivalis,  in  contrast  to  TLR4  which  recognises  lipopolysaccharides  from 
enterobacteria such as Escherichia coli and Salmonella (Erridge et al., 2004; Tapping et 
al., 2000). The properties of atypical LPS differ structurally from enterobacteria LPS by 
the number of acyl chains in the lipid A component (Netea et al., 2002).
It  has  been  shown  that  TLR2  is  recruited  to  macrophage  phagosomes  after  the 
internalisation  of yeast  mannan,  and  this  triggers  the  downstream  TLR2  signalling 
pathway  resulting  in  the  production  of pro-inflammatory  cytokines  including  TNFa 
(Underhill  et al.,  1999). This demonstrates that TLR2  recruitment to phagosomes  is a 
functional  link  between  macrophage  phagocytosis  and  the  production  of  pro-
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inflammatory cytokines. This may also indicate a potential  cooperation  between other 
non-TLR  pattern  recognition  receptors  that  recognise  and  internalise  pathogens,  and 
TLRs that  are  recruited  to  phagosomes  and  trigger cytokine  production.  This  further 
increases the likelihood that specific targeting of TLRs to defined locations facilitates 
the recognition of specific ligands.
TLR2  cooperates with TLR1  and TLR6. TLR1  and TLR6 are  very closely related  in 
their amino acid sequence, showing 69.3% overall identity and over 90% identity in the 
TIR domains (Takeuchi et al.,  1999). Functional  association of TLR2 with TLR1  and 
TLR6  confers  discrimination  among  different  microbial  components,  allowing 
differentiation  between  triacylated  bacterial  and  diacylated mycoplasmal  lipopeptides. 
TLR2 and TLR6 functionally cooperate to recognise diacylated  lipopeptides (Ozinsky 
et  al.,  2000;  Takeuchi  et  al.,  2001),  while  TLR2  and  TLR1  cooperate  to  recognise 
triacylated lipopeptides (Takeuchi et al., 2002; Wyllie et al., 2000). TLR1  may also be 
responsible for recognising subtle differences among lipid moieties of lipopeptides. The 
ability  of TLR2  to  functionally  associate  with  at  least TLR1  and  TLR6  allows  finer 
discrimination between pathogen components than perhaps allowed by single TLRs.
Toll-like receptor 3
The ligand for Toll-like receptor 3 (TLR3) was identified in 2001  to be double-stranded 
RNA (dsRNA), a molecular pattern associated with viral infection, as it is produced by 
many  virus families  at  some  point during their replication  cycle  (Alexopoulou  et  al., 
2001).  Using  a  synthetic  analogue  to  dsRNA,  polyinosinic-polycytidylic  acid 
(poly(LC)),  TLR3'1 ' mice were shown to have impaired responses to poly(LC) in terms 
of IL-6 and TNFa production, and impaired upregulation of CD69, CD80 and CD86 in 
B  cells.  Responses  to  poly(LC)  in  MyD##"7 '  mice  were  also  impaired  in  terms  of 
dendritic cell production of IL-12 and nitric oxide (N02) production from macrophages, 
demonstrating the involvement of MyD88 downstream of TLR3  signalling in cytokine 
responses.
There  are  however  other  cellular  receptors  for  dsRNA,  including  dsRNA-dependent 
protein kinase (PKR) (Proud,  1995).  However, PKR-deficient mice still  showed  some 
responses  to  dsRNA,  demonstrating  the  presence  for additional  cellular  receptors  for 
this  viral  motif (Yang  et  al.,  1995).  Because  so  many  viruses  synthesise  dsRNA  or
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RNAs with extensive secondary structures during their replicative cycle, dsRNA  is an 
important viral motif for the host to recognise. Accordingly, recognition of dsRNA by 
TLR3  also  results  in  the  activation  of  interferon  regulatory  factor  (IRF)-3,  a 
transcription  factor that  can  activate  a number  of interferon-stimulated  genes  (ISGs), 
including  interferon-a  and  interferon-p  (IFNa/p)  in  the  absence  of  prior  secreted 
interferon (Servant et al., 2002). Therefore, in addition to the core response induced by 
all TLRs through the adaptor protein MyD88, the antiviral action of TLR3, through the 
activation  of IRF-3,  is  mediated  through  another adaptor protein  TRIF/TICAM-1,  as 
discussed in Section 1.1.3.
The  endogenous  ligand  for TLR3  has  been  shown  to  be  messenger  RNA  (mRNA), 
presumably through the presence of dsRNA in dynamic secondary structures (Kariko et 
al.,  2004).  Similar to HSPs, the presence of extracellular mRNA  may be the result of 
cellular necrosis, and act as a signal  for surrounding tissue damage that may trigger an 
immune response in innate immune cells that detect mRNA through TLR3.
In contrast to TLR4 and TLR2, studies have shown an intracellular localisation of TLR3 
in  dendritic  cells  (Matsumoto  et  al.,  2003).  This  is  in  contrast  to  the  cell  surface 
expression  of TLR3  in  fibroblasts  (Matsumoto  et  al.,  2002).  Exogenous dsRNA  still 
stimulated IL-12 and IFNa/p production in DCs, demonstrating that TLR3  is triggered 
after  dsRNA  is  internalised.  This  confers  cell-type  specificity  in  the  induction  of 
antiviral responses via TLR3, where cells with a high capacity for endocytosis may be 
more likely to detect viral nucleic acids intracellularly, as opposed to stromal cells like 
fibroblasts  that  do  not  have  a  capacity  to  phagocytose,  and  rely  upon  detection  of 
dsRNA extracellularly.
Toll-like receptor 9
Bacterial  DNA  is  distinguished  from  vertebrate  DNA  by  its  high  frequency  of 
unmethylated  CpG  motifs  (Bestor,  1990;  Hendrich  and  Tweedie,  2003).  These 
structural differences allow bacterial DNA to be distinguished from self DNA (Heeg et 
al.,  1998).  The  discovery  that  unmethylated  bacterial  CpG-DNA  motifs  have 
immunostimulatory  properties  (Krieg  et  al.,  1995),  and  the  recognition  that  bacterial 
DNA  induces  the  nuclear translocation  of NF-kB  with  the  subsequent  production  of 
pro-inflammatory  cytokines TNFa  and  IL-6  (Sparwasser et  al.,  1997),  alluded  to the
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role  of bacterial  CpG  DNA  as  a  potential  molecular  pattern  recognised  by  TLRs. 
Subsequently,  it  was  discovered  that  Toll-like  receptor 9  (TLR9)  is  essential  for the 
recognition of bacterial DNA (Bauer et al., 2001).
In  addition  to  bacterial  CpG  DNA,  TLR9  also  recognises  herpes  simplex  virus-1  
(HSV-1)  and  HSV-2,  demonstrated  in  murine  and  human  plasmacytoid  DCs 
respectively (Hochrein et al., 2004; Krug et al., 2004; Lund et al., 2003). Lund et al also 
demonstrated that purified HSV-2 genomic DNA can trigger the release of IFNa, which 
is  inhibited  by  inhibitory  CpG  oligonucleotide  in  a  dose-dependent  manner.  The 
production of IFNa required the adaptor protein MyD88. TLR9 has also been shown to 
recognise malaria schizonts (Pichyangkul et al., 2004).
Comparison  between  TLR  signalling  activated  by  LPS  and  CpG-DNA  revealed 
different  intracellular localisation of TLR4 and TLR9.  Similar to TLR3, TLR9 is also 
expressed  intracellularly, and upon  stimulation with CpG-DNA,  TLR9 with  its ligand 
and  MyD88 both co-localise to  lysosomal  compartments (Ahmad-Nejad  et al.,  2002). 
This  recruitment  of MyD88  to  endosomal  compartments  is  also  seen  for TLR7  and 
TLR8 with their respective ligands (Heil et al., 2003). The requirement for endocytosis 
for  TLR9  triggering  is  demonstrated  by  the  failure  of  TLR9-mediated  signal 
transduction  in  the  presence  of inhibitors  of endocytosis  (Ahmad-Nejad  et  al.,  2002; 
Lund  et al.,  2003). This  is  in contrast to the  independence  of LPS  internalisation  and 
triggering of TLR4 (Ahmad-Nejad et al., 2002), showing that signalling by TLRs is also 
specific to intracellular location. Accordingly, expression of intracellular TLRs such as 
TLR3,  and  members  of the  TLR9  family,  are targeted  to  locations within  the cell  to 
optimise their detection  of viral  and  bacterial  nucleic  acids.  The  contribution  of such 
TLRs to the antiviral response is further detailed in Section  1.2.3.2.
Table 1.1  Ligands for human Toll-like receptors
Activating ligands for members of the human Toll-like receptor family, subdivided into classes of 
pathogens from which the components are derived. Endogenous (host) proteins can also act to 
trigger  TLRs.  Such  pathogen  components  trigger TLRs  to  raise  the  alarm  for  activating  the 
immune system.
30Bacterial components Viral components Fungal I parasitic  components Endogenous factors
TLR1
TLR2
TLR3
TLR4
TLR5
TLR6
TLR7
TLR8
TLR9
TLR10
TLR11
Tri-acyl lipopeptides 
(mycobacteria)
Lipoproteins (Gram- bacteria, 
mycoplasma, spirochetes) 
PTG, LTA (Gram+ bacteria) 
Porins (Neisseria) 
Lipoarabinomannan 
(mycoplasma)
Atypical LPS (Leptospira, 
porphyromonas)
H.  pylori
Lipopolysaccharide (Gram- 
bacteria)
Flagellin (Gram- bacteria) 
Di-acyl  lipopeptides 
(mycobacteria)
LTA
CpG DNA, H. pylori
Not determined (uropathogenic 
bacteria)  _____________
HSV-1
Measles virus  (Haemagluttinin)
dsRNA,
MCMV
RSV (Fusion protein), 
MMTV (Envelope protein)
ssRNA
ssRNA
HSV-1, HSV-2, 
MCMV
Glycoinositolphospholipids 
(Trypanosoma cruzi) 
Glycolipids (Treponema 
maltophilum)
Zymosan (fungi)
Cryptococcus neoformans
Zymosan (fungi)
Plasmodium falciparum schizonts 
Not determined
mRNA
HSP
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1.1.3  TLR-mediated signalling pathways
Both TLR and IL-1  receptor (IL-1R) families activate similar signalling cascades upon 
stimulation,  due to their similar cytoplasmic  domains. Neither Toll-like  receptors nor 
the  IL-1  receptor possess  intrinsic  kinase activity,  and rely on  recruitment of adaptor 
proteins to mediate downstream signalling events. There are currently 5 members of the 
TLR  adaptor  family,  all  of  which  possess  a  TIR  domain  at  the  carboxy-terminal 
(McGettrick  and  O'Neill,  2004).  MyD88  was  the  first  adaptor  protein  identified  to 
mediate  signalling  events  downstream  of IL-1R  and  TLR4  (Medzhitov  et  al.,  1998; 
Muzio  et  al.,  1997;  Wesche  et  al.,  1997).  Stimulation  of MyD88~''  mice  with  LPS 
showed  incomplete  abolition  of  downstream  TLR4-induced  responses  including 
activation of NF-kB and MAP kinases, suggesting that other adaptors probably existed 
(Kawai  et  al.,  1999).  Mal/TIRAP  (MyD88-adapter-like  or  TIR  domain-containing 
adapter  protein)  was  the  second  adaptor  protein  discovered  (Fitzgerald  et  al.,  2001; 
Homg  et  al.,  2001),  and  has  subsequently  been  found  to  function  with  MyD88 
downstream of TLR2 and TLR4 (Homg et al., 2002; Oshiumi et al., 2003a; Yamamoto 
et  al.,  2002a).  Other  TIR-containing  TLR  adapters  include  TRIF  (TIR  domain- 
containing adaptor inducing IFN-p), also known as TICAM-1  (TIR domain-containing 
adaptor molecule-1), which functions downstream of TLR3 and TLR4 (Oshiumi et al., 
2003a;  Hoebe  et al.,  2003a;  Yamamoto  et  al.,  2002b);  TRAM  (TRIF-related  adaptor 
molecule),  also  known  as  TICAM-2  (TIR  domain-containing  adaptor  molecule-2), 
which  functions  downstream  of  TLR4  as  a  bridging  adaptor  to  TRIF/TICAM-1 
(Fitzgerald et al., 2003b; Oshiumi et al., 2003b; Yamamoto et al., 2003b); and  SARM 
(SAM and ARM containing protein), of which a C.  elegans ortholog has been found to 
contribute  to  innate  immunity  (Couillault  et  al.,  2004).  The  existence  of different 
adaptors  allows  recruitment  by  TLRs,  singly  or  in  combination,  to  activate  distinct 
signalling pathways. MyD88 probably functions as a universal adaptor for TLRs, with 
the  possible  exception  of TLR3  (Jiang  et  al.,  2003),  whereas  the  usage  for  Mai, 
TRIF/TICAM-1  and TRAM/TICAM-2 are more limited. The role of SARM  in human 
TLR signalling is yet to be demonstrated.
The variety of TLR adaptor proteins further suggest that differential adaptor utilisation 
by  TLRs  may  mediate  receptor-specific  patterns  of gene  expression.  The  signalling 
pathways  of  TLR4  and  TLR3  demonstrating  MyD88-dependent  and  MyD88- 
independent signalling are discussed below.
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MyD88’dependent signalling pathway
The adaptor protein  MyD88  has  a TIR  domain  in  its  C-terminal  portion  and  a death 
domain  (DD)  in  its N-terminal  portion  (Muzio et al.,  1997).  Downstream  of MyD88, 
members of the IRAK (IL-1  receptor associated kinase) family are recruited. IRAK-4 is 
crucial to the induction of innate immunity (Suzuki et al., 2002), and activates IRAK-1. 
Upon  activation,  IRAK-1  becomes  hyperphosphorylated  and  interacts  with  TRAF6 
(tumour necrosis factor (TNF) receptor-associated factor 6). TRAF6 is a member of the 
TNF  receptor-associated  factor  (TRAF)  family  of  proteins,  which  have  been 
characterised  as  adaptor  molecules  that  mediate  signals  downstream  of  the  TNF 
receptor superfamily,  leading to the activation of NF-kB and MAP (mitogen-activated 
protein) kinases (Wajant et al., 2001). TRAF6 is the only member of the TRAF family 
to participate in IL-1  receptor and TLR signalling (Cao et al.,  1996; Zhang et al.,  1999), 
suggesting that TRAF6 may be a central point where signals induced by the TLR and 
TNF receptor families converge.
TRAF6 complexes with  a number of different proteins,  two  immediate  factors called 
TRIKA1  (TRAF6-regulated  IKK  activator  1)  and  TRIKA2.  TRIKA1  is  a  dimeric 
ubiquitin-conjugating  enzyme  complex  composed  of Ubcl3  and  UevlA.  This  Ubc 
complex  together  with  TRAF6  catalyses  the  activation  of IKK  (Deng  et  al.,  2000), 
which go on to phosphorylate the inhibitory proteins IkBs, resulting in the activation of 
NF-kB  (Siebenlist  et  al.,  1994).  The  IKKs  also  phosphorylate  and  regulate  p i05 
(NFKB1) and pi 00 (NFKB2)  leading to their processing to p50 and p52  respectively 
(Siebenlist et al.,  1994). TRIKA2 is composed of TAK-1  (transforming growth factor (3 
(TGFp)-activated  kinase-1,  also  known  as  mitogen-activated  protein  kinase  kinase 
kinase  7),  TAB1  (TAKl-binding  protein  1)  and TAB2  (Ninomiya-Tsuji  et  al.,  1999; 
Takaesu et al., 2000). The two complexes associated with TRAF6 can activate both NF- 
kB and MKK6 (mitogen-activated protein kinase kinase 6), the upstream kinase of p38 
and  JNK  (Jiang  et  al.,  2003;  Wang  et  al.,  2001).  TAK-1,  together  with  TRAF6, 
therefore acts as a branch point that activates both the NF-kB pathway and the MAPK 
pathway (Wang et al., 2001) (Figure 1.3).
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MyD88-independent signalling pathway
TLR4 and TLR3  are unique among the members of the TLR family  in that these two 
receptors  can  signal  independently  of MyD88,  and  still  result  in  the  activation  and 
nuclear  translocation  of NF-kB  (Yamamoto  et  al.,  2003a).  The  MyD88-independent 
signalling  pathway  is  mediated  through  the  adaptor  protein  TRIF  (also  known  as 
TICAM-1) (Floebe et al., 2003a; Oshiumi et al., 2003a; Yamamoto et al., 2002b). TRIF 
is recruited  directly by TLR3,  and  indirectly  by TLR4  via a bridging adaptor TRAM 
(also known as TICAM-2) (Fitzgerald et al., 2003b; Oshiumi et al., 2003b; Yamamoto 
et al., 2003b) (Figure 1.3).
TRIF  associates  with  TRAF6,  which  then  binds  to  TBK-1  (TRAF  family  member- 
associated  NF-kB  activator  (TANK)  binding  kinase  1)  and  IKKc  (Fitzgerald  et  al., 
2003a). Both TBK1  and IKKc are distantly related to IKKa and IKKp, and activate the 
antiviral  response  through  activation  of NF-kB  and  IRF-3  (Fitzgerald  et  al.,  2003a; 
Fitzgerald et al., 2003b; McWhirter et al., 2004; Sato et al., 2003; Sharma et al., 2003; 
Takeuchi et al., 2004), the coordinate activation of NF-kB  and  IRF-3  being necessary 
for  the  induction  of IFNp  (Panne  et  al.,  2004).  It  has  also  been  demonstrated  that 
poly(I:C)-induced  activation  of  TLR3  results  in  TRIF  binding  to  TRAF6,  and 
downstream events similar to that described for MyD88-dependent signalling, involving 
TAK-1, TAB1  and TAB2 also lead to the activation of NF-kB and MAP kinases (Jiang 
et al., 2003).
Though  TLR3  and  TLR4  signal  through  common  MyD88-dependent  and  MyD88- 
independent signalling pathways, gene expression studies (Doyle et al., 2002; Doyle et 
al., 2003) and investigations of other activation parameters (Hoebe et al., 2003b; Wietek 
et al., 2003) have indicated a diverging gene expression program mediated by the two 
TLRs.  The existence  of known  TLR3-  and  TLR4-specific  signalling  pathways  might 
also suggest the existence of similar diversity in signalling pathways of other TLRs.
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Figure 1.3 MyD88-dependent and MyD88-independent signalling pathways
The  suggested  intracellular  signalling  pathways  downstream  of TLR4  on  the  cell  surface  (A) 
and  TLR3  in  intracellular  compartments  (B).  TLR4  utilises  both  a  MyD88-dependent  and 
MyD88-independent  signalling  pathway.  The  MyD88-independent  signalling  pathway  is 
mediated  by the adaptor protein TRIF,  recruited directly by TLR3,  and  indirectly by TLR4 via a 
bridging adaptor (TRAM). TRAF6 seems to be activated downstream of both MyD88 and TRIF, 
and the proteins associated with TRAF6 may differ depending on the activating adaptor protein. 
Transcription factors IRF-3 and NF-kB are activated downstream of TLR3/4 activation, and JNK 
can  activate  c-jun to form the transcription  factor AP-1.  p38  also  enters the  nucleus and  may 
have  a  role  in  histone  modification  that  is  required  for  genes  whose  promoter  regions  are 
masked  by surrounding  histones.  p38  may also  mediate  a  phagocytic gene  program  (Blander 
and  Medzhitov,  2004;  Doyle  et  al.,  2004).  The  activation  of the  combination  of transcription 
factors  leads  to the  characteristic gene  expression  program  of immune cells  characterised  by 
cytokine and interferon production and cell-specific changes downstream of NF-kB activation.
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1.1.4  Transcription factors activated in TLR signalling pathways 
NF-kB
Nuclear factor of kappa light polypeptide gene enhancer in  B cells (NF-kB) was first 
identified  as  a  nuclear  factor necessary  for the  transcription  of immunoglobulin  (Ig) 
light chains in B cells (Sen and Baltimore,  1986). Subsequently NF-kB was shown to be 
expressed  in  a  variety of cell  types.  NF-kB  proteins  are evolutionary conserved.  In 
Drosophila, NF-kB members include Dorsal, Dorsal-related immunity factor and Relish 
(Section  1.1.1).  Mammalian  NF-kB  members  include:  RelA  (p65),  RelB,  c-Rel, 
pl05/p50  (NF-kB 1),  and  pl00/p52  (NF-kB2),  related  through  their  Rel  homology 
domains  (RHD)  (Ghosh  et  al.,  1998).  NF-kB 1   and  NF-kB2  are  synthethised  as 
precursors, pi05 is cleaved to release p50, and p i00 is cleaved to release p52. The NF- 
kB proteins are dimeric in vivo, and p65/p50 heterodimers are the most abundant form 
of NF-kB in many cells (Siebenlist et al.,  1994).
NF-kB  proteins  exist  in  the  cytoplasm  in  an  inactive  form,  as  a  result  of  their 
association  with  the  IkB  proteins,  the  most  common  of which  are  IkBoi,  IkBP,  and 
IkBe.  These  proteins  are  identified  by  the  presence  of  ankyrin  repeats.  There  is 
continuous  movement  of  NF-kB-IkBch  and  NF-kB-IkBe  between  the  nuclear  and 
cytoplasmic compartments, mediated by the nuclear localisation  sequences (NLSs) on 
NF-kB p50/p65 subunits, and nuclear export signal (NES) located in the IkBcx (Birbach 
et al., 2002). Complexes of NF-kB-IkBP are retained in the cytoplasm due to masking 
of both NLS in NF-kB by IkBP, in contrast to IkBoc which only masks one NLS (Malek 
et al., 2001).
The  activation  of NF-kB  is  the  most  well-characterised  outcome  of TLR  signalling. 
This  results  in  the  production  of a range  of inflammatory  cytokines  and  acute  phase 
proteins such as IL-1, TNFa, IL-6, CXCL8, IL-12p40,  ICAM1  (Baeuerle and Henkel,
1994).  The  activation  of  NF-kB  in  dendritic  cells  also  has  important  functional 
consequences affecting DC activation (Section 1.2.3.1).
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AP-1
The activating protein-1  (AP-1) family of transcription factors consists of homodimers 
and  heterodimers  of the  Jun  and  Fos  family  (Karin,  1995).  The  activity  of AP-1  is 
upregulated  through  phosphorylation  by  the  MAP  kinases  JNK  (c-Jun  NF^-terminal 
kinase,  MAPK8)  and  ERK  (extracellular  signal-regulated  kinase,  MAPK3)  (Karin,
1995).  MAP  kinase  pathways  involving  ERK  and  JNK  are  activated  by  a  range  of 
stimuli such as growth factors and cytokines, bacterial and viral infections (Chu et al.,
1999). LPS and peptidoglycan has been shown to enhance the transcriptional activity of 
AP-1  (Mackman et al.,  1991), and viral infection and dsRNA activate AP-1  through the 
induction of JNK (Chu et al.,  1999). Differential activation of TLRs has been shown to 
correspond to variation in downstream activities of the ERK pathway (Agrawal et al., 
2003). Activation of the MAP kinase pathway downstream of TLRs may result from the 
downstream effects of TAK-1, though such a link has not yet been reported.
IRF-3
Interferon  regulatory  factors  (IRFs)  constitute  a  family  of transcription  factors  that 
mediate activation of interferons and interferon-related response genes (Taniguchi et al.,
2001). There are nine members of the IRF  family.  IRFs are differentially  induced  by 
viral infections (Bose and Banerjee, 2003), and are activated by downstream signalling 
pathways of cytokine receptors including interferons (Taniguchi et al., 2001). IRF-3 can 
also be activated downstream of TLR3 and TLR4 signalling (Doyle et al., 2002), and it 
has been recently shown that IRF-7 is also activated downstream of TLR-9 and MyD88 
(Honda et  al.,  2004).  IRF-3  and  IRF-7  are  also  activated  directly  as  a  result of viral 
infections, but their activation are temporally segregated. IRF-3  is activated upon viral 
entry (Hiscott et al.,  1999),  resulting  in the activation  of the  IFN(3 and  IFNal  genes. 
Feedback signalling from the interferon receptor results in the activation of interferon- 
stimulated genes (ISGs)  including IRF-7, which  results  in the transcription  of the full 
range IFNs, thereby amplifying the antiviral response. Virus infection can activate IRF- 
3  via  numerous  signalling  pathways,  and  kinases that  phosphorylate  IRF-3  include  a 
virus-associated  kinase  (VAK)  and  the  dsRNA-activated  protein  kinase  R  (PKR) 
(Servant et al., 2002).
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The coordinate activation and combinatorial regulation of multiple transcription factors, 
and the  integration  of their downstream  effects,  results  in  a fine-tuned transcriptional 
control  of gene  expression.  With  respect  to  the  immune  response,  clusters  of genes 
regulated in cell type- or pathogen-specific manners are likely to represent specific gene 
expression  programmes  that  are  regulated  by  unique  combinations  of  such  core 
transcription factors.
1.1.5  Expression and distribution of TLRs
Expression  of TLRs vary between  cell types,  ranging from  the  ubiquitous  (TLR1) to 
more limited expression of the other TLRs (Homung et al., 2002; Muzio et al., 2000). 
Most innate immune cells express TLRs, including myeloid and plasmacytoid dendritic 
cells,  macrophages,  monocytes  (Armstrong  et  al.,  2004),  eosinophils  (Nagase  et  al.,
2003), neutrophils (Hayashi  et al.,  2003), and natural  killer (NK) cells (Becker et al., 
2003; Schmidt et al., 2004). TLRs are especially important in antigen presenting cells, 
including  DCs,  macrophages  and  B  cells,  where  active  phagocytosis  contributes  to 
increased recognition of PAMPs. TLR activation also results in DC maturation (Section 
1.2.3.1)  Consequently,  such  cells  express  the  widest  range  of TLRs.  Dendritic  cells 
further  differentiate  their  expression  of  TLRs,  depending  on  subset  and  stage  of 
maturation.  Myeloid  DCs  (MDCs)  and  plasmacytoid  DCs  (PDCs)  express  a  broadly 
complementary  panel  of TLRs:  MDCs  express  TLR2,  TLR3,  TLR4,  TLR5,  TLR6, 
TLR8; PDCs express TLR7, TLR9 (Jarrossay et al., 2001; Kadowaki et al., 2001; Krug 
et al., 2001).  However, the data regarding exclusive expression  of TLRs by particular 
subsets  is  conflicting.  For  example,  TLR7  has  also  been  shown  to  be  expressed  on 
myeloid DCs (Ito et al., 2002; Krug et al., 2001). The differential expression of TLRs 
according to DC subsets allows a theoretical “division of labour” where the two subsets 
of DCs are able to recognise different antigenic ligands. TLR3  is the only TLR that is 
transcriptionally  upregulated  upon  DC  maturation  (Matsumoto  et  al.,  2003),  possibly 
through an interferon-dependent pathway (Doyle et al., 2003; Heinz et al., 2003; Tanabe 
et al.,  2003). Transcript levels of other TLRs (TLR1, TLR2, TLR3,  TLR7) have also 
been  shown to be  induced  in macrophages  in response to viral  infections,  in an  IFN- 
dependent manner (Miettinen et al., 2001).
In addition to the expression of TLRs on cells of the innate immune system, TLRs are 
also  expressed  on  cells  resident  at  barrier  sites  to  infection  such  as  epithelial  cells,
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endothelial  cells,  fibroblasts  and  keratinocytes  (Takeda et al.,  2003).  The  location  of 
these stromal cells also function to contribute to inflammatory responses by recognising 
pathogens (Sato and Iwasaki, 2004; Zarember and Godowski, 2002).
1.1.6 Regulation of adaptive immunity by TLRs
The presence of TLRs on a wide variety of cell types means that activation of TLRs can 
mediate a range of effector functions that influence adaptive immunity. The specificity 
conferred by TLRs in terms of responses to specific microorganisms forms the basis for 
driving  a pathogen-specific  immune response.  Upon triggering of TLRs,  downstream 
events result in a complex and coordinated change  in DCs that allow acquisition of a 
“mature” phenotype,  which  make  DCs effective antigen  presenting  cells that  interact 
with  T  cells  and  to  initiate  and  shape  the  downstream  adaptive  immune  response 
(Section l.2.3.1).
In addition to the “maturation” effects on dendritic cells, TLR triggering also leads to 
the secretion  of a variety of pro-inflammatory cytokines by  stromal  cells that express 
TLRs,  innate  immune  cells,  and  DCs  (Andonegui  et  al.,  2003;  Farina  et  al.,  2004; 
Gewirtz et al., 2001; Kagnoff and Eckmann,  1997; Mazzoni and Segal, 2004; Schmitz 
et al., 2004; Supajatura et al., 2001). The secretion of pro-inflammatory cytokines has a 
wide  range  of effects,  and  cytokines  as  intercellular  messengers  are  important  in 
modulating  the  immune  response  (Holloway  et  al.,  2002).  The  activation  of MyD88 
downstream  of  TLR  signalling  resulting  in  the  production  of  pro-inflammatory 
cytokines by dendritic cells has also been shown to be essential  for naive CD4 T cell 
activation (Pasare and Medzhitov, 2004). Studies have shown that although PAMPs that 
stimulate  different  TLRs  induce  similar  changes  of surface  phenotype  of DCs,  they 
often  induce distinct patterns of cytokines which may be pathogen-specific (Pulendran 
et  al.,  2001;  Qi  et al.,  2003). Triggering of different TLRs,  singly  or  in combination, 
may  lead  to  subtly  different  programs  of activation,  including  differential  range  of 
effector cytokines secreted by cells.
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1.2  Dendritic cells
1.2.1  Dendritic cell biology
Dendritic  cells  (DCs)  are  specialised  antigen  presenting  cells  in  the  immune  system. 
These cells constitute the innate immune system, and interface with adaptive immunity 
in  their  immune  response.  The  nature  of the  infectious  stimuli  influences  how  DCs 
respond  and  mature.  Encounter  with  pathogens  in  the  periphery  provides  activation 
signals  which  are  transduced  via  TLRs  and  the  relevant  downstream  signalling 
pathways. DCs then carry this information into lymph nodes where they prime antigen- 
specific T cells and induce a polarised response specific for the pathogen. The antigen- 
specific  nature  of the  adaptive  immune response  is therefore reliant on  the  ability  of 
DCs to distinguish between pathogens and affect appropriate outcomes.
1.2.2  Dendritic cell subsets
The  existence  of  numerous  DC  subsets  strongly  suggest  their  importance  and 
specialised functions as antigen presenting cells. DCs are responsible for the induction 
of central and peripheral tolerance, as well as for priming effector and memory T cells 
to  induce  the  adaptive  immune  response to  infection.  These  apparently contradictory 
roles  could  be  attributed  to  either distinct  DC  lineages  endowed  with  unique T  cell 
stimulatory  capacity,  or  to  a  single  DC  type,  which  is  instructed  by  environmental 
stimuli to perform different functions (McLellan and Kampgen, 2000).
DCs  arise  from  myeloid  and  lymphoid  progenitors  in  the  bone  marrow,  which 
differentiate from the pluripotent haematopoietic stem cells. Different DC subsets carry 
different  lineage  markers  that  distinguish  their origin.  Myeloid  DCs  (MDCs)  share  a 
CD34+  precursor  with  monocytes  and  macrophages,  and  are  CDlahlgh,  CDllb+, 
CD llc+,  and  CD 14'.  DCs  generated  in  vitro  by  culturing  CD14+  monocytes  in 
granulocyte/macrophage colony-stimulating  factor (GM-CSF) and  interleukin-4 (IL-4) 
(Sallusto  and  Lanzavecchia,  1994)  are  the  classical  in  vitro  monocyte-derived  DC 
(moDC) which stimulate effector and memory responses in T cells.
Thymic  DCs  are  involved  in  clonal  deletion  of self-reactive  T  cells  (Ardavin  et  al., 
1993). Lymphoid progenitors were found to differentiate into thymic DCs, as well as T, 
B and natural killer (NK) cells, giving rise to a lymphoid origin of DCs to distinguish
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them  from  the  classical  myeloid  DCs  (Ardavin  et  al.,  1993).  As  thymic  DCs  are 
involved  in  the  negative  selection  of T  cells  in  the  thymus  and  the  induction  of 
tolerance, these cells will not be further explored here.
Plasmacytoid cells were discovered more recently in  1958, their name attributed to their 
morphological similarities to plasma cells. Because these cells did not possess markers 
of plasma cells, and were found in T cell-zones in lymph nodes, they were first termed 
plasmacytoid  T  cells.  Plasmacytoid  T  cells  can  differentiate  into  dendritic  cells,  and 
appear to be the main natural  interferon-producing cells (NIPC)  in the blood (Grouard 
et al.,  1997;  Siegal  et al.,  1999).  The origin of plasmacytoid DCs (PDCs) has not yet 
been resolved, with arguments for both a myeloid and lymphoid origin (Olweus et al., 
1997;  Shigematsu  et  al.,  2004;  Spits  et  al.,  2000).  PDCs  are  CD4+,  CD123a+  (IL-3 
receptor), CD1 lb' and CD1 lc\ Immature plasmacytoid DCs can secrete large amounts 
of IFNa at the early stages of viral  infection and can be induced to mature in response 
to viruses (Yonezawa et al., 2003) and ligands of TLR7 and 9, which are expressed on 
PDCs (Kadowaki et al., 2001). Recently,  it has been shown that PDCs, upon injection 
with  dsRNA,  together with  the  resulting  secreted  type  I  interferons,  can  differentiate 
into MDCs (Zuniga et al., 2004). Developmental  plasticity  is also suggested by recent 
evidence showing that PDCs can differentate from both common myeloid and common 
lymphoid  progenitors  (Shigematsu  et  al.,  2004).  The  distinction  and  relationship 
between DC subsets are constantly re-evaluated, and are probably not as straightforward 
as was once thought.
Functional  differences between dendritic cell  subsets  mainly  involve  innate functions. 
Myeloid  and  plasmacytoid  DCs  express  a  complementary  range  of TLRs  (Section
1.1.5),  and  the  pattern  of cytokine  production  is  also  different.  Myeloid  DCs  secrete 
large  quantities  of IL-12  upon  ligation  of TLRs,  whereas  plasmacytoid  DCs  secrete 
large quantities of IFNa (Ito et al., 2002). However, upon CD40 ligation, both myeloid 
and plasmacytoid  DCs secrete IL-12 (Krug et al.,  2001).  Similarly, dsRNA introduced 
into  the  cytosol  of myeloid  DCs  are  also  induced  to  secrete  high  amounts  of IFNa 
(Diebold et al., 2003). Myeloid and plasmacytoid DCs are also plastic in their induction 
of adaptive immune responses, having been shown to be able to polarise both ThI  and 
Th2  responses  (Boonstra  et  al.,  2003;  de  Heer  et  al.,  2004;  Farkas  et  al.,  2004;
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Kapsenberg,  2003).  This  indicates  that  the  ability  to  initiate  differential  adaptive 
immune responses is a property of both myeloid and plasmacytoid DCs.
1.2.2.1  Distribution of dendritic cells
Dendritic  cells are widely distributed,  and  the localisation  of these cells reflects their 
function in vivo, at primary barrier sites and areas of maximum antigen encounter such 
as epidermis in the skin (Langerhans cells and dermal DCs), mucosa lining the gut (gut- 
associated lymphoid tissue GALT), respiratory, and urogenital tracts (together known as 
mucosa-associated lymphoid tissue MALT). At these peripheral locations, DCs form a 
contiguous  network  of  cells  extending  their  surface  projections  between  resident 
epithelial cells. The unifying feature of DCs is their dendritic morphology, contributing 
to their ability to effectively sample their surroundings for antigens.
Different  subsets  of DCs  have  also  been  shown  to  localise  to  specific  tissues  and 
compartments, and show distinct migration patterns (Penna et al., 2002). Myeloid DCs 
comprise tissue resident DCs in the skin, epithelial surfaces, liver, lung, mucosa, as well 
as circulating DCs in the blood.  In the absence of maturation  stimuli, these  immature 
DCs constitutively  migrate at a  low  rate to  draining  lymph  nodes,  and  do not  induce 
effector responses (Kurts et al.,  1997).  In inflammatory conditions and upon infection, 
resident  DCs  respond  to  infection  and  migrate  to  lymph  nodes  to  stimulate  T  cells. 
Monocytes  from the  blood  are also recruited  to the site  of infection  and  differentiate 
into DCs under the influence of the local cytokine environment (Randolph et al.,  1999). 
The  constant  flux  of  migration  of  maturing  DCs  leaving  inflamed  tissues  and 
recruitment of monocytes into inflamed tissues are regulated at the level of chemokine 
receptor  expression  and  chemokine  production  (Sallusto  et  al.,  2000).  In  contrast, 
plasmacytoid  DCs  are  found  in  the  blood  and  localise to  secondary  lymphoid  organs 
(thymus,  bone  marrow,  spleen,  tonsils,  and  lymph  nodes)  (Celia  et  al.,  1999a).  The 
difference  in  distribution  and  migration  patterns  may  be  attributable  to  differential 
chemokine production and chemokine receptor usage in myeloid DCs and plasmacytoid 
DCs (Penna et al., 2002; Sallusto et al.,  1999), where myeloid DCs are recruited to sites 
of inflammation and infection, and plasmacytoid DCs recruited to secondary lymphoid 
tissues, by virtue of their expression of particular chemokine receptors.
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Signals from surrounding tissues are also interpreted by DCs to promote different types 
of T cell responses (Vieira et al., 2000). DCs from bronchial and intestinal mucosa skew 
responses toward Theiper (Th)2 (Alpan et al., 2001; Stumbles et al.,  1998), whereas those 
isolated  from  spleen  promote  ThI  responses  (Everson  et  al.,  1996).  DCs  in  the 
respiratory tract and intestinal mucosa are exposed to a plethora of inhaled allergens and 
commensal microflora respectively, where an  immune response activated by DCs may 
be  inappropriate  and  pathogenic.  Therefore,  the  location  in  which  DCs  reside  may 
preferentially induce a Th1/Th2 response. However, the demonstration that DCs in the 
lung can still mount ThI-type responses show that DC subset and location do not define 
the type of responses as either ThI  or Th2 (Dahl et al., 2004; Stumbles et al., 1998). The 
context  in  which  DCs  are  activated  are  important  in  influencing  DC  responses  to 
pathogens,  in  order  to  effectively  tailor  appropriate  pathogen-specific  immune 
responses for the local environment.
1.2.3  Dendritic cell function in immune response
Dendritic  cells  are  absolutely  required  for the  initiation  of T cell  immunity.  Because 
antigen-specific  T  cells  are  rare,  about  1   in  104  to  106,  and  infected  cells  displaying 
specific  antigen-MHC  complexes  do  not  often  express  co-stimulatory  molecules 
necessary to drive clonal expansion of antigen-specific T cells, there is a need to focus 
immune-initiating  stimuli to appropriate T cells. Dendritic cells  provide the means of 
such a focus. This function of DCs as professional antigen presenting cells is one that is 
acquired through the final  differentiation process from  immature DCs to mature DCs. 
This “maturation” process is triggered by infectious agents and inflammatory products, 
and is central to the function of DCs.
1.2.3.1  Dendritic cell maturation
Immature dendritic cells are resident in tissues and blood.  Immature  DCs have a very 
high  capacity  for  endocytosis  and  antigen  uptake,  effectively  sampling  their 
surroundings for infectious agents. Antigen uptake is achieved by phagocytosis (Inaba 
et al.,  1993; Reis e Sousa et al.,  1993), pinocytosis (Sallusto et al.,  1995), and receptor- 
mediated endocytosis (Jiang et al.,  1995; Stahl and Ezekowitz,  1998; Tan et al.,  1997). 
In  addition  to  expressing  pattern  recognition  receptors  to  mediate  antigen  uptake, 
immature DCs also express a wide range of activatory Toll-like receptors which allow
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the  recognition  of a  range  of infectious  agents.  Immature  DCs  respond  quickly  and 
vigorously  to  many  microbial  and  inflammatory  stimuli  via  TLRs  and  cytokine 
receptors.  Interestingly,  DCs  express  high  levels  of  all  NF-kB  proteins  (Granelli- 
Pipemo et al.,  1995),  not just activities.  This may  help to  explain  how  DCs  react  so 
quickly and vigorously to many stimuli that signal through NF-kB, for example TLRs 
and receptors of the tumour necrosis factor receptor family (TNFRs).
Triggering  of TLRs  and  cytokine  receptors  results  in  the  activation  of a  complex 
“maturation”  program  in  DCs  that  involves  migration  out  of peripheral  tissues  into 
draining lymph nodes, phenotypic changes, and secretion of cytokines (Banchereau and 
Steinman,  1998).  DCs  downregulate  endocytic  receptor  expression  and  endocytosis 
itself (Garrett et al., 2000), and upregulate molecules that are required to interact with T 
cells. These include intercellular adhesion molecule (ICAM)-l  (also known as CD54) to 
attach to integrins expressed on T cell, CD40, which interacts with CD40L on T cells to 
increase  DC  survival  and  enhance  DC-T  cell  interactions,  upregulation  of  co­
stimulatory  molecules  CD80  and  CD86,  secretion  of chemokines  such  as  CXCL8, 
CCL3 and CCL4 (Caux et al.,  1994), and IL-12 production (Celia et al.,  1996; Krug et 
al., 2001; Reis e Sousa et al.,  1997). Mature DCs are very potent at stimulating T cells: 
low levels of antigen and small numbers of DCs can  induce a strong T cell responses 
(Bhardwaj et al.,  1993).
DCs  provide  three  signals  that  are  necessary  to  activate  naive  CD4+  Theiper  cells. 
Stimulatory  signal  1   results  from the  ligation of T cell  receptors (TCR) by pathogen- 
derived peptides presented with MHC class II complexes. This determines the antigen- 
specificity of the response. Stimulatory signal 2 is in the form of co-stimulation for the 
antigen-specific T cell.  Without co-stimulation,  antigen-specific Th  cells are  rendered 
anergic, which may lead to tolerance (Harding et al.,  1992; Tan et al.,  1993). DCs also 
secrete polarised cytokines, IL-12 or IL-4, as signal 3 to polarise the downstream T cell 
response to TH1- or TH 2- directed immunity (Kalinski et al.,  1999; Kapsenberg, 2003). 
Such  cytokine-induced  polarising  conditions  have  been  shown  to  activate  key 
transcription  factors  that  instruct  TH1   and  TH 2  differentiation  (Lu  et  al.,  2004). 
Polarisation of T cell responses also depend on the activation state of DCs, determined 
by the  strength  of the  antigen  signal  (Eisenbarth  et  al.,  2002;  Oh  and  Eichelberger, 
2000; Ruedl et al., 2000) as well as the length of time after the DCs are exposed to the
44Introduction
antigen (Langenkamp et al., 2000). The cytokines secreted by DCs, and the activation 
state  of DCs,  are  both  strongly  dependent  on  the  environment  in  which  they  were 
stimulated, and the nature of the pathogens.
However, in addition to the role of cytokines and DC activation states in polarising a T 
cell response, a recent study has attributed Notch ligands Delta and Jagged expressed on 
DCs  to  be  responsible  for  affecting  a  TH1   and  TH 2  response  in  CD4+  Theiper  cells 
respectively (Amsen et al., 2004). Jagged was expressed on DCs upon exposure to TH2- 
predisposing stimuli,  and corresponding Notch activation on T cells resulted  in a Th2 
polarised response. Delta expression on DCs correlated with TH1   polarisation, though 
the  induction  of TH1   responses  does  not absolutely  require  the  Notch  pathway.  This 
shows  that  T  cell  polarisation  is  more  complex  than  initially  suggested,  involving 
specific ligand-receptor interactions between DCs and T cells in addition to polarising 
cytokines  in  the  surrounding  environment,  and  suggests  an  additional  dimension  that 
should  be  considered  in  investigating  plasticity  of  DCs  in  response  to  pathogenic 
stimuli.
Adaptive  immunity  is  therefore  influenced  by  numerous  factors  including  pathogen- 
derived  signals  and  cellular  environmental  signals  that  effectively  polarise  DCs  to 
modulate  downstream  adaptive  immune  responses  that  are  tailored  for the  particular 
pathogen in a particular context of host infection.
1.2.3.2  Dendritic cell response to infection
The  location  of DCs  at  immune  barrier  sites  render  them  particularly  susceptible  to 
infections with pathogens. Many pathogens have targeted DCs in order to modulate the 
host  immune  response  to  ensure  the  survival  and  dissemination  of  the  pathogen. 
Bacteria,  viruses,  fungi  and  parasites have all  been  shown  to  interact with  DCs, with 
varying  outcomes.  Microbes can  interfere  at  several  stages  of DC-induced  immunity. 
These include the generation of DCs from precursor cells, DC survival and maturation, 
antigen  processing  and  presentation,  T  cell  activation  and  priming.  Conversely,  the 
responses regulated by DCs to pathogens, through recognition by differential TLRs and 
PRRs, are also specifically tailored in order to affect appropriate immune responses to 
the pathogen  in question. The interplay between pathogen-driven  immune dysfunction
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and pathogen-specific immune responses are clearly illustrated in pathogen interactions 
with DCs.
Bacteria
Phagocytes  of the  innate  immune  system  and  the  humoral  and  cellular  responses  of 
adaptive immunity are the main effectors to combat bacterial  infections. Macrophages 
and immature DCs as phagocytic cells are important for initiating the adaptive immune 
response,  as they  can  degrade  bacterial  peptides  and  present these  peptides  on  MHC 
class I and class II molecules for T cell recognition. Accordingly, bacteria target the two 
antigen  processing  pathways  to  subvert  antigen  presentation  and  avoid  T  cell 
recognition. This is achieved by preventing antigen processing by inhibiting phagosome 
maturation (Clemens and Horwitz,  1995;  Sturgill-Koszycki  et al.,  1994),  inhibition  of 
MHC  class  II  surface  expression  (Noss  et  al.,  2001),  and  impairing  MHC  class  I 
synthesis  and  expression  (Kirveskari  et  al.,  1999).  However,  the  expression  of TLRs 
that recognise various bacterial components, including lipoproteins, lipopolysaccharide, 
and  bacterial  CpG  DNA,  together  with  scavenger  receptors  and  mannose  receptors, 
allow macrophages and DCs to rapidly and efficiently uptake and activate in response 
to bacteria. Macrophages and dendritic cells probably have complementary roles in the 
immune response to bacterial infections. Macrophages are highly phagocytic, though do 
not  have  the  migratory  capacity  of  DCs.  Therefore,  macrophages  are  probably 
important in presenting bacterial components to effector T cells at infected tissue sites, 
producing and eliciting cytokines, and controlling bacterial  replication (Harding et al.,
2003).  Conversely,  DCs  are  critical  at  initiating  the  adaptive  immune  response  to 
bacterial  infections  by  presenting  bacterial  peptides to  antigen-specific  T cells  in  the 
lymph nodes.
Intracellular bacteria  such  as Mycobacterium  leprae  have  been  shown  to  infect  DCs 
(Hanekom et al., 2003; Hashimoto et al., 2002; Henderson et al.,  1997). The two forms 
of  leprosy,  tuberculoid  and  lepromatous,  are  characterised  by  ThI-  and  TH 2-type 
responses  respectively  (Modlin,  1994).  M.  leprae  activates  TLR1  and  TLR2,  which 
were found to be more highly expressed in  lepromatous lesions of tuberculoid leprosy 
compared to lesions in lepromatous leprosy (Krutzik et al., 2003). The clinical spectrum 
of disease  corresponds to  immune responses to the  pathogen,  strongly  suggesting the 
involvement of dendritic cells in polarising the immune response.
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Fungus
Fungi generally display either of two growth modes, yeast-like or filamentous (hyphae) 
forms.  Dimorphic  fungi  can  alternate  between  a  yeast  phase  and  a  hyphal  phase, 
depending  on  environmental  stimuli  (Wendland,  2001).  Virulence  is  associated  with 
fungi dimorphism (van Burik and Magee, 2001), and examples of dimorphic fungi are 
Candida  albicans,  Saccharomyces  cerevisiae,  and  Aspergillus fumigatus.  DCs  are 
unique in that they can phagocytose both yeast and hyphae forms of C. albicans and A. 
fumigatus, and these dimorphic forms engage distinct receptors on DCs. This results in 
differential  downstream  effects  in  terms  of T  cell  activation  and  cytokine  secretion 
(Buentke and Scheynius, 2003). In the case of Candida, the yeast form,  recognised by 
the mannose receptor, results in DCs activating ThI-driven immunity, characterised by 
secretion of IL-12. The hyphae form of Candida is recognised by complement receptor 
3  (CR3)  and  FcyR,  and  internalisation  mediated  by the  two  receptors  results  in  DCs 
activating  Tn2-driven  immunity,  characterised  by  secretion  of IL-4  (d'Ostiani  et  al., 
2000; Montagnoli et al., 2002). The conidia and hyphae forms of Aspergillus fumigatus 
induce  similarly  disparate  ThI  and  Th2  responses  in  murine  DCs  respectively,  as 
measured by their cytokine production (Bozza et al., 2002). The engagement of distinct 
receptors by dimorphic forms of fungi may explain the link between fungi morphology 
and  virulence,  as  differential  engagement  of receptors  results  in  differential  immune 
outcomes (Romani et al., 2004).
Parasites
Parasites  have  also  been  shown  to  modulate  immune  responses  by  targeting  DCs 
(McKee et al., 2004; Sher et al., 2003). Many factors affect DC responses to parasites, 
including  the  stage  of  parasite  life  cycle  (Prina  et  al.,  2004).  Toxoplasma  gondii 
preferentially  invades  immature  DCs  without  activating  these  cells,  and  renders  the 
immature DCs resistant to subsequent activation by TLR ligands or CD40L (McKee et 
al., 2004). A non-activatory infection of DCs by Leishmania amazonensis also results in 
impaired DC function (Prina et al., 2004).
The  diseases  caused  by  Leishmania  infection  present  as  a  clinical  spectrum  that 
correlates with the level of immune response to the pathogen. Resistant and susceptible 
mouse  strains  (C57BL/6  and  BALB/c  mice  respectively)  mount  differential  Theiper
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responses  that  correlate  with  disease  outcome.  Localised  self-limiting  infections  in 
C57BL/6 mice are critically dependent on development of a TH1   response; non-healing 
lesions in BALB/c mice are characterised by a TH 2 response. DCs have been shown to 
be infected with amastigote forms of L.  major (Moll  et al.,  1993), which are released 
from  macrophages  and  other  lysed  host  cells.  This  corresponds  to  delayed  DC 
activation and  initiation of cellular immunity,  prolonging the  initial  phase  of parasite 
growth, resulting in a robust infection with high parasite loads. Gene expression studies 
have shown that responses of DCs and macrophages infected with Leishmania include 
downregulation of IFNy-induced genes (Chaussabel et al., 2003). As the production of 
IFNy  from  ThI  cells  is  crucial  to  activate  macrophages to  kill  parasites,  the  lack  of 
activation signals received by L. /wq/'or-infected macrophages contributes to the delay in 
induction of the immune response. In contrast, L.  major-infected DCs retain the ability 
to  secrete  IL-12  (von  Stebut  et  al.,  1998),  which  contributes  to  the  initiation  of 
protective ThI-dominated immunity.
Virus
Interactions  between  viruses  and  dendritic  cells  have  been  widely  investigated.  DCs 
recognise  and  allow  virus  entry  by  various  mechanisms:  the  expression  of specific 
receptors and co-receptors on the cell surface that mediate DC activation and maturation 
as well as internalisation of the virus, and the endocytic capacity of DCs depending on 
the stage of DC maturation. Similar to bacteria, fungi and parasites, the clinical disease 
manifested by viral  infection is dependent upon the general  immune status of the host, 
as well as virus-specific factors.
Detection of viruses and the surrounding microenvironment
The  first  step  in  innate antiviral  immunity  is the  recognition  of viral  components via 
pattern  recognition  receptors,  and  detection  of tissue  injury  in  the  microenviroment. 
Many TLRs recognise viral components (Table 1.1). TLR2 has been shown to recognise 
herpes simplex virus (HSV)-l  (Kurt-Jones et al.,  2004) and the  haemagglutinin  (HA) 
protein  of  measles  virus  (MV)  (Bieback  et  al.,  2002).  TLR3  recognises  dsRNA 
(Alexopoulou et al., 2001), a motif found in viruses as a replication intermediate and as 
secondary structures in the viral genome. TLR4 has been shown to recognise the fusion 
(F)  protein  of respiratory  syncytial  virus  (RSV)  (Kurt-Jones et  al.,  2000)  and  murine 
mammary  tumour virus  (MMTV)  (Burzyn  et  al.,  2004).  TLR7  and  TLR8  have  both
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been  shown  to  recognise  single-stranded  (ss)RNA  (Diebold  et  al.,  2004;  Heil  et  al.,
2004).  TLR7  also  recognises  Influenza  genomic  RNA  (Diebold  et  al.,  2004).  TLR9 
recognises HSV-1  and HSV-2 viral DNA, independently of viral replication (Hochrein 
et al., 2004; Krug et al., 2004; Lund et al., 2003). As viral nucleic acids are generally 
not “seen” by the cell until internalisation,  it has been hypothesised that TLRs 3,  7,  8 
and 9 localise in endosomal compartments in the cell and recognise viral ligands at the 
point  of endosomal  degradation  of viral  particles.  This  intracellular  localisation  has 
been shown for TLR3 (Matsumoto et al., 2003) and TLR9 (Ahmad-Nejad et al., 2002; 
Latz  et  al.,  2004;  Takeshita  et  al.,  2001).  Novel  TLR  chimera  studies  have  also 
implicated the intracellular location of TLR7 and TLR8 (Nishiya and DeFranco, 2004). 
In contrast, TLRs that detect viral glycoproteins (TLR2 and TLR4) are expressed on the 
cell surface.
The antiviral response is the hallmark of viral infection, characterised by the production 
of type I interferons. Accordingly, TLRs that recognise viral ligands are able to induce 
such  an  antiviral  response.  TLR3  and  TLR4  utilise  a  MyD88-independent  signalling 
pathway  to  mediate  antiviral  effects  in  DCs  (Section  1.1.3)  via  the  adaptor 
TRIF/TICAM-1  and the subsequent activation of IRF-3. Activation of IRF-3  activates 
IFNp  and  other  ISGs.  Signalling  downstream  of members  of the  TLR9  family  are 
strictly  MyD88-dependent  (Wagner,  2004).  TLR9  induces  IFNp  through  MyD88 
(Hoshino  et  al.,  2002),  and  the  activation  of TLR9  by  HSV-2  in  plasmacytoid  DCs 
results in the production of IFNa that is both MyD88- and IRF7-dependent (Kawai et 
al.,  2004;  Lund  et al., 2003). TLR7 recognises  ssRNA,  and  ssRNA  viruses  including 
Influenza  and  vesicular stomatitis virus  (VSV)  results  in  IFNa  production  in  murine 
PDCs  (Diebold  et  al.,  2004;  Heil  et  al.,  2004;  Lund  et  al.,  2004).  Such  TLRs  that 
recognise viruses, especially intracellular TLRs that recognise foreign nucleic acids, are 
likely  to  synergistically  trigger  transcription  factors  to  activate  the  innate  antiviral 
response via the production of type I interferons and other host inflammatory mediators 
(Triantafilou et al., 2005).
In addition to TLRs that trigger DC activation and maturation, other pattern recognition 
receptors expressed on DCs may contribute to receptor-mediated endocytosis and viral 
entry. These PRRs include carbohydrate-binding C-lectin transmembrane proteins that 
function  as  receptors  that  recognise  carbohydrate  moieties  on  pathogens.  DC-SIGN
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(DC-specific  ICAM-3  grabbing  non-integrin,  CD209),  langerin  (CD207),  mannose 
receptor  (MR,  CD206),  and  human  DEC-205  (CD205)  are  expressed  on  DCs.  The 
expression of these receptors vary according to DC maturation status (Kato et al., 2000), 
and generally function to mediate endocytosis. The mannose receptor expressed on DCs 
has been shown to be responsible for non-specific recognition of enveloped DNA and 
RNA  viruses  and  the  subsequent  stimulation  of  IFNa  production  (Milone  and 
Fitzgerald-Bocarsly, 1998).
DC-SIGN also recognises viral  envelopes of human  immunodeficiency virus (HIV)-l 
(Geijtenbeek et al., 2000), dengue virus (DV) (Tassaneetrithep et al., 2003), hepatitis C 
virus (HCV) (Lozach et al., 2003; Pohlmann et al., 2003), Ebola virus (Alvarez et al.,
2002), and cytomegalovirus (CMV) (Halary et al., 2002). This suggests that DC-SIGN 
is a pathogen receptor with broad specificities. The use of DC-SIGN  may be a broad 
pathogen  strategy  to  utilise  non-activating  carbohydrate  receptors  expressed  on 
dendritic cells to escape immunity (Geijtenbeek and van Kooyk, 2003; van Kooyk et al., 
2004; van Kooyk and Geijtenbeek, 2003). The uptake of HIV-1  by DC-SIGN does not 
result  in  viral  entry (Geijtenbeek et al.,  2000),  and  HCV  seems to  utilise this  uptake 
mechanism as a way of avoiding lysosomal degradation (Ludwig et al., 2004). This may 
be a strategy of the virus to take advantage of the highly mobile DC to facilitate viral 
dissemination.
Effector components of innate immunity initiated by DCs
The primary antiviral  innate response  is the  secretion  of type  I  interferons (IFNa/(3). 
Interferons  (IFNs)  were  originally  discovered  as  antiviral  proteins  that  inhibit  virus 
replication.  The  ability  to  produce  and  respond  to  interferons  is  not  restricted  to 
specialised  immune  cells.  Stromal  cells  like  epithelial  cells  and  fibroblasts  can  also 
produce and respond to interferon by inducing an antiviral state (Stark et al.,  1998). In 
addition  to  their  antiviral  properties,  IFNs  are  involved  in  many  other  physiological 
processes including cell growth and proliferation, cell death, activation of the  immune 
response  including  NK  cells  and  macrophages,  enhancement  of  MHC  class  I 
expression,  TH1   polarisation,  and  differentiation  of DC  (Stark  et  al.,  1998).  The  IFN 
signalling pathway has been extensively studied. On binding of IFNs to their cognate 
receptors,  the  JAK-STAT  (Janus  kinases  and  Signal  transducers  and  activators  of 
transcription) signal transduction pathway is triggered, culminating in the transcription
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of interferon-stimulated  genes  (ISGs)  that  mediate  the  functions  of interferons.  The 
proteins encoded by ISGs include many antiviral effectors: the dsRNA-activated protein 
kinase  R  (PKR),  which  inhibits  viral  protein  synthesis  via  phosphorylation  of the 
eukaryotic  translation  initiation  factor  (eIF)2a;  the  2’,5’-oligoadenylate  synthetase 
(OAS1), which activates RNase L to degrade viral  RNA; and the Mx GTPases (Mxl 
and Mx2), which block viral transport inside the cell (Haller and Kochs, 2002; Pavlovic 
et  al.,  1993;  Stark  et  al.,  1998).  Other  ISGs  include  ISG56  (which  inhibits  protein 
translation  via  eukaryotic  translation  initiation  factor  eIF3),  and  the  P200  family  of 
interferon-inducible  proteins  which  impair  cell  proliferation  through  cellular 
transcription factors such as NF-kB, YY1, p53, MyoDl, E2F, and c-myc (Asefa et al.,
2004).
Plasmacytoid  DCs  are  the  most  powerful  type  I  interferon-producing  cells,  and  are 
sometimes called natural  interferon-producing cells (NIPCs).  However, viral  infection 
also induces interferon production from myeloid DCs (Diebold et al., 2003).  Infection 
of MDC with a variety of viruses including herpes simplex virus (HSV)-l  (Pollara et 
al., 2004), measles virus (MV) (Tanabe et al., 2003) and Influenza (Coccia et al., 2004) 
leads to low levels of IFNa/p production, and Influenza virus infection results in MxA 
expression  in  infected  DCs,  conferring  resistance  to  cytopathic  effects  of the  virus 
(Celia et al.,  1999b). The production of IFNa/p has very powerful effects both  in the 
infected cells and neighbouring uninfected cells, due to the autocrine-paracrine effects 
that  IFNs  exert.  Viruses  have  numerous  mechanisms  of  inhibiting  the  IFN  innate 
defence at different levels (Basler and Garcia-Sastre, 2002; Garcia-Sastre, 2004).
In addition to  interferons, the cytokine TNFa also mediates antiviral  effects (Guidotti 
and Chisari, 2001). TNFa,  in  addition to  its role as a pro-inflammatory cytokine,  has 
numerous  additional  immunomodulatory  functions,  including  promoting  an  antiviral 
state  in  cells  (Bose  et al.,  2003),  inducing DC  differentiation  (Morrison  et  al.,  2003; 
Santiago-Schwarz et al.,  1993; Santiago-Schwarz et al.,  1998), and triggering apoptosis 
via signalling through TNF  receptors (Gupta,  2001). TNFa  binds to TNF  receptors  1  
and 2 expressed on the cell surface, and downstream signalling results in the activation 
of NF-kB. This results in DC differentiation and maturation, as well as the transcription 
of NF-xB-responsive antiviral genes,  for example IFNp. Additionally, TNFa can also
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recruit  and  activate  effector  cells  such  as  macrophages,  NK  cells  and  T  cells  to 
participate in the antiviral response.
Recruitment  of effector  cells  such  as  neutrophils,  monocytes,  macrophages  and  NK 
cells  to  the  site  of infection  requires  the  production  of other  cytokines  to  mediate 
chemotaxis, such as CXCL8, CXCL10, CCL3, CCL4, and CCL5 (Moser et al., 2004). 
These effector cells are important for the lysis of virally-infected cells (mediated by NK 
cells), and promote an inflammatory response to raise the alarm for the immune system. 
The production of cytokines are among the earliest immune mediators produced upon 
virus  infections,  and  their  role  to  coordinate  cellular  activation,  proliferation, 
differentiation and chemotaxis help to orchestrate the induction and maintenance of the 
innate and adaptive antiviral responses.
The  importance  of  the  cytokine  and  chemokine  system  in  modulating  antiviral 
immunity  is also supported by the numerous mechanisms viruses (mostly  large DNA 
viruses  such  as  poxviruses  and  herpesviruses)  have  evolved  to  evade  the  immune 
system by encoding homologues of cytokines, chemokines and their receptors (Alcami,
2003). Many virus-encoded mechanisms block the effector functions of cytokines, such 
as the antiviral state induced by IFNs or apoptosis triggered by TNFa, as well as TNFa 
or IL-l/TLR signalling. Poxviruses encode four soluble viral TNF receptors (Hu et al., 
1994; Loparev et al.,  1998; Saraiva and Alcami, 2001; Smith et al.,  1991a; Smith et al.,
1996), likely to block the activity of TNFa in different tissues. Vaccinia virus encodes a 
soluble  IFNa/p-binding  protein  that  binds  to  the  cell  surface  to  prevent  type  I 
interferons  from  binding  to  cellular  IFN  receptors  and  inducing  an  antiviral  state  in 
surrounding uninfected cells (Colamonici et al.,  1995).
Adaptive antiviral immune response
As  mentioned  previously,  DCs  are  essential  to the  initiation  of the  adaptive  immune 
response.  This  involves the  activation  of distinctive  effector cells,  including  B  cells, 
CD4+ helper T cells, CD8+ cytotoxic T cells, which are capable of specific recognition 
of microbial  components.  Viruses  can  modulate  the  adaptive  immune  response  by 
interfering with dendritic cell function in a variety of ways: to suppress the maturation 
and migration capacity of DCs; expression of viral gene products that directly alter the 
immune  response,  for  example  cytokines  and  cytokine  receptor  homologues;
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interference  with  antigen  presentation;  and  skew  T  cell  responses  through  altered 
cytokine  production.  Interfering  with  dendritic  cell  function  is  a  strategic  target  for 
viruses,  with the aim to subvert the host antiviral response.  Some of the mechanisms 
used by viruses to escape adaptive  immunity through their interactions with dendritic 
cells are described below.
DC activation and maturation
Influenza virus productively infects both myeloid and plasmacytoid DCs, and results in 
DC  activation,  including  upregulation  of co-stimulatory  molecules,  increased  T  cell 
stimulatory capacity, and secretion of polarising cytokines (Celia et al., 2000; Celia et 
al.,  1999b;  Fonteneau  et  al.,  2003;  Oh  and  Eichelberger,  2000).  In  contrast,  Measles 
virus also replicates in myeloid DCs (Fugier-Vivier et al.,  1997;  Servet-Delprat et al.,
2000)  and  induces  their  maturation.  However,  MV-infected  DCs  fail  to  stimulate  T 
cells,  and  even  induce  T  cell  apoptosis.  This  occurs  through  the  expression  of viral 
glycoproteins on the DC  surface which negatively signals to T cells,  and secretion of 
TNFSF10 (formerly  known  as TNFa  related apoptosis-inducing  ligand or TRAIL) to 
mediate cytotoxicity (Dubois et al., 2001; Fugier-Vivier et al.,  1997; Hahm et al., 2004; 
Vidalain et al., 2000). The contrast between Influenza and Measles virus effects on DCs 
may contribute and relate to the clinical disease manifested in the host, where Influenza 
infection  is a relatively acute  infection that is resolved  in  a matter of weeks, whereas 
Measles  virus  can  cause  lymphopaenia  and  severe  immunosuppression  for  several 
weeks (Wright and Webster, 2001; Griffin, 2001).
Antigen presentation
Clinical  isolates of human  cytomegalovirus  (CMV) have  been  shown to productively 
infect  monocyte-derived  DCs  (Grigoleit  et  al.,  2002;  Moutaftsi  et  al.,  2002).  CMV- 
infected DCs compared to uninfected DCs have decreased surface expression of MHC 
class  I  and  class  II  molecules,  CD40,  CD80,  and  consequently  impaired 
immunostimulatory capacity. CMV glycoproteins also specifically target MHC class I- 
dependent antigen presentation (Rehm et al., 2002), to inhibit the surface expression of 
processed  viral  antigens associated  with  MHC  class I  molecules,  and  escape CD8+ T 
cell cytotoxicity.
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DC interaction with T cells
Varicella zoster virus (VZV) and human immunodeficiency virus-1   (HIV-1) also utilise 
the  function  of DCs  as  T  cell  stimulators  as  a  means  of transport  to  facilitate  their 
dissemination  to  their  target  cells.  Varicella  zoster  virus  establishes  a  productive 
infection in both immature and mature myeloid DCs (Abendroth et al., 2001; Morrow et 
al.,  2003),  though  its  effects  on  plasmacytoid  DCs  are  unknown.  Experiments  have 
shown that VZV-infected DCs showed no significant decrease in cell viability, and no 
significant phenotypic  maturation.  Importantly,  VZV-infected  DCs  cocultured with  T 
cells resulted  in  infection of T cells, and  infectious virus was recovered from T cells. 
This suggests that VZV is able to utilise the infection of DCs as a means of transport to 
infect target T cells in the lymph nodes. Similarly, HIV-1, shown to infect both myeloid 
and plasmacytoid DCs (Canque et al.,  1996;  Fong et al.,  2002;  Patterson et al., 2001) 
has  also  been  proposed  to  utilise  DCs  to  transmit  infectious  virus  to  target  T  cells 
(Tsunetsugu-Yokota  et  al.,  1995).  DC-SIGN  is  a  carbohydrate-binding  C-lectin 
transmembrane  protein  expressed  on  DCs that  interacts with  ICAM3  expressed  on  T 
cells to stabilise DC-T cell interactions (Geijtenbeek et al., 2000), as well as functioning 
as a pattern  recognition  receptor that recognises carbohydrate  moieties on  pathogens. 
DC-SIGN binds to HIV-1  glycoprotein gpl20, resulting in internalisation into low pH 
non-lysosomal compartments. This internalised virus retains infectivity, and when DCs 
are in contact with T cells, the virus infects target T cells in trans (Geijtenbeek et al., 
2000;  Kwon  et  al.,  2002).  HIV-1  infection  of T  cells  contributes  to  AIDS  disease 
progression, and illustrates the virus’ strategy to hijack DCs as a means of transport and 
virus dissemination.
A DC-centric view of immunity provides a means of understanding the way in which 
immune responses to pathogens are initiated and shaped, and a helpful viewpoint from 
which to focus immunotherapeutic strategies such as the design of vaccines and tumour 
therapies.  The  concerted  orchestration  by  the  dendritic  cell  involves  capturing  and 
processing  antigens,  resulting  in  effector  and  antigen  presenting  functions  that 
propagate the innate response and initiate the adaptive immune response to pathogens. 
Consequently, pathogens have evolved to subvert DC function in numerous ways, and 
the  dynamic  interplay  between  pathogen  and  dendritic  cell  is  manifested  in  the  host 
immune response to infection.
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1.3  RNA viruses
1.3.1  Replication of Influenza virus
Influenza is a member of the Orthomyxoviridae family of viruses. These are enveloped 
viruses  with  a  segmented  single-stranded  negative  sense  RNA  genome.  Influenza  A 
viruses  are  divided  into  subtypes  depending  on  the  envelope  glycoproteins 
haemagluttinin (HA) and neuraminidase (NA). Species specificity is largely determined 
by  the  amino  acid  sequence  of HA.  Influenza  uses  carbohydrates  as  their  host  cell 
recognition molecules, and entry into host cells is initiated by the binding of HA spikes 
to  iV-acetyl-neuraminic  acid  (sialic  acid)  residues  on  cell  surface  glycoproteins  and 
glycolipids  (Skehel  and  Wiley,  2000).  This  binding  is  followed  by  endocytosis  via 
clathrin-coated  pits  into  endocytotic  vesicles  and  finally  endosomes.  Fusion  of the 
endosome with an acidic lysosome lowers the pH of the vesicle to around 5, triggering 
cleavage  of HA  into  HAi  and  HA2.  This  activates  the  membrane  fusion  function  of 
HA2. Fusion of the virus envelope with the endosome membrane allows the 8 segments 
of the  Influenza  genome to  be  released  directly  into  the  cytoplasm.  Specific  nuclear 
targeting sequences in NP result in translocation of the nucleocapsid into the nucleus.
Influenza  is  unique  among  the  RNA  viruses  in  that  replication  occurs  in  the  cell 
nucleus.  The  Influenza  genome  consists  of 8  segments  (7  segments  in  Influenza  C). 
Each  segment  is  associated  with  nucleoprotein  (NP)  to  form  RNP  (RNA  and 
nucleoprotein) associated with  3  polymerase  polypeptides,  PB1,  PB2  and  PA  (Portela 
and Digard, 2002). The three viral polymerase proteins are encoded on segments  1, 2, 
and  3,  and together form  an enzyme complex that functions  in  both transcription and 
replication.
The  segments  of  RNA  are  wrapped  around  the  NP  proteins,  together  with  the  3 
polymerase polypeptides.  This  nucleocapsid  then  identifies  patches of cell  membrane 
that contain  viral  envelope glycoproteins,  associated with  matrix  protein  on the  inner 
surface.  Interactions  of  nucleocapsid  proteins  with  matrix  proteins  initiates  the 
formation of the bud, where the nucleocapsid becomes enwrapped in membrane to form 
a vesicle that is then “pinched off’ from the membrane to release the enveloped virions 
(Whittaker, 2001).
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1.3.2  Immune response to Influenza infection
Influenza is an acute respiratory infection with high morbidity and significant mortality, 
primarily because of its  complications  in very young  and  very  old  persons (Renegar,
1992).  Symptoms  include  sudden  onset  of malaise  and  fever,  followed  by  upper and 
lower respiratory manifestations as well as myalgia and headache.  In adults, the fever 
and  other  systemic  features  usually  last  3  days,  whereas  respiratory  symptoms  may 
persist for 1  to 2 weeks.
Influenza virus replicates throughout the respiratory tract in epithelial cells and resident 
macrophages and dendritic cells. Virus is recoverable from upper and lower respiratory 
tracts of infected  individuals. The virus is released from the apical  surface of the cell, 
which  may  serve  to  limit  the  infection  locally  and  prevent  systemic  dissemination. 
However  this  also  concentrates  the  virus  in  the  lumen  of the  respiratory  tract  and 
facilitates  dissemination to the next  susceptible  host (Blau  and  Compans,  1996).  The 
extremely  short  incubation  period  between  infection  and  clinical  illness  implies  that 
innate immunity is important.
Studies in experimentally  infected human volunteers have correlated the  formation of 
symptoms to cytokine production, especially IL-6, IFNa, TNFa, and CXCL8 (Hayden 
et al.,  1998; Van Reeth, 2000). Whereas IL-6 and IFNa correlated with acute symptoms 
and  viral  titres,  TNFa  responses  peaked  when  viral  shedding  and  symptoms  were 
subsiding,  and CXCL8  levels correlated with  lower respiratory tract symptoms which 
occurred later in the disease process.
Both  humoral  and  cellular  immunity  are  important  in  the  clearance  of  Influenza. 
Antibodies to  Influenza HA, NA, NP,  and  M  proteins  are produced,  and the  level  of 
serum antibody to HA and NA correlate with resistance to illness (Couch, 2003). Both 
CD4+ and CD8+ T cells contribute to clearance of Influenza, the former providing help 
to the latter to lyse virally infected cells. CD8+ T cells are activated via the presentation 
of viral antigens by professional APCs.
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1.3.3  Influenza interactions with DCs
Influenza  has  been  shown  to  be  capable  of establishing  productive  infection  in  both 
myeloid and plasmacytoid DCs (Bhardwaj et al.,  1994; Celia et al., 2000; Celia et al., 
1999b). The interaction of Influenza with DCs is necessary for efficient anti-influenza T 
cell responses (Bhardwaj et al.,  1994; Oh and Eichelberger, 2000), and a ThI-mediated 
immune responses  is necessary for recovery  from  Influenza virus  infection  in  murine 
experimental  models  (Lopez  et  al.,  2002).  Influenza  infection  of  immature  MDCs 
results in DC activation, upregulation of surface expression of maturation markers, and 
increased T cell stimulatory capacity (Celia et al.,  1999b). The production of IFNa and 
IL-12  by  Influenza-infected  DCs  also  suggests  the  ability  to  drive  polarised  ThI 
responses  (Celia  et  al.,  2000;  Celia  et  al.,  1999b).  However,  the  dose  of Influenza 
exposed to DCs may also affect to the polarity of the T cell  response  induced  by the 
infected DCs (Oh and Eichelberger, 2000).
DCs residing in the respiratory tract are believed to play a central role in the induction 
of adaptive  immune responses to pulmonary  infections.  Intranasal  inoculation of mice 
with  Influenza  show  that  DCs  and  macrophages  recovered  from  the  lungs  and 
mediastinal  lymph nodes of infected mice are  indeed  antigen-positive  and  are able to 
stimulate  virus-specific  cytotoxic  T  cells  (Hamilton-Easton  and  Eichelberger,  1995). 
However the migration of respiratory DCs to regional lymph nodes has been shown to 
be  limited  to  the  early  phase  of pulmonary  infection;  after  24  hours  the  DCs  are 
refractory to migration following further stimulation (Legge and Braciale, 2003). This 
highlights the importance of timing of antigen exposure in considering the generation of 
the downstream adaptive immune response.  y
While it is agreed that DCs exposed to inactivated Influenza are also able to elicit CTL 
responses by presenting viral antigens with MHC class I molecules (Bender et al., 1995; 
Saurwein-Teissl  et  al.,  1998),  there  is  contention  as  to  whether  virus  replication  is 
necessary to drive a THl-type immune response (Lopez et al., 2001; Lopez et al., 2002; 
Saurwein-Teissl et al.,  1998). However, comparisons between effects elicited from DCs 
exposed to live and inactivated virus is limited to measurement of cytokine production, 
which may not fully capture the range of DC responses.
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1.3.4  Replication of Rhinovirus
Rhinoviruses (RV) are members of the Picornaviridae family of viruses. These are non­
enveloped  viruses  with  a  single-stranded  RNA  genome  of positive  polarity.  Other 
members  include  foot  and  mouth  disease  virus,  poliovirus,  coxsackie  virus,  and 
hepatitis A virus. There are over  100 serotypes of Rhinovirus; depending on the entry 
receptor utilised, Rhinoviruses are classified as major (approximately 90 serotypes) or 
minor (approximately  10 serotypes) group viruses that utilise the intercellular adhesion 
molecule-1   (ICAM1  or  CD54)  or  low-density  lipoprotein  receptor  (LDL-R) 
respectively (Greve et al.,  1989; Hofer et al.,  1994; Staunton et al.,  1989). Rhinoviruses 
replicate in the nasopharynx, are extremely acid-labile, and are important agents of the 
common cold.
Interaction  of  Rhinovirus  capsid  with  its  entry  receptor  is  followed  by  receptor- 
mediated endocytosis via clathrin coated pits. Uncoating is triggered by acidification of 
endosomes, which  results  in conformation  change  in the capsid.  Fusion of the capsid 
with  the  vesicle  membrane  leads  to  release  of the  viral  genome  into  the  cytoplasm 
(Racaniello, 2001).
Rhinoviruses replicate  in the cytoplasm,  and the process  starts with  translation  of the 
positive strand RNA genome. The 5’ end of the viral genomes contain long untranslated 
regions  (leaders),  which  contain  conserved  sequences  to  direct  cellular  translational 
machinery to an  internal  site, termed the internal  ribosomal entry site.  Ribosomes and 
other  cellular  proteins  are  then  recruited,  including  the  C-terminal  fragment  of the 
cleaved  eukaryotic  translation  initiation  ofactor  (elF)  4G,  permitting  attachment  of 
ribosomal subunits to the viral genomic RNA molecule. RV proteins are synthesized by 
the translation of a single, long, open reading frame on the viral (+)sense RNA genome, 
followed by cleavage of the polyprotein by virus-encoded proteases 2Apr0 and 3Cpro to 
release  individual  proteins.  This  strategy  allows  the  synthesis  of  multiple  protein 
products from a single RNA genome (Racaniello, 2001).
Synthesis of viral RNAs begins as soon as the first polyproteins have undergone their 
nascent  and  early  maturation  cleavages  to  provide  the  enzymes  and  other  factors 
necessary  for  the  process.  The  viral  RNA-dependent  RNA  polymerase  3D  (3Dpo1) 
allows  the  initiation  of  complementary  (-)sense  strand  (cRNA)  synthesis.  This
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replicative  intermediate  serves  as the template  for multiple  (+)sense  strands,  some  of 
which are translated, and some of which form genomic viral RNA (vRNA). Viral RNA 
is packaged into preformed capsids, and infectious viruses are released upon cell lysis.
1.3.5  Immune response to Rhinovirus
Rhinoviruses are the most common upper respiratory pathogens, inducing the majority 
of common  colds  worldwide.  The  incubation  period  to  onset  of virus  shedding  into 
nasal secretions is 1  to 4 days (Douglas et al.,  1966). Local symptoms include sneezing, 
nasal obstruction and discharge, sore throat and cough, while systemic symptoms such 
as  headache  and  malaise  also  feature.  Illness  is  maximal  for  2  to  3  days;  then  the 
symptoms progressively improve.
The primary site of infection is the epithelial surface of the nasal mucosa. Similarly to 
Influenza, symptoms of Rhinovirus-induced colds are attributed to chemical mediators, 
including IL-1(3, IL-6, CXCL8 and TNFa detected at elevated levels in nasal secretions 
of infected persons (Gern et al.,  1996a; Terajima et al.,  1997; Zhu et al.,  1997; Zhu et 
al.,  1996). However, the relative importance of different cytokines and effector cells are 
yet to be determined.
Though the  lower respiratory tract is less susceptible to Rhinovirus  infection than the 
nasopharynx, Rhinoviruses can also infect the lower respiratory tract, and this leads to 
the  development  of  lower  respiratory  symptoms.  This  is  particularly  important  for 
patients  in  vulnerable  age  groups,  patients  with  chronic  lung  conditions,  and 
immunocompromised patients.
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1.4  DNA microarrays
1.4.1  Introduction to genomics
Genomics is defined as the comprehensive study of whole sets of genes, gene products, 
and their  interactions.  The  completion  of the  draft  human  genome  sequence  in  2001 
(Lander et al., 2001; Venter et al., 2001), in addition to completed genome sequences of 
over 150 bacterial genomes and 1500 viral genomes (Entrez gene, September 2004), has 
made the opportunity for the study of gene expression on a genomic scale of both host 
and pathogens possible. The interaction between host and pathogens is the question that 
drives research in infectious diseases and immunology, and exploring this on a global 
genome scale offers unparalleled insights into the interactions of the host and pathogen.
DNA  microarrays  are  an  ideal  tool  for  exploring  the  genome  in  a  way  that  is  both 
systematic and comprehensive. Studying the regulation of gene expression at the level 
of transcript abundance is the rationale behind microarray experiments. This is founded 
on the basis that there exists a tight connection between the function of a gene product 
and  its  expression  pattern.  Gene  promoters  that  control  expression  of  genes  are 
constantly responding to changing inputs of information about the identity, internal state 
and surrounding environment of the cell. Therefore the complement of genes that are 
expressed dictates cellular phenotype and function that are specific to a particular state. 
As we  learn  to  infer biological  consequences of specific  features  of gene  expression 
patterns, microarrays allow a comprehensive and dynamic view of the studied system.
1.4.2  Description of DNA microarrays
The basis behind all microarrays is the precise positioning of DNA fragments (probes) 
at high density on a solid support so that they can act as molecular detectors. In practice, 
microarrays  vary  from  the  solid  support  used  (such  as  glass  or  filters),  the  surface 
modifications with various substrates, the type of DNA fragments on the array (such as 
cDNA,  oligonucleotides,  or  genomic  fragments),  whether the  gene  products  are  pre­
synthesised  and  deposited  or synthesised  in  situ,  to  the  machinery  used  to  place  the 
fragments on the array (such as inkjet printing, spotting, mask or micro-mirror based in 
situ  synthesis).  Currently,  combinations  of these  variables  are  used  to  generate three 
main  types  of  microarrays:  filter  arrays,  spotted  glass  slide  arrays,  and  in  situ 
synthesised oligonucleotide arrays (Affymetrix GeneChips).
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Expression analysis using glass slide microarrays is typically done by the competitive 
hybridisation of two targets (typically known as test and reference), each labelled with a 
specific fluorescent dye (cyanine dyes Cy™5 and Cy™3) (Schena et al.,  1995;  Shalon 
et  al.,  1996).  Because  levels  of gene  expression  are  relative,  the  use  of a  universal 
reference allows comparative analysis between multiple test samples. A  large quantity 
of reference  RNA  must  be  made  at  the  outset.  Where  several  batches  are  required, 
pairwise  comparisons  should  be  made  to  control  for  and  reduce  batch-to-batch 
variation. Universal references are also available from commercial suppliers, including 
Stratagene  and  Clontech.  The  degree  of batch-to-batch  variation  from  commercially 
supplied reference is not clear. Affymetrix array users may use a reference-like pool of 
spiked RNAs and have developed algorithms to facilitate comparisons across groups of 
arrays,  similar  to  the  method  for  spotted  arrays  reference  comparisons,  and  for 
determination of absolute concentrations of cellular RNA species.
In order to measure gene expression, RNA (total RNA or messenger RNA) needs to be 
labelled. This is usually achieved by the incorporating labelled nucleotides into cDNA 
reverse-transcribed from RNA. For two-colour microarrays the fluorophores are usually 
Cy3  and  Cy5.  Nucleic  acid  from  the  two  samples  competitively  hybridise  to 
complementary probes on the array. The output of such array image analysis is a ratio 
between the Cy3  and Cy5  signal, a measure of the relative amounts of each  sequence 
between the two samples. The use of a Cy3-labelled reference also serves as an internal 
control for hybridisation conditions of each array (Figure 1.4).
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Figure 1.4 Two-colour microarray experiment protocol
The sequences of genes of interest are obtained and amplified. Following the printing of desired 
PCR amplification  products  onto  glass  slides,  biological  samples  are  reverse transcribed  and 
labelled  with  a  fluorophore,  commonly  Cy5.  A  standardised  reference  mixture  is  similarly 
reverse  transcribed  and  labelled  with  Cy3.  The  two  samples  (test  and  reference)  are  mixed 
together  and  are  allowed  to  competitively  hybridise  onto  the  glass  array.  After  an  overnight 
incubation, the arrays are washed and scanned. This involves exciting the microarray with two 
lasers that emit wavelengths corresponding the excitation energy of the two fluorophores. The 
corresponding  signals  emitted  by  the  fluorescently-labelled  hybridised  spots  are  detected  by 
photomultiplier tubes.  The  resulting  image  showing  ratios  of signal  intensities  detected  at the 
two excitation wavelengths are analysed by various software, and the data extracted for further 
computer analysis. (Figure adapted from Duggan et al.,  1999)
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1.4.3  Using DNA arrays to study gene expression
Microarrays have been applied to address wide-ranging biological problems,  from the 
purpose of diagnostics in the clinical  setting (DeRisi  et al.,  1996;  Golub et al.,  1999; 
Rhodes  and  Chinnaiyan,  2004),  to  understanding  the  cell  cycle  in  yeast  (Chu  et  al., 
1998;  DeRisi  et  al.,  1997;  Spellman  et al.,  1998;  Wodicka  et  al.,  1997).  The  use  of 
microarrays to monitor global changes in gene expression  is now widespread,  and  its 
ability to monitor global changes offers a systems-level overview into the responses of 
biological systems to disease and environmental changes.
The  power  of  microarrays  to  systematically  profile  thousands  of  genes  makes  it 
particularly suited to the study of host immune system and its response to infection. The 
immune response  is extraordinarily complex,  involving dynamic  interactions between 
wide array of cells, cytokines, and signalling pathways. To date, there have been  large 
numbers of such global transcriptional  studies of developmental  pathways of immune 
cells, and immune cell and stromal cell responses to infection. The gene expression of 
immune  cells  under  a  variety  of  physiological  stimuli  have  been  profiled  using 
microarrays, including macrophages (Ma et al., 2003), neutrophils (Fessler et al., 2002; 
Malcolm et al., 2003), eosinophils (Temple et al., 2001),  B  cells (Ollila and Vihinen, 
2003),  T cells (Geserick et al.,  2004;  Huang  et  al.,  2004),  plasma cells  (Tarte  et  al., 
2003; Underhill et al., 2003), and dendritic cells (Dietz et al., 2000; Ju et al., 2003; Le 
Naour  et  al.,  2001;  Tureci  et  al.,  2003).  These  studies  have  proved  very  useful  in 
shedding light on the global transcriptional changes that occur in the development and 
evolution  of  a  cell’s  activation,  differentiation,  and  response  to  physiological 
stimulation in the course of an immune response. Additionally, understanding of normal 
function of cells is crucial to the understanding of pathology, for example in the case of 
B cell tumours. B cell tumours can arise from cells in any stage of B cell development 
and  differentiation,  and  the  resulting  tumour  phenotype  mirrors  that  of  the 
corresponding B cell  differentiation  stage from which the tumour arose.  Accordingly, 
understanding B cell development allows the accurate classification of B cell tumours, 
and has effects on directing suitable therapy (Jenner et al., 2003).
There are also numerous studies profiling responses to various stimuli of non-immune 
cells such as endothelial cells (Ahn et al., 2003; Wang et al., 2004; Warke et al., 2003), 
epithelial cells (Bohn et al., 2004; Zhang et al., 2003b), fibroblasts (Blader et al., 2001),
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liver  cells  (Aizaki  et  al.,  2002;  Smith  et  al.,  2003)  and  cells  of the  central  nervous 
system (Galey et al., 2003; Roep, 2003). In addition, the use of microarrays in disease 
classification,  especially  in  oncology,  has revealed  important biological  markers,  and 
affects clinical management of disease (Guo, 2003; van't Veer et al., 2002).
The  dynamic  interaction  between  host  and  pathogen  has  also  been  studied  using 
microarrays,  and  in  vitro  studies  have  included  monitoring  expression  changes  in 
macrophages (Nau et al., 2002; Rodriguez et al., 2004), dendritic cells (Granucci et al., 
2001a;  Huang et al., 2001;  Izmailova et al.,  2003),  neutrophils (Fessler et  al.,  2002), 
peripheral  blood  mononuclear  cells  (PBMCs)  (Boldrick  et  al.,  2002;  Feezor  et  al., 
2003), T cells (Corbeil et al., 2001; Jones and Arvin, 2003), and B cells (Jenner et al., 
2003;  Kanamori  et  al.,  2004),  in  response to various bacteria,  viruses,  parasites,  and 
their components.
The importance of these studies in furthering our understanding of the immune response 
to pathogens are further detailed in Section 1.4.5.
1.4.4  Microarray data analysis
There  are  numerous  methods  for  extracting  biological  information  for  the  results  of 
microarray experiments. As the technology is well-established, analysis techniques have 
also  flourished,  and  numerous  publications  describing  the  analysis  pipeline  of 
microarrays are readily available (Knudsen, 2002; Causton et al., 2003). This  section 
therefore focuses on analysis methods suitable for biological problems addressed with 
microarrays,  and  the  clustering  analysis  and  visualisation  beyond  basic  data  analysis 
(Quackenbush, 2002).
1.4.4.1  Binary comparisons
The simplest type of microarray experiment is a binary system, where the comparison 
between two samples  identifies differentially expressed genes.  Such  experiments may 
address the effects of a particular drug (Wilson et al.,  1999), or comparisons between 
normal and  cancerous tissue (DeRisi,  1996).  Replicates  should  be performed on  such 
data to confirm results (Lee et al., 2000; Yang and Speed, 2002). Biological replication 
is  essential  in  experimental  design  because  it  allows  an  estimate  of variability.  The
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ability  to  assess  such  variability  allows  identification  of  biologically  reproducible 
changes in gene expression levels
As transcriptional profiling has grown in popularity, statistical methods for interpreting 
the data have proliferated.  Variants of common  statistical tests generally  involve two 
parts:  calculating  a  test  statistic  and  determining  the  significance  of the  observed 
statistic.  A  standard  statistical  test  for detecting  significant  change  between  repeated 
measurements of a variable in two groups is the Mest (Kerr et al., 2000); this can  be 
generalised  to  multiple  groups  via  the  analysis  of  variance  (ANOVA)  F  statistic 
(Churchill, 2004; Park et al., 2003). Variations on the Mest statistic (often called “Mike 
tests”)  for microarray analysis are abundant (Golub et al.,  1999; Tusher et al., 2001). 
However, the Mest assumes the data to be normally distributed. As gene elements are 
not individual entities, and the correlation between genes significant and complex, non- 
parametric  tests  are  also  used.  Rank-based  non-parametric  statistics  include  both 
traditional  statistical  methods  (Zhan  et  al.,  2002)  and  ones  especially  designed  for 
microarray  data  (Ben-Dor et  al.,  1999;  Park  et  al.,  2003;  Troyanskaya  et  al.,  2002). 
However, when testing thousands of genes, correction for multiple testing is important. 
The standard Bonferroni correction (multiplying the uncorrected p-value by the number 
of genes  tested)  is  overly  restrictive.  This  is  because  corrections  are  based  on  the 
assumption  that  each  gene  represents  an  independent  test.  A  way  of estimating  the 
distribution  of  the  data  is  from  randomising  the  class  labels  of  the  data.  Such 
permutation tests, generally carried out by repeated scrambling the samples’ class labels 
and  computing  the  t  statistics  for  all  genes  in  the  scrambled  data,  best  captures  the 
unknown structure of the data (Tusher et al., 2001).
1.4.4.2  Time-series analyses
Analysis methods for microarray experiments that focus on differential gene expression 
over a time-series have received relatively  little  attention.  A  lack of robust statistical 
methods tailored to such problems has meant that most analyses generally applied for 
binary  comparisons  are  also  used  for time-series  analyses.  In  particular,  analysis  of 
variance  (ANOVA)  has  been  applied  to  time-series  analysis.  This  requires  replicate 
samples  at  each  timepoint,  and  binary  comparisons  are  used  to  find  differentially 
expressed genes between timepoints. This approach does not rely on any assumptions
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about the spacing between timepoints, but does not take into account known temporal 
relationships of gene expression over time.
Another  way  of approaching  time-series  analysis  is  by  assuming  that  there  is  some 
relationship  between  the  timepoints,  for  example  a  linear  relationship  or  cyclical 
phenomena.  Mathematical  models  can  then  be  applied  (linear  modelling  or  Fourier 
transformations respectively) as a statistical analysis tool (Spellman et al., 1998).
Experimental designs that follow biological processes over time offer much insight to 
such processes. Applying current binary analysis methods that do not take into account 
the temporal  relationship between  samples means that  such  initial  knowledge  is  lost. 
However,  if the  temporal  element  is  considered,  then  assumptions  need  to  be  made 
about the gene expression pattern in order to apply mathematical models for statistical 
tests,  if there  are  no  prior  knowledge  or  expectations  on  the  biological  response, 
clustering remains a way to discover temporal relationships.
1.4.4.3  Pattern discovery
The term “clustering” applies to a wide variety of unsupervised methods for organising 
multivariate  data  into  groups  with  roughly  similar  patterns.  Clustering  has  many 
applications  in  expression  data  analysis.  Clues  to  unknown  gene  function  may  be 
inferred  from  clusters  of genes  similarly  expressed  across  many  samples.  Clustering 
samples  over  expression  levels  of multiple  genes  has  been  proposed  as  a  way  of 
defining  new  disease  subclasses  (Alizadeh  et  al.,  2000;  Golub  et  al.,  1999).  Cluster 
analysis may be used primarily for data reduction and visualisation, or it may be used to 
generalise or predict the categorisation of new samples (Jenner et al., 2003).
The most frequently  used clustering method  is hierarchical  clustering.  In this method, 
all  data points start  in their own clusters, and the two clusters most closely related by 
some  similarity  metric  (usually  the  Pearson  correlation  coefficient)  are  merged.  The 
process of merging the two closest clusters  is repeated  until  a single cluster remains. 
This arranges the data into a tree structure that can be broken into the desired number of 
clusters  by  cutting  across  the  tree  at  a  particular  height.  Tree  structures  are  easily 
viewed  and  understood,  and  the  hierarchical  clusters  provide  potentially  useful 
information about the relationships between clusters.
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Partition or centroid algorithms require the number of clusters (&) to be specified, and 
start with k data points that may be chosen randomly or deliberately. These k points are 
then used as centre points of an initial set of clusters. The algorithm then partitions the 
samples into the k clusters, the centres of each cluster readjusted for the new clusters’ 
centre  points,  and  this  is  iterated  until  all  the  samples are  assigned to the number of 
specified  clusters.  The  &-means  method  is  one  such  approach.  A  variation  of this 
method that allows samples to influence the location of neighbouring clusters is known 
as  the  self-organising  map  or  Kohonen  map  (Kohonen  et  al.,  1996;  Tamayo  et  al.,
1999).  Such  maps  are  particularly  valuable  for  describing  the  relationships  between 
clusters.
There are many other clustering methods, such as clustering based on a pre-defined data 
model.  However, the optimal clustering method  is still dependent on the data and the 
goals  of  the  microarray  experiments.  Clustering  enables  pattern  discovery  and  a 
reduction in dimensionality that makes the data easier to understand.
Visualisation and understanding of microarray data can also be facilitated by reducing 
dimensionality  in  the  data.  Principal  component  analysis  (Landgrebe  et  al.,  2002; 
Raychaudhuri et al., 2000), multi-dimensional scaling (Bittner et al., 2000; Khan et al., 
1998), and single value decomposition (Alter et al., 2000; Holter et al., 2000) are related 
techniques that facilitate visualisation and understanding by reducing the dimensionality 
of the data. Each of these approaches projects the data into a new space that retains a 
large  amount  of the  original  data’s  variation.  These  techniques  rely  on  the  idea that 
most  of the  data’s  variation  can  be  explained  by  a  smaller  number  of transformed 
variables. When this is true, a two- or three-dimensional representation of highly multi­
dimensional data may offer invaluable insight. However, much information can be lost, 
and noise that contributes to variability will also be captured.
1.4.4.4  Domain knowledge
Beyond  cluster  analysis,  data  mining  including  function  prediction  and  promoter 
prediction together to infer regulatory pathways and networks further enable a systems- 
view of microarray gene expression data. Genes with unknown function that appear in 
the same cluster as genes with known function may be inferred to have similar function.
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This  is  because  genes  in  the  same  cluster  share  similar  transcription  response  to 
different conditions, and this is likely to be caused by some commonality in function or 
role.  Comparison  of array  results  with  information  in  the  literature  and  in  public 
expression  databases  facilitate  function  prediction.  This  approach  relies  heavily  on 
existing functional  annotation which  is often  incomplete.  Similarly, genes that are co­
expressed may be co-regulated, and share common transcription factor binding sites in 
their promoter.  This  can  be  explored  by  transcription  factor  databases  (Transcription 
Element  Search  Software  TESS:  http://www.cbil.upenn.edu/tess,  Schug  and  Overton, 
1997) that hold sequences of transcription factor binding sites for known transcription 
factors.  Inferring  regulatory  networks  and  complex  gene  relationships  rely  on  time- 
series  data  and  steady-state  data  of gene  knockouts.  Bayesian  networks  applied  to 
published  data  have  rediscovered  known  relationships,  propose  revisions  or 
contradictions of others, and suggest novel interactions (Friedman et al., 2000; Kim et 
al., 2003a; Savoie et al., 2003; Tamada et al., 2003). In general, models that incorporate 
existing  constraints  from  other  data  sources  seem  to  produce  hypotheses  that  agree 
better with existing biological knowledge than do models learned from expression data 
alone (Hartemink et al., 2002).
1.4.5  Gene expression profiling in immunology
To date, there are over  100 publications involving microarrays as applied to infectious 
agents causing pathogenesis, and over 50 publications involving microarrays as applied 
to  host  immune  response  to  infections.  From  the  perspective  of  pathogen  studies, 
microarrays have been applied to the understanding genetic determinants that contribute 
to  pathogenicity,  such  as  microbial  toxins  and  virulence  factors  (Bohn  et  al.,  2004; 
Geiss  et  al.,  2003;  Lorenz,  2002;  Raman  et  al.,  2004;  Schoolnik,  2002;  Yang  et  al., 
2002).  In terms  of host studies,  microarray  investigations  into cells of the  innate  and 
adaptive  immune  system  have yielded  a vast  amount  of information  as to  how these 
cells are activated  in response to pathogens and physiological  stimuli  (Alizadeh et al., 
2000; Diehn et al., 2002; Ehrt et al., 2001; Huang et al., 2001; Staudt and Brown, 2000). 
However,  it is the information and knowledge gleaned from  host-pathogen  interaction 
studies  that  provide  the  key  to  understanding  the  immune  response  to  infection,  the 
infectious  disease  process.  This  has  allowed  us  to  understand  not  only  how  the  host 
“sees” microbes, but to dissect the level at which this discrimination occurs.
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1.4.5.1  Stereotyped responses
As the function of innate immunity is to provide an immediate host defence response to 
incoming  pathogens,  components  of innate  immunity  regulate  responses  which  are 
largely similar regardless of the pathogen encountered, such as the acute inflammatory 
response mounted  in response to  infection.  So far,  gene expression  array experiments 
have  been  carried  out  in monocytes, macrophages,  dendritic  cells  and  neutrophils,  in 
response  to  various  pathogens  and  physiological  stimuli  (Section  1.4.3).  Stereotyped 
responses are generally responsible for pro-inflammatory “alarm” signals that marshal 
components  of  innate  defence,  including  pleiotropic  acute  inflammatory  cytokines. 
Such responses are usually also mediated in response to whole pathogens, inactivated or 
killed pathogens as well as pathogen components (Boldrick et al., 2002;  Huang et al., 
2001;  Malcolm  et  al.,  2003;  Nau  et  al.,  2002;  Subrahmanyam  et  al.,  2001).  Such 
microarray results are in agreement known biology of innate immune cells that express 
patterm recognition receptors to recognise diverse pathogens via conserved pathogen- 
associated molecular patterns.  It will be  important to identify the central  regulators of 
this common immune response, and the ways in which microbes attempt to thwart this 
process.
In a seminal study, by comparing the gene expression responses of dendritic cells to a 
bacterium  (.Escherichia coli),  a  virus (Influenza A)  and  a  fungus  (Candida albicans), 
Huang et al found a core of 166 genes that were commonly regulated by each organism 
in dendritic cells (Huang et al., 2001). The inclusion of multiple timepoints allowed the 
dynamics  of expression  of these  genes  to  be  elucidated,  indicating  how  microarray 
studies can show the sequence of events and pathways involved  in  immune responses. 
Similarly,  time-series  analysis  of  dendritic  cell  responses  to  single  pathogens  or 
pathogen  components  have  also  revealed  cascades  of transcription  programming that 
allow insight into dynamics of gene expression regulated by dendritic cells (Granucci et 
al., 2001a; Matsunaga et al., 2002; Tureci et al., 2003).  Peripheral  blood mononuclear 
cells (PBMCs) and macrophages exposed to different bacteria also regulate stereotyped 
responses (Boldrick et al., 2002; Nau et al., 2002),  including immune activation genes 
that have both local and systemic effects. Stereotyped responses are generally attributed 
to activation of toll-like receptors that signal to activate common transcription  factors 
like NF-kB.
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1.4.5.2 Differentiating between infectious agents
In  addition  to  stereotyped responses,  dendritic cells  and  macrophages have also been 
shown to demonstrate pathogen-specific responses (Boldrick et al., 2002; Chaussabel et 
al.,  2003; Huang et al., 2001; Nau et al.,  2002).  Pathogen-specificity  is  important for 
DCs to coordinate the downstream adaptive immune response, and effector functions of 
macrophages  should  be  similarly  tailored  towards  particular  pathogens.  Huang  et  al 
showed that DCs are able to regulate unique transcriptional programs in response to E. 
coli  and  Influenza.  Responses  to  bacteria  showed  preferential  induction  of  innate 
immune response genes such as neutrophil chemoattractant cytokines and inflammatory 
genes;  in contrast, responses to virus showed  preferential  induction  of antiviral  genes 
including  interferons.  Macrophages  can  similarly  differentiate  different  strains  of 
bacteria  (Nau  et  al.,  2002),  where  Mycobacterium  tuberculosis  infection  in 
macrophages results in a compromised production of IL-12 compared to infection with 
E. coli. Pathogen-specificity at the innate immune cell  level is important in modulating 
differential  downstream  adaptive  immune  responses  that  are  tailored  to  incoming 
pathogens.
1.4.5.3 Infection-related experimental issues
There  are  important  experimental  issues  to  consider  with  experiments  that  aim  to 
determine pathogen-specificity in the responses of various cell types. For example, the 
study of Huang et al determined DC responses to virus by the host genes regulated  in 
response to  Influenza.  However,  influenza  virus  establishes  a productive  infection  in 
DCs (Bhardwaj et al.,  1994), and has numerous host immunomodulatory properties in 
its  encoded  genes  (Geiss  et  al.,  2001;  Geiss  et  al.,  2002).  Similarly,  a  “specific” 
response of impaired  IL-12 production as a result of interaction between macrophages 
and M.  tuberculosis  (Nau  et al.,  2002)  is  possibly  an  active  process  mediated  by the 
pathogen to downmodulate the immune response. Therefore, the question addressed by 
such microarray experiments, to discover differential pathogen-specific host responses, 
need to distinguish  between  gene expression  profiles  of host  infected-states  and  gene 
expression  profiles  of the  host  responding  to  recognition  of different  pathogens.  To 
address  the  ability  of  the  host  to  discriminate  between  pathogens,  responses  to 
inactivated pathogens or defined pathogen components should be explored in parallel to 
control  for possible confounding effects of active replication and  pathogen-modulated 
responses downstream of infection.
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The temporal aspect of host response to pathogens is also an important consideration in 
determining downstream immune responses. The sequence of host responses is central 
to  understanding  the  development  and  evolution  of the  immune  response  as  well  as 
immunopathogenesis.  Experiments  examining  host  gene  expression  responses  to 
infection  that  have  been  published to  date  include  measurements  at  only  one or two 
timepoints (Chaussabel et al., 2003; Detweiler et al., 2001; Dietz et al., 2000; Messmer 
et al.,  2003). This  leaves open the possibility that a phase  shift  in  the  kinetics of the 
responses  to  two  stimuli  will  be  interpreted  as  a  significant  difference  in  gene 
expression  profiles.  Extended  timecourse  experiments  are  therefore  critical  in  fully 
evaluating the regulation of gene expression in response to pathogen stimuli. Similarly, 
the  “dose” effect of pathogen  input varies the  “potency”  of gene  expression  changes 
(Boldrick et al., 2002; Eisenbarth et al., 2002; Oh and Eichelberger, 2000; Ruedl et al.,
2 0 0 0), and this should be appropriately controlled for.
71Introduction
1.5  Aims of this thesis
Discovering  the  determinants  and  subsequent  outcome  of dendritic  cell  responses  to 
pathogens  and  their  derived  components  are  crucial  for  the  understanding  of  the 
generation  of host immune  responses to pathogens,  pathogen  strategies to escape and 
downmodulate  the  immune  response,  and  the  interplay  which  leads  to  the  eventual 
outcome of an  infection.  It may also provide  information about potential  intervention 
therapies that may be applied to benefit the host in the face of pathogenic infections.
The  aim  of this  thesis  is  to  harness  the  power  of DNA  arrays  to  globally  profile 
dendritic cell responses to a number of pathogens and derived components, in order to 
understand how dendritic cells transcriptionally regulate responses that affect their role 
as antigen presenting cells. The questions that are addressed include:
1.  What are the transcriptional responses of dendritic cells to established maturation 
stimuli, LPS and dsRNA?
2.  What  are  the  gene  expression  changes  that  occur  during  the  dendritic  cell 
“maturation” response?
3.  What  are  the  responses  of DCs  to  different  purified  preparations  of  live  and 
inactivated RNA viruses (Influenza and Rhinovirus)?
4.  What are the gene expression changes  in DCs responding to such  RNA viruses, 
and are there core and virus-specific responses?
5.  What  are  the  functional  consequences  of  transcriptional  regulation  of  DC 
responses to such pathogens and pathogen components?
The results of attempts to answer these questions, together with their interpretation, are 
the subjects of Chapters 3 to 5. Chapter 3  deals with the array results of dendritic cell 
responses to LPS and dsRNA, which further characterises the DC maturation response. 
Chapter 4  contains results of DC  responses to Influenza and  Rhinovirus measured  by 
phenotype  changes  and  DC  viability,  as  well  as  initial  array  analyses  of  DC 
transcriptional  responses to the two  viruses.  Chapter  5  further explores the  theme  of 
transcriptional  plasticity of DCs in response to viruses, and  investigates the functional 
consequences of such transcriptional plasticity.
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Chapter 2 
Materials and Methods
2.1  Buffers and solutions
Table 2.1. Constituents of buffers and solutions.
Deoxynucleotide 
triphosphate mix (dNTPs)
100 mM of deoxyadenosine triphosphate (dATP), 
deoxythymidine triphosphate (dTTP), deoxyguanosine 
triphosphate (dGTP), deoxycytidine triphosphate (dCTP)
20x Saline sodium citrate 
(SSC)
3 M sodium chloride, 0.3 M sodium citrate, pH 7.0
Tris-acetate-EDTA (TAE) 40 mM Tris pH 7.8, 20 mM sodium acetate, 1  mM 
ethylenediaminetetraacetic acid  (EDTA)
Tris-EDTA (TE) 10 mM Tris pH 7.4, 1  mM EDTA
Hanks’  Balanced Salt 
Solution (HBSS)
138 mM sodium chloride, 5 mM potassium chloride, 4 mM 
sodium bicarbonate, 1  mM calcium chloride, 0.5 mM 
magnesium chloride, 0.4 mM potassium phosphate 
(monobasic), 0.3 mM sodium phosphate (dibasic), pH 7.4
Saline-sodium phosphate- 
EDTA buffer (SSPE)
2.98 M sodium chloride, 0.02 M EDTA, 0.2 M phosphate 
buffer, pH 7.4,
Phosphate buffered saline 
(PBS)
137 mM sodium chloride, 2 mM potassium chloride,  10 mM 
sodium hydrogen phosphate (dibasic), 2 mM potassium 
hydrogen phosphate (dibasic), pH 7.4
2.2  Dendritic cells
2.2.1  Culturing dendritic cells
Culturing  dendritic  cells  involves  a  8-day  protocol,  starting  from  day  0  with  the 
collection  of blood. The source of dendritic  cells was  either peripheral  venous blood 
from healthy volunteers, or buffy coats from the National Blood Service (NBS). Buffy 
coats are the  leukocyte-enriched  fractions separated  in the processing  of whole blood 
donations  from  voluntary  donors  for  the  National  Health  Service.  The  buffy  coats 
received  from  the  NBS  are  deemed  unsuitable  for  platelet  production  due  to  an 
extended bleed time of 15  minutes. Both buffy coat and peripheral blood preparations 
are diluted in Hanks’ Balanced Salt Solution (HBSS) (Gibco Invitrogen, UK) (in a ratio 
of blood to  HBSS  of 2:1  for whole blood  from  healthy volunteers,  and  1:6  for buffy 
coats), and carefully layered on  17.5 ml Ficoll  Lymphoprep (Nycomed, Norway). This 
is  centrifuged  at  800g  for  30  minutes  to  allow  separation  of plasma,  leukocytes  and
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erythrocytes. The leukocytes form an interface, and this layer is harvested, spun down 
(250g,  10  minutes),  and  washed  twice  with  HBSS  by  repeat  centrifugation  and 
resuspension.  The cells  are then  plated  into  6-well  plates  (Becton  Dickinson  Falcon, 
UK) in Roswell Park Memorial Institute (RPMI) medium  1640 (Gibco Invitrogen, UK) 
supplemented  with  10%  foetal  calf serum  (FCS),  100  pg/ml  streptomycin,  and  100 
U/ml penicillin (hereafter referred to as complete medium), and incubated at 37°C, 5% 
CO2 for 2 hours which allows the monocytes to adhere to the plate. In the case of buffy 
coats,  plating  is  preceded  by  a red-cell  lysis  stage,  which  involves  incubation  of the 
harvested cells with  10 ml Red blood cell lysing buffer (Sigma-Aldrich, UK) for 10 to 
15  minutes  to  Iyse  remaining  erythrocytes.  Lysed  red  cells  are  removed  by  repeat 
washing with HBSS, and the cells are then plated in complete medium. After 2 hours at 
37°C, 5% CO2, non-adherent cells are removed by gentle pipetting, and the remaining 
adherent cells are cultured in complete medium with human recombinant GM-CSF (100 
ng/ml)  and  IL-4  (50  ng/ml)  (both  gifts  from  Schering-Plough  Research  Institute),  at 
37°C, 5% C02.
On day 4, the cells are collected and layered onto Lymphoprep, and again centrifuged at 
800g  for  30  minutes.  The  layer  of cells  was  collected,  washed,  and  counted  with  a 
haemocytometer. Dendritic cells were distinguished from small contaminating T cells, 
B  cells,  and NK  cells.  The number of small  cells  counted  determined  the  amount of 
mouse anti-CD2 antibody (mouse mAb MAS  593, IgG2t> ; Harlan  SeraLabs, UK), anti- 
CD3  antibody  (supernatant  mouse  mAb  UCHT1,  IgGi;  gift  from  P.C.L.  Beverley, 
Edward Jenner Institute for Vaccine Research, Compton, UK) and anti-CD19 antibody 
(supernatant  mouse  mAb  BUI2,  IgGi;  gift  from  D.  Hardie,  Birmingham  University, 
UK) that is incubated with the cells. The cells are incubated with anti-CD2,  anti-CD3 
and anti-CD19 antibodies at 4°C for 30 minutes in 2 ml of complete medium. After 2 
washes  in  cold  HBSS,  the  cells  are  incubated  with  sheep  anti-mouse  IgG-coated 
immunomagnetic beads (Dynal,  Merseyside,  UK,  lOpl  per  106 small cells counted) at 
4°C for 45 minutes on a rotating mixer, which removes the T, B and NK cells that have 
bound the mouse antibodies. The beads are then removed, the remaining cells counted, 
and  re-plated  in  complete  medium  with  GM-CSF  and  IL-4  at  a  density  of  5x10s 
DCs/ml. The resulting DCs were >90% pure as judged by flow cytometry (Chapter 3, 
Figure 3.1 A).
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On  day  7  the  immature  DCs  are  ready  to  use.  To  induce  maturation  with  LPS 
(Salmonella Minnesota strain) or polyinosinic-polycytidylic acid (poly(I:C), both from 
Sigma-Aldrich, UK), these are added directly into the culture medium, at concentrations 
of 100 ng/ml  for LPS  and 25  pg/ml  for poly(I:C).  Control  mock-stimulated  DCs  are 
treated with the equivalent volume of complete medium.
2.2.2 Infecting dendritic cells
Day  7  immature  DCs  were  collected,  centrifuged,  and  counted.  Depending  on  the 
required  multiplicity  of infection  (MOI),  the  appropriate  number of cells  were  again 
centrifuged,  the  supernatant  removed,  and  infected  with  virus  in  a  small  volume 
(approximately  lOOpl). This virus-DC  mixture was  incubated at 37°C,  5% CO2  for  1  
hour.  After  an  hour,  HBSS  was  added  to  the  cells,  and  this  was  centrifuged  and 
resuspended,  and repeated, to  ensure  removal  of unbound  virus.  The  cells were then 
replated in complete medium with GM-CSF and IL-4 for the required amount of time at 
37°C, 5% CO2, before RNA harvesting or phenotyping by flow cytometry.
2.2.3 Virus preparations
Sucrose-gradient  purified  Influenza  virus  (strain  A/PR8/34,  H1N1)  and  Rhinovirus 
(major group RV16)  were  gifts  from  collaborators  at  the  University  of Reading  (W. 
Barclay) and University of Leeds (R. Rowlands and T. Tuthill) respectively. The virus 
preparations were stored in aliquots of 50 pi or 100 pi at -70°C until required. The titre 
of the viruses were at  l-3xl0 9 plaque forming units (pfu)/ml, as determined on Madin- 
Darby canine kidney (MDCK) or HeLa (Ohio strain) cells for Influenza and Rhinovirus 
respectively.
2.2.4 Inactivation of viruses
Virus  aliquots  were  thawed  on  ice,  and  the  appropriate  volume  was  transferred  to  a 
0.5 ml eppendorf, and exposed directly to short wave UV-light (R-52 Grid Lamp, UVP, 
Cambridge,  UK)  on  ice  for 2  minutes.  This  was  then  used  as  inactivated  virus,  and 
incubated with DCs as in Section 2.2.2.
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2.2.5 Monitoring extracellular phenotype by flow cytometry
Stimulated  or virus-exposed DCs were collected  after the appropriate  length  of time, 
and  monitored  for  surface  expression  of a  number  of maturation  markers,  including 
MHC  class  II  (HLA-DR,  supernatant mouse  mAb  L243,  IgG2a;  gift  from  P.  C.  L. 
Beverley), MHC class I (HLA-ABC, W6/32; Serotec, Oxford, UK), CD8 6 (supernatant 
mouse mAb BU63, IgGi; gift from D. Hardie), and ICAM-1  (mouse mAb HA58, IgGi, 
eBioscience, UK). DC surface expression of CD la (supernatant mouse mAb NA1/34, 
IgG2a;  gift  from  A.  McMichael,  John  Radcliffe  Hospital,  Oxford,  UK)  and  CD14 
(supernatant  mouse  mAb  HB246,  IgG2b;  gift  from  P.  C.  L.  Beverley)  was  also 
determined. DCs were first incubated in HBSS containing 0.1% sodium azide and  10% 
rabbit serum (blocking solution) to block non-specific binding, at  105 cells per  1 0 0 pi, 
at  4°C  for  15  minutes.  The  cells  were then  incubated  with  50  pi  of the  appropriate 
primary antibody at 4°C for 30 minutes. Cells were washed twice in blocking solution, 
and  then  incubated  with  50  pi  of rabbit  anti-mouse  IgG  conjugated  to  fluorescein 
isothiocyanate (FITC, DakoCytomation, UK, diluted  1:20) at 4°C for 30 minutes in the 
dark.  Cells  were  then  washed  twice  in  HBSS  containing  0.1%  sodium  azide  (wash 
solution),  then  resuspended  in  50  pi  wash  solution  and  fixed  in  100  pi  3.7% 
formaldehyde.  Cells  were  then  analysed  by  flow  cytometry  within  2  days  using  a 
FACScan with Cellquest software (Becton Dickinson, UK).
2.2.6 Monitoring intracellular protein production by flow cytometry
Intracellular  staining  was  used  to  monitor  levels  of  intracellular  protein  in  DCs, 
including cathepsin E (mouse mAb CE1.1,  IgM),  Influenza nucleoprotein (NP, mouse 
mAb  AA5H,  IgG2a;  ImmunologicalsDirect,  Oxfordshire,  UK),  and  whole  Rhinovirus 
particles (guinea pig HRV16 antiserum, American Type Culture Collection, UK).
DCs were collected and spun down, and fixed in 400 pi of 4% paraformaldehyde at 4°C 
for 10 minutes. Cells were washed twice in HBSS containing 2% FCS and 0.1% sodium 
azide  (wash  solution),  and  then  permeabilised  in  100  pi  0.1%  Triton-XlOO  (Sigma- 
Aldrich,  UK)  at  4°C  for  10  minutes.  The  cells  were  again  washed  twice  in  wash 
solution, and then blocked in HBSS containing  10% goat serum and 0.1% sodium azide 
(blocking solution), at 3xl05 cells per 100 pi, at 4°C for 10 minutes. The cells were then 
incubated with 50 pi of the appropriate primary antibody at 4°C for 45 minutes, washed
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twice  in  blocking  solution,  then  incubated  with  1 0 0  pi  of the  appropriate  secondary 
antibody  for 45  minutes  at  4°C  in  the  dark.  Cells  were  then  washed  twice  in  wash 
solution, and analysed by flow cytometry immediately.
2.2.7 Monitoring apoptosis by Annexin V staining
The  Becton  Dickinson  Pharmingen  Annexin  V-FITC  Apoptosis  detection  kit  (BD 
Biosciences, UK) was used to monitor DC viability following virus infections and other 
stimuli.  Following culture with the appropriate stimulus,  DCs were collected,  washed 
and  centrifuged,  and  resuspended  in  100  pi  lx  Annexin  V  Binding  Buffer  at  lxlO 6 
cells/ml. The cells were incubated with 5 pi of AnnexinV-FITC and 5 pi of Propidium 
Iodide for 15 minutes in the dark at room temperature, after which 400 pi  lx Annexin V 
Binding  Buffer  was  added  to  the  samples,  and  the  samples  were  analysed  by  flow 
cytometry immediately.
2.2.8 Harvesting dendritic cells for arrays
Cultured DCs were harvested at the appropriate timepoints after incubation with LPS or 
poly(I:C), or infection with virus. For time 0, the stimulus was added to the media, then 
the medium was immediately removed with a pipette, and T R Izol®  reagent (Invitrogen, 
UK) added directly to the plate containing adherent DCs. The medium containing non­
adherent DCs was centrifuged, the supernatant removed and  frozen at -20°C,  and the 
T R Izol®  from the plate was used to resuspend the cell pellet, and this was then frozen 
at  -70°C.  This  was  the  protocol  for  harvesting  subsequent  timepoints,  where  the 
supernatants  were  stored  at  -20°C  and  the  T R Izol®   aliquot  was  used  to  lyse  both 
adherent and non-adherent DCs.
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2.3  Cell culture
Table 2.2 Cell lines used in as reference RNA in this study
Cell line  Origin___________________________ Culture conditions
HeLa Cervical epithelium DMEMf, 10% FCS
HuH7 Hepatoma DMEM, 10% FCS
Ramos B cell RPMI*, 10% FCS
MRC5 Embryonic fibroblast DMEM, 10% FCS
BMVEC Breast microvascular endothelium EGM-2-MV, 5% FBS (with BulletKit5)
SSCEM T cell RPMI, 10% FCS
U937 Monocytes RPMI, 10% FCS
f Dulbecco’s Modified Eagle’s Medium (Gibco Invitrogen, UK)
* Roswell Park Memorial Institute 1640 medium (Gibco Invitrogen, UK)
§ Microvascular Endothelial Growth Medium-2 (Clonetics, BioWhittaker, Cambrex, USA)
2.3.1 Thawing cells
Cells removed from  liquid nitrogen were thawed rapidly at 37°C. Cells were added to 
20 ml  of the appropriate medium,  Dulbecco’s Modified Eagle’s Medium (DMEM) or 
Roswell  Park Memorial  Institute  (RPMI)-1640 medium  (both  from  Gibco Invitrogen, 
UK)  with  10%  foetal  calf serum  (Helena Biosciences,  UK),  100  U/ml  penicillin  and 
100 pg/ml streptomycin (both from Gibco Invitrogen, UK). The cells were then pelleted 
at 325g for 5 minutes, resuspended in 10 ml media and counted with a haemocytometer. 
The cells were centrifuged for a further 5  minutes and resuspended at 5xl0 6 cells/ml. 
The medium was replaced after 24 hours.
Breast  microvascular  endothelial  cells  (BMVEC)  (gift  from  C  Boshoff,  University 
College  London,  UK)  were  maintained  in  EGM-2-MV  (Clonetics,  Biowhittaker, 
Cambrex,  USA)  with  supplements  provided  as  single-use  aliquots  in  the  Bullet-Kit 
(including 5% foetal bovine serum (FBS), human recombinant epidermal growth factor, 
fibroblast growth factor, vascular endothelial growth factor,  insulin-like growth factor, 
vitamin C, hydrocortisone, gentamicin, amphotericin-B).
2.3.2 Passaging cells
Cells were cultured in growth medium with  10% FCS (or 5% FBS for BMVECs) and 
antibiotics  penicillin  and  streptomycin  (or  gentamicin  and  amphotericin-B  for 
BMVECs)  in 5% CO2 at 37°C for the initial  1-2 weeks after thawing. Cells were split 
1:2 to 1:5, depending on cell density and rate of growth, approximately twice a week.
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2.3.3 Mycoplasma testing
After thawing,  cells were grown for  1   week in the same growth medium that did not 
contain antibiotics, and the culture medium was harvested for mycoplasma testing at the 
Institute of Cancer Research. The cell lines in Table 2.2 used for making the microarray 
common reference were verified as mycoplasma negative by Hoechst (DNA) stain.
2.3.4 Freezing cells
n
Cells were centrifuged at 325g for 5  minutes and resuspended at  10  cells/ml  in cold 
medium  (DMEM or RPMI-1640) with 20% FCS,  100  U/ml  penicillin  and  lOOpg/ml 
streptomycin.  An  equal  volume  of media  containing  20%  FCS,  100  U/ml  penicillin, 
lOOpg/ml  streptomycin  and  20%  dimethyl  sulphoxide  (DMSO,  Sigma-Aldrich,  UK) 
was added. Cells were aliquoted  into cryovials (Nunc,  USA) and  gradually cooled to 
-70°C  in  an  isopropanol-containing  cryo-container  (Nalgene,  USA)  before  being 
transferred to liquid nitrogen after 24 hours.
2.3.5 Harvesting cells for reference RNA
Cells  were  gradually  bulked  up  over  2  to  3  weeks  (depending  on  rate  of growth), 
gradually seeding into larger flasks. When sufficient numbers of cells were cultured, the 
culture  medium  was  replaced  with  fresh  medium  24  hours  before  harvesting.  For 
adherent cells,  the  culture  medium was  removed,  and TRIzol® directly added to the 
flask,  1   ml  TRIzol® per  10 cm2.  The cell  lysate was  passed  several  times through  a 
pipette,  and  aliquoted  into cryovials  and  frozen  at -70°C.  For non-adherent  cells,  the 
culture medium with cells was removed, centrifuged, and TRIzol® was added directly 
to the cell pellet, at 1   ml per 5-10xl06 cells.
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2.4  Dendritic cell microarrays
Human  cDNA  microarrays  were  supplied  by  the  Human  Genome  Mapping  Project 
Resource  Centre  (HGMP-RC)  Microarray  Programme.  The  majority  of the  clones 
printed  on  these  arrays  are  from  the  HuGen  cDNA  set,  the  HGMP-RC’s  minimally 
redundant human gene set, as well as PCR inserts from an “Angiogenesis set” prepared 
by the Reproductive Molecular Research Group, Department of Pathology,  University 
of Cambridge.  Throughout  the  period  from  2002  to  2004,  the  content  and  layout of 
these human  arrays  have changed  from  array  version  1  to  array  version  2,  to  further 
incorporate  clones  from  the  Mammalian  Gene  collection.  Accordingly,  35  out  of 45 
microarray  experiments  that  are  included  in  this thesis were  hybridised  on  version  1  
microarrays, and the remaining 10 on version 2 microarrays (Table 2.3, Figure 3.4).
Table 2.3 Gene elements and microarray experiments hybridised to different microarrays
Human cDNA array version 1 Human cDNA array version 2
Gene elements 9,216 11,520
Experiments Control, LPS, poly(l:C) (24)r LPS (3)
Influenza (6) Inactivated Influenza (1)
Inactivated Influenza (5) Rhinovirus (6)
dumber of arrays hybridised with RNA from DCs treated with the indicated stimuli
2.4.1  Total RNA purification
Frozen T R Iz o l lysates (sections 2.2.8 and 2.3.5) were thawed at 37°C and centrifuged 
at  12,000g  for  10  minutes at 4°C  to  remove  insoluble  material.  The  supernatant was 
transferred  to  a  new  eppendorf tube  and  left  at  room  temperature  for  5  minutes. 
Chloroform was then added, 200 pi  per ml of T R Iz o l, and the solution shaken by hand 
for 15 seconds. After incubation at room temperature for 2-3 minutes, the aqueous layer 
was separated from the organic layer by centrifuging at  12,000g for 15 minutes at 4°C. 
The top  aqueous  layer was transferred  to  a  new tube  and  500pl  (per ml  T R Iz o l)  of 
chloroform  was  added  to  repeat the  chloroform  extraction.  After  incubation  at  room 
temperature  for  2-3  minutes  and  centrifuging  at  12,000g  for  15  minutes  at  4°C,  the 
aqueous  layer was transferred  to  a  new tube.  Isopropanol  was  added  (500  pi  per ml 
T R Iz o l)  to  the  aqueous  layer  to  precipitate  RNA.  The  solution  was  vortexed  and 
incubated  at  room  temperature  for  10  minutes  before  the  RNA  was  pelleted  by 
centrifugation at  12,000g for  15 minutes at 4°C. The supernatant was discarded and the 
pellet washed with  1   ml  75% ethanol  and centrifuged at 7,500g for 5  minutes at 4°C.
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The supernatant was removed once more and the pellet dried at room temperature. The 
RNA  was  then  resuspended  in  lOOpl  diethyl  pyrocarbonate  (DEPC)-treated  distilled 
water.  RNA  was  quantified  by  UV-spectrophotometry,  measuring  UV  absorbance  at 
260 nm. An absorbance of 1   unit/cm was taken to be equivalent to 40 pg/ml RNA. The 
purity of RNA was measured by the ratio of the absorbencies at 260 nm and 280 nm. 
Contaminating  DNA  was removed  from  RNA  by treatment with  DNase  I  (Promega, 
UK) according to the following protocol:
This  was  incubated  at  37°C  for  1   hour.  The  reaction  was  stopped  by  adding  1/10th 
volume of terminator mix (0.1M  EDTA  pH  8,  1   mg/ml  glycogen). The RNA was re­
extracted  by  adding  an  equal  volume  of phenol:chloroform:isoamylalcohol  (25:24:1, 
Sigma-Aldrich, UK). The mixture was vortexed for 15 seconds, centrifuged at  14,000g 
for  10  minutes,  and  the  top  aqueous  layer transferred  to  a  new  tube.  This was then 
repeated with phenol:chloroform:isoamylalcohol, and once with chloroform to remove 
any remaining phenol.  RNA  was  precipitated  at -20°C  for 2  hours  with  l/5th volume 
ammonium  acetate  (8M)  and  2.5  volumes  of 95%  ethanol.  RNA  was  pelleted  by 
centrifugation  at  14,000g  for 30  minutes at 4°C,  the  pellet washed  with  200  pi  80% 
ethanol, and centrifuged at  14,000g for  10 minutes. The ethanol was removed, and the 
RNA  pellet  was  air-dried  on  the  bench  at  room  temperature.  RNA  was  resuspended 
100 pi  DEPC-treated distilled water, quantified and quality-assessed using the Agilent 
Bioanalyzer (Agilent, UK) RNA 6000 Nano assay protocol for total RNA, and stored at 
-70°C.
2.4.2  mRNA purification
mRNA  was  purified  from  total  RNA  using  Oligotex  (Qiagen,  UK),  which  separates 
nucleic acids containing poly-dA sequences through hybridisation to oligo-dT bound to 
microscopic  polystyrene-latex  particles.  Before  purification,  the  Oligotex  suspension 
and OBB buffer (binding buffer) was warmed to 37°C,  vortexed and then returned to 
room  temperature,  and  buffer OEB  (elution  buffer)  heated  to  70°C.  Total  RNA  was
Starting RNA 50yg  100yg  150yg  200yg
RNA
DNase buffer 
DNase I (1 U/pl) 
DEPC water 
Total
100  100  100  100
15  20  30  40
5  10  15  20
30  70  155  240
150|ul  200jd  300|al  400^1
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made up to 250 pi in DEPC-treated water and mixed with 250 pi buffer OBB and  15 pi 
Oligotex suspension. This was incubated at 70°C  for 3  minutes to denature the RNA, 
and  the  Oligotex  and  RNA  allowed  to  anneal  at  room  temperature  for  20  minutes. 
Subsequently, the Oligotex was pelleted by centrifugation at  14,000g for 2 minutes and 
the  supernatant  discarded.  The  pellet was  resuspended  in  400  pi  buffer OW2  (wash 
buffer), mixed and applied to a Qiagen spin column. This was centrifuged at  14,000g 
for  1   minute,  the  Oligotex  resuspended  in  an  additional  400  pi  buffer  OW2  and 
centrifuged again. The bound mRNA was eluted by resuspending the Oligotex in 100 pi 
of buffer OEB  (70°C)  and centrifuging through  the  column  at  14,000g  for  1   minute. 
This was repeated to give a final volume of 200 pi mRNA in elution buffer. The mRNA 
was  quantified  and  quality-assessed  by  using  the  Agilent  Bioanalyzer  (Agilent,  UK) 
RNA 6000 Nano assay protocol for messeger RNA, and stored at -70°C.
2.4.3  mRNA labelling
mRNA  was  concentrated  to  approximately  100  ng/pl  by  centrifugation  through  a 
Microcon YM-30 column  (Millipore,  UK) at  14,000g  for  8 minutes. The mRNA was 
recovered by inverting the column and centrifuging at  lOOOg for 3  minutes. Reference 
RNA  was  made  by  mixing  mRNA  from  the  different  cell  lines  in  the  following 
proportions:  HeLa 25%,  U937  25%,  SSCEM  15%,  Ramos  15%,  HuH7  10%,  MRC5 
5%,  BMVEC  5% (Table 3.2). The RNA was labelled  using the CyScribe First-Strand 
cDNA  Labelling  Kit  (Amersham  Pharmacia  Biotech,  UK).  The  initial  annealing 
reaction  mixtures  included  the  concentrated  mRNA  from  sample  or  reference,  1   pi 
oligo(dT) primer,  1   pi random nonamers, and DEPC-treated water up to a final volume 
of 11  pi. This was mixed and heated at 70°C for 5 minutes, and then the mixture cooled 
at  room  temperature  for  10  minutes.  The  RNA  was  then  reverse  transcribed, 
incorporating  Cy5  (sample)  and  Cy3  (reference)  fluorophores,  to  make  differentially 
labelled cDNA.
RNA, oligo(dT), random nonamers 
5x CyScript buffer
llpl
4pl
2pl
lpl
lpl
lpl
0.1MDTT
dCTP nucleotide mix
Cy3 or Cy5 dCTP(lmM)
CyScript reverse transcriptase (lOOU/pl)
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This was mixed,  vortexed  and the  incubated  at  42°C  for  90  minutes.  The  remaining 
mRNA was then denatured with 2.5 jj.1  0.5M EDTA (pH 8.0) and  10 pi 0.1M NaOH at 
70°C  for  10  minutes,  then  neutralised  with  10  pi  0.1M  HC1.  Cot-1  DNA  (3pl, 
Invitrogen, UK) was added to suppress hybridisation of repetitive DNA,  and the final 
volume made up to 300 pi with Tris-EDTA (TE, pH 8.0).
Unincorporated  nucleotides  were  removed  and  the  labelled-cDNA  concentrated  by 
serial centrifugations through  a Microcon  YM-30 column  (Millipore, UK) at  14,000g 
for 5 minutes. At each stage the filtrate was retained, the Microcon column filled with 
300  pi  TE and centrifuged  again.  This was  repeated two times,  and the  concentrated 
cDNA was recovered by inverting the Microcon column and centrifuging at  l,000g for 
3  minutes. The desired volume was  13  pi or below. The initial  20 pi of dilute cDNA, 
20 pi of the subsequent filtrates, and l/25th of the final concentrated cDNA was run on a 
1% agarose gel  (with no ethidium  bromide) at 50V  for 2 hours. Cy-dye  incorporation 
and  removal  of  unincorporated  Cy-dyes  was  verified  by  scanning  the  gel  with  a 
fluorimeter (Storm 860, Molecular Dynamics, UK). The scanner emits light at 635nm to 
detect Cy5 incorporation, and at 450nm to detect Cy3 incorporation.
2.4.4  Hybridisation
The hybridisation mix was made as follows:
20x saline sodium phosphate EDTA (SSPE, Sigma, UK)  20pl
0.5MEDTA  1.1 pi
poly-dA (8pg/pl, Amersham  Biosciences, UK)  2pl
yeast tRNA (4pg/pl, Sigma,  UK)  2pl
Cy5-labelled sample cDNA 
Cy3-labelled reference cDNA
TE (pH 8.0)  up to 45 pi
10% SDS (added last)  1 pi
The cDNA was denatured at 98°C for 2 minutes, then incubated at 37°C for 20 minutes. 
After incubation,  lpl  lOOx Denhardt’s solution (Sigma-Aldrich, UK) was added to the 
hybridisation mix, and any insoluble material removed by centrifugation at  14,000g for 
15  minutes.  Meanwhile,  the  HGMP  glass  array  was  placed  inside  the  hybridisation 
cassette  (Ambion  (Europe),  UK)  and  warmed  to  65°C  for  around  15  minutes.  The 
mixed  cDNA  probe  was  pipetted  onto  the  glass  array,  and  an  ethanol-washed  glass
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coverslip  (22x64mm,  no.O thickness,  Chance-Propper,  UK)  was  placed  on  top  of the 
glass microarray in the chamber. The hybridisation cassette was humidified by addition 
of 150 pi of 4x SSPE, the lid was screwed on, and the whole cassette was transferred to 
a 65°C waterbath for 16-18 hours overnight.
After the overnight hybridisation, the array was the removed and placed in 2x SSPE at 
50°C  until  the  coverslip  became  detached  from  the  array,  and  the  array  was 
subsequently washed in 2x SSPE for 2 minutes,  lx SSPE for 2 minutes, and O.lx SSPE 
for 3 minutes. The microarray was rapidly dried by centrifugation at 200g for 2 minutes. 
The  array  was  then  scanned  with  a  GenePix  4000B  microarray  scanner  (Axon 
Instruments, US).
2.4.5  Scanning and data extraction
The microarrays were scanned with a GenePix 4000B microarray scanner, controlled by 
GenePix Pro 3.0 software (Axon Instruments, USA), at 10 pm resolution. Cy3 and Cy5 
were  simultaneously  excited  at  532  nm  and  635  nm  respectively  and  the  resultant 
emitted light detected with two photomultiplier tubes (PMTs). The voltages across the 
PMTs were  adjusted  so  that the  signals  from  the  array  elements  were balanced.  The 
PMTs were generally set around 650V to maximise the signal to background ratio. The 
GenePix software combines the data from the two channels to create a single composite 
image.  Arrays  found  to  have  hybridised  unevenly  or  with  high  background  were 
repeated.
A  GAL  file  (GenePix  Array  List  file)  was  fitted  over the  array  image  using  a  spot- 
finding  software  algorithm.  Array  elements  from  which  no  signal  could  be  detected 
were  flagged  as  not  found  by  the  GenePix  software.  All  9,216  (Human  cDNA  array 
version  1)  or  11,520  (Human  cDNA  array  version  2)  elements  on  each  array  were 
checked by eye and the template altered if necessary. Array elements spoiled by debris, 
scratches  or with  a high  local  background  were  flagged  as  bad.  Data were  extracted 
from  the  image  by  the  software  using  the  adjusted  template.  Signal  intensity  is 
measured as the average number of bits, ranging from 0 to 65,535 units, for spot pixels 
in the image file. Expression ratios were calculated by the software as the median of the
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ratios  between  the  local  background-subtracted  Cy3  and  Cy5  signals,  on  a  pixel-by- 
pixel basis.
The data were exported to HGMPAnalyser, a spreadsheet created in Microsoft Excel, 
and  the  median  of ratios  filtered  using  Boolean  operators  to  remove  flagged  array 
elements and elements for which the signal to background ratio (termed signal to noise 
ratio SNR) was below the averaged SNR of designated negative genes in each array in 
the Cy3 and Cy5 channels (Table 3.3). The expression ratios for the gene elements that 
pass  the  SNR  filter were  then  log-transformed  (to  base  2),  and  exported  for  use  in 
Cluster.
2.5  Microarray data analysis
2.5.1  Cluster analysis
The  log2 expression  ratios  from  different microarray  experiments  were  imported  into 
Cluster software (Eisen et al.,  1998). The first operation  in Cluster allows removal of 
genes that do not have an expression ratio above the negative SNR cut-off determined 
on a per-array basis. For each set of arrays used for Cluster analysis, only the genes that 
passed the negative SNR filter for all the arrays in the set were used for further analysis 
(filtered genes on  100% presence). Genes and arrays were then normalised by median 
centring  across genes  and  arrays.  The genes  were then  ordered with  a  1-dimensional 
self-organising map (SOM) algorithm. The number of nodes was set to the square root 
of the number of gene elements to the nearest whole number (e.g. V4320 = 65.6 =  6 6  
nodes).  This  ordering  was  used  to  control  the  orientation  of  nodes  generated  by 
hierarchical clustering, to take into account relationships between neighbouring clusters 
that  is  incorporated  in  the  SOM  algorithm.  Both  arrays  and  genes were  clustered  by 
average-linkage hierarchical  clustering  using the  uncentred Pearson  correlation  as the 
similarity metric (the algorithm by which the  similarity of the expression patterns are 
judged).  Hierarchical  clustering  does  not  take  into  account  temporal  relationship 
between array samples. The results were visualised with the software Treeview (Eisen 
et al., 1998).
Treeview  is the complement software to Cluster that allows visualisation  of clustered 
data. The data matrix table of expression ratios are represented graphically by a colour
85Materials and Methods
that is defined by the user: black for log2 expression ratios of 0,  increasingly positive 
log2 expression ratios with reds of increasing intensity,  and increasingly negative log2 
expression  ratios  with  greens  of increasing  intensity.  A  representation  of the  array 
sample and gene dendogram are appended to the coloured table indicates the nature of 
the relationships between the samples and the genes in the table.
2.5.2  Significance Analysis of Microarrays (SAM)
Significance  Analysis  of Microarrays,  a  program  run  as  an  Microsoft  Excel  add-in, 
allows  binary  comparisons  of  microarray  data,  a  gene-specific  Mest  that  gives 
significantly  regulated  genes,  and  includes  a  permutation  algorithm  that  allows 
estimation of error, termed the false discovery rate (FDR) (Tusher et al., 2001). From 
Cluster,  genes  that  passed  the  100%  presence  filter  (i.e.  genes  that  pass  SNR  filter 
across all arrays analysed) were separated into corresponding technical repeats to give 
two expression ratios per gene. This effectively doubles the number of arrays analysed, 
as each  array that formerly contained  gene duplicates are  separated  into two  separate 
technical  repeat  arrays  (Table  3.4).  These  normalised  log2  expression  ratios  across 
different  array  experiments  (mock-stimulated  control,  LPS  and  poly (I:C),  27  arrays), 
with the corresponding Genbank Accession numbers, were used as input data for SAM.
SAM was used to compare genes that were regulated by DCs in response to LPS and 
poly(I:C)  stimulus  compared  to  control  mock-stimulated  DCs.  The  comparisons  are 
shown  in Table 3.4. The estimation  of false discovery rate  (FDR)  is determined  by a 
user-defined Delta value, which also determines a threshold for identifying significantly 
regulated genes (Section 3.2.7.1). Delta values for each binary comparison were chosen 
to  maintain  a  consistent FDR  of approximately  5%  (i.e.  5  genes  in  every  100  genes 
found to be significantly regulated may be falsely identified). Lists of significantly up- 
and  down-regulated  genes  were  assembled  for  each  binary  comparison  (numbers  of 
genes shown  in Table 3.5),  which  is correlated to a graphical  output  in  Excel,  which 
plots  the  observed  (input)  data  values  of log2  expression  ratios  (y-axis)  versus  the 
expected (permuted) values (x-axis) (Figure 3.11).
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2.5.3  Mann-Whitney U (Wilcoxon-rank) test
MWU was used as a non-parametric statistical method to determine genes significantly 
regulated by DCs in response to LPS and dsRNA. The same input data for SAM was 
used  for  Mann-Whitney  U  (MWU)  analysis  in  Microsoft  Excel  (Table  3.4).  The 
expression ratio for each gene element was converted  into ranks relative to that gene 
element across the arrays in the binary comparison. A U-value for each array element 
was calculated by:
mock-stimulated DC samples (6)
Ri  = sum  of ranks  for the  ith  array element  in the  LPS-  or poly(I:C)-stimulated  DC 
samples
The probability associated with each Z-value was calculated in Excel (ZTEST), and the 
level of significance (chosen to be /?<0.0 1) determined the number of genes found to be 
significantly  regulated  by  DCs  in  response  to  LPS  or  poly(LC)  compared  to  control 
mock-stimulated DCs (Table 3.6).
Ui = ni,ini> 2  + ((nifi(ni,i+1))/2) -  Ri
Where:
tyi = the number of non-filtered expression ratios for the ith array element in the LPS- or 
poly(I:C)-stimulated DC samples (6)
r\ 2= the number of non-filtered expression ratios for the ith array element in the control
The U values were converted to the standard normal variable for the  ith array element 
(Z j) with the equation:
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2.6  Transcript confirmation of microarray data
Table 2.4 Primers used for transcript confirmation
Gene Sequence Product size Reference
TNFoc F: ATGAGCACTGAAAGCATGAT 232 bp
R: TGACTGCCTGGGCCAGAGGG
CCL2 F: TGTGCCTGCTGCT  CATAG 235 bp (Beck et al.,  1999)
R: GAAT  CCT  GAACCCACTT  CT  G
CD40 F: GTCAGTGCTGTTCTTTGTGC 502 bp Jenner RG
R: AAG  AT  GAT  GGGGAT  CACCAC
NF-kB F: ATT  GAAGT  GAT  CC  AGGC  AGC 529 bp Jenner RG
R: GCAGCTGGCAAAGCTTAGTA
CD86 F: GTAI I  I IGGCAGGACCAGGA 664 bp (Denfeld et al., 1995)
R: GCCGCTTCTTCTTCTTCCAT
CXCL12 F: AT  GAACGCCAAGGTCGTGG 175 bp
R: T  CT  GAAGGGCACAGTTTGG
a-tubulin F: ATGCGT  G  AGT  GC  AT  CT  CCA 298 bp Jenner RG
R: GGCATAGTTATTGGCAGCA
2.6.1  RT-PCR
RT-PCR  confirmation  was  performed  for  the  genes  shown  in  Table  2.4,  in  DCs 
stimulated with LPS and poly(I:C). Total RNA was purified by the methods detailed in 
Section 2.4.1  and contaminating DNA removed by treatment with DNase  I  (Promega, 
UK). The integrity and quantity of RNA was assessed by the Agilent Bioanalyzer RNA 
Nano  6000  Assay.  The  Stratagene  StrataScript™  First-Strand  Synthesis  System 
(Stratagene, USA) was used for cDNA synthesis. 3  pi of oligo-dT primers (0.1  pg/pl) 
were annealed to  5  pg of total  RNA  in  41  pi  final  volume by  heating  at  65°C  for  5 
minutes and cooled slowly at room temperature for 10 minutes. cDNA was synthesised 
in the following reaction:
RNA and primers 41 pi
1  Ox first-strand buffer 5pl
RNase Block Ribonuclease Inhibitor (40U/pl) lpl
dNTPs (100 mM) 2pl
StrataScript™ reverse transcriptase (50U/pl) lpl
The reaction was mixed gently and incubated at 42°C for 1   hour, and then terminated at 
95°C  for  5  minutes.  The  cDNA  was  cooled  on  ice  for  subsequent  use  in  PCR 
amplification immediately, or stored at -20°C until needed.
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cDNA was amplified for transcripts shown  in Table 2.4. The PCR conditions for the 
primers are shown  in Table 2.5. The PCR reactions were carried  out  in  200  pi  thin- 
walled tubes using Bioline BioTaq DNA polymerase (Bioline, UK):
cDNA  2pl
Primers  2 + 2pl
1  Ox NH4 buffer  5pi
MgCl2 (50 mM)  1.5pl
dNTPs (10 mM)  lpl
DNA polymerase  0.25pl
Distilled water  36.25pl
PCR  products  were  resolved  on  a  1.5%  agarose  gel  containing  0.2  pg/ml  ethidium 
bromide. Size of the PCR products were verified by GeneRuler™ DNA ladders 1   kb (to 
resolve 250 bp to  10 kb) and  100 bp (to resolve  80 bp to  1000 bp) (MBI  Fermentas, 
UK).
Table 2.5 PCR conditions for PCR amplification
Gene PCR conditions
TNFcc,
a-tubulin
1.  95°C 2 minutes
2.  2. 95°C 30 seconds
3.  57°C 30 seconds
4.  72°C 1  minute
5.  repeat steps 2-4 for 35 cycles
6.  72°C 2 minutes
CCL2 1.  94°C 2 minutes
2.  94°C 1  minute
3.  55°C 1  minute
4.  72°C 1  minute
5.  repeat steps 2-4 for 35 cycles
6.  72°C 5 minutes
CD40,
NF-kB
1.  94°C 2 minutes
2.  94°C 30 seconds
3.  58°C 30 seconds
4.  72°C 1  minute
5.  repeat steps 2-4 for 40 cycles
6.  72°C 5 minutes
CD86 1.  94°C 2 minutes
2.  94°C 1  minute
3.  55°C 1  minute
4.  72°C 1  minute
5.  repeat steps 2-4 for 40 cycles
6.  72°C 5 minutes
CXCL12 1.  95°C 2 minutes
2.  95°C 30 seconds
3.  55°C 30 seconds
4.  72°C 1  minute
5.  repeat steps 2-4 for 40 cycles
6.  72°C 2 minutes
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2.6.2  Real-time RT-PCR
Real-time  RT-PCR  confirmation  was  performed  for  TNFa  in  DCs  stimulated  with 
different virus treatments. Total RNA was purified by the methods detailed in Section 
2.4.1  and contaminating DNA removed by treatment with DNase I. The  integrity and 
quantity of RNA was assessed by the Agilent Bioanalyzer RNA Nano 6000 Assay.  1   pi 
of oligo-dT primers (0.5  pg/pl) were annealed to  100 ng of total  RNA  in  12  pi  final 
volume by heating at 70°C for 10 minutes and cooled slowly at room temperature for 10 
minutes. cDNA was synthesised in the following reaction:
The  reaction  was  mixed  gently  and  incubated  at  42°C  for  50  minutes,  and  then 
terminated at 70°C for 15 minutes. The cDNA was cooled on ice for subsequent use in 
PCR amplification immediately, or stored at -20°C until needed.
Specific TaqMan® primers and FAM™ dye-labelled probe for TNFa were purchased 
from  Applied  Biosystems  (Assays-on-Demand™  Gene  Expression  product  number 
HsOOl 74128). The PCR reaction for TaqMan® quantification were as follows:
The reactions were prepared in a 96-well optical reaction plate (ABgene,  Surrey, UK) 
and  run  on  the  ABI  Prism®  7000  Sequence  Detection  System  (Applied  Biosystems, 
USA). The PCR thermal cycling conditions were:
1.  50°C for 2 minutes
2.  95°C for 10 minutes
3.  95°C for 15 seconds
4.  60°C for 1  minute
5.  repeat steps 3 and 4 for 40 cycles.
RNA and oligo-dT primers 
5x first-strand buffer 
DTT (0.1M) 
dNTPs (100 mM)
Promega AMY reverse transcriptase (9U/pl)
1 2pl
4pl
2 pl
lpl
lpl
cDNA  diluted in RNase free water 
20x TNFa assay mix (primers and probe) 
2x TaqMan® Universal Master Mix buffer
22.5pl
2.5pl
25pl
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Quantification  of TNFa  transcripts  in  virus-exposed  DC  timecourse  samples  were 
calculated based on relative changes to samples at time zero using the comparative Cj 
(cycle  threshold)  method  (User Bulletin  #2,  Applied  Biosystems).  This  method  was 
adapted  so that  Ct  values  of virus-exposed  DC  samples  were  first  normalised  to  Cj 
values of control  mock-stimulated DC  samples at corresponding timepoints,  and then 
these  values  were  divided  by  the  respective  time  zero  virus-exposed  DC  samples  to 
derive fold changes of TNFa transcript relative to time zero.
2.7  Protein quantification of cytokine secretion
2.7.1  TNFa sandwich immunoassay
Transcript levels of TNFa were further investigated by measuring bioactive TNFa  in 
culture supernatants from DCs stimulated with LPS, poly(I:C), and exposed to different 
virus  treatments.  Sandwich  enzyme-linked  immunosorbent  assay  (ELISA)  for TNFa 
was  performed  with  a  commercial  kit  from  eBioscience,  and  using  Maxisorp  Flat- 
bottom  96-well  plates  (Nunc,  UK).  Phosphate  buffered  saline  (pH  7.0)  with  0.05% 
Tween  20  (Sigma-Aldrich,  UK)  was  used  for  all  washes,  and  the  experiment  was 
performed  according  to  the  manufacturer’s  protocol.  Biotin-conjugated  anti-human 
antibody  was  detected  by  avidin-horseradish  peroxidase  (HRP)  linked  detection 
antibody, and this bound conjugate was allowed to react to tetramethylbenzidine (TMB) 
substrate  solution.  After the  reaction  was  stopped  by  addition  of sulphuric  acid  (2N 
H2SO4), absorbances were read at 450 nm on a microplate reader (Dynex Technologies, 
UK). TNFa concentrations were calculated by interpolation from a standard curve and 
all determinations were performed in triplicate.
2.7.2  FAST®Quant MicroSpot ELISA
A novel cytokine array platform from Schleicher & Schuell BioScience, Germany, is a 
high throughput system for multiplex cytokine quantification. The FAST®Quant Human 
II  system allows the simultaneous detection of 10 different cytokines:  IL- 8 (CXCL8), 
GM-CSF,  IL-IO, IL-lp, IL-12p70, IL-2, MCP-1  (CCL2), IL-4, RANTES (CCL5), and 
IL-6 .  The  10  cytokines  are  spotted  in  triplicate,  along  with  6  “dummy”  controls,  in 
nitrocellulose,  making  up  36  spots  per reaction  pad.  Each  assay  consists  of 4  slides 
containing  16  reaction  pads each,  making  up  a total  of 64  reaction  pads.  A  cytokine
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cocktail mixture of a fixed concentration of the  1 0 cytokines is provided with the assay, 
and diluted to form a titration curve with  8 dilutions. This allows the assay of a further 
56  individual  samples,  enabling  the  simultaneous  measurement  of the  levels  of  1 0  
different  cytokines  in  triplicate.  DC  culture  supernatants  stimulated  with  LPS, 
poly(I:C), and exposed to different virus treatments were assayed for the presence of the 
1 0 cytokines.
Biotinylated  anti-cytokine  antibodies  linked  to  streptavidin-Cy5  (Amersham 
Bioscience,  UK) enabled cytokine quantification by fluorescence  intensity. The slides 
were scanned on the GenePix 4000B microarray scanner at  10 pm resolution. Images 
from  the  4  slides  were  “stitched”  together  using  ArrayVision™  FAST®  version  8.0 
software (Imaging Research Inc). A spot-finding algorithm was applied, and a “protocol 
editor”  file  with  details  of assayed  cytokines  and  titration  curve  generated  standard 
curves  for  the  1 0  cytokines  which  correlated  fluorescence  intensities  to  cytokine 
concentrations.  The  data  of  fluorescence  intensities  and  converted  cytokine 
concentration values were exported to Microsoft Excel, and further analysed to adjust 
for saturated fluorescence intensities by extrapolating from the standard titration curves.
2.7.3  Type I interferon sandwich immunoassay
To  assess  the  contribution  of secreted  type  I  IFNs  in  the  induction  of the  common 
antiviral responses in DCs, bioactive IFNa and IFN(3 in culture supernatants from DCs 
exposed to different virus treatments were investigated. Sandwich ELISA for IFNa and 
IFN{3  were  performed  with  two  commercial  kits  from  PBL  Biomedical  Laboratories. 
The  human  IFNa  ELISA  kit  is  specific  for all  13  subspecies  of IFNa  (IFN-aA,  a2, 
aA/D,  aB2,  aC,  aD,  aG,  aH,  al,  aJ,  aK,  a4b,  and  aWA).  All  the  reagents  were 
supplied  with  the  kit,  and  the  experiment  was  performed  according  to  the 
manufacturer’s  protocol.  Absorbances  were  read  at  450  nm  on  a  microplate  reader 
(Dynex Technologies). IFNa and IFNp concentrations were calculated by interpolation 
from standard curves and all determinations were done in triplicate.
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Chapter 3 
Dendritic cell activation and differentiation 
Introduction
The  activation  and  differentiation  of  dendritic  cells,  commonly  referred  to  as  the 
dendritic  cell  “maturation  program”,  was  profiled  using  DNA  microarrays.  Current 
investigations  into  dendritic  cell  maturation  are  assessed  by  a  number  of biological 
endpoints which  are measured at the proposed  end of the  maturation,  24 or 48 hours 
after dendritic cell stimulation. Such outcomes include upregulation of the cell surface 
expression  of  antigen  presenting  molecules,  co-stimulatory  molecules,  adhesion 
molecules  and  chemokine  receptors,  morphological  changes  in  the  acquirement  of 
dendritic  processes,  loss  of phagocytic  activity,  the  increased  capacity to  stimulate T 
cells, and the secretion of inflammatory and chemotactic cytokines, including polarising 
cytokines to mediate a polarised T cell response. We propose that measurement of these 
outcomes  at  the  end  of the  maturation  process  belie  its  complexity.  Transcriptional 
profiling using DNA microarrays of dendritic cells throughout this maturation process 
will  allow more detailed  understanding of dendritic cell activation and differentiation, 
thereby revealing in greater detail the intricacies of dendritic cell function.
Dendritic  cell  maturation  was  investigated  using  characteristic  maturation-inducing 
agents,  lipopolysaccharide  (LPS)  and  polyinosinic-polycytidylic  acid  (poly(I:C)),  a 
synthetic analogue of double-stranded (ds)RNA. These are ligands for two members of 
the toll-like receptor (TLR) family, TLR4 and TLR3  respectively, both of which share 
similar downstream signalling components. The time-dependent nature of dendritic cell 
maturation  indicate  the  importance  of monitoring  transcriptional  changes  over  time, 
rather than simply at the end of maturation. This has revealed distinct stages of dendritic 
cell maturation,  defined  by transcriptional  profiles, which correspond to dendritic cell 
phenotype as they progress through activation and differentiation.
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Results 
3.1 Growing and characterising dendritic cells
Dendritic cells (DCs) were cultured from monocytes isolated from peripheral blood of 
healthy donors, or buffy coats obtained from the National Blood Service. Immature DCs 
were  differentiated  from  monocytes  in  the  presence  of GM-CSF  and  IL-4  (Section 
2.2.1). The phenotype of in vitro-derived immature DCs are similar to those of myeloid 
DCs,  which  are  CDlahieh  and  CDM',  HLA-DR+,  CD8 6low  (Figure  3.1A,  B).  Upon 
stimulation with maturation-inducing agents such as LPS and poly(I:C), immature DCs 
undergo phenotypic  changes resulting  in  upregulation  of HLA-DR and CD8 6 (Figure 
3.IB). Titration of LPS and poly(I:C) was carried out to determine the optimal dose for 
HLA-DR and CD8 6 upregulation (Figure 3.1C), without compromising the viability of 
the  DCs  (assessed  by  the  size  and  geometry  of cells  by  flow  cytometry,  data  not 
shown).  The  antigen  doses,  100  ng/ml  for  LPS,  25  pg/ml  for  poly(LC),  resulted  in 
similar upregulation of HLA-DR and  CD8 6 as determined by flow cytometry (Figure 
3.IB, C, D).
3.2 Gene expression analysis of DC maturation
3.2.1  Sample preparation
Immature dendritic cells differentiated from buffy coat monocytes cultured in GM-CSF 
and IL-4 were used for all array experiments. LPS and poly(I:C) were added on day 7 to 
immature  DCs  to  induce  maturation  (Section  2.2.1).  Alternatively,  an  equivalent 
volume of culture medium was added as a control for mock-stimulated DCs. Cells were 
harvested over a 24-hour timecourse. Each timecourse consisted of cells from the same 
buffy coat preparation.  Biological  replicates at 0,  5,  and  18  hours  post-stimulus were 
performed to confirm reproducibility of the arrays and to control for inherent biological 
variability between different donor sources of these buffy coats (Table 3.1). Total RNA 
was  extracted,  DNase  treated,  and  quality-  and  quantity-assessed  by  Agilent 
Bioanalyzer RNA  6000 Nano Assay  (Figure  3.2A,  B).  From  total  RNA,  mRNA was 
purified  (Figure  3.2C),  reverse transcribed to cDNA  and  labelled  with Cy5. This was 
hybridised to arrays together with equivalent amounts of Cy3-labelled reference cDNA.
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Figure 3.1  Immunophenotype of immature and mature dendritic cells
A  (i)  Immature  DCs  are  gated  by  forward  and  side  scatter  (>90%  of  cells  within  gated 
population), and are (ii) CD1ah'9h (red histogram) and (iii) CD14-  (red histogram).
B Mature DCs, 24 hours after stimulation with LPS (100ng/ml) or poly(l:C) (25pg/ml) upregulate 
surface  expression  of  HLA-DR  and  C86  (grey  histograms),  compared  to  mock-stimulated 
control DCs (black unfilled histogram).
(isotype controls shown by dotted histogram for all plots)
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Figure 3.1  Immunophenotype of immature and mature dendritic cells (continued)
C  Escalating  amounts  of  LPS  (3ng/ml,  black  histogram;  10ng/ml,  red  histogram;  30  ng/ml, 
green  histogram;  100 ng/ml,  blue filled  histogram),  and  poly(l:C) (2.5 pg/ml,  black histogram;  5 
pg/ml, red histogram;  10|ag/ml, green histogram; 25|ag/ml, blue filled histogram) lead to different 
degrees of CD86 upregulation.
D  Titration  of amounts of LPS  and  poly(l:C)  show  peak CD86 surface  expression  at  100ng/ml 
for LPS, and 25pg/ml for poly(l:C).
(isotype controls shown by dotted histogram for all plots)
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Table 3.1  Source of cells for DC maturation timecourse arrays
Buffy
coat
Stimulus Timepoints HGMP array Reference 
batchf
1 Control
Poly(l:C)
0, 5, 18h 
0, 5,  18h
Human cDNA array version 1  
Human cDNA array version 1
1
2 Control
Poly(l:C)
LPS
0, 2, 5, 10, 18, 24h 
0, 2, 5, 10, 18, 24h 
0, 2, 5, 10, 18, 24h
Human cDNA array version 1 
Human cDNA array version 1  
Human cDNA array version 1
2
3 LPS 0, 5, 18h Human cDNA arrav version 2 3
^Reference  RNA  consisted  of a  mixture  of  mRNAs  extracted  from  different  human  cell  lines 
(see Table 3.2)
B
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Figure 3.2 Dendritic cell RNA as measured by Agilent Bioanalyzer RNA 6000 NanoAssay
A total RNA, showing 18S and 28S ribosomal peaks, and no contaminating DNA 
B “virtual” electrophoretic gel of total RNA with bands corresponding to ribosomal RNA 
C messenger RNA purified from total RNA.
Quantification of samples is achieved by comparison with a known concentration of RNA ladder 
(lane L), which contains distinct sized fragments resulting in 6 peaks, seen in the gel in B.
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3.2.2  Creating a common reference for gene expression profiling
A  common  reference  RNA  approach  was  used  for  the  two-colour  microarrays  as 
previous studies have shown that this method allows multi-comparative analyses across 
different  samples  (Introduction  Section  1.4.2).  The  microarrays  used  for  this  study 
contain  a  broad  range  of human  cDNA  probes  for  different  cell  types  and  gene 
functions.  It  is  therefore  important  that  a  reference  RNA  is  representative  of this 
spectrum,  in  order that the number of detectable  expression  ratios  are  maximised  for 
each sample. The reference RNA was designed to cover a range of different cell types 
to  broaden  the  range  of  transcripts  represented.  The  relative  composition  of  the 
reference RNA mixture used is shown in Table 3.2.
Large batches (5xl07 to 108 cells) of each cell type were grown to minimise differences 
in  RNA  abundances  in  different  batches  of reference  RNA.  In  total,  3  batches  of 
reference RNA  were made from these cells.  Comparison  of sample  arrays hybridised 
with  different  batches  of  reference  RNA  gave  high  correlation  ratios  (median 
correlation ratio 0.89, standard deviation (SD) 0.11) (Figure 3.3 and Figure 3.5).
Table 3.2 Composition of the common reference RNA*
Cell line Cell type Composition (%)
HeLa Human cervical epithelial cells 25
U937 Human monocytes 25
Ramos Human B cell 15
SS-CEM Human T cell 15
HuH7 Human hepatoma 10
BMVEC Human breast microvascular endothelial cells 5
MRC5 Human embryonic lung fibroblast 5
t This reference mixture was used for all dendritic cell array experiments
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Figure 3.3 Correlation coefficients of biological repeat arrays
Biological  replicates  of  dendritic  cell  experiments  (mock-stimulated,  LPS-  and  poly(l:C)- 
stimulated DC timecourses at t=0, t=5, t=18, from different buffy coat preparations (as indicated 
in Table 3.1) hybridised with 3 different batches of reference RNA were compared to assess the 
correlation  between  batches  of  reference  RNA.  The  median  correlation  coefficient  was  0.89 
(blue square),  standard  deviation  (SD)  0.11.  The  box indicates the  25th and  75th quartiles,  the 
whiskers the range of correlation coefficients.
3.2.3  Filtering noise from data
Before  array  data  from  multiple  samples  can  be  compared,  high  variance  and  low 
intensity spot data need to be removed. Each element on the arrays is quantified by two 
intensity  values  at  635  nm  (Cy5  emission  -  sample)  and  532  nm  (Cy3  emission  - 
reference) as detected by two PMTs. The feature intensity measurements for each spot 
have  corresponding  background  intensity  measurements.  The  signal-to-noise  ratio 
(SNR) is derived from the quotient of feature intensity divided by background intensity 
for the two wavelengths. The microarrays contain a set of control genes that were used 
for data filtering (Table 3.3). These control genes are replicated within each block of the 
arrays,  resulting  in  24  replicates  of control  genes.  These  serve  as  a  robust  internal 
control  for  each  array  hybridisation  (Figure  3.4).  Negative  controls  and  yeast  gene 
probes were selected as they gave consistently low or background intensity values  for 
both wavelengths. The SNRs of these negative controls were averaged over 24 repeats 
spotted on the array to give an averaged value for filtering the remaining elements on 
the array. The gene elements with either Cy5 or Cy3  SNR greater than the filter values 
were  interpreted  as  having  a  positive  signal  above  background,  and  were  used  for 
further analysis. Each array was filtered independently, so the genes selected for further 
analysis from each array were only dependent on experimental variation that manifested 
in that particular array hybridisation experiment.
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Table 3.3 Control genes present on HGMP cDNA arrays version 1  and version 2
Control genes - cDNA array version 1 Control genes -  cDNA array version 2
Positive control 1 Human Positive control Total human genomic DNA
Positive control 2 Human
Housekeeping gene 1 Housekeeping gene 1 Actin gamma 1
Housekeeping gene 2 Housekeeping gene 2 Glyceraldehyde-3-phosphate dehydrogenase
Housekeeping gene 3 Housekeeping gene 3 Ubiquinol-cytochrome c reductase core protein II
Housekeeping gene 4 Housekeeping gene 4 Casein kinase II beta polypeptide
Housekeeping gene 5 Housekeeping gene 5 EST highly similar to NY-REN-37 antigen
Housekeeping gene 6 Housekeeping gene 6 Human hydroxymethyl glutaryl-CoA lyase
Housekeeping gene 7 Housekeeping gene 7 Neuroblastoma RAS viral oncogene homolog
Housekeeping gene 8 Housekeeping gene 8 Eukaryotic translation initiation factor 4A, isoform 1
Housekeeping gene 9 Housekeeping gene 9 Ubiquinol-cytochrome c reductase core protein II
Housekeeping gene 10 Housekeeping gene 10 Enoyl Coenzyme A hydrolase, short chain 1
Housekeeping gene 11
Dynamic range control 1 relative abundance 3.3% - Yeast Dynamic range control 1 Yeast Intergenic Region from Chrom XI
Dynamic range control 2 relative abundance 1%  - Yeast Dynamic range control 2 Yeast Intergenic Region from Chrom XI
Dynamic range control 3 relative abundance 0.1% - Yeast Dynamic range control 3 Yeast Intergenic Region from Chrom VII
Dynamic range control 4 relative abundance 0.033% - Yeast Dynamic range control 4 Yeast Intergenic Region from Chrom VII
Dynamic range control 5 relative abundance 0.01% - Yeast Dynamic range control 5 Yeast Intergenic Region from Chrom XII
Dynamic range control 6 relative abundance 0.0033% - Yeast Dynamic range control 6 Yeast Intergenic Region from Chrom XII
Negative control 1 Arabidopsis thaliana protein G1 p Negative control 1 Arabidopsis thaliana protein G1p
Negative control 2 Negative control 2 Poly-dA oligonucleotide
Negative control 3 50%DMSO Negative control 3 Spotting buffer
Negative control 4 Bacterial Negative control 4 Bacillus subtilis gene
Negative control 5 Bacterial Negative control 5 Bacillus subtilis gene
Ratio control  1 1:3 -  Yeast Ratio control 1 Yeast Intergenic Region from Chrom XII
Ratio control 2 3:1 -  Yeast Ratio control 2 Yeast Intergenic Region from Chrom XII
Ratio control 3 1:10-Yeast Ratio control 3 Yeast Intergenic Region from Chrom XII
Ratio control 4 10:1 -  Yeast Ratio control 4 Yeast Intergenic Region from Chrom XIII
The genes in red are the ones used to determine negative filter values for Cy5 and Cy3 SNRs. 
All the control genes, except the positive controls, were spotted on every subgrid of the HGMP 
cDNA version  1  array,  and on every other subgrid of the  HGMP cDNA version 2 array (Figure 
3.4),  resulting in  24 copies of each  negative control gene.  The average Cy5 and  Cy3  SNR for 
the  negative  control  genes  (9  for  HGMP  cDNA  array  version  1,  15  for  HGMP  cDNA  array 
version  2) were  averaged,  and  used  as  a  filter  SNR for the  remaining  gene  elements  on  the 
arrays.
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HGMP cDNA array version 1 HGMP cDNA array version 2
MC1, MR1  MC2, MR1
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Figure 3.4 Layout of HGMP cDNA version 1  and 2 array
The  HGMP  cDNA version  1  arrays  were  used  for dendritic  cell timecourse experiments  from
buffy coat preparations  1  and 2 (Table 3.1). The layout of the array is such that gene elements 
spotted in metacolumn (MC) 2 are the same as the gene elements spotted in MC1. The control 
genes (shown in red) were spotted on the top row of every subgrid,  resulting in 24 control gene 
data points, to serve as a monitor of hybridisation conditions across the array.
The  HGMP  cDNA version  2  arrays  were  used  for dendritic cell timecourse experiments  from
buffy  coat  preparations  3,  and  array experiments  in  Chapter 4. Here,  gene elements  in  MC3
and  MC4  are  the  same  as  the  gene  elements  in  MC1  and  MC2  respectively.  The  range  of 
control  genes (in  red) were spotted on the top row over two subgrids,  giving 24 data points for 
all the negative control genes.
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The signal to background filtering was applied on a per array basis to the entire dataset. 
On  average,  filtering  removed  15%  of  the  array  elements  (1383  gene  elements, 
SD=10.4,  number  of arrays  (n)  =  45).  To  confirm  that  the  filtering  criteria  actually 
reduce experimental variation, the effect on the correlation  between the time-matched 
biological  replicates  (mock-stimulated, LPS-  and  poly(I:C)-stimulated  DCs  at  Oh,  5h, 
18h) and time zero replicates (mock-stimulated, LPS- and poly(I:C)-stimulated DCs at 
Oh,  Figure 3.5A) were examined.  For  12 of 15  (80%)  possible pair-wise comparisons 
for  time  zero  replicates,  the  filtered  data  are  more  correlated,  hence  less  variable, 
compared to the unfiltered data (Figure 3.5B).  The 3  comparisons where filtering did 
not  improve  correlation  were  comparisons  between  experiments  hybridised  on  two 
different  HGMP  arrays  (cDNA  array  version  1   and  version  2,  Figure  3.5A  and  B, 
shown by asterixes),  for reasons that remain difficult to explain.  However,  it is noted 
that  filtering  of these  arrays  does  not  adversely  affect  correlation.  To  confirm  this 
improvement in correlation was not merely an effect of removing data, equal numbers 
of random  genes  were  filtered  from  the  data.  Removing  random  genes  does  not  to 
improve correlation coefficients above those of unfiltered data, demonstrating that the 
filtering process selectively removes experimental variation.
The correlation between filtered log2 expression ratios for all replicate experiments was 
calculated.  This  included  15  pair-wise comparisons between the time zero  repeats  (6  
time zero arrays, Figure 3.5A, B), and  6 pair-wise comparisons between time-matched 
repeats  at  5  hours  and  18  hours  (12  arrays,  Figure  3.5B).  This  totalled  21  different 
pairwise  comparisons.  The  average  correlations  for all  biological  replicates was  0.84 
(n=21 different pairwise comparisons, from 18 biological replicate arrays) (Figure 3.6).
The consistency of the high correlation coefficients between biological replicates show 
that DCs derived from different buffy coat preparations are cross-comparable,  both as 
immature mock-stimulated  DCs (correlation  between  array experiments at time zero), 
and  in  their responses to  LPS  and  poly(I:C) (correlation  between time-matched  array 
experiments  at  t=5  and  t=18).  The  filtering  method  used  is  effective  at  removing 
experimental variation that arises from hybridisation conditions and  inefficient Cy-dye 
labelling, and is effective at removing noisy data by improving correlation coefficients 
between  arrays  of experimental  replicates.  This  forms  a  good  basis  for  further  array 
analysis.
102Dendritic cell activation and differentiation
Figure 3.5 Filtering microarray data by signal to noise ratio (next page)
A Histograms showing distribution of log2 median of ratios for the six time zero arrays,  and the 
corresponding  scatter plots showing correlation  between the  arrays.  The orange  scatter plots 
show correlation between dendritic cells derived from the same buffy coat preparations, which 
tend to be higher.  LPS t=0 (3)  is hybridised on the  HGMP cDNA version  2 array,  resulting  in 
lower  correlation  when  compared  to  other  time  zero  arrays.  The  asterixes  show  the  three 
pairwise comparisons where filtering did not improve correlation (Section 3.2.3).
B  Correlation  coefficients  before  and  after  filtering  for  all  21  pairwise  comparisons,  15 
comparisons  between  time  zero  arrays  and  6  comparisons  between  time-matched  arrays. 
Comparison of the correlation coefficients after filtering to random removal of the same number 
of genes  shows that  18  out of 21  total  correlation  coefficients  improved  by  selective filtering 
based  on  Cy5  and  Cy3  SNR  of negative  genes.  The  3  comparisons that did  not  improve 
with  selective  filtering  (asterixed) were  arrays  hybridised  on  version  2  arrays  (Section 
3.2.3).
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Figure 3.6 Correlation between time zero and time-matched array replicates
Filtered  log2  expression  ratios  of the  15  pairwise  comparisons  of 6  time  zero  arrays,  and  9 
comparisons  between  the  9  time-matched  arrays,  were  compared  to  generate  correlation 
coefficients.  Correlation  coefficients  of  time  zero  arrays  (median  0.840,  SD  0.10)  and  time- 
matched  arrays  (median  0.836,  SD  0.11)  were  very  similar.  Blue  squares  indicate  median 
correlation coefficient, box marks the 25th and 75th percentiles.
3.2.4  Cluster analysis of dendritic cell timecourse
Hierarchical  clustering  was  used  to  assess  similarity  in  filtered  gene  expression 
measurements  of dendritic  cell  stimulation  over  24  hours.  The  3  conditions  (mock- 
stimulated,  LPS-,  and  poly(I:C)-stimulated  DCs,  9  arrays  from  each  condition)  were 
clustered together (Figure 3.7A). The filtered log2 median of ratios from 27 arrays were 
median  centred  and  both  the  arrays  and  genes  clustered  using  average  linkage 
hierarchical clustering as implemented in the program Cluster (Eisen et al.,  1998). The 
sample  (array)  cluster dendogram generated relates  correlation  in the  gene  expression 
patterns  of two  linked  samples  to  vertical  branch  lengths,  where  the  total  summed 
vertical branch lengths between samples are proportional to the distance, or correlation, 
in gene expression between the samples. When all 27 arrays are clustered together, the 
dendogram  differentiates  control  mock-stimulated  DCs  from  LPS-  and  poly(I:C)- 
stimulated  DCs  (Figure  3.7A).  In  addition,  mock-stimulated  DCs  do  not  follow  a 
temporal ordering, in contrast to LPS- and poly(I:C)-stimulated DCs. This shows mock- 
stimulated DCs do not significantly alter their gene expression profiles over 24 hours in 
culture.  This  is  also  reflected  in  the  high  correlation coefficient between  36  pairwise 
comparisons of the 9 control mock-stimulated DC experiments over 24 hours (average 
correlation coefficient 0.915, SD 0.02, Figure 3.17B).  Correlation coefficients of LPS- 
stimulated  DCs  over  24  hours  (median  correlation  coefficient  0.72,  SD  0.15)  and
-
Time zero  Time-matched 
arrays  arrays
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poly(I:C)-stimulated  DCs over 24 hours (median correlation coefficient 0.81, SD 0.08) 
were  significantly  lower  (p<10‘8,  Figure  3.7B).  Both  LPS-stimulated  and  poIy(I:C)- 
stimulated DC arrays at time zero also cluster with the control mock-stimulated arrays 
(Figure 3.7A). As mentioned in Section 3.2.3, the slight discrepancy of the experiments 
hybridised on HGMP version 2 arrays appear as outliers within the temporal clusters, 
but  are  noted  to  still  cluster within  the  correct  temporal  ordering  (labelled  as  LPS3 
arrays, Figure 3.7A, Figure 3.8).
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Figure 3.7 Relationship between DC timecourse arrays
A  Dendogram  of  DC  timecourse  arrays  27  arrays  from  the  3  conditions  were  clustered 
together. Control mock-stimulated DC arrays cluster together with LPS and poly(l:C)-stimulated 
t=0  arrays,  and  LPS-  and  poly(l:C)-stimulated  arrays  cluster  separately,  following  a  temporal 
order.
B Correlation between control mock-stimulated, LPS, and poly(l:C) arrays
Log2  gene  expression  ratios  of  mock-stimulated,  LPS-  and  poly(l:C)-stimulated  arrays  were 
compared,  36  pairwise  comparisons  for  9  arrays  for  each  condition.  Blue  squares  indicate 
median correlation coefficient, box shows 25th and 75th percentiles. Correlation between control 
mock-stimulated  DC arrays is significantly higher than correlation  between  LPS- and  poly(l:C)- 
stimulated DC arrays over 24 hours (p<10'8, calculated by the standard Student’s paired f-test).
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Because  of the  high  correlation  coefficient  between  mock-stimulated  DC  timecourse 
arrays, these experiments can be treated  as biological  replicates.  They were excluded 
from further cluster analysis to prevent disproportionate skewing of the sample cluster 
tree. The remaining 18 LPS- and poly(I:C)-stimulated DC timecourse experiments over 
24 hours were filtered for the gene elements that passed the SNR filtering criteria in all 
18 array experiments, resulting in the cluster analysis of 5108 genes. These genes and 
arrays were median centred and clustered. The dendogram generated clearly reflects a 
temporal ordering in the arrays from 0 to 24 hours post stimulation (Figure 3.8).
e e « 0  4DCDC0 4*4* 
e e o o N M i n i n n i n H H H H r i H N N
coe\iGMHcsic\i(oeMGViHes»CMCoHeMCMeM«M
P hP mH H P hHPmP hH H P hHPmHPmHPIhH
Time Oh 24h
Figure 3.8 Dendogram of LPS-stimulated and poly(l:C)-stimulated DC timecourses
Hierarchical clustering of 9 LPS-stimulated DC arrays and 9 poly(l:C)-stimulated DC arrays over 
a 24-hour timecourse generated this sample dendogram. The DC samples cluster in a temporal 
ordering  according  to  the  times  at  which  the  DC  RNA  samples  were  harvested,  and  the 
ordering is independent of LPS or poly(LC) treatment.
3.2.5  Temporal ordering of transcriptional changes during DC 
“maturation”
The  dendogram  reveals  that  transcriptional  responses  of dendritic  cells  to  LPS  and 
poly(I:C)  are  very  similar,  with  greater  time-dependent  relationships  than  diversity 
generated  by  LPS-  and  poly(I:C)-dependent  maturation  responses.  Both  TLR4  and 
TLR3 share common intracellular signalling pathways that involve the adaptor proteins 
MyD8 8 and TRIF, resulting in the activation of similar transcription factors, which help 
to explain the common response.  This also confirms the equivalence of the two stimuli 
in  terms of comparable dosage  effecting  similar  levels  of transcriptional  responses  in 
DCs (Figure 3.IB).
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The  branch  structure  of the  tree  suggests  there  may  be  distinct  stages  in  the  DC 
maturation  process:  the  first cluster groups  together  samples  between  0  and  2  hours, 
showing  that  gene  expression  patterns  of DCs  responding  to  LPS  and  poly(I:C)  are 
more similar at early timepoints than at later timepoints; the next cluster groups together 
samples  between  5  and  10  hours  post  stimulation,  corresponding  to  an  intermediate 
“transitional” stage of DC maturation; the last cluster groups together samples between 
18 and 24 hours post stimulation, reflecting similarity in the gene expression profiles of 
fully  mature DCs.  The  ordering  of the  samples therefore  reflects the  time-dependent 
“maturation” response of dendritic cells, and allows the identification of defined stages 
of the DC maturation response.
3.2.6  Distinct transcriptional signatures delineates stages of DC 
maturation
The program Treeview (Eisen et al.,  1998) was used to visualise the expression pattern 
of the filtered set of 5108 genes expressed across the  18 LPS- and poly(I:C)-stimulated 
dendritic cell  arrays (Figure 3.9). This analysis shows  how the  genes vary  across the 
timecourse  during  the  process  of DC  maturation.  Genes  cluster  together  by  similar 
function  and/or  similar  expression  across  the  arrays  (termed  gene  expression 
signatures),  a  number  of which  can  be  identified  in  this  dataset.  The  kinetics  of 
expression  of gene  groups  have  important  functional  implications  for  dendritic  cell 
responses to antigens.
Figure 3.9 Hierarchical clustering LPS- and poly(l:C)-stimulated DC arrays (next page)
Genes in the 18 LPS- and poly(l:C)-stimulated DC arrays were filtered for genes which passed 
the  SNR  filter  in  all  18  arrays,  and  the  resulting  5108  genes  and  18  arrays  were  clustered 
together with  hierarchical  clustering.  The  dendrogram  on  the  left  represents  the  relationship 
between genes in terms of their expression pattern.  Gene  expression  is  shown as a  pseudo­
coloured  representation  of  log2  expression  ratio  with  red  being  above  and  green  below  the 
row/column  median  level  of  expression  (set  to  0)  as  shown  by  the  scale.  The  sample 
dendogram is shown enlarged in Figure 3.8. The coloured bars to the right mark the position of 
gene  function  clusters  (gene  expression  signatures),  which  vary  in  expression  across  the 
dataset.
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3.2.7  Statistical analysis of transcriptional signatures
In  order  to  more  specifically  define  subsets  of genes  that  are  characteristic  of DC 
maturation  stages, the genes were  analysed according to the three  maturation  phases, 
evident from the tree structure of the DC timecourse arrays (Figure 3.8). From this data, 
DC maturation can therefore be classified into three stages, where early activated DCs 
combine gene expression data between 0 and 2 hours post-stimulation, transitional DCs 
combine gene  expression  data between  5  and  10  hours  post-stimulation,  and  mature 
DCs  combine  gene  expression  data  between  18  and  24  hours  post-stimulation.  This 
classification  and  temporal  grouping  allows  statistical  comparison  of  LPS-  and 
poly(I:C)-stimulated DC arrays to time-matched control mock-stimulated DC arrays, as 
we have previously determined that mock-stimulated DCs are  largely transcriptionally 
stable  over  24  hours.  Using  two  statistical  analysis  methods,  significantly  regulated 
genes  in  DCs  responding  to  LPS  and  poly(I:C)  can  be  identified.  As  DCs  are  so 
responsive  to  external  stimuli,  and  even  culture  in  vitro  over  time  can  result  in 
phenotypic changes,  it is important that LPS- and poly(I:C)-stimulated DC timecourse 
arrays  are  compared  with  time-matched  mock-stimulated  DC  arrays.  This  should 
control  for  background  transcriptional  changes  that  occur  with  time  but  that  are 
independent of the stimuli received.
3.2.7.1  Significance Analysis of Microarrays
Significance Analysis of Microarrays  (SAM)  functions  as  a  Microsoft  Excel  Add-in, 
and was developed as a tool for discovering significantly up- and down-regulated genes 
in  microarray  data  (Tusher et  al.,  2001).  A  general  issue  with  statistical  analyses  of 
microarray data is that most statistical tests make an assumption  about the data being 
normally distributed, and that genes are independent variables. This  is clearly not the 
case for microarray data, as genes cannot be assumed to be independent entities, as they 
can co-vary and can be co-regulated. In addition, the imbalance between the number of 
genes  that  are  variable  (in  magnitude  of  thousands),  compared  to  the  number  of 
observations  in  terms  of experimental  samples  (often  in  tens),  will  result  in  a  large 
number of genes being identified as significantly regulated just by chance. For example, 
a  99%  confidence  level  in  a dataset  of 5000  genes  will  falsely  identify  50  genes  as 
significantly regulated. SAM functions as a gene-specific Mest to find significantly up- 
and down-regulated genes between samples, but has an advantage in that it incorporates 
a method to estimate the percentage of genes identified by chance, the false discovery
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rate (FDR). The FDR is generated by balanced permutations of the measurements blind 
to  the  way  the  data  is  classified  (equivalent  to  the  null hypothesis).  Within  SAM,  a 
threshold (termed Delta) can be defined that determines the number of genes identified 
as  significantly  up-  or  down-regulated.  Delta  is  linked  to  the  FDR.  The  higher  the 
threshold  for  discovery  of  significant  genes,  the  smaller  set  of genes  identified  as 
significantly regulated,  but consequently, the  lower the  FDR,  i.e.  a smaller number of 
genes that are likely to be called significant based on chance. This relationship between 
the number of significant genes discovered, the threshold (Delta) and the FDR is shown 
in  Figure  3.10,  for  one  of the  comparisons  between  poly(I:C)-stimulated  DCs  and 
mock-stimulated DCs at a time interval.
Median FDR 
(Left axis)
Number of significant 
genes (Right axis)
Delta
Figure 3.10 Relationship between Delta, FDR and significant genes in SAM
For a  range of delta  values,  the effects on  FDR  (blue diamonds,  left axis)  and  the  number of 
significant genes called  (red  squares,  right axis) are shown. As Delta increases, the number of 
significant  genes  called  decreases,  approximately  exponentially.  As  Delta  increases,  FDR 
decreases to a minimum, after which increasing Delta results in an increasing FDR.
For  analysis  of  significantly  up-  and  down-regulated  genes  in  LPS-  and  poly(I:C)- 
stimulated  DCs  compared  to  control  mock-stimulated  DCs  at  the  defined  stages  of 
maturation, a FDR of 5% was chosen. This means  1   in 20 genes identified by SAM as 
differentially regulated between two conditions will be a false discovery. This seemed 
an  acceptable  compromise  between  the  number  of  significant  genes  found  and  the 
number  of  genes  that  were  found  by  chance  (Figure  3.10  and  Table  3.5).  The 
relationship between Delta, FDR and number of significant genes called for each binary
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comparison is unique to the comparison in question, therefore having a standard FDR 
for each binary test allowed comparison between the sets of significant genes that were 
generated for different comparisons.  The comparisons analysed by SAM are shown in 
Table 3.4.
SAM  requires a minimum  of four gene measurements  in  each  group to  generate the 
balanced  permutations  for calculating  FDR.  To  facilitate this  analysis  we  partitioned 
each array into two, based on the duplicate gene spots, to give two measurements per 
gene. Partitioning the data in this way results in six measurements per gene within each 
group.  Because  of this  strategy,  only the  genes where both  duplicates on  the  arrays 
passed the SNR filter in all 27 arrays were analysed in SAM. The array data across the 
27 arrays (Figure 3.7A) were filtered and median centred in  Cluster.  This normalised 
data was used as the initial input data in SAM. There were 4320 genes that passed the 
SNR filter across all 27 arrays, and of these,  1762 genes with duplicates on each array 
(termed “technical” repeats A, B) were analysed in SAM (Table 3.4).
Table 3.4 Partitioning of array data for analysis by SAM
LPS v Control Poly(l:C) v Control
LPS Control Poly(l:C) Control
Early 
Oh, 2h
LPS2 Oh(ALOh(B) 
LPSSOh£A)/Oh{B) 
LPS2 2WA), 2NB)
Com 0h(A), 0h(B) 
Con2 0h(A), 0h(B) 
Con2 2h(A>, 2h(B)
PIC1  Oh(A), 0h(B) 
PIC2 0h(A), 0h(B) 
PIC2 2h(A), 2h(B)
Corn  0h(A), Oh(B) 
Con2 Oh(A), Oh(B) 
Con2 2h(A), 2h(B)
Transitional 
5h, 10h
LPS2 5h(A), 5h(B) 
LPS3 5h(A), 5h(B) 
LPS2 10h(A), 10h(B)
Con1  5h(A), 5h(B) 
Con2 5h(A), 5h(B) 
Con2 10h(A), 10h(B)
PIC1 5tKA), 5h{B) 
PIG2 5h{A), 5h(B)  , 
PIC210WA), 10WB)
Corn 5h(A), 5h(B) 
Con2 5h(A), 5h(B) 
Con2 IOWA), 10WB)
Mature 
18h, 24h
LPS2 18h(A), 18b(B) 
LPS318b(A), 18h(B) 
LPS2 24h(A), 24h(B)
Con1  18h<A), 18h(B) 
Con218h(A), 18b(B) 
Con2 24h{A), 24h(B)
PIC1  18h(A), 18h(B) 
PIC2 18h(A), 18h(B) 
PIC2 24h(A), 24h(B)
Con1  18h(A), 18h(B) 
Con2 18h(A), 18h(B) 
Con2 24h(A), 24h(B)
The  data  from  27  arrays  were  partitioned  to  analyse  significantly  regulated  genes  by  DCs 
responding to  LPS- and poly(l:C)-stimulation  at three  maturation  stages.  Technical  repeats of 
duplicate genes on each array (A,  B) were used to increase the number measurements in the 
groups in each comparison.
Six comparisons were made, to find genes significantly differentially regulated by DCs 
responding to LPS and poly(I:C) compared to control mock-stimulated DCs at the three 
maturation stages (Table 3.4). SAM generates a graph plot of expected gene expression 
values (x-axis) from balanced random permutations of the data, against observed gene 
expression values (y-axis) from the input data (Figure 3.11). The plot demonstrates that 
genes that are differentially and significantly regulated between the compared groups lie
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outside of the line of identity (y=x, solid blue lines in Figure 3.11) (i.e. different to gene 
expression  values  that  are  generated  by  random  permutations  of data  groups).  The 
tramlines on the plot serve as the user-defined threshold that determines whether or not 
the genes are significantly regulated. Genes which lie outside the tramlines are assigned 
as significantly up- or down-regulated between the data groups, genes that lie inside the 
tram  lines  are  not  significantly  regulated  between  the  data  groups.  The  width  of the 
tramlines  is  determined  by  the  Delta  value.  This  therefore  affects  the  number  of 
significant genes that are found, as illustrated in Figure 3.10. The wider the tramlines, 
the  larger  the  Delta  value,  the  smaller  number  of  significant  genes  found,  and 
consequently  the  smaller  the  FDR.  Each  of the  6  comparisons  have  adjusted  Delta 
values  to  correspond  to  a  FDR  of approximately  5%.  The  numbers  of significantly 
regulated genes in the comparison groups are shown in Table 3.5.
Table 3.5  Significantly up- and down-regulated genes as identified by SAM
UP DOWN  Total FDR
LPS v Control
Early 127 217  334(18) 5.05%
Transitional 464 534  998 (50) 4.96%
Mature 482 523  1005(51) 5.09%
Poly(l:C) v Control
Early 50 67  117(6) 4.82%
Transitional 478 568  1046(53) 5.06%
Mature 459 593  1052(52) 4.95%
The  number of genes  found  to  be  significantly  up-  or down-regulated  in  the  comparisons  of 
LPS-  and  poly(l:C)-stimulated  DCs  compared  to  mock-stimulated  DCs.  The  numbers  in 
parentheses indicate the number of genes out of the total found to be significantly regulated that 
may be identified by chance (as corresponding to the FDR).
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Figure 3.11  SAM plots of com parisons between stimulated and mock-stimulated DCs
Six  comparisons  were  made  between  LPS-  and  poly(l:C)-stimulated  DCs  and  control  mock- 
stimulated DCs at three different maturation stages. Genes that are found to be significantly up- 
regulated in stimulated  DCs are shown in  red, genes significantly down-regulated are shown in 
green. The blue  lines are y=x for each plot, the dotted black lines are the tramlines determined 
by Delta, which corresponds to the width of the tramlines.
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3.2.7.2 Mann-Whitney U test
As  SAM  is  a  parametric  /-test  associated  with  a  FDR  related  to  the  random 
misclassification  of differentially  regulated  genes,  we  decided  to  analyse  the  same 
binary comparisons by another statistical method. The Mann-Whitney U test was used 
as an additional statistical test.
The  Mann-Whitney  U  (MWU)  is  a  non-parametric  test  that  does  not  assume  the 
distribution of gene expression values to be a normal distribution. Also known as the 
Wilcoxon rank sum test, the Mann-Whitney U tests the null hypothesis that the medians 
of two populations are equal, against a specified alternative. MWU transforms the gene 
expression  data  into  ranks,  thereby  normalising  the  data,  and  compares  these  ranks 
across the groups by testing the equality of means across the two groups. The result is a 
z-score related to the normal distribution. Significantly regulated genes can be identified 
by choosing the relevant p-value for the desired level of significance. MWU has been 
used  as  a  standard  non-parametric  test  for  analysing  microarray  data,  and  has  been 
shown  to be a conservative method  for identifying  significantly regulated  genes (low 
true positive rate TPR), with a low false positive rate (FPR) (Troyanskaya et al., 2002). 
We  therefore  reason  that  by  comparing  the  subset  of differentially  regulated  genes 
identified  by  SAM  with  the  subset  of genes  generated  by  MWU,  genes  commonly 
identified by both methods should have minimal false discoveries.
As with SAM, normalised filtered data from Cluster was the input data for MWU, and 
the MWU test was performed in Microsoft Excel. The same 6 binary comparisons were 
analysed  (Table  3.5)  by  MWU  to  identify  genes  significantly  regulated  in  LPS-  and 
poly(I:C)-stimulated  DCs  compared  to  control  mock-stimulated  DCs  at  the  three 
maturation  stages. The expression ratio for each gene was converted into ranks across 
the arrays undergoing the binary comparison, and the U-value was calculated by:
Ui = n u iv  + ((niii(niii+1))/2) -  Ri
Where:
r\i  =  the  number  of gene  expression  ratios  for  the  ith  array  element  in  the  LPS-  or 
poly(I:C)-stimulated DC samples (6)
i \ 2  = the number of gene expression ratios for the ith array element in the control mock- 
stimulated DC samples (6 )
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Ri  =  sum  of ranks  for the  ith  array element  in  the LPS-  or poly(I:C)-stimulated DC 
samples.
The U  values were converted to the standard normal variable for the ith array element 
( Z j )  with the equation:
,  _   Ui- ( ( ni.A 2)/2)
V (nl.ini,2(ni,1+ni,2 +1)/12)
The probability associated with each z-value was calculated in Excel (ZTEST).
The number of genes identified by MWU, at the significance level of /?<0.01  were very 
comparable to the numbers computed by SAM (Table 3.6 and Table 3.5).
Table 3.6 Significantly up- and down-regulated genes identified by Mann-Whitney U test
LPS v Control Poly(LC) v Control
UP DOWN Total P UP DOWN Total P
Early 104 148 252 0.01 50 53 103 0.01
Transitional 353 361 714 0.01 351 424 775 0.01
Late 342 384 726 0.01 379 396 775 0.01
Using  Microsoft  Access,  genes  that  were  commonly  identified  by  the  two  statistical 
tests SAM (FDR 5%) and MWU (/?-value <0.01) were used for further analysis (Table 
3.7  and  Figure  3.12).  These  genes,  commonly  identified  by  both  statistical  methods, 
should  be  reliable  markers  for  genes  regulated  by  DCs  in  response  to  LPS-  and 
poly(I:C)-stimulation.  MWU  consistently  identifies  a  smaller  set  of  significantly 
regulated  genes  compared  to  SAM;  this  is  probably  due  to  the  difference  in  the 
acceptable  level  of error  of the  two  methods;  a  FDR  of 5%  approximates to  a 95% 
confidence  interval,  whereas  a /?-value  of 0.01  approximates  to  a  99%  confidence 
interval. If the FDR used in SAM is lowered to  1%, the number of genes identified by 
SAM  as  significantly  regulated  by  LPS-  or  poly(I:C)-stimulated  DCs  compared  to 
mock-stimulated  DCs  should  be  even  more  comparable  to  the  number  of  genes 
identified by MWU as significantly regulated between stimulated and mock-stimulated 
DCs.
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Table 3.7 Significantly regulated genes commonly identified by SAM and MWU
LPS v Control Poly(l:C) v Control
SAM+ MWU* Common SAM1 MWU* Common
Early UP 127 104 82 50 50 38
DOWN 217 148 138 67 53 43
Transitional UP 464 353 334 478 351 343
DOWN 534 361 353 568 424 419
Late UP 482 342 323 459 379 369
DOWN 523 384 374 593 396 391
* Number of genes significantly up- and down-regulated at 5% FDR
* Number of genes significantly up- and down-regulated at p <0.01
LPS v Control Poly(l:C) v Control
\3 1 1
13f  (
687 762  )
M   I * 284
Transitional
292
Figure 3.12 Com parisons of significantly regulated genes found by SAM and  MWU
Genes  identified  by  SAM  and  Mann-Whitney  U  in  the  6  comparisons  of  LPS-stimulated  and 
poly(l:C)-stimulated  DCs  compared  to  mock-stimulated  DCs.  Significant  genes  identified  by 
MWU are shown in blue, genes identified by SAM are shown in orange, common genes shown 
in bold (overlap in Venn diagram).
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3.2.8  Common genes regulated upon DC maturation
Using  Microsoft  Access,  the  genes  commonly  regulated  by  DCs  responding  to  both 
LPS and poly(I:C) were identified (Figure 3.13A). These were defined as the core set of 
genes significantly regulated in DCs in response to LPS and poly(I:C) over the 24 hour 
maturation  process.  These  core  genes were regulated  over different maturation  stages 
(Figure 3.13B),  and  included genes that were differentially expressed at each stage as 
well as genes regulated across more than one of the three phases of DC maturation. For 
example, the differential expression of 295 genes in LPS- and poly(I:C)-stimulated DCs 
compared  to  mock-stimulated  DCs  is  commonly  observed  in  both  transitional  and 
mature stage DCs (Figure 3.13B).
3.2.8.1  Gene expression pattern of early activated DCs
As  this  phase  includes  genes  regulated  between  0  and  2  hours  post-stimulation,  the 
transcriptional signature corresponds to both immature and early activated DCs (Figure 
3.14). In reality Oh represents transcript changes about 5 to 10 minutes post-stimulation, 
and  the  genes  that  typify  this  early  phase  are  identified  by  SAM  and  MWU  to  be 
significantly  regulated  compared  to  mock-stimulated  DCs.  These  genes  therefore 
represent  genes  that  are  strongly  expressed  in  immature  DCs  that  are  slowly 
downregulated  throughout  DC  maturation.  These  genes  include  tissue  inhibitor  of 
metalloproteinases (TIMP) 2, the integrins (ITG) ITG(32, ITGaM, ITGa2, ITG(31 - and 
ITG(34-binding proteins, actin related protein 2/3  complex,  Wiskott-Aldrich syndrome 
protein,  p21/Cdc42/Racl-activated  kinase  1,  partner of Racl,  Rho  GTPase  activating 
protein  1,  MHC  class  II  (HLA-DM),  various  proteasome  subunits,  the  mannose 
receptor,  and  E-cadherin (Figure  3.14).  As predicted, these genes are compatible with 
the  function  of early-activated  DCs  following  encounter  with  pathogens,  including 
cytoskeleton  remodelling  following  pathogen  uptake  and  upregulating  the  antigen 
processing  machinery.  Recent  evidence  shows  that  murine  DCs  stimulated  by  TLR 
ligands transiently upregulate endocytic capacity by remodelling the actin cytoskeleton 
(West  et  al.,  2004).  Early  activated  DCs  also  upregulate  transcripts  encoding  pro- 
inflammatory and chemo-attractive cytokines such as interleukin- 1  and interleukin-16, 
and genes encoding cAMP signalling such as protein kinase A (PRKA), PRKA anchor 
protein, cAMP responsive element binding protein-like  1. However, the early-activated 
DC  transcriptional  signature  seems  more  stimulus-dependent  compared  to  at  other
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maturation stages (Figure 3.13A), perhaps reflecting inherent differences between LPS 
and  dsRNA  that  are  initially  perceived  by  the  DC.  These  differences  are  much  less 
evident at later timepoints.
Early Transitional Mature
LPS  Poly(l:C) LPS  Poly(l:C) LPS  Poly(l:C)
144
195
219
B Transitional
543
Early
248
295
207
Mature
502
Figure 3.13 Genes commonly regulated by DCs in response to LPS and poly(l:C)
A  Genes  identified  as  significantly  regulated  by  LPS-stimulated  DCs  (red)  ard  poly(l:C)- 
stimulated  DCs  (blue)  compared  to  control  mock-stimulated  DCs  at  the  differen:  maturation 
stages were  analysed,  and  genes that were  commonly  regulated  by  DCs  responding  to  both 
LPS and poly(l:C) are shown as the intersection of Venn diagrams.
B Commonly regulated genes were regulated at specific maturation stages. For exe mple, out of 
543  genes  commonly  regulated  by  DCs  responding  to  LPS  and  poly(l:C)  at  the  transitional 
stage,  248  genes  were  specific  to  this  transitional  stage,  whereas  295  genes  were  also 
regulated by DCs responding to LPS and poly(l:C) at the mature stage.
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Figure 3.14 Transcriptional signature of early activated DCs
This  gene  expression  signature  of  early  activated  DCs  is  enriched  for  genes  involved  in 
actin/cytoskeleton  remodelling  (genes  in  blue),  cell-cell  adhesion  (genes  in  red),  and  antigen 
uptake and  processing  (genes in green).  Inflammatory genes are also present in this profile (in 
purple). These genes are most strongly induced in early activated DCs.
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Figure 3.14 Transcriptional signature of early activated DCs (continued)
122Dendritic cell activation and differentiation
3.2.8.2  Gene expression in transitional DCs
Genes  regulated  by  transitional  phase  DCs  encode  transcription  factors  as  well  as  a 
broader spectrum of upregulated pro-inflammatory cytokines, chemokines and some of 
their  receptors  (Figure  3.15).  Pro-inflammatory  cytokines  include  tumour  necrosis 
factor (TNFa), interleukin (IL)-l, IL-6 , IL-15, chemokine (C-C motif) ligand 2 (CCL2, 
formerly  known  as  monocyte  chemoattractant  protein  (MCP)-l),  chemokine  (C-X-C 
motif)  ligand  1   (CXCL1),  CXCL2,  CXCL8  (formerly  known  as  IL-8 ),  and  CXCL9. 
Receptors for IL-1  and  IL-2  are also  upregulated.  The transcriptional  profile of these 
acute  pro-inflammatory  cytokines  are  upregulated  very  strongly  at  5  hours  post­
stimulation,  and  this  upregulation  is  sustained  until  1 0  hours,  after which  expression 
returns to basal levels by 18 hours post-stimulation. It should be noted that transcripts of 
some pro-inflammatory cytokines like TNFa, CXCL1  and CXCL2 are upregulated at 2 
hours after LPS- and poly(I:C)-stimulation (Figure 3.15). This is reflective of their rapid 
induction  kinetics  following  TLR4  and  TLR3  ligation.  However,  because  these 
transcripts are significantly upregulated at both  5  hours and  10 hours after stimulation 
compared  to  control  mock-stimulated  DCs,  these  genes  are  classified  as  being 
significantly regulated at the transitional phase of DC maturation.
The  transcription  factor  signal  transducer  and  activator  of  transcription  (STAT)4, 
apoptosis-regulatory  genes  like  caspase  4,  bcl-2-related  protein  A1  (BCL2A1),  and 
BH3-interacting  domain  death  agonist  (BID)  are  also  upregulated  at  this  transitional 
phase,  and transcript  levels return  to  basal  levels  at the  mature  phase.  CD40,  a TNF 
family  receptor expressed  on  DCs  upon  maturation,  which  functions to  interact with 
CD40  ligand  expressed  on  T  cells  to  facilitate  DC-T  cell  interactions,  is  also 
upregulated  in  this  manner  during  the  transitional  phase  of  DC  maturation.  Other 
members of the TNF receptor family  such  as TNFRSF1A  (the TNFa  receptor), TNF 
receptor-associated  factor  (TRAF)  2,  and  genes  encoding  proteins  that  function 
downstream  of  TNFa  signalling  including  CRADD  (CASP2  and  RIPK1  domain 
containing adaptor with death domain) are also regulated with similar kinetics. Reverse- 
transcription (RT) polymerase chain reaction (PCR) analysis confirmed the induction of 
TNFa, CCL2 and CD40 transcript at this transitional phase (see Section 3.2.8.3, Figure 
3.17B).
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Figure 3.15 Transcriptional signature of transitional DCs
This  gene  expression  signature  is  enriched  for  genes  encoding  pro-inflammatory  cytokines 
(genes  in  purple),  transcription  factors  (genes  in  red),  and  genes  involved  in  TNFa  signalling 
(genes  in  green).  There are  also anti-apoptotic  and  cell-signalling  proteins  encoded  by genes 
within this cluster. This gene expression profile characterises transitional DCs.
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Coagulation factor 3 (thromboplastin, tissue factor) 
ras homolog gene family, member N 
ras homolog gene family, member N 
Phytanoyl-CoA hydroxylase interacting protein 
Erythrocyte membrane protein band 4.2 
Chloride channel 7
Pleiotrophin (heparin binding growth factor 8, neurite growth-promoting factor 1) 
Ras and Rab interactor 2 
Syndecan4 
Syndecan 4
Prostaglandin E receptor 2 
Interphotoreceptor matrix proteoglycan 1 
Interphotoreceptor matrix proteoglycan 1
Lymphocyte cytosolic protein (SH2 domain containing leukocyte protein of 76kDa) 
Lymphocyte cytosolic protein (SH2 domain containing leukocyte protein of 76kDa) 
HNRNPG-T  Testes-specific heterogenous nuclear ribonucleoprotein G-T 
Myosin, light polypeptide 3, alkali; ventricular, skeletal, slow 
Mitogen-activated protein kinase kinase 3 (MKK3)
Mitogen-activated protein kinase kinase 3 (MKK3)
Plexin A2
Solute carrier family 16 (monocarboxylic acid transporters), member 5 
Talin 1
CASP2 and RIPK1 domain containing adaptor with death domain 
Usher syndrome 2A (autosomal recessive, mild)
Platelet-derived growth factor, beta polypeptide (v-sis oncogene homolog) 
Platelet-derived growth factor, beta polypeptide (v-sis oncogene homolog) 
Platelet-derived growth factor, beta polypeptide (v-sis oncogene homolog) 
Phospholipase A2, group V 
Homeobox D10 
KIAA0317 gene product
Figure 3.15 Transcriptional signature of transitional DCs (continued)
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From the Venn diagram in Figure 3.13B, over half of the genes significantly regulated 
by DCs responding to LPS and poly(I:C) at the transitional phase are also significantly 
regulated  at  the  mature  phase  of DC  maturation.  The  gene  expression  profile  of this 
sustained  response  is  shown  in  Figure  3.16.  This  response  includes  additional  genes 
encoding  proteins downstream  of TNFa  signalling:  TRAF  family  member-associated 
NF-kB  activator (TANK), TAK1 -binding protein  2,  TRADD (TNFRSFlA-associated 
via death domain), TNFa-induced protein 3 (TNFAIP3, a transcription factor formerly 
known  as  A20),  TNFAIP2,  TNFAIP6 ,  TNFRSF10C  (formerly  known  as  TRAIL 
receptor 3, a decoy receptor without a death domain), and TNFSF13B (formerly known 
as  B  cell  activating  factor  BAFF).  Some  of these  genes  have  apoptosis  regulating 
functions,  including  the  pro-apoptotic  TRADD,  caspase  3,  caspase  10  and  DPF2,  a 
transcription  factor  also  known  as  requiem.  Anti-apoptotic  genes  upregulated  in  the 
transitional and mature phase of DC  maturation  include CFLAR (CASP8 and FADD- 
like apoptosis regulator, also known as c-FLIP), baculoviral inhibitor of apoptosis (IAP) 
repeat-containing 2  (BIRC2,  also known as cIAPl),  BIRC3  (cIAP2),  death-associated 
protein 6  (DAXX),  and  immediate early response 3  (IER3).  BIRC2  inhibits apoptosis 
by  binding to TRAF1  and TRAF2,  IER3  functions to protect against TNFa  and Fas- 
induced apoptosis, and DAXX is a transcriptional repressor that interacts with CFLAR 
and  suppresses JNK activation (Kim  et al.,  2003b) and pro-apoptotic  gene expression 
(Chen  and  Chen,  2003).  NF-kB  subunits  p50  and  p65,  as  well  as  NF-kB  inhibitors 
IicBa, are similarly upregulated in the transitional and mature phase.
Additional  upregulated  genes  including  transcription  factors  and  immune-function 
genes are activated downstream of cytokine signalling. These include STATs (STATI, 
STAT3,  STAT5A), interferon-responsive genes IFIT5  (interferon-induced protein with 
tetratricopeptide  repeats  5),  2’,5’-oligoadenylate  synthetase  (OAS1),  IFITM1  and 
IFITM2,  Mx2,  interferon-stimulated  protein  15kDa  (ISG15),  immuno-proteasome 
subunits,  interferon  regulatory factor (IRF)2,  and  co-stimulatory  molecules CD8 6  and 
CD83,  markers  of  DC  maturation.  Overall,  this  suggests  that  the  induction  and 
sustained  upregulation  of these genes over the transitional  and  mature phase function 
downstream  of secreted  cytokines  that  function  in  an  autocrine  manner to  target  the 
activation of transcription factors, immune-response and pro-survival genes in DCs, and 
are involved in mediating DC differentiation.
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TNFRSFIA-associated via death domain 
TNFRSF1 A-associated via death domain 
Chemokine (C-C motif) ligand 4 
Tumour necrosis factor, alpha-induced protein 3 
Pannexin 1
Chromosome 6 open reading frame 6 
Aminolevulinate, delta-, synthase 1 
Aminolevulinate, delta-, synthase 1 
Integrin, alpha 9 
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Interleukin 7 receptor
Enhancer of rudimentary (Drosophila) homolog 
Enhancer of rudimentary (Drosophila) homolog 
Wilms’ tumour 1-associating protein 
Wilms' tumour 1-associating protein 
Protein kinase C, delta 
Protein kinase C, delta
Caspase 10, apoptosis-related cysteine protease 
C aspase 10, apoptosis-related cysteine protease 
Inhibin, alpha 
Interleukin 7 receptor 
DKFZP566C134 protein
N-deacetylase/N-sulfotransferase (heparin glucosaminyl) 1 
N-deacetylase/N-sulfotransferase (heparin glucosaminyl) 1 
Helicase with SNF2 domain 1 
U4/U6-associated RNA splicing factor 
Inhibin, beta B (activin AB beta polypeptide)
Inhibin, beta B (activin AB beta polypeptide)
Mitofusin 1
Retinoic acid- and interferon-inducible protein (58kD)
Retiruic acid- and interferon-inducible protein (58kD)
Nuclear domain 10 protein 
Nuclear domain 10 protein 
Mitofusin 1
Ubiquitously transcribed tetratricopeptlde repeat gene, X chromosome 
Ubiquitously transcribed tetratricopeptide repeat gene, X chromosome 
Enhancer of zeste homolog 2 (Drosophila)
Enhancer of zeste homolog 2 (Drosophila)
Retinal outer segm ent membrane protein 1 
Collagen, type VIII, alpha 1 
GTP cyclohydroiase 1  (dopa-responsive dystonia)
GTP cyclohydroiase 1  (dopa-responsive dystonia)
Collagen, type VIII, alpha 1 
TNFRSF10C Tumour necrosis factor receptor superfamily, member 10c 
FGFR3  Fibroblast growth factor receptor 3
FGFR3  Fibroblast growth factor receptor 3
TNFSF13B  Tumour necrosis factor (ligand) superfamily, member 13b 
SIAT9  Slalyltransferase 9
CDK5R2  Cyclin dependent kinase 5, regulatory subunit 2 (p39)
2’ 5 -oligoadenylate synthetase 1  (40-46kD)
2.5'-oligoadenylate synthetase 1  (40-46kD)
Purine-rich element binding protein B 
Purine-rich element binding protein B 
RAB1 A, member of RAS oncogene family 
Methylene tetrahydrofolate dehydrogenase 
Methylene tetrahydrofolate dehydrogenase
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Figure 3.16 Transcriptional signature in transitional and mature phase DCs
Genes  shown  are characteristically upregulated  over the transitional  and  mature  phase  of DC 
activation  and  differentiation.  Such  genes  include  transcription  factors  (genes  shown  in  red), 
immune-response  genes  (shown  in  blue),  genes  regulating  apoptosis  (shown  in  purple),  and 
additional genes activated downstream of TNFa and other cytokine signalling (shown in green).
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BIRC2  Baculoviral IAP repeat containing 2
TANK  TRAF family member-associated NFKB activator
TANK  TRAF family member-associated NFKB activator
MAP3K7IP2 Mitogen activated protein kinase kinase kinase interacting protein 2
MAP3K7IP2 Mitogen activated protein kinase kinase kinase interacting protein 2
UBE2D3  Ubiquitin-conjugating enzyme E2D 3
UBE2D3  Ubiquitin-conjugating enzyme E2D 3
BIRC2  Baculoviral IAP repeat containing 2
STK17B  Serine/threonine kinase 17b (apoptosis-inducing)
VRK2  Vaccinia related kinase 2
VRK2  Vaccinia related kinase 2
STK4  Serine/threonine kinase 4
CG018  Hypothetical protein CG018
BCL7B  B-cell CLL/lymphoma 7b
BCL7B  B-cell CLL/lymphoma 7b
IGF1R  Insulin-like growth factor 1  receptor
IGF1R  Insulin-like growth factor 1  receptor
WNT5A  Wingless-type MMTV integration site family, member 5A
LGALS9  Lectin, galactoside-binding, soluble, 9 (galectin 9)
LGALS9  Lectin, galactoside-binding, soluble, 9 (galectin 9)
CMAH  Cytidine monophosphate-N-acetylneuraminic acid hydroxylase
SEMA4D  Semaphorin 4D
SEMA4D  Semaphorin 4D
TNFAIP6  Tumour necrosis factor, alpha-induced protein 6
NR4A3  Nuclear receptor subfamily 4, group A, member 3
NR4A3  Nuclear receptor subfamily 4, group A, member 3
IFITM2  Interferon-induced transmembrane protein 2 (1-BkD)
IFITM2  Interferon-induced transmembrane protein 2 (1-8kD)
IFITM1  Interferon-induced transmembrane protein 1  (9-27kD)
IFITM1  Interferon-induced transmembrane protein 1 (9-27kD)
STAT1  Signal transducer and activator of transcription 1,91kD
STAT1  Signal transducer and activator of transcription 1, 91kD
C20orf188  Chromosome 20 open reading frame 188 
ST  ATI  Signal transducer and activator of transcription 1, 91 kD
UBE2L6  Ubiquitin-conjugating enzyme E2L 6
APOBEC3B Apollpoprotein B mRNA editing enzyme, catalytic polypeptide-like 3B 
APOBEC3B Apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3B 
MX2  Myxovirus (influenza) resistance 2, homolog of murine
MX2  Myxovirus (influenza) resistance 2, homolog of murine
CMAH  Cytidine monophosphate-N-acetylneuraminic acid hydroxylase
STAT1  Signal transducer and activator of transcription t , 91 kD
UBE2L6  Ubiquitin-conjugating enzyme E2L 6
CD38  CD38 antigen (p45)
CD38  CD38 antigen (p45)
TCTEL1  T-complex-associated-testis-expressed 1-like 1
PSME2  Proteasome (prosome, macropain) activator subunit  2 (PA28 beta)
PSME2  Proteasome (prosome, macropain) activator subunit  2 (PA28 beta)
LAD1  Ladinin 1
NAPA  N-ethylmaleimide-sensitive factor attachment protein, alpha
LAD1  Ladinin 1
TAP1  Transporter 1, ATP-binding cassette, sub-family B (MDR/TAP)
TAP1  Transporter 1, ATP-binding cassette, sub-family B (MDR/TAP)
IRF2  Interferon regulatory factor 2
IRF2  Interferon regulatory factor 2
FLN29  FLN29 gene product
FLN29  FLN29 gene product
CASP3  Caspase 3, apoptosus-related cysteine protease
CASP3  Caspase 3, apoptosus-related cysteine protease
NMI  N-myc (and STAT) interactor
NMI  N-myc (and STAT) interactor
NBS1  Nigmegen breakage syndrome 1  (nibrin)
NBS1  Nigmegen breakage syndrome 1  (nibrin)
M  Adrenomedullin
M  Adrenomedullin
2A  Metallothionein 2A
2A  Metallothionein 2A
X38  DEAH (Asp-Glu-Ala-His) box polypeptide 38 
CDBP  Pleckstrin homology, Sec7 and coiled/coil domains, binding protein 
X38  DEAH (Asp-Glu-Ala-His) box polypeptide 38 
tC3  Baculoviral IAP repeat containing 3
IC3  Baculoviral IAP repeat containing 3
PA  N-ethylmaleimide-sensitive factor attachment protein, alpha 
0 3   Flavin containing monooxygenase 3
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Figure 3.16 Transcriptional signature in transitional and mature phase DCs (continued)
128Dendritic cell activation and differentiation
11   i  |
r i m   frfT l
2 4h
G A T A 6
D A \  *
DAXX
BZW1
BZW1
STAT5A
TNFAIP2
TNFAIP2
NRP2
NRP.
:;d .v
INHBA
INHBA
STAT3
STAT 3
STAT5A
IRAK.;
! RAF."
RO • : '
rLR2
NFKBIA
TNFAIP3
CFLAR
DPF2
SLC31A2
b r  m
■
NFKB1
N F K B 1
DU SP5
PFKFB3
PFKFB3
UCL  i
'
'OR-;
C D 4 4
I,INH
h  I
ICAM1
ICAM1
■
DNAJB4
GATA-binding protein 6
v-ral simian leukemia viral oncogene homolog B (ras related; GTP binding protein)
Death-associated protein 6
Death-associated protein 6
Basic leucine zipper and W2 domains 1
Basic leucine zipper and W2 domains 1
IMP (inosine monophosphate) dehydrogenase 1
Signal transducer and activator of transcription SA
Tumour necrosis factor, alpha-induced protein 2
Tumour necrosis factor, alpha-induced protein 2
Spermidine/spermine N1-acetyltransferase
Neuropilin 2
Neuropilin 2
CD86 antigen (CD28 antigen ligand, B7-2 antigen)
Inhibin, beta A (activin A, activin AB alpha polypeptide)
Inhibin, beta A (activin A, activin AB alpha polypeptide)
E74-like factor 4 (ets domain transcription factor)
CD86 antigen (CD28 antigen ligand, B7-2 antigen)
Signal transducer and activator of transcription 3 
Signal transducer and activator of transcription 3 
Signal transducer and activator of transcription 5A 
Interferon-stimulated protein, 1 SkDa 
TNF receptor-associated factor 2 
TNF receptor-associated factor 2 
CASP8 and FADD-like apoptosis regulator 
Interferon-stimulated protein, 15kDa
CD83 antigen (activated B lymphocytes, immunoglobulin superfaily)
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CASP8 and FADD-like apoptosis regulator
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D4, zinc and double PHD fingers family 2
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Dual specificity phosphatase 5
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Nuclear factor of kappa light gene enhancer in B-cells 1 (piOS)
Nuclear factor of kappa light gene enhancer in B-cells 1  (p105)
Dual specificity phosphatase 5
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Myeloid cell leukemia sequence 1  (BCL2-relatod)
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CD44 antigen (homing function and Indian blood group system)
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Jun B proto-oncogene
Jun B proto-oncogene
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Figure 3.16 Transcriptional signature in transitional and mature phase DCs (continued)
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3.2.8.3  Cytokine production by DCs
The  upregulation  of transcription  factors,  immune-response and  pro-survival  genes at 
the transitional and mature phase of DC maturation are likely to be a result of autocrine 
feedback signalling from the initial burst of cytokine and chemokine production (Figure 
3.17A).  TNFa  transcript  is  induced  as  early  as two  hours  post-  LPS-  and  poly(I:C)- 
stimulation (Figure 3.17A, B). Upregulation of genes encoding proteins associated with 
TNFa signalling and transcription factors downstream of TNFa signalling support this 
hypothesis.  This  suggests  that  TNFa  produced  by  DCs  in  response  to  LPS-  and 
poly(I:C)-stimulation functions in an autocrine manner to contribute to DC maturation, 
in  addition  to  its  general  pro-inflammatory  role  in  the  context  of  infection  and 
inflammation  (Chomarat  et al.,  2003;  Ritter et  al.,  2003;  Van  Lieshout  et  al.,  2004). 
When measured by enzyme-linked immunoassay from DC culture supernatants, a very 
marked  burst  of TNFa  production  by  DCs  was  observed,  beginning  as  early  as two 
hours post-stimulus (Figure 3.18A). This correlates with both the microarray-based and 
RT-PCR  transcript  confirmation  (Figure  3.17),  both  showing  the  induction  of TNFa 
mRNA  by  2  hours  post-stimulation.  In  addition  to  TNFa,  production  of other  pro- 
inflammatory  cytokines  (IL-6 )  and  chemokines (CXCL8 ,  CCL2  and  CCL5)  was also 
investigated using the FAST®Quant cytokine array system (Section 2.7.2). This showed 
a very rapid production  of these cytokines by DCs at early timepoints, which reached 
peak levels between 2 and 5 hours post-stimulation (Figure 3.18A).
The rate of production of these cytokines appears to vary, with peak levels of cytokine 
detected  between  2  hours  (CXCL8 )  and  10  hours  (CCL5).  The  rate  of  cytokine 
production  of  mock-stimulated  DCs  and  LPS-  and  poly(I:C)-stimulated  DCs  was 
compared, approximately derived as the levels of cytokine produced over a given time 
period  (Figure 3.18B). This shows that the rate of cytokine production  is significantly 
higher in stimulated DCs, confirming at the protein level the microarray data. However, 
CXCL8  protein  levels reach the maximum detection  limit by 2 hours post-stimulation 
(6000 pg/ml), whereas the microarray data show CXCL8 transcript induced at 2 hours 
post-stimulus.  Functional  studies  have  shown  CXCL8  responses to  pro-inflammatory 
mediators are rapid (Roebuck,  1999). CXCL8 is regulated primarily at the level of gene 
transcription,  and  its  promoter  sequence  contains  binding  sites  for  the  inducible 
transcription  factors  NF-kB,  AP-1,  NF-IL6   (further  explored  in  Section  5.4.2).  This 
suggests  that  sampling  at  an  earlier timepoint  before  2  hours will  show  induction  of
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CXCL8  transcript,  leading  to  CXCL8  protein  detection  at  2  hours.  Microarray  data 
suggests there is further transcriptional upregulation of CXCL8 between 2 and 5 hours 
after LPS- and poly(I:C)-stimulation.
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TNF Tumour necrosis factor a
TNF Tumour necrosis factor a
IL6 Interleukin 6
IL6 Interleukin 6
IL6 Interleukin 6
IL6 Interleukin 6
CCL2 Chemokine (C-C motif) ligand 2
CCL2 Chemokine (C-C motif) ligand 2
CCL2 Chemokine (C-C motif) ligand 2
TNFRSF5 CD40 antigen
TNFRSF5 CD40 antigen
CXCL8 Chemokine (C-X-C motif) ligand 8
CXCL8 Chemokine (C-X-C motif) ligand 8
IL15 Interleukin 15
IL15 Interleukin 15
IL-1A Interleukin 1a
IL1R2 Interleukin 1   receptor 2
IL1R2 Interleukin 1   receptor 2
IL2RB Interleukin 2 receptor p
IL2RB Interleukin 2 receptor p
TNFa
CD40
a-tubulin
Figure 3.17 Transcript levels of pro-inflammatory cytokines in stimulated DCs
A  Microarray  gene  expression  detail  of  the  upregulation  of  pro-inflammatory  cytokines  and 
chemokines expressed in LPS- and poly(l:C)-stimulated DCs
B RT-PCR confirmation for TNFa, CCL2, and CD40, in DCs stimulated with LPS. DC RNA was 
harvested  at the  specified  timepoints.  NTC  is  no cDNA template control,  a-tubulin  is the  non­
changing housekeeping gene.
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Figure 3.18 Protein levels of pro-inflammatory cytokines in stimulated DCs
A  Levels  of  CXCL8,  CCL2,  IL-6,  CCL5  and  TNFa  produced  in  DCs  stimulated  with  medium 
(blue  ♦),  LPS  (red  ■)  and  poly(I.C)  (green  ▲),  measured  from  DC  culture  supernatant.  Error 
bars represent SD.
B Rate of cytokine production, measured over the hours post stimulation as specified. Bars with 
asterix  (*)  indicate  significant  difference  compared  to  time-matched  mock-stimulated  DCs,  at 
p<0.01. Two asterixes (**) indicate significance at p<0.001.
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3.2.8.4  Gene expression signature in late mature DCs
Genes  regulated  at  the  late  phase  of DC  maturation  are  generally  involved  in  the 
inducible  immune and antigen presenting functions of DCs (Figure  3.19).  Such  genes 
are well-represented in the gene expression signature shared by transitional and mature 
phase  DCs (Section  3.2.8.2),  such  as upregulation  of transcription factors  STATs and 
NF-kB downstream of initial cytokine production. In this late phase of DC maturation, 
further chemokines, chemokine receptors, cell motility and cell adhesion molecules are 
upregulated,  which  mostly  likely  function  to  facilitate  and  maintain  DC-T  cell 
interactions, in agreement with the antigen presenting role of DCs stimulating T cells to 
initiate the adaptive immune response.
Cytokines and Chemokines
Cytokines  are  clearly  important  in  modulating  immune  cell  function.  Cytokine  gene 
expression  at this  late  stage  of DC  maturation  gives  an  indication  as to the  intended 
target  for  these  signals.  Chemokine  (C-X-C  motif)  ligand  12  (CXCL12,  formerly 
known as stromal cell-derived factor  1) is upregulated at the transcript level  in mature 
DCs  (Figure  3.19  and  3.20A).  CXCL12  is  induced  by  a  range  of pro-inflammatory 
cytokines including TNFa, and is a chemoattractant for T cells and monocytes (Blades 
et  al.,  2002a;  Blades  et  al.,  2002b),  as  well  as  being  important  in  regulating  DC 
trafficking  (Vanbervliet  et  al.,  2003).  Upregulation  of  CXCL12  transcript  (Figure 
3.19A),  followed by  its secretion, may  function to form a gradient of CXCL12 which 
attracts T cells to facilitate T cells and DCs making contact. The receptor for CXCL12 
is  CXCR4  (Bleul  et  al.,  1996),  which  is  also  upregulated  on  DCs  at this  late  phase, 
correlating with an increased CXCR4 surface expression (Figure 3.20B). CXCR4 is not 
expressed on immature DCs, but is upregulated upon DC maturation (Lin et al.,  1998a; 
Sallusto  et  al.,  1998)  and  infection  of DCs  by  HIV-1  (Kawamura  et  al.,  2001).  The 
upregulation  of CXCL12  and  its  receptor  CXCR4  on  mature  DCs  suggests  a  further 
autocrine role for CXCL12, in addition to its T cell chemoattractant properties.
The  TGFp  receptor  is  also  upregulated  at  this  late  phase  of  DC  maturation.  The 
upregulation  of  TGFp  receptor  follows  that  of  TGFp  upregulation  during  the 
transitional  phase  of  DC  maturation.  This  phase  shift  in  time  suggests  the  earlier 
upregulation of TGFp transcript leads to production of functional TGFp, and this may
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be linked to the upregulation of its receptor. Alternatively, the delayed upregulation of 
TGF(3  receptor  allows  an  orchestrated  and  appropriate  TGFp  effect.  The  autocrine 
effects of TGFp include inhibitory and regulatory effects on dendritic cells (Geissmann 
et al.,  1999;  Sato et al.,  2000a;  Strobl and Knapp,  1999) and T cells (Campbell et al., 
2001;  Chen  et  al.,  2001;  Schramm  et  al.,  2003;  Wahl  et  al.,  2004).  The  extensive 
transcriptional  modulation  of cytokines  and  their  receptors  highlight  the  functional 
importance  of  their  effects  on  DCs  as  well  as  their  effects  on  polarising  T  cell 
responses.
Immunological synapse
In order for DCs to present antigen in the form of the MHC-peptide complex to T cells, 
an  immunological  synapse  must  be  formed,  which  consists  of central  and  peripheral 
supramolecular activation clusters (c-SMAC and p-SMAC). The central clusters involve 
the  signalling  molecules  which  include  the  ligand-specific  T  cell  receptor  and  the 
relevant MHC  molecule, and CD28 on T cells receiving co-stimulation in the form of 
CD80  or  CD8 6   from  DCs.  The  peripheral  cluster  consists  of  adhesion  molecules 
(integrins  from  T  cells  interacting  with  ICAMs  from  DCs)  (Monks  et  al.,  1998). 
Formation  of this  immunological  synapse  (IS)  involves  extensive  microtubule  and 
cytoskeleton reorganisation (Das et al., 2002;  Dustin and Cooper, 2000; Krummel and 
Davis, 2002; Wulfing and Davis, 1998).
Histone deacetylase HDAC6   is upregulated  in  mature phase DCs,  and plays a role  in 
linking the tubulin cytoskeleton with formation of the immunological synapse (Hubbert 
et al., 2002; Zhang et al., 2003c). Synaptogyrin and synaptopodin, similarly upregulated 
at this stage, may also be involved as structural scaffolds in IS formation (Figure 3.19). 
NAPA  (N-ethylmaleimide-sensitive  factor  (NSF)  attachment  protein  alpha,  formerly 
known as SNAPa) was upregulated in the transitional and late phase of DC maturation, 
and is also involved in membrane fusion and possibly as part of IS formation (Das et al., 
2004; Sollner et al.,  1993).
The small GTP-binding protein Racl  is also upregulated  strongly at this mature phase 
(Figure  3.19).  Upon  maturation,  DCs  reorganise  their  actin  cytoskeleton  and  project 
dendrites which increase the potential surface area of contact to capture antigen-specific 
T cells (Granucci et al., 2003a; Mempel et al., 2004; Miller et al., 2004). Small GTPases
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of the Rho family regulate the actin cytoskeleton (Burridge and Wennerberg, 2004) and 
subquently  control  aspects  of  the  immune  response  that  involves  cytoskeleton 
remodelling. It has been recently shown that Rac 1   and Rac2 expression by mature DCs 
are required for T cell priming, formation of dendrites, and the the polarised short-range 
movement toward T cells (Benvenuti et al., 2004).
Neuropilin 2 (NRP2), upregulated at transitional and late stages of DC maturation, may 
also  participate  in  DC-T  cell  interactions  (Figure  3.20C).  Neuropilin  1   (NRP1)  and 
NRP2  receptors were  initially described  as receptors for axon  guidance  factors of the 
class III  semaphorin  subfamily  (He and  Tessier-Lavigne,  1997).  Subsequently,  it was 
shown that in endothelial cells NRP1  and NRP2 function as receptors for some forms of 
vascular  endothelial  growth  factors  (VEGF),  and  promote  angiogenesis  and  cell 
migration (Soker et al.,  1998). NRP1  is expressed on immature monocytes-derived DCs 
(Tordjman  et  al.,  2002)  and  plasmacytoid  DCs  (Dzionek  et  al.,  2002),  and  has  been 
shown to be essential for the initiation of primary immune response, involved in DC-T 
cell  adhesion  and  clustering  (Tordjman  et  al.,  2002).  From  the  array  results,  NRP1 
transcript  is present in  immature DCs, and this  is downregulated as the DCs progress 
through  maturation.  Conversely, NRP2  is upregulated as DCs mature (Figure  3.19C). 
This suggests that the expression of neuropilins may be  important in mediating DC-T 
cell  interactions,  and their roles  in  axonal  guidance  in the nervous  system  as well  as 
angiogenesis  and  cell  migration  in  endothelial  cells may point to new  possibilities  in 
their roles in the immune system.
NRP1  and  NRP2  have  varying  affinities  for  different  members  of the  semaphorin 
family, and this may confer specificity  in their actions.  Dendritic cells, T cells and  B 
cells express semaphorins that are involved  in activation of these cells during  immune 
responses. Semaphorin 4D (SEMA4D or CD100) has been shown to be required for T 
cell  activation,  and  DCs  also  upregulate  SEMA4D  at  the  late  stage  of maturation 
(Figure 3.20C). SEMA4D binding to its receptor CD72 on B cells results in enhanced B 
cell  responses  to  antigen  and  CD40  ligation  (Kumanogoh  and  Kikutani,  2001).  The 
coordinated  upregulation  of NRP1  and  NRP2  as  well  as  their  ligands,  VEGF  and 
semaphorins, may function to regulate dendritic cell migration and T cell activation at 
the  immunological  synapse  that  involves  cell  adhesion  functions  mediated  by 
neuropilins and their ligands.
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Apoptosis regulation
As dendritic cells mature, they approach the end of their lifespan and die by apoptosis. 
Some  apoptosis-regulating  genes  that  function  downstream  of  TNFa  signalling 
upregulated  at  the  transitional  and  mature  phase  were  discussed  in  Section  3.2.8.2. 
Additional apoptosis regulatory genes upregulated at this mature phase include growth 
arrest and DNA-damage-inducible (GADD) genes (GADD45),  death effector domain- 
containing  protein  (DEDD),  caspase  3,  cullin  1,  and  TRAF5.  Mature  DCs  need  to 
carefully  regulate  apoptosis  to  balance  effecting  their  own  survival  to  perform  their 
antigen  presentation  function,  and  to  appropriately  apoptose  to  prevent  excessive 
immune  stimulation.  For  example,  GADD45p,  a  NF-KB-responsive  gene,  is 
upregulated  during  the  transitional  and  late  phase  of  DC  maturation.  GADD45|3 
functions by suppressing the JNK cascade (Papa et al., 2004), which results in apoptosis 
in DCs.
Figure 3.19 Transcriptional signature of late mature DCs (next page)
This gene expression signature is enriched for genes involved  in  apoptosis  regulation  (genes 
shown in red), DC migration (genes shown in blue), cell-cell interaction (genes shown in green), 
and  additional  transcription  factors  (genes  shown  in  purple).  These  genes  are  most  strongly 
induced in late mature DCs.
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kl  ATPase, H+ transporting, lysosomal (vacuolar proton pump),  member J
___________  >E  ATPase, H+ transporting, lysosomal (vacuolar proton pump), 31 kD
ATP6E  ATPase, H+ transporting, lysosomal (vacuolar proton pump),  31kD
Hypothetical protein LOC157567
ABCC5  ATP-binding cassette, subfamily C (CFTR/MRP), member 5
CLCN6  Chloride channel 6
CLCN6  Chloride channel 6
IDS  Iduronate 2-sulfatase (Hunter syndrome)
TSG101  Tumour susceptibility gene  101
ZNF22  Zinc finger protein 22 (KOX15)
RAD23B  RAD23 homolog B (S. cerevisiae)
RAD23B  RAD23 homolog B (S. cerevisiae)
SIAH1  Seven  in absentia homolog  1 (Drosophila)
SIAH1  Seven  in absentia homolog  1 (Drosophila)
CREG  Cellular repressor of E1A-stimulated genes
ZNF384  Zinc finger protein 384
CREG  Cellular repressor of E1 A-stimulated genes
SNX1  Sorting nexin 1
SNX1  Sorting nexin 1
PIGC  Phosphatidylinositoi glycan, class C
EST, putative cAMP-dependent protein kinase type II, beta regulatory chain 
RBPSUH  Recombining binding protein suppressor of hairless  (Drosophila)
RBPSUH  Recombining binding protein suppressor of hairless  (Drosophila)
CCNG2  Cyclin G2
CCNG2  Cyclin G2
ZNF22  Zinc finger protein 22 (KOX 15)
EST, putative cAMP-dependent protein kinase type II, beta regulatory chain 
TIAM1  T-cell lymphoma invasion and m etastasis 1
NFIL3  Nuclear factor, interleukin 3 regulated
NFIL3  Nuclear factor, interleukin 3 regulated
ILF1  Interleukin enhancer binding factor 1
ZNF142  Zinc finger protein 142
BCL6  B-cell CLL/lymphoma 6 (zinc finger protein 51)
JUND  Jun D proto-oncogene
TSG101  Tumour susceptibility gene 101
CST7  Cystatin F (leukocystatln)
CST7  Cystatin F (leukocystatin)
TGIF  TGFB-induced factor (TALE family homeobox)
TGIF  TGFB-induced factor (TALE family homeobox)
USP11  Ubiquitin specific protease 11
SEPW1  Selenoprotein W, 1
ZYG  ZYG homoiog
DEDD  Death effector domain-containing
IGFBP3  insulin-like growth factor binding protein 3
PPP4C  Protein phosphatase 4 (formerly X), catalytic subunit
PPP4C  Protein phosphatase 4 (formerly X), catalytic subunit
HDAC6  Histone deacetylase 6
HDAC6  Histone deacetylase 6
SPK  Symplekin; Huntingtin interacting protein 1
TRAF5  TNF receptor-associated factor 5
MNDA  Myeloid ceil nuclear differentiation antigen
MNDA  Myeloid ceil nuclear differentiation antigen
SEMA3C  Semaphorin 3C
SLC20A1  Solute carrier family 20 (phosphate transporter), member 1
SLC20A1  Solute carrier family 20 (phosphate transporter), member 1
LRP8  Low density lipoprotein receptor-related protein 8, apolipoprotein E receptor
EST, putative histone H2B 
XPNPEP1  X-prolyl aminopeptidase 1, soluble
XPNPEP1  X-prolyl aminopeptidase 1, soluble
DDX9  DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide 9
Hypothetical protein 669 
Hypothetical protein 669
CASP3  C aspase 3, apoptosis-related cysteine  protease
CASP3  C aspase 3, apoptosis-related cysteine  protease
CUL1  Cullin 1
MGEA5  Meningioma expressed antigen 5 (hyaluronidase)
KPNB2  Karyopherin (importin) beta 2
HDAC6  Histone deacetylase 6
CCL19  Chemokine (C-C motif) ligand 19
CHST2  Carbohydrate (chondroitin 6/keratan) sulfotransferase 2
CHST2  Carbohydrate (chondroitin 6/keratan) sulfotransferase 2
DBI  Diazepam binding inhibitor (GABA receptor modulator, acyl Coenzyme A binding protein)
DBI  Diazepam binding inhibitor (GABA receptor modulator, acyl Coenzyme A binding protein)
TGFBR3  Transforming growth factor, beta receptor III
NK4  Natural killer cell transcript 4
NK4  Natural killer cell transcript 4
RAC1  Ras-refated C3 botulinum toxin substrate 1  (rho family, small GTP binding protein Rac1) 
Hypothetical protein MGC4276 similar to CG8198 
H2AFL  H2A histone family, member L
SMARCD1  SWl/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 1 
SMARCD1  SWl/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 1 
CAPN1  Calpain 1  (mu/l) large subunit
CAPN1  Calpain 1  (mu/l) large subunit
NLVCF  Nuclear localisation signal deleted in velocardiofacial syndrome 
EST, putative histone H2B 
KIAA0053  KIAA0053 gene product
NLVCF  Nuclear localisation signal deleted in velocardiofacial syndrome
KLF5  Kruppel-like factor 5 (intestinal)
EXTL2  Exostoses (multiple)-like 2
EXTL2  Exostoses (multiple>-like 2
Hypothetical protein MGC4276 similar to CG8198 
EST
TGFBR3  Transforming growth factor, beta receptor III 
ALDH1  Aldehyde dehydrogenase 1, soluble
137Dendritic cell activation and differentiation
r a T i  lm?i
-4-2  0 + 2 + 4
2 4 h
CXCL12
RH'  1
f.'itjR  i
TOM34
TOM34
SLC12A4
COX17
MAP3K14
M
TRIP10
TRIP10
TNFRSF6
MT il
MT1G
ATP183
ATP1B3
NFE2L1
'  ,M
TGM2
KIAA0664
KIAA0664
■
TRAF 5
p.  RP.
BCRP2
M1MR4
KIAA0669
C U G 8P2
CU G BP2
i
PTK2B
PTK2B
PH F16
KIAA0669
n ..  a
■   i i
-'•N'  ,,
F  I
f  Ft4
D  •  1  1
PHF1
FXYD1
SFMA'A
Chemokine (C-X-C motif) ligand 12 
G protein-coupled receptor 
Synaptopodin
TRAF2 and NIK interacting kinase 
Translocase of outer mitochondrial membrane 34 
Translocase of outer mitochondrial membrane 34 
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COX17 (yeast) homolog, cytochrome c oxidase assembly protein 
Mitogen activated protein kinase kinase kinase 14
Colony stimulating factor 2 receptor, beta, low affinity (granulocyte-macrophage) 
Endometrial bleeding associated factor
Inhibitor of DNA binding 2, dominant negative helix-loop-helix protein 
Thryoid hormone receptor interactor 10 
Thryoid hormone receptor interactor 10
Pleckstrin homology, Sec7 and coiled/coil domains, binding protein 
Tumour necrosis factor receptor superfamily, member 6 
Metallothionein 1L 
Metallothionein 1G 
Metallothionein 11
Metallothionein 3 (growth inhibitory factor (neurotrophic))
ATPase, Na+/K+ transporting, beta 3 polypeptide 
ATPase, Na+/K+ transporting, beta 3 polypeptide 
Nuclear factor (erythroid-derived 2)4ike 1 
Transglutaminase 2 (C polypeptide)
Transglutaminase 2 (C polypeptide)
KIAA0664 protein 
KIAA0664 protein
Dipeptidylpeptidase IV (CD26, adenosine deaminase complexing protein 2)
TNF receptor-associated factor 5 
Breakpoint cluster region protein, uterine leiomyoma, 2 
Breakpoint cluster region protein, uterine leiomyoma, 2 
ATP-binding cassette, subfamily c (CFTR/MRP), member 5 
EST, putative cathepsin L precursor 
Cathepsin L 
Cathepsin L
Myotubularin repated protein 4 
Myotubularin repated protein 4 
KIAA0669 protein
CUG triplet repeat, RNA binding protein 2 
CUG triplet repeat, RNA binding protein 2 
Protein tyrosine kinase 2 beta 
Protein tyrosine kinase 2 beta 
PHD finger protein 16 
immunoglobulin superfamily, member 3 
KIAA0669 protein
Chemokine (C-X-C motif), receptor 4 (fusin)
Synuclein, alpha (non A4 component of amyloid precursor)
Chemokine (C-X-C motif), receptor 4 (fusin)
Synuclein, alpha (non A4 component of amyloid precursor)
Chemokine (C-X-C motif), receptor 4 (fusin)
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Vascular endothelial growth factor 
Vascular endothelial growth factor 
Vascular endothelial growth factor 
Vascular endothelial growth factor 
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PHD finger protein 1
FXYD domain-containing ion transport regulator 1 
Semaphorin 7A 
GADD45A  Growth arrest and DNA-damage-inducible, alpha
RAC1  Ras-related C3  botulinum toxin substrate  1 (rho family, small GTP binding protein Rac1)
RAC1  Ras-related C3  botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1)
RAC1  Ras-related C3  botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1)
EST, putative laminin S B3 chain precursor 
ELF4  E74-like factor 4 (els domain transcription factor)
STAT5A  Signal transducer and activator of transcription 5A
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Tweety homolog 2 (Drosophila)
Runt-related transcription factor 3 
Pim-1 oncogene 
Pim-1 oncogene 
Janus kinase 3
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Figure 3.19 Detail of the transcriptional signature in mature phase DCs (continued)
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Figure 3.19 Detail of the transcriptional signature in mature phase DCs (continued)
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Figure 3.20 Transcript and protein levels of genes strongly expressed in mature DCs
A RT-PCR confirmation of upregulation  of CXCL12  mRNA at the late phase of DC  maturation, 
following a timecourse of poly(l:C) stimulation.
B  Flow cytometric analysis showing  upregulation of surface expression of CXCR4 on  DCs.  (i) 
CXCR4  at  5  hours  after  poly(l:C)-stimulation,  (ii)  CXCR4  at  24  hours  post-stimulation.  Grey 
filled  histogram -  CXCR4,  black histogram -  mock-stimulated  DCs,  dotted  histogram -  isotype 
control.
C Array-based transcript levels of neuropilin 1, neuropilin 2, and their ligands the semaphorins.
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3.2.9  Differential transcriptional regulation of signalling pathways 
during DC maturation
Genes coordinately regulated by DCs stimulated with LPS and poly(I:C) over 24 hours 
of  DC  activation  and  maturation  were  compiled,  and  the  corresponding  Genbank 
Accession  numbers  were  uploaded  into  DAVID,  the  Database  for  Annotation, 
Visualisation, and  Integrated Discovery (Dennis et al.,  2003).  DAVID  is a web-based 
client/server application that allows mapping of gene accession numbers via a relational 
database to detailed functional annotation. DAVID draws upon resources from several 
public databases, including LocusLink at the NCBI (National Center for Biotechnology 
Information),  Gene  Ontology  (GO),  Protein  Families  Database  of  alignments  and 
HMMs (PFAM), and Kyoto Encyclopedia of Genes and Genomes (KEGG) charts and 
pathways.
Approximately  50  genes  significantly regulated by  stimulated DCs were  identified as 
involved  in the MAPK pathway (Figure 3.21, 3.22). These genes are transcriptionally 
up- or down-regulated in response to LPS and poly(I:C) compared to mock-stimulated 
controls,  at  different  stages  of DC  maturation.  Transcriptional  regulation  shows  an 
activation of the MAPK pathway. This view of pathway induction and activation is at 
the transcriptional  mRNA  level,  different to the classic method  of analysing pathway 
activation based on protein phosphorylation of pathway components. The activation of 
the MAPK pathway by cytokines and growth factors and second messengers like cAMP 
lead  to  activation  of  upstream  kinases,  downstream  kinases  and  their  phosphatase 
inhibitors. Focusing on the end kinases and their effector proteins such as transcription 
factors, the ERK pathway and the corresponding upstream elements of this pathway are 
consistently upregulated throughout the timecourse of DC  maturation.  In contrast, the 
p38  pathway  is  only  upregulated  at  the  transitional  phase  of  DC  maturation,  and 
downregulated  at  later stages. This  suggests a differential  requirement  for proteins of 
the two MAPK  pathways that varies according to the  stage of DC  maturation  (Figure
3.22).
Figure 3.21  Mitogen-activated protein kinase signal transduction pathway
Genes  identified  as  significantly  regulated  by  DCs  in  response  to  LPS  and  poly(LC)  were 
submitted  to  DAVID,  and  a  number of genes  encoded  proteins that were  components of the 
MAPK  signalling  pathway.  This  pathway  was  visualised  by  KEGG  charts.  The  component 
proteins in red are encoded by genes which were significantly regulated on the transcript level 
by DCs in response to LPS and poly(l:C) at different stages of maturation.
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3.2.10  MAPK inhibitors affect DC maturation at different stages
The differential requirement for MAPK pathway components can be explored by using 
specific  pharmacological  inhibitors  to  p38  and  ERK.  The  pyridinyl  imidazole 
SB203580 (hereafter referred to as SB) is selective in its binding and inhibition of p38 
activity, not its phosphorylation (Tong et al.,  1997). PD98059 (hereafter referred to as 
PD)  prevents  the  activation  of  MEK1  (systematic  name  MAP2K1),  the  upstream 
activating  kinase  of  ERK1/ERK2,  and  therefore  prevents  the  activation  and 
phosophorylation of ERK1/ERK2 (Alessi et al., 1995).
ERK  has  been  shown  to  function  as  a  negative  regulator  in  human  dendritic  cell 
phenotypic  and  functional  maturation  (Puig-Kroger  et  al.,  2001),  and  also  regulates 
survival  in  mouse  dendritic  cells  (Rescigno  et  al.,  1998).  There  is  also  extensive 
literature documenting the effects of p38 inhibition on DC maturation, that demonstrate 
p38 to be necessary in the phenotypic maturation of DCs (Arrighi et al., 2001; Yu et al., 
2004).  However,  these  studies  focus on measuring the activation  of p38  and  ERK  in 
DCs within minutes or hours after stimulation with LPS, TNFa or CD40L, and suggest 
a continuous role for both p38 and ERK throughout the process of maturation. It is a 
common  theme  to  extrapolate  the  initial  MAPK  activities  measured  only  minutes  or 
hours post-stimulation to their role in modulating phenotypic responses of DCs 24 or 48 
hours later.
There is no literature on the temporal requirement and transcriptional regulation of ERK 
and  p38  in  the  DC  activation  and  differentiation  process.  The  array  data  suggest  a 
temporal  transcriptional  regulation  of p38  and  ERK  that  differentially  varies  (Figure
3.22). The p38 arm of the MAPK pathway seems to be transiently activated, where after 
initial  upregulation  of MKK3  (the  upstream  kinase  of p38),  components  of the  p38 
pathway  are  significantly  downregulated  in  LPS-  and  poly(I:C)-stimulated  DCs  at 
transitional or mature stages (Figure 3.22A-C). In contrast, the ERK pathway seems to 
be  consistently  activated.  The  upstream  component  SOS1  (a  guanine  nucleotide 
exchange factor that activates Ras), downstream effectors SRF (serum response factor) 
and  FOSL1  (fos-like  antigen  1)  are  significantly  upregulated  in  LPS-  and  poly(I:C)- 
stimulated  DCs  at  transitional  and  mature  phases  (Figure  3.22D-F).  The  effects  of 
inhibiting the two MAPK components p38 and ERK at two different timepoints on DC 
phenotype, function, and viability was therefore investigated.
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Figure 3.22 Transcriptional regulation of MAPK pathways (next 2 pages)
A  Components  of p38/JNK  pathway  significantly up-  and  down-regulated  (shown  by  red  and 
green  arrows  respectively)  in  the core  DC  activation  and differentiation  response to  LPS  and 
poly(l:C);
B  Representation of normalised log2 expression  ratios of components of the  p38 pathway,  as 
visualised in Treeview;
C Log2 expression ratios of the same components (shown in B) of the p38 pathway plotted over 
time, in mock-stimulated DCs (broken blue lines), LPS-stimulated DCs (red lines), and poly(l:C)- 
stimulated DCs (green lines).
D Components of ERK pathway significantly up- and down-regulated (shown by red and green 
arrows respectively) in the core DC activation and differentiation response to LPS and poly(l:C); 
E Representation of normalised log2 expression ratios of components of the ERK pathway,  as 
visualised in Treeview;
F Log2 expression ratios of the same components (shown in E) of the ERK pathway plotted over 
time, in mock-stimulated DCs (broken blue lines), LPS-stimulated DCs (red lines), and poly(l:C)- 
stimulated DCs (green lines).
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3.2.10.1  Role of p38 and ERK in affecting DC phenotype
p38 pathway
To investigate the role of p38 and ERK at the early phase of DC maturation, DCs were 
pre-incubated with SB or PD inhibitor prior to stimulation with LPS. To investigate the 
role of p38 and ERK at the late phase of DC maturation, the inhibitors were added  10 
hours  after  DCs  were  stimulated  with  LPS.  In  accordance  with  the  literature,  pre­
incubation  of DCs  with  SB  (inhibition  of p38)  rendered  the  DCs  less  effective  at 
upregulating CD8 6   and HLA-DR in response to LPS (Figure 3.23A). The addition of 
SB  inhibitor alone  did  not  have  noticeable effects  on  DC  phenotype.  This  inhibitory 
effect was not observed when SB was added to DCs at  10 hours after LPS stimulation 
(Figure 3.24), demonstrating that the requirement of p38 in affecting DC phenotype is 
at the early stages of DC maturation. This is in agreement with the array results which 
show a downregulation of p38 pathway components at the transitional and mature phase 
of DC maturation (Figure 3.22).
ERK pathway
In  contrast  to  SB,  pre-incubation  of  DCs  with  PD  inhibitor  alone  resulted  in  an 
upregulation  of CD8 6   and  HLA-DR  (Figure  3.23B).  In  addition,  DCs  pre-incubated 
with  PD  inhibitor  followed  by  stimulation  with  LPS  displayed  enhanced  phenotypic 
maturation (Figure 3.23B). This is in agreement with the literature which shows ERK to 
function  as  a  negative  regulator of phenotypic  maturation  (Puig-Kroger et al.,  2001). 
The  effect  of PD  on  immature  mock-stimulated  DCs suggests that ERK  is  functional 
and active in immature DCs acting as a “brake” for phenotypic maturation. When ERK 
activity is inhibited by PD in the absence of LPS stimulation, immature DCs respond by 
upregulating  surface  expression  of  CD8 6   and  HLA-DR,  because  the  negative 
maturation  control  is  released.  In  addition,  when  ERK  is  inhibited,  phenotypic 
maturation  may  be  further  potentiated  by  LPS,  resulting  in  an  even  higher  level  of 
surface expression of CD8 6  and HLA-DR. Similar to the results of SB, addition of PD 
to DCs at  10 hours after LPS stimulation does not affect DC phenotype (Figure 3.24). 
Together, this  suggests suppression of ERK  activity  is required  in the DC phenotypic 
maturation process at the early stages of DC maturation.
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Figure 3.23 Immunophenotype of DCs pre-incubated with SB or PD inhibitor
DCs  were  stimulated  with  LPS  following  pre-treatment  with  p38  or  ERK  inhibitors.  Surface 
expression  of  CD86  and  HLA-DR  of  mock-stimulated  DCs  (black  unfilled  histogram),  DCs 
stimulated  with  LPS  (grey filled  histogram),  and  treatment with  (A)  SB203580  (red  histogram) 
with  or  without  LPS  stimulation,  and  (B)  PD98059  (red  histogram)  with  or  without  LPS 
stimulation,  were  measured  by  flow  cytometry  at  24  hours  post-LPS-stimulation.  Dotted 
histograms show the relevant isotype controls.
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Figure 3.24 Immunophenotype of LPS-stimulated DCs treated with SB and PD inhibitors
DCs  were  stimulated  with  LPS,  and  SB203580  or  PD98059  inhibitors  were  added  10  hours 
after  LPS-stimulation.  Flow  cytometry was  carried  out  at  24  hours  post-LPS-stimulation,  and 
cells  analysed  for  surface  expression  of  CD86  and  HLA-DR.  Mock-stimulated  DCs  (black 
unfilled  histogram),  LPS-stimulated  DCs  (grey  filled  histograms),  DCs  treated  with  SB  (top 
panel)  or  PD  inhibitor  (bottom  panel)  10  hours  after  LPS-stimulation  (red  histograms).  Dotted 
histograms show the relevant isotype controls.
149Dendritic cell activation and differentiation
3.2.10.2  Donor variability and differential responses to MAPK 
inhibition
Typical  of  experiments  involving  human  dendritic  cells,  there  are  inherent  donor 
variability  in  responses  to  fixed  concentrations  of various  stimuli  such  as  LPS  and 
poly(I:C).  The  same  variable  effect  is  observed  for  DC  responses  to  fixed 
concentrations  of PD  inhibitor,  evident  in  the  levels  of HLA-DR  and  CD86  surface 
expression. This suggests that sensitivity of DCs to SB or PD inhibitor reflects donor 
variability, possibly reflecting differences in the basal activities of p38 and ERK.
The role of  ERK and its relationship to LPS-responsiveness
Data presented here show that ERK is functionally active in immature DCs to prevent 
inappropriate phenotypic maturation (Figure 3.23B). This effect was consistently found 
among DCs from different donors, where the addition of PD to immature DCs resulted 
in  enhancement  of CD86  surface  expression  (Figure  3.25A  and  B, p-value = 0.011). 
The effect of PD on HLA-DR surface expression was less marked, though still showed 
a general trend of increased surface expression  in DCs exposed to PD (Figure 3.25B). 
However, the enhancing effect of PD was not seen in LPS-stimulated DCs, when results 
from different donors were averaged (Figure 3.25A).
Further analysis of the effects of PD  inhibitor in individual donors showed a negative 
correlation  between  a  donor’s  DCs’  responsiveness to  LPS  (as  determined  by  CD86 
upregulation  in response to LPS) and the enhancing phenotypic effect of PD in mock- 
stimulated  DCs  (Figure  3.26).  The  stronger  response  a  donor’s  cells  have  to  LPS 
stimulation,  the  less  CD86  upregulation  occurs  when  PD  is  added  to  immature  DCs 
(e.g. donor 4  in  Figure 3.26). Conversely, where there is a weaker response to LPS as 
measured by CD86 upregulation, there is a commensurate phenotype enhancing effect 
of PD  (e.g.  donor  1   in  Figure  3.26).  This  implies  that  donors  whose  DCs  have  a 
potential  to  strongly  respond  to  LPS  (indicated  by  level  of CD86  upregulation  in 
response to  LPS)  may  have correspondingly higher basal  levels of ERK. Therefore, a 
fixed  dose of PD  may  be  suboptimal  and not be  sufficient at inhibiting ERK  activity 
fully  in  the  corresponding  immature  DCs.  It  is  important to  note that this  individual 
variation was not seen when the results were averaged (Figure 3.25A), highlighting the 
importance of examining individual variation as well as averaged trends.
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This data suggests that individual donor DCs have different levels of ERK activity that 
is  correlated  to  their  LPS-responsiveness.  It  is  therefore  likely  that  a titration  of PD 
inhibitor per donor will  identify  levels  where  PD  is  able to  inhibit all  ERK  activity, 
shown by the greatest phenotypic enhancement of CD86 surface expression  indicating 
the release of the negative maturation control of the ERK pathway.
The role of  p38 and its relationship to LPS-responsiveness
In contrast to the subtle effects of ERK inhibition that vary with individuals, results of 
p38  inhibition  showed  consistent  impaired  phenotypic  maturation  in  SB-treated  DCs 
responding to LPS (Figure 3.27). There does not seem to be a relationship between the 
inhibition of p38 and LPS responsiveness as measured by CD86 surface expression in 
individual donor DCs.
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Figure 3.25 Donor variability effects on phenotype of PD-treated DCs
A  DCs  from  individual  donors  were  either  mock-stimulated  (-LPS)  or  stimulated  with  LPS 
(+LPS),  with  or without pre-treatment with  PD  inhibitor.  Averaged  CD86  MFI  values from flow 
cytometric analysis of 5 donors,  visualised  as  box-and-whisker plots,  were compared  between 
the groups.  P-values  indicated  are generated  by the  Student’s  f-test for comparisons between 
control mock-stimulated and control LPS-stimulated DCs, and between mock-stimulated control 
and mock-stimulated PD-treated DCs.
B The CD86  MFI values plotted for each individual donor to visualise donor-specific responses 
to PD-treatment in mock-stimulated (-LPS) and LPS-stimulated (+LPS) DCs.
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Figure 3.26 Donor variability effects of LPS- and PD-treated DCs
DCs from individual donors were either mock-stimulated or stimulated with LPS, in the presence 
or  absence  of  pre-treatment  with  PD  inhibitor.  CD86  MFI  values  were  compared  between 
control  mock-stimulated and control LPS-stimulated  DCs to generate a ratio of CD86 MFI (pink 
bars)  indicating  LPS-responsiveness,  and  between  mock-stimulated  control  and  PD-treated 
DCs (blue bars), indicating the enhancing effect of PD, for four individual donors.
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Figure 3.27 Donor variability effects on phenotype of SB-treated DCs
A  DCs  from  individual  donors  were  either  mock-stimulated  (-LPS)  or  stimulated  with  LPS 
(+LPS),  with  or without  pre-treatment with  SB  inhibitor.  Averaged  CD86  MFI  values from flow 
cytometric analysis of 7 donors,  visualised  as  box-and-whisker plots,  were compared  between 
the groups.  P-values  indicated  are generated  by the  Student’s  f-test for comparisons between 
control  mock-stimulated  and  control  LPS-stimulated  DCs,  and  between  LPS-stimulated  control 
and LPS-stimulated SB-treated DCs.
B The CD86 MFI  values plotted for each individual donor to visualise donor-specific responses 
to SB-treatment in LPS-stimulated control and LPS-stimulated SB-treated DCs.
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3.2.10.3  Role of ERK and p38 in TNFa production
To  investigate  further  the  role  of ERK  and  p38  in  DC  maturation,  the  production  of 
TNFa  in  DCs  pre-incubated  with  SB  and  PD  inhibitor  followed  by  stimulation  with 
LPS was investigated. TNFa was chosen because of its rapid induction characteristics, 
and  its  clear  role  in  DC  maturation  (Lyakh  et  al.,  2000;  Nelson  et  al.,  1999).  Pre­
treatment  of DCs  with  both  SB  and  PD  inhibitor  before  LPS-stimulation  effectively 
reduced TNFa production in DCs responding to LPS, and the extent of the reduction is 
dependent on the  individual donors (Figure 3.28).  This  shows that both ERK and p38 
are required in maturing DCs for the production of TNFa following LPS-stimulation.
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Figure 3.28 Effects of SB and PD inhibitors on TNFa production in DCs
DCs were either untreated  (control) or pre-treated with SB  (SB203580) or PD (PD98059).  DCs 
were then  mock-stimulated  (control)  or stimulated  with  LPS  (LPS) for 24  hours  in  culture.  DC 
culture  supernatants were  harvested  after 24  hours,  and  levels of TNFa were measured  by a 
sandwich  immunoassay  for  TNFa  (Section  2.7.1).  Results  show  5  donor  samples  for  pre­
treatment  with  SB,  3  donor  samples  for  pre-treatment  with  PD.  Averaged  levels  of  TNFa 
production  were  compared  between  LPS-stimulated  control  DCs  and  inhibitor-treated  DCs  to 
determine level of significance by the Student’s paired f-test.
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The role of  p38 in TNFa secretion by DCs
DCs pre-incubated with SB inhibitor alone consistently produced a small but detectable 
amount of TNFa, compared to untreated control DCs (Figure 3.28). This also seemed to 
be  donor-dependent,  but  comparison  between  mock-stimulated  SB-treated  DCs  and 
control DCs with averaged levels of TNFa production across donors masked this effect 
at the  individual donor level. This enhancement of TNFa production by SB treatment 
was investigated. In mock-stimulated DCs, pre-treatment with SB slightly increased the 
level of TNFa production. This increase in the level of TNFa production is correlated 
to the reduction in levels of TNFa production as a result of SB pre-treatment in LPS- 
stimulated  DCs  (Figure  3.29).  This  can  be  visualised  on  a plot of the ratio of TNFa 
secretion between  SB treated and control  DCs at the  immature (mock-stimulated) and 
mature (LPS-stimulated) stage, where an enhancement in TNFa secretion is seen as a 
ratio greater than  1, and a reduction in TNFa secretion is seen as a ratio less than 1. For 
example,  immature DCs  from donor 2  (Figure  3.29)  exposed to  SB  inhibitor produce 
the highest levels of TNFa compared to the other 4 donors (orange bars). Conversely, 
SB pre-treatment in  LPS-stimulated DCs from the same donor resulted  in the greatest 
reduction of TNFa production (purple bars). This suggests that a fixed dose of SB that 
effectively inhibits the basal activity of p38 in  immature DCs results in optimal TNFa 
production, and that the same dose of SB producing effective inhibition of p38 results in 
the greatest reduction in TNFa levels in LPS-stimulated DCs.
This enhancing effect of TNFa production  by DCs  incubated with  SB  inhibitor alone 
suggests the role of basal activity of p38 in preventing inappropriate TNFa secretion by 
immature  DCs.  This  data  suggests  a  dual  role  for  p38,  where  in  the  absence  of 
appropriate  maturation  stimuli,  p38  functions  to  prevent  inappropriate  TNFa 
production.  However,  in  the  presence  of  appropriate  maturation  stimuli,  p38  acts 
synergistically  or  functions  downstream  of TLR  signalling  to  result  in  optimal  and 
appropriate TNFa  production  by  DCs. Therefore,  the higher the basal  p38  activity  in 
donor  DCs,  the  less  enhancement  by  TNFa  production  is  seen  when  DCs  are  pre­
treated with  suboptimal dose of SB  inhibitor.  Similarly, this amount of SB inhibitor is 
also  less effective  at  inhibiting p38 to reduce  levels of TNFa  production  in the  same 
DCs stimulated with LPS. Individual donor DCs also appear to have different levels of 
p38 activity that is correlated to their LPS-responsiveness related to TNFa production.
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It is therefore likely that a titration of SB inhibitor per donor will identify levels where 
SB  is able to inhibit all p38 activity and thereby release the negative control of TNFa 
production by the p38 pathway in immature DCs.
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Figure 3.29 Donor variability effects on TNFa secretion
DCs  were  either  untreated  or  pre-treated  with  SB.  DCs were  then  mock-stimulated  or further 
stimulated  with  LPS  for 24  hours  in  culture.  DC  culture  supernatants were  harvested  after 24 
hours,  and  levels  of TNFa  were  measured  by  a  sandwich  immunoassay for TNFa.  Ratios  of 
TNFa  production  (y-axis)  were  generated  between  mock-stimulated  SB-treated  or  untreated 
DCs  (orange  bars),  and  LPS-stimulated  untreated  and  SB-treated  DCs  (purple  bars).  This  is 
shown on a log10 scale.
Orange bars show increase in TNFa production as a result of p38 inhibition in mock-stimulated 
DCs,  and  purple  bars  show reduction  in TNFa  production  as  a  result of p38  inhibition  in  LPS- 
stimulated DCs.
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3.2.10.4  Role of ERK in DC viability
The effects of SB and PD inhibitors on DC viability was also investigated. Forward and 
side scatter plots of DCs suggest that the size and geometry of the cell population was 
altered in the presence of PD treatment (data not shown). This was further investigated 
with Annexin V  and propidium  iodide staining to  identity cells undergoing apoptosis. 
To identify effects of p38  and ERK  inhibition  in  immature and mature DCs, viability 
was measured in DCs in various conditions (Figure 3.30A). DCs were pre-treated with 
SB  or PD,  and were “mock-stimulated  (“mock-stimulated” panel  in  Figure 3.30B), or 
stimulated with LPS (“Early” panel in Figure 3.30B). Effects of p38 and ERK inhibition 
in  maturing  DCs were  investigated by  adding the  inhibitors  10 hours after DCs were 
stimulated with LPS (“Late” panel in Figure 3.30B). DCs were harvested after 24 hours, 
and early apoptotic cells were identified by Annexin V staining.  The results show that 
the addition of PD to the cells results in an increased number of apoptotic (Annexin V 
positive) cells in all three groups. The effect of ERK inhibition resulting in the increase 
in apoptotic DCs was most evident in mock-stimulated immature DCs (“control mock- 
stimulated” group contained  15.37% Annexin V positive cells compared to “PD mock- 
stimulated” group which contained 53.75% Annexin V positive cells), though this effect 
was  also  maintained  in  PD  pre-treated  LPS-stimulated  DCs.  The  effect  of  ERK 
inhibition does not seem significant at the later stage in mature DCs. This suggests that 
ERK has a role in protecting both immature DCs (mock-stimulated and LPS-stimulated) 
from  apoptosis,  and  the  ERK  signalling  pathway  therefore  mediates  an  early  pro­
survival signal to DCs.
Addition of SB to immature and maturing DCs had no effect on DC viability (data not 
shown).
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Figure 3.30 DCs treated with PD98059 have increased susceptibility to apoptosis
A Control and inhibitor-treated DCs were stimulated with LPS at the point marked *, or were left 
mock-stimulated.  Inhibitors  SB or PD were  either added to  immature  DCs  1  hour prior to  LPS 
stimulation  (“early”),  or  inhibitors  were  added  at  10  hours  (“late”)  following  LPS  stimulation. 
Cells were harvested for flow cytometry at 24 hours.
B  Representative AnnexinV (AV) and  Propidium  iodide (PI) staining of control  DCs (top panel) 
or PD-treated  DCs  (bottom  panel).  The numbers  in  the quadrants  indicate  percentages of the 
total cell  population.  In the comparisons between untreated and PD-treated  DCs, PD-treatment 
of  mock-stimulated  immature  DCs  and  LPS-stimulated  DCs  resulted  in  greater  numbers  of 
Annexin  V  positive  cells,  indicating  a  larger  proportion  of  cells  undergoing  apoptosis  in  the 
presence of PD inhibitor.
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Discussion
The dendritic cell maturation response, induced by two we 1 1 -characterised TLR ligands 
LPS  and  poly(I:C)  was  investigated  by  transcriptional  profiling  using  cDNA 
microrrays.  Sampling  over  an  extended  timecourse  allowed transcriptional  signatures 
DC maturation stages to be identified. This greatly expands the gene expression data for 
the maturation and differentiation of human dendritic cells. The importance of antigen 
dosage,  donor  and  biological  variability  between  dendritic  cells,  and  the  biological 
relevance of sampling at pertinent timepoints were addressed in this study, resulting in a 
robust  dataset  of core  DC  “maturation”-regulated  genes  identified  by  two  statistical 
methods.
Time-dependent transcriptional profiles of DC maturation
The  process  of  antigen-initiated  dendritic  cell  “maturation”  is  a  continuous  time- 
dependent process where dendritic cells change from an immature immune sentinel to a 
mature antigen presenting cell. The two states do not arise by a simple binary transition 
from  one  to  the  other.  Rather,  this  maturation  process  involves  a  number  of stages, 
where  immature DCs change  and functionally remodel through time to a fully mature 
phenotype.  Previous  studies  using  gene  expression  analysis  of DC  maturation  range 
from  sampling  DCs at time zero hours and 24  hours or 48 hours after the addition of 
maturation stimulus (Dietz et al., 2000; Messmer et al., 2003; Moschella et al., 2001), to 
studies that  include  various  single  “intermediate” timepoints  (Granucci  et  al.,  2001b; 
Matsunaga et al., 2002; Tureci et al., 2003), to extensive timecourse analyses that cover 
the timeframe relevant for DC maturation (Granucci et al., 2001a; Huang et al., 2001). 
Therefore,  only  the  studies  of Granucci  and  Huang  produce  definitive  datasets  for 
mouse and human dendritic cell maturation respectively.
The  study  by  Huang  et  al  identified  a  core  response  comprising  only  166  genes 
regulated  by  dendritic  cells  in  response  to E.  coli,  Influenza,  and  C.  albicans.  These 
genes were  therefore  termed  pathogen-independent.  Most  of the  genes  identified  had 
known  functions relating to  DC  biology,  and  the  induction  of these genes followed a 
temporal order. However, this set of core response genes is clearly an underestimate, as 
Influenza infection of DCs results in a productive infection with cytopathic effects, and 
Influenza  also  results  in  a  significant  transcriptional  downregulation  of a  number of
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genes  (Chapter  4).  These  effects  of Influenza  infection  in  dendritic  cells  were  not 
addressed  in  Huang’s  study,  and  other  pathogen-specific  effects  may  be  similarly 
overlooked. Temporal ordering of genes regulated in the DC core response to pathogen 
in Huang’s study used a self-organising map algorithm to cluster genes. In contrast, the 
work here used two statistical methods to validate genes involved in the transcriptional 
stages of DC maturation.  Significantly regulated genes identified by the two statistical 
methods totalled  1055 genes out of 4321  genes analysed, a proportion of nearly 25% of 
genes expressed in DCs that comprised the core activation and differentiation response.
Transcriptional  profiles  defining  stages  of DC  maturation  were  suggested  for murine 
dendritic  cells  (Ricciardi-Castagnoli  and  Granucci,  2002),  based  on  gene  expression 
studies in a murine DC line stimulated with E. coli (Granucci et al., 2001a). Granucci’s 
study defined temporal ordering of gene expression based on cluster analysis of genes 
divided into functional families. The validity of the clustering was tested by comparison 
to  established  markers  of DC  function  where  the  kinetics  of gene  regulation  were 
known.  This  functional  classification  of genes therefore relies on  information already 
known  about DCs,  and additional  information  inferred  from this potentially limits the 
amount of new biological  information that can be found. The statistical approach used 
in this study therefore produces a wider-encompassing set of genes that are involved in 
the DC maturation programme.
Kinetic analysis of gene expression  of dendritic cells responses to pathogens has also 
identified  the  differences  between  activation  and  differentiation,  both  processes 
occurring under the broader term of DC “maturation”. Activatory responses are defined 
as  transient  (Huang  et  al.,  2001;  Ricciardi-Castagnoli  and  Granucci,  2002),  where 
transcript levels undergo transient induction or repression, followed by return to basal 
levels.  This  type  of  response  is  particularly  well-illustrated  in  the  transcriptional 
induction  of pro-inflammatory  cytokines  and  chemokines  that  are  identified  in  the 
transitional  phase  of  DC  “maturation”.  In  contrast,  differentiation  responses  are 
sustained,  and result  in  DCs reaching a new  steady  state. These responses are seen  in 
the group of genes  statistically  identified  as significantly regulated over two stages of 
maturation,  in particular the transitional and mature phase (Figure 3.13B). These genes 
comprise  transcription  factors  and  other  immune  response  and  interferon-inducible 
genes,  highlighting  the  functional  differentiation  of  DCs  from  an  innate  immune 
sentinel to an effective antigen presenting cell as part of the maturation process.
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Components  of  the  MAPK  pathway  identified  in  this  work  as  being  differentially 
temporally regulated may also fit this model of activation and differentiation. There is a 
transient  requirement  for  p38  in  the  early  phase  of  DC  maturation  involved  in 
upregulating surface expression of CD86 and HLA-DR, and production of TNFa. This 
suggests  that  the  activation  of  p38  is  a  result  of  “activation”  stimulus,  as  this 
requirement  for  p38  is  not  sustained.  In  contrast,  modulation  of  ERK  activity,  as 
reflected  at the  transcript  level,  is  required throughout DC  maturation to  regulate  DC 
phenotype and survival, which may suggest a role in mediating DC differentiation.
Whereas cascades  of transcriptional changes have been suggested for human dendritic 
cells (Huang et al., 2001; Tureci et al., 2003), no studies have specifically use statistical 
methods to define significantly regulated genes during the maturation process of human 
dendritic cells in response to two well-characterised maturation stimuli. Work presented 
here on the human dendritic cell maturation process is a result of detailed transcriptional 
profiling  throughout  the  24-hour  DC  maturation  timecourse  and  reveals  statistically 
distinct transcriptional stages of DC maturation.
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Figure 3.31  Transcriptional stages of DC “m aturation”
The transcriptional  profile of DC activation and  differentiation  in  response to  LPS and  poly(l:C) 
can  be  divided  into  distinct stages  that  correspond  to  early,  transitional  and  mature  DCs.  The 
transcriptional signatures are typified  by genes that are strongly expressed at various stages of 
DC activation and differentiation, and delineate between temporary (dotted lines) and sustained 
(solid lines) induction of genes.
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The  genes that  are  regulated  as the  DCs  traverse  this  maturation  pathway  reflect the 
biology  and  function  of  maturing  DCs.  The  similarity  between  the  responses  to 
poly(I:C) and  LPS  suggest that the TLR3  and TLR4  signalling pathways functionally 
converge, to a large extent. TLR3 and TLR4 are unique among the TLR family in that 
in addition to a MyD88-dependent pathway shared by all TLRs, both utilise a MyD88- 
independent  signalling  pathway  (Alexopoulou  et al.,  2001;  Kaisho et al.,  2001). This 
allows  TLR3  and  TLR4  ligands  to  stimulate  an  interferon  response  through  the 
activation of the adaptor molecule TRIF resulting in the activation of IRF-3  (Doyle et 
al.,  2002).  The  integration  of the  signalling  pathways  therefore  determines  common 
transcriptional and phenotypic responses, both of which are seen in this analysis. In this 
study,  DCs  therefore  regulate  a  dominant  time-dependent  response  rather  than  a 
stimulus-specific response.
LPS  and  poly(LC)  are  simple  antigen  components  that  DCs  functioning  as  immune 
sentinels should recognise as representative of gram negative bacteria and intracellular 
virus respectively. Using these antigens makes the study of downstream transcriptional 
responses  more  relevant  to  the  biological  and  physiological  setting  where  immature 
DCs  encounter  pathogens  and  regulate  a  maturation  response.  This  is  in  contrast to 
studies that use conditioned medium, cytokine cocktails or members of the TNF family 
(e.g. TNFa or CD40L) to induce DC maturation. In these cases the maturation response 
of DCs is not necessarily biologically relevant, especially when considering the role of 
DCs which  is  to  initiate  the  immune  response  in  the  face  of pathogens.  In  addition, 
within the context of the immune response,  it is important to consider when DCs will 
encounter TNFa  and  CD40L.  As an  initial  stimulus to the process of DC maturation, 
DCs will primarily see antigen; in the transient phase of maturation, DCs will produce 
TNFa which  should act  in  an  autocrine manner,  binding to TNF receptors on DCs to 
further  propagate  downstream  effects.  Upregulation  of  CD40  transcript  leading  to 
surface  upregulation  of CD40  in  the  mature  phase  of dendritic  cell  differentiation  is 
necessary  for  optimising  DC-T  cell  interactions  in  lymph  nodes.  Therefore,  the 
relevance  of using  CD40L  and TNFa  to  stimulate  DC  maturation  can  be questioned. 
The temporal context should always be an important consideration when deciding upon 
maturation-inducing  stimuli  in  order  to  gain  biologically  relevant  insight  into  DC 
function and immune responses.
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Transcriptional regulation of signalling pathways
The dataset of core genes regulated by DCs have also revealed differential modulation 
of the MAPK pathway. This signalling pathway has been demonstrated to be important 
in modulating wide-ranging effects in the cell, including dendritic cells. The use of the 
gene annotation tool DAVID (Dennis et al., 2003) allowed visualisation of the large sets 
of genes  identified as significantly regulated, that relate to biologically functional and 
relevant pathways.
Study of signalling pathways, MAPK included, have classically involved comparison of 
phosphorylated and unphosphorylated forms of protein kinases to assess the activity of 
a  particular  pathway.  However,  microarray  analysis  allows  an  overview  of  the 
transcriptional regulation of components of such signalling pathways, and offers a view 
of the  gene  regulatory  control  of signalling  pathways.  The  caveat that transcriptional 
induction of such genes actually represents the normal activity of a pathway rather than 
an induction of a pathway in response to stimulus has to be considered. However, the 
overall  “tone”  of an  integrated  signalling  pathway  can  be  assessed  by  focussing  on 
specific  endpoints  that  are  consistently  up-  or down-regulated.  We  found  that  serum 
response  factor  (SRF)  and  c-fos,  transcription  factors  downstream  of  ERK,  were 
signficantly  upregulated  at transitional  and  mature  stages  of DC  differentiation;  p53, 
downstream of p38 signalling, was downregulated at the transitional and mature phase 
of DC differentiation. This therefore highlighted ERK and p38 for further study, where 
both  have  been  shown  to  be  active  in  immature  DCs  in  modulating  appropriate 
responses in terms of phenotype, cytokine secretion, and maintenance of survival. p38 
has been shown to be necessary for phenotypic maturation of DCs in response to LPS 
and  TNFa  (Arrighi  et  al.,  2001),  and  this  was  also  shown  here  using  p38  inhibitor 
which impaired DC phenotype maturation in response to LPS. ERK has been shown to 
function as a negative regulator of DC  maturation, where inhibition of ERK results in 
enhanced surface expression of antigen presenting molecules, costimulatory molecules, 
and  greater  production  of IL-12  upon  stimulation  of DCs  with  LPS  or TNFa  (Puig- 
Kroger  et  al.,  2001).  It  was  further  identified  that  ERK  has  a  role  in  mediating  DC 
survival  in  immature  mock-stimulated  and  LPS-stimulated  DCs,  which  has  not  been 
previously  reported.  In  mature DCs  ERK  inhibition  has been  shown  not to affect DC 
survival  (Ardeshna  et  al.,  2000),  and  this  is  in  agreement  with  the  data  shown  here. 
Therefore,  the  continued  transcriptional  upregulation  of SRF  and  c-fos  at  the  mature
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phase of DC  differentiation  indicates a role for ERK  signalling at this  late  stage,  and 
may contribute to other aspects of DC function.
The modulation of DC responses by ERK and p38 has potential importance in affecting 
how DCs polarise appropriate adaptive immune responses. The use of MAPK inhibitors 
may  have  therapeutic  potential.  As  p38  is  a  positive  regulator  of  functional  and 
phenotypic  DC  maturation,  inhibition  of p38  may  be  useful  in  autoimmune  diseases 
which  arise  from  an  overactive  immune  response.  In  support  of  this,  pyridinyl 
imidazoles that are closely related to SB203580 have shown efficacy in animal models 
of chronic inflammatory disease such as rheumatoid arthritis (Jackson and Bullington, 
2002; Revesz et al., 2004). Anti-TNFa therapy is used for rheumatoid arthritis, further 
suggesting  a  potential  role  for  inhibition  of p38  (McLay  et  al.,  2001;  Westra  et  al., 
2004). It will be interesting to look at the function of p38 and ERK in DC responses to 
antigens  that  induce  a  Th2  response  such  as  prostaglandin  E  and  cholera  toxin 
(Kapsenberg, 2003).
An  important  consideration  for  therapeutic  intervention  with  MAPK  inhibitors  is 
variability between individuals. This variability was evident in the studies involving p38 
and ERK inhibitor, where different donors’  cells responded differently to a fixed dose 
of inhibitor and  to  LPS.  This  is  a widely  accepted  problem  in the  study  of dendritic 
cells,  and  the  variability  is  tackled  by  increasing  the  number  of donors  in  order  to 
observe reproducible trends. In the case of responsiveness to SB203580 and PD98059, 
there is a trend that correlates with responsiveness to LPS. This suggests that levels of 
p38  and  ERK varies between  individuals,  corresponding to  individual “set-points” for 
DC activation  and differentiation. This highlights the importance of obtaining patient- 
specific  optimal  therapeutic  doses  if such  inhibitors  are  used  to  treat  immunological 
diseases, as the basal levels of p38 and ERK are variable between individuals.
The array experiments in this chapter form a basis for extending the hypothesis of DC 
transcriptional plasticity to antigens. Although differential responses were limited, their 
presence  at  early  timepoints  suggested  that  DCs  do  have  an  ability  to  differentiate 
pathogen components. Having identified a statistically significant core set of maturation 
response genes, DC responses extending to whole pathogens can be investigated.
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Chapter 4 
Plasticity of Dendritic cell responses to Viruses 
Introduction
In the previous chapter, dendritic cell responses to defined pathogen components were 
characterised.  Transcriptional  profiling  revealed  a  defined,  core  “activation”  and 
“differentiation”  programme.  This  programme  was  initiated  through  both  TLR4 
(lipopolysaccharide)  and  TLR3  (dsRNA)  and  downstream  signalling  through  these 
receptors.  The  core  maturation  programme  is  very  similar  between  the  two  stimuli, 
presumably  as  they  are  simple  antigens,  essentially  pathogen  components.  However, 
subtle  differences can  be  seen  in  DC  transcriptional  responses to  LPS  and  poly(I:C) 
(Figure 3.13A,  Chapter 3). This is consistent with previous work with diverse antigen 
exposure  to  DCs  (Huang  et  al.,  2001).  Here  we  investigate the  LPS-  and  poly(I:C)- 
induced  differential  responses  in  DCs  in  more  detail.  The  hypothesis  that  DCs  are 
plastic in their response to antigens was then further investigated with more biologically 
relevant and complex antigens by using whole viruses, Influenza and Rhinovirus.
Both  Influenza  and  Rhinovirus  are  RNA  viruses.  Influenza  viruses  are  enveloped 
viruses  with  a  segmented  single-stranded  RNA  (ssRNA)  genome  that  is  “negative 
sense”,  with  viral  messenger RNAs  (mRNAs)  being transcribed  from  the  viral  RNA 
segments.  Rhinoviruses  are  non-enveloped  viruses  with  a  ssRNA  genome  that  is 
positive  (mRNA)  sense.  Influenza  and  Rhinovirus  are  both  respiratory  viruses  that 
infect  airway  epithelial  cells.  Importantly,  Influenza  has  been  shown  to  be  able  to 
productively  infect dendritic  cells,  a fact not controlled  for in  an  earlier study  of DC 
transcriptional  responses  to  diverse  pathogens  (Huang  et  al.,  2001).  To  distinguish 
between  effects  of DC-virus  interaction  at the  cell  surface  and  effects  of active viral 
replication, DC responses to exposure with inactivated virus was also investigated.
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Results 
4.1 LPS-specific transcriptional responses
In addition to the dendritic cell core activation and differentiation response to LPS and 
poly(I:C),  DCs  also  regulate  LPS-  and  poly(l:C)-specific  genes  (Figure  3.13A  and
4.1 A). These genes were determined to be significantly up- or down-regulated by SAM 
and  MWU  (Section  3.2.7).  In  response  to  LPS-stimulation,  DCs  transcriptionally 
regulate a larger number of genes at the early phase between 0 and 2 hours after LPS- 
stimulation compared to poly(I:C)-stimulation. These results were further explored by 
focusing  on  sustained  differential  responses,  genes that are  differentially  regulated  at 
early timepoints which are also similarly up- or down-regulated at later phases of DC 
maturation. The gene expression differences described below are sustained throughout 
10  hours  or  24  hours  of the  maturation  programme.  The  number of genes that were 
consistently differentially regulated throughout DC maturation  in response to LPS- or 
poly(I:C)-stimulation are shown in Figure 4.IB.
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Figure 4.1  Genes differentially regulated in DCs in response to LPS and dsRNA
A Genes differentially regulated  by DCs in  response to LPS or poly(l:C) that are not part of the 
core response commonly induced  in DCs in response to both stimuli, at the defined  maturation 
stages of  Early,  Transitional  and  Mature.  Genes  in  green  are  transcriptionally downregulated, 
genes in red are transcriptionally upregulated.
B  Number of genes  significantly differentially  regulated  at the early  phase of DC  maturation  in 
response  to  LPS  and  poly(l:C).  The  solid  bars  indicate  genes  unique  to  the  early  phase, 
hatched  bars  indicate  genes common to  early and  transitional,  or early and  mature  phases of 
DC maturation.
C  Number  of  genes  significantly  differentially  regulated  at  the  transitional  phase  of  DC 
maturation  in  response  to  LPS  and  poly(l:C).The  sold  bars  indicate  genes  unique  to  the 
transitional  phase,  hatched  bars  indicate  genes common  to transitional  and  mature  phases  of 
DC maturation.
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This analysis shows that approximately 40% of genes that are significantly regulated by 
DCs in response to LPS-stimulation at the early phase of DC maturation, (0 and 2 hours 
post-stimulation), are sustained differential responses (Figure 4.IB). This suggests that 
the transcriptional induction and repression of these genes at the early phase are real and 
biologically  significant,  as the  effects  are  maintained  at  later timepoints.  In  addition, 
functional  analysis also  indicates biological  significance. An example of LPS-specific 
gene regulation is the sustained upregulation acyloxyacyl hydrolase (AOAH). AOAH is 
a  lipase  that  targets  fatty  acyl  chains  of lipid  A  regions  of bacterial  endotoxins  for 
hydrolysis,  and  may  modulate  the  host  inflammatory  response  to  Gram-negative 
bacteria (Hagen et al.,  1991). As LPS is a component of the cell wall of Gram-negative 
bacteria,  the  specific  and  statistically  significant  upregulation  of  AOAH  in  DCs 
responding to LPS-treatment and not dsRNA-treatment demonstrates the potential  for 
functional bias in DC responses to particular antigens.
Downregulated  genes  in  early  phase  DCs  stimulated  with  LPS  that  are  also 
downregulated at the transitional or mature phases include basic transcription factor 3, 
c-myc binding protein, RAP1A, and components of the mitochondrial respiratory chain 
(NADH dehydrogenase complexes). The downregulation of the NADH components in 
the  mitochondrial  respiratory  chain,  responsible  for  electron  transport,  may  be 
functionally  coupled  with  the  LPS-specific  upregulation  of  NADPH  oxidase 
(cytochrome  b-245)  at  the  transitional  phase.  NADPH  oxidase  participates  in  the 
generation of reactive oxygen species (ROS) (Segal et al.,  1992). It is therefore possible 
that the  function  of the  mitochondria are diverted  away  from  cellular respiration to a 
directed microbicidal response, and that this is coordinated at the transcriptional level.
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4.2  dsRNA-specific responses
Transcriptional responses regulated by DCs specifically to dsRNA do not seem to be as 
consistently  regulated  throughout  the  different  phases  of maturation.  Genes  that  are 
regulated by DCs  in  response to poly(I:C) at early or transitional phases do not retain 
this poly(I:C)-specificity at later stages. For example, genes that are “dsRNA-specific” 
at the transitional  phase of DC  maturation  converge to being commonly regulated by 
LPS and poly(I:C) at the mature phase. This may demonstrate downstream  integration 
of signalling  pathways  of TLR3  and  TLR4.  Alternatively,  initial  differences between 
regulated genes at the early stage in response to LPS and poly(I:C) may reflect different 
signalling  strengths of the doses of stimuli  used, where LPS may be a more “robust” 
initial  stimulus  for  its  receptor,  and  poly(I:C)  a  “weaker”  initial  stimulus.  Early 
transcriptional responses are therefore more marked for LPS-stimulated DCs compared 
to poly(I:C)-stimulated DCs. However, the number of genes significantly regulated by 
the two stimuli at later transitional and mature stages are comparable between LPS and 
poly(I:C) (Figure 4.1 A).
DC transcriptional responses specific to dsRNA are further explored later in this chapter 
in comparison with DC responses to viral antigens. As the motif of dsRNA is believed 
to  be  plentiful  in  RNA  virus  replication,  transcriptional  responses of DCs to dsRNA 
serve as a useful comparison between DC responses to viruses.
These  results  demonstrate  that  at  the  level  of  simple  single-component  antigens, 
dendritic  cells  are  transcriptionally  plastic  in  their  responses.  However,  presumably 
because  of the  cross-talk  and  commonality  in  the  signalling  pathways  of TLR3  and 
TLR4,  DC  responses  to  dsRNA  and  LPS  are  largely  similar,  and  the  differences 
observed  are  subtle  and  difficult  to  interpret.  In  order  to  view  more  substantial  and 
biologically  relevant  transcriptional  regulation,  we  decided  to  use  more  complex 
antigens in the form of whole virus to investigate dendritic cell plasticity.
Although  only  sustained  differential  responses (over more than  one maturation  stage) 
are  investigated  here, transient changes affected by LPS  and  dsRNA were seen  in the 
DC  activation  and  differentiaton  response,  in  particular  the  rapid  induction  of pro- 
inflammatory  cytokines  that  return  to  basal  levels.  Therefore,  differential  LPS-  and 
poly(I:C)-induced transient changes also merit further investigation.
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4.3  Establishing a method for detecting viral infection in DCs
4.3.1  Intracellular staining for cathepsin E
In  order to  compare  between  DC  responses  to  different  viruses,  it was  necessary  to 
standardise  methods  for measuring the  actual  number of DCs exposed to a give virus 
titre. This  is to ensure that DCs are exposed to a high multiplicity of infection (MOI), 
thereby  synchronising the  DC  population  response.  In the case of Influenza, which  is 
able  to  replicate  in  DCs,  a  high  MOI  will  also  help  ensure  that  replication  is 
synchronous. This  is an  important consideration,  as the effects of virus spreading and 
downstream  secondary effects will  increase variation  and hinder interpretation  of DC 
responses  to  replicating  virus.  For  inactivated  viruses,  comparisons  between  DC 
responses are only valid if DCs exposed to different virus treatments “see” comparable 
amounts of virus particles.
A  robust  and  reliable  method  was  developed  to  monitor  for  the  presence  of viral 
proteins  inside  infected  dendritic  cells,  by  intracellular staining for viral  antigens and 
flow cytometry for quantification. Cathepsin E was used as the intracellular antigen in 
DCs to establish and standardise the technique. Cathepsin E staining was confirmed for 
permeabilised cells by  flow cytometry, with positive staining greatly reduced for non- 
permeabilised cells (Figure 4.2). This is seen as the high median fluorescence intensity 
(MFI)  for cathepsin  E  in  permeablised  DCs  (intracellular),  and  low background  MFI 
levels of cathepsin E in non-permeabilised DCs (extracellular).
Intracellular Extracellular
° Ff 
10° 102
FL2-Height
10° 10* 102
FL2-Height
Figure 4.2 Cathepsin E staining in dendritic cells
DCs were  stained for cathepsin  E,  in the presence  (intracellular)  or absence  (extracellular)  of 
prior permeabilisation.  Shaded histogram  show DCs stained with cathepsin E,  black histogram 
show staining with isotype IgM.
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4.3.2  Detection of Influenza nucleoprotein in Influenza-infected DCs
Influenza nucleoprotein (NP) is a viral protein that is necessary to encapsidate the virus 
genome for RNA transcription,  replication and  packaging, and  is produced in infected 
cells  during  active  viral  replication.  NP-encapsidated  virus  genome  forms  a 
ribonucleoprotein  (RNP)  complex,  in  which  segments of genomic RNA are bound to 
stoichiometric quantities of NP monomers. Having established a method for detecting 
intracellular antigen in DCs, Influenza infection in DCs could be monitored by staining 
for Influenza NP. The proportion of cells positive for NP staining should correlate with 
the titre of Influenza virus, showing the proportion of DCs infected with Influenza.
Human Influenza virus A/Puerto Rico/8/34 (A/PR/8/34, H1N1) was a gift from Dr W 
Barclay  (University  of Reading,  UK).  This  virus  was  grown  in  Madin-Darby  canine 
kidney (MDCK) cells, and sucrose gradient density purified. Virus stocks, in aliquots of 
lOOpl, were supplied at titres of 109 plaque-forming units (pfu)/ml. Plaque assays were 
carried out in confluent monolayers of MDCK cells.
Infection of DCs with different Influenza MOI (as determined by MDCK titre) resulted 
in a titration of the percentage of cells which stained positive for NP (Figure 4.3). At a 
MOI of 0.3, approximately  75% of DCs are positive for NP; at MOI of 1   and 3, over 
95% of cells are positive  for NP,  as determined by flow cytometry. From this data,  it 
appears  that  the  infectious  dose  of  Influenza  as  determined  on  MDCK  cells 
underestimates the infectious dose for DCs. A true MOI of 1   would give approximately 
68%  infected  cells  as  calculated  by  the  formula  below,  based  on  the  Poisson 
distribution.
where:
m = multiplicity of infection (MOI) 
n = number of virus infecting a cell 
P(n) = probability cell will be infected with n virus
This  suggests  that  MOIs  as  determined  on  MDCK  cells  may  actually  correspond  to 
higher MOIs in DCs, and that DCs may be more susceptible to Influenza infection than
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MDCK  cells.  For  clarity  the  stated  MOI  corresponding  to  the  MDCK  virus  titre 
determination is used.
DCs infected with Influenza at a MOI of I  showed two DC populations with different 
NP levels. At a MOI of 3, the  levels at which NP was expressed in DCs were higher, 
and  showed  a more  uniform population of NP-positive staining. This is  likely to be a 
direct reflection of multiple infections of Influenza at this high MOI. Though it is not 
known how many virus particles a DC will encounter in vivo, an average of 5 infectious 
virus particles per DC results from a MOI of 3 as calculated by the Poisson distribution. 
Although  this  is  likely  to  be  an  underestimate,  this  nevertheless  seemed a reasonable 
exposure  level,  and  this  was  therefore  chosen  as  the  MOI  for  further  work  with 
Influenza infection of DCs.
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Figure 4.3 Influenza nucleoprotein staining in Influenza-infected DCs
A DCs were infected with  Influenza virus at a range of MOIs. After 1  hour for virus adherence, 
DCs were washed,  and  cultured  in  complete  medium  with  GM-CSF and  IL-4 for a further  18 
hours.  Infected  DCs  were  harvested,  permeabilised,  and  stained  for  Influenza  nucleoprotein 
(NP).  NP  expression  was  assessed  by  flow  cytometry.  M1  indicates  the  region  of  positive 
fluorescence  intensity,  which  includes  2%  of events  counted  for  negative  isotype  control  IgG 
stained  DCs.  Shaded  histogram  MOI=3,  thick  black  histogram  MOM,  unfilled  lack histogram 
MOI=0.3, dotted histogram isotype control.
B  Relationship  of  median  fluorescence  intensity  and  MOI  from  flow  cytometric  analysis  of 
MOI titration of Influenza infection of DC (n=3).
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4.3.3  UV-inactivation of Influenza
To compare the effects on DCs between those mediated by initial DC-virus interactions 
at the cell surface and those of active virus replication, Influenza virus replication was 
blocked.  Influenza  was  inactivated  by  exposure  to  UV-light,  which  results  in  cross- 
linking of viral nucleic acids and virus inactivation. Direct exposure of the virus to short 
wave  UV  resulted  in  inactivation  of the  virus,  as confirmed  by the  abrogation  of NP 
expression in DCs exposed to inactivated Influenza. This was seen  for a range of virus 
exposure  times  to  UV,  from  30  seconds  to  10  minutes,  on  an  initial  MOI of 1.  UV 
exposure  for  2  minutes  was  chosen  to  be  effective  for  Influenza  inactivation,  with 
inactivated  Influenza  exposed-DCs  having  the  same  NP  background  staining  as 
uninfected DCs (Figure 4.4).
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Figure 4.4 Intracellular staining for Influenza NP after different UV-exposure times
DCs were infected with Influenza, washed after 1  hour for viral adherence, and further cultured 
for  18 hours in  complete  medium with GM-CSF  and  IL-4.  DCs were harvested,  permeablised, 
and  stained  for  Influenza  NP.  Shaded  histogram  shows  NP  staining  in  infected  cells,  unfilled 
black histogram shows NP staining in uninfected cells.
A  DCs  infected  with  Influenza  MOM,  B  DCs  exposed  to  UV-inactivated  (30  seconds) 
Influenza,  C  DCs  exposed  to  UV-inactivated  (1  minute)  Influenza,  D  DCs  exposed  to  UV- 
inactivated  (2  minutes)  Influenza,  E  DCs  exposed  to  UV-inactivated  (5  minutes)  Influenza,  F 
DCs exposed to UV-inactivated (10 minutes) Influenza.
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4.4  Rhinovirus interaction with DCs
4.4.1  Detection of Rhinovirus entry receptor on DCs
Human  Rhinovirus  serotype  16  (HRV16)  was a  gift  from  Dr T Tuthill  and  Prof D J 
Rowlands (University of Leeds, UK). This virus was grown in HeLa cells (Ohio strain, 
which  have  increased  surface  expression  of ICAM1),  and  sucrose  gradient  density 
purified.  Virus  stocks  in  aliquots  of 50pl  were  supplied  at  titres  of 3xl09  plaque- 
forming units (pfu)/ml. Plaque assays were carried out in confluent monolayers of Ohio 
HeLa cells.
Major group Rhinoviruses utilise the intercellular adhesion molecule ICAM1  (CD54) as 
a receptor for entry into cells (Greve et al.,  1989; Staunton et al.,  1989). As there were 
no reports of Rhinovirus establishing a productive infection in DCs, the presence of the 
HRV16 entry receptor on DCs was first confirmed. Flow cytometric analysis using an 
antibody to ICAM1  clearly shows the presence of this molecule on the surface of DCs 
(Figure 4.5). This suggests that HRV16 will be able to bind and possibly infect DCs.
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Figure 4.5 Extracellular staining of ICAM1 on immature DCs
Immature DCs were harvested and stained for extracellular ICAM1  (CD54).  Shaded histogram 
show  DCs  stained  for  ICAM1,  black  unfilled  histogram  show  DCs  stained  for  isotype  control 
IgG,.
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4.4.2  Detection of Rhinovirus particles in Rhinovirus-exposed DCs
The rhinovirus genome  is a single positive-strand  RNA  genome.  Once the viral  RNA 
enters the cell cytoplasm, it is translated to provide viral proteins essential  for genome 
replication  and  the  production  of new  virus  particles.  Using  the  same  method  for 
intracellular  staining  as  with  Influenza-infected  DCs,  polyclonal  sera  to  whole 
Rhinovirus was used to detect intracellular Rhinovirus particles in DCs exposed to live 
Rhinovirus.  However,  Rhinovirus  particles  were  not  detected  in  permeabilised  DCs 
exposed to live Rhinovirus (Figure 4.6).
FL1-Height
Figure 4.6 Intracellular staining for Rhinovirus particles inside Rhinovirus-exposed DCs
DCs were  exposed to  HRV16  at MOI  of  10.  Virus  adherence was carried  out for  1  hour,  the 
cells were washed,  and  cultured  in  complete  medium  with  GM-CSF  and  IL-4 for a further 24 
hours.  These  DCs were  harvested,  permeabilised,  and  stained for whole  Rhinovirus particles. 
Shaded histogram show cells stained with anti-HRV16 antiserum, black unfilled histogram show 
cells stained with control guinea pig antiserum. Inset, the same cells staining for cathepsin E, to 
demonstrate effective permeabilisation.
This  suggests  that  DCs  do  not  support  active  Rhinovirus  replication,  as  whole 
Rhinovirus particles are not present in Rhinovirus-exposed DCs. Alternatively, the lack 
of a positive control means that it remains possible that the intracellular staining method 
was not functional  for measuring HRV  particles  in  DCs  using this particular antisera. 
However,  other  groups  have  also  reported  the  lack  of  Rhinovirus  infection  of 
monocytes  and  airway  macrophages  (Gem  et  al.,  1996a)  and  dendritic  cells 
(Kirchberger et al., 2003).
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4.4.3  Detection of bound Rhinovirus particles on surface of DCs
To determine if Rhinovirus attached to DCs via its entry receptor ICAM1, extracellular 
staining  for  bound  Rhinovirus  particles  to  DCs  was  carried  out  using  the  same 
polyclonal antisera to whole Rhinovirus particles. After  1   hour of viral adherence, DCs 
were washed vigorously, stained with the antisera for Rhinovirus particles, and analysed 
by  flow  cytometry.  The  presence  of  bound  Rhinovirus  particles  was  monitored 
following  washing  and  replating  at  an  additional  three  timepoints  (Figure  4.7). 
Rhinovirus particles clearly bound to the surface of DCs one hour after virus adherence, 
and this extracellular staining was  shown to slowly decrease over time. This suggests 
that Rhinovirus particles are able to bind their entry receptor ICAM1  on the surface of 
DCs,  and  possibly  mediate  entry  by  triggering  endocytosis.  The  same  pattern  of 
extracellular virus  binding  and  decreased  staining  over time  was  also  found  for  DCs 
exposed to UV-inactivated  Rhinovirus  (Figure 4.7),  showing that the  UV-inactivation 
procedure  does  not  alter  the  virus’  ability  to  bind  ICAM1.  The  UV-inactivation 
procedure  is the same as that for Influenza, namely 2 minutes direct exposure to UV- 
radiation. UV-inactivation of Rhinovirus was effective at reducing the infectious titre by 
more  than  6  logs,  from  109  pfu/ml  to  less  than  103  pfu/ml,  resulting  in  no  plaque 
formation on Ohio HeLa cells (103 pfu/ml was the detection limit of the plaque assay). 
The plaque assays were carried out by Dr T Tuthill.
Figure 4.7 Timecourse of binding of Rhinovirus particles to surface of DCs (next page)
A DCs were exposed to Rhinovirus, inactivated Rhinovirus, or mock-stimulated (control). After 1  
hour for viral adherence, cells were washed,  and were either replated in complete medium with 
GM-CSF  and  IL-4  for  indicated  times  (2  hours,  5  hours,  and  24  hours  after  initial  virus 
exposure), or stained for Rhinovirus particles with polyclonal antisera to whole virus. The same 
staining  procedure  was  carried  out  at  later timepoints.  Shaded  histogram  show  cells  stained 
with anti-Rhinovirus antiserum,  black unfilled  histogram  show cells stained with control guinea 
pig serum.
B  Relationship  between  median  fluorescence  intensity  (MFI)  and  time  post-infection  in  cells 
exposed to  live  Rhinovirus  (grey  ■),  UV-inactivated  Rhinovirus  (purple  A), and control  mock- 
stimulated cells (blue ♦), stained with anti-Rhinovirus antiserum.
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4.5  Effect of virus treatment on DC phenotype
The effects of the different virus exposures (live  Influenza,  inactivated  Influenza,  live 
Rhinovirus and inactivated Rhinovirus) on dendritic cell phenotype in terms of surface 
expression  of maturation  markers  HLA-DR,  HLA-ABC,  CD86,  CD40,  and  ICAM1, 
were  investigated.  Rhinovirus  exposure  of DCs  at  MOI  of  10  was  chosen,  as  this 
induced phenotypic changes consistent with DC maturation, without compromising DC 
viability (Section 4.6).
The  exposure  or  infection  with  the  different  virus  treatments  resulted  in  differential 
phenotypic changes in DCs in terms of cell surface expression of a range of molecules. 
DCs  infected  with  Influenza  (MOI  =  3)  generally  upregulated  all  the  phenotypic 
markers  of maturation  relative  to  control  mock-stimulated  DCs,  including  ICAM1 
(interacts with LFA-1  on T cells), HLA-DR (a MHC class II  molecule),  HLA-ABC (a 
MHC  class  I  molecule),  CD40  (receptor  for CD40L  expressed  on  T  cells),  CD83  (a 
marker of mature DCs), and CD86 (a co-stimulatory molecule). Compared to Influenza, 
the effects of UV-inactivated Influenza on DC phenotype are more marked for ICAM1, 
HLA-DR and  CD86  surface  upregulation.  Rhinovirus and  UV-inactivated  Rhinovirus 
generally  produced  less  potent  upregulation  of these  markers,  with  some  not  being 
upregulated  at  all.  DCs  exposed  to  Rhinovirus  slightly  upregulate  HLA-DR,  CD86, 
CD40  and  CD83,  but  not  ICAM1  or  HLA-ABC.  This  is  in  contrast  to  Rhinovirus 
infection  of  bronchial  and  lung  epithelial  cells  which  mediate  an  upregulation  of 
ICAM1  surface expression (Papi and Johnston,  1999). DCs exposed to UV-inactivated 
Rhinovirus do not seem to upregulate any markers. To summarise,  DCs  infected with 
Influenza and DCs exposed to inactivated Influenza seem to undergo the most dramatic 
phenotypic  changes,  whereas  DCs  exposed  to  Rhinovirus  undergo  a  less  dramatic 
“maturation” response with slight upregulation of HLA-DR and CD86. DCs exposed to 
inactivated Rhinovirus do not seem to undergo any phenotypic changes at all, relative to 
control mock-stimulated DCs.
Figure 4.8 Immunophenotype of DCs treated with the different viruses (next page)
DCs were infected or exposed to the indicated viruses or mock-stimulated (control), and after 1 
hour for virus  adherence,  the cells were washed  and  replated  in  complete  medium with  GM- 
CSF and IL-4. After 24 hours, DCs were harvested, and stained for the indicated markers. Grey 
shaded histograms show cells stained with the indicated  markers,  unshaded histograms show 
cells stained with the corresponding isotype controls.
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Influenza-infected  DCs have been shown to be potent stimulators of T cells,  inducing 
strong proliferative and cytolytic responses from CTLs (Bhardwaj et al.,  1994). This has 
also been shown for DCs exposed to UV-inactivated Influenza, which can also induce 
strong  Influenza-specific  CTL  responses  (Bender et  al.,  1995).  This  indicates that de 
novo synthesis of viral proteins due to viral replication is not necessary to charge MHC 
class I molecules to elicit CTL responses.
By  contrast,  Rhinovirus  has  not  been  shown  to  be  able  to  productively  infect  DCs, 
despite the expression of Rhinovirus entry receptor ICAM1  on these cells (Kirchberger 
et al.,  2003).  HRV16 has been shown to enter monocytes and airway macrophages in 
vitro and activate these cells without active replication of the virus (Gem et al.,  1996a), 
inducing non-specific activation of lymphocytes (Gem et al.,  1996c) and  inhibition  of 
antigen-specific T cell  proliferation  (Gem  et al.,  1996b;  Stockl  et al.,  1999).  To  date 
there are no studies of Rhinovirus effects on dendritic cells.
4.6  Effects of virus treatment on DC viability
Forward  and  side  scatter  profiles  of DCs  infected  with  or  exposed  to  different  virus 
treatments suggest that the different viruses may  also have differential  effects on  DC 
viability. Annexin V and propidium iodide staining was used to assess DCs undergoing 
apoptosis in response to virus infection or exposure. Staining  18 hours post-infection or 
exposure  revealed  a  gradation  in  cytotoxic  effects,  with  Influenza  being  the  most 
cytotoxic  (23%  DC  population  were  remaining  viable  cells),  followed  by  UV- 
inactivated  Influenza-exposed DCs (44% viable), Rhinovirus-exposed DCs (64%), and 
UV-inactivated  Rhinovirus-exposed  DCs  (80%  viable  cells).  Control  mock-infected 
cells stained at  18 hours retained 84% viability by comparison (Figure 4.8), and  LPS- 
stimulated DCs retain approximately 75% viability at 18 hours after stimulation (Figure 
3.30B  and  data  not  shown).  The  apoptosis-inducing  capability  of Influenza  is  well- 
documented in the literature (Lowy, 2003; Oh et al., 2000; Schultz-Cherry,  1998). The 
cytotoxic effects of the different virus treatments should not be extrapolated to serve as 
an  indicator for effects on  DC  phenotype,  because even though  Influenza  is the most 
cytotoxic,  inactivated  Influenza  is  a  more  potent  stimulator  in  terms  of  inducing 
phenotypic changes in DCs (Table 4.1).
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Figure 4.9 Viability of mock-infected and virus-treated DCs
DCs were  infected  with  or exposed  to  different virus treatments,  or mock-stimulated  (control). 
Following  1  hour viral  adherence,  cells  were  washed  and  replated  in  complete  medium  with 
GM-CSF  and  IL-4.  DCs  were  harvested  18  hours  post-infection  for  Annexin  V  /  Propidium 
iodide staining. The numbers in the quadrants represent percentage of the gated cell population
(R1 )-
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Table 4.1 Summary of effects of virus treatments on DC viability and phenotypet
Control Influenza Inactivated
Influenza
Rhinovirus Inactivated
Rhinovirus
Viability 84% 23% 44% 64% 80%
ICAM1 - + + - -
HLA-DR - ++ +++ + -
CD40 - + ++ + -
CD83 - ++ +++ + -
CD86 - ++ +++ + -
HLA-ABC - ++ + - -
Qualitative  summary  of the  effects  of virus  treatment  on  DC  phenotype,  relative  to  control 
mock-stimulated  DCs (pictorially shown  in  Figure 4.8).  Summary of data from  phenotype and 
viability experiments performed in triplicates.
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4.7  Gene expression analysis of DC response to Influenza and 
Rhinovirus
Analysis of dendritic cell transcriptional responses to core maturation-stimuli LPS and 
dsRNA  has  revealed  a  core  activation  and  differentiation  programme  that  comprise 
clearly  defined  transcriptional  signatures  corresponding  to  three  phases  of  DC 
maturation.  Though  DC  transcriptional  responses  to  LPS  and  dsRNA  are  largely 
similar,  there  are  some  differences  that  are  stimulus-specific,  suggesting  functional 
plasticity  of  DC  responses  to  antigens.  This  plasticity  has  been  suggested  for  DC 
responses to three distinct pathogens: bacteria (E.  coli), virus (Influenza) and yeast (C. 
albicans) (Huang et al., 2001). However,  Huang’s study did not differentiate between 
responses regulated by DCs to virus exposure and virus replication. This is an important 
distinction, as virus replication events  invariably cause transcriptional changes  in host 
cells, and not controlling for virus replication-induced responses will  lead to  incorrect 
identification  of genes  that  are  regulated  by  DCs  in  response  to  virus  stimulation. 
Influenza virus infection and exposure results in differential effects in DCs in terms of 
surface expression of classical markers (Table 4.1). This differential effect was further 
investigated  on the transcriptional  level,  using  gene expression  arrays to  monitor DC 
responses  to  virus  treatments  over time.  As  inactivated  Rhinovirus  exposure  did  not 
affect  a  phenotypic  response  in  DCs,  array  experiments were not performed  for DCs 
exposed to inactivated Rhinovirus at this time.
4.7.1  Sample preparation
In  total  3  timcourses  were  performed,  one  for  each  virus  condition  (Influenza, 
inactivated  Influenza,  Rhinovirus,  Table  4.2).  Total  RNA  was  extracted  as  before, 
DNase  treated,  quantified,  mRNA  purified  and  reverse  transcribed  to  cDNA  labelled 
with  Cy5.  The  same  Cy3-labe!led  common  reference  used  for  LPS-  and  poly(LC)- 
stimulated DC arrays (Section 3.2.2) was used for virus-stimulated DC arrays. The Cy5- 
and  Cy3-labelled  cDNA  was  mixed  in  equal  amounts,  and  hybridised  to  HGMP 
(version  1   or version 2) cDNA arrays.
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Table 4.2 DC timecourse experiments of virus infection and virus exposure
Buffy
coat
Stimulus Timepoints HGMP array Reference
batch
4 Influenza 0, 2, 5, 10, 18, 24h Human cDNA array version 1 3
5 Inactivated
Influenza
2, 5, 10, 18, 24h Human cDNA array version 1 3
6 Rhinovirus 0,2, 5, 10, 18, 24h Human cDNA arrav version 2 3
7 Inactivated
Influenza
Oh Human cDNA arrav version 2 3
4.7.2 Data extraction
Scanned array images from GenePix Pro were extracted and processed as in Materials 
and  Methods  (Section  2.4.5).  Low  signal  to  noise  ratio  (SNR)  data  was  filtered  as 
described  in  Section  3.2.3.  Genes  in  each  independent  array  was  filtered  using  the 
averaged signal-to-noise ratios of defined negative control genes as the SNR cut-off. A 
total  of 18  arrays  comprised the timecourse  of dendritic  cell  responses  to  Influenza, 
inactivated Influenza, and Rhinovirus.
4.7.3 Cluster analysis of DC responses to Influenza and Rhinovirus
Hierarchical  clustering was used as an exploratory data analysis method to assess the 
similarity  in  gene  expression  of dendritic  cells  infected  or  exposed  to  Influenza  and 
Rhinovirus.  As  UV-inactivated  Rhinovirus  did  not  induce  any  marked  phenotypic 
changes in DCs, array experiments were not performed at this time, although it would 
be interesting to examine transcription responses of DCs to inactivated Rhinovirus. The 
18  virus-DC  array  experiments  were  clustered  together  with  the  9  arrays  of  DC 
responses to poly(I:C). This was used to provide a means for comparison between DC 
responses to different virus treatments and the core maturation program (Chapter 3). In 
addition,  this  allowed  comparison  of virus-induced  processes  that  may  involve  DC 
responses  to  dsRNA  produced  during  the  replication  of  Influenza  or  present  as 
secondary  structures  within  the  virus  genomes.  The  log2  expression  ratios  of  the 
combined 27 arrays were compiled, filtered and normalised using Cluster (Eisen et al., 
1998)  (Section  3.2.4).  In  total,  1713  genes  passed the  SNR  filtering criteria  in  all  27 
array experiments. Following construction of a one-dimensional self-organising map for 
the  genes,  hierarchical  clustering  produced  the  sample  cluster  dendogram  in  Figure 
4.10.
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Figure 4.10 Cluster dendogram of virus and poly(l:C) arrays
Hierarchical clustering of 9 poly(l:C)-stimulated DC arrays (PIC1  and PIC2), 6 Influenza-infected 
DC arrays (F), 6 UV-inactivated  Influenza-exposed DC arrays (uvF), and 6 Rhinovirus-exposed 
DC arrays (R), over a 24-hour timecourse generated this sample dendogram in Cluster.  Letters 
refer to the major sample groups discussed further in the text below.
The  cluster  dendogram  shows  two  main  branches  at  the  highest  level  (Figure  4.10, 
branches  a  and  b  separated  from  branches  c  and  d).  These  branches  discriminated 
between  DCs  exposed to  all  viruses  at  early  timepoints  and the  complete  Rhinovirus 
timecourse,  and  DCs  responding  to  poly(I:C)  and  DCs  responding  to  UV-inactivated 
Influenza and Influenza at later timepoints.  We have shown that DCs respond to LPS 
and poly(I:C)  in a time-dependent manner,  suggesting that gene  expression  correlates 
well with DC activation and differentiation over time. DC responses to viruses are also 
broadly  time-dependent,  allowing  an  ordering  of  the  arrays  over  time.  However, 
clustering also reveals differential DC responses that are stimulus-specific.
From the left (a in Figure 4.10), the first broad cluster groups together all DC arrays at 
early  timepoints,  0  and  2  hours  after  stimulation  with  Influenza  (F),  UV-inactivated 
Influenza (uvF), Rhinovirus (R), and poly(I:C) (PIC). This group also contains the array 
of  DCs  exposed  to  Rhinovirus  at  5  hours.  This  suggests  that  DC  transcriptional 
activation by Rhinovirus is delayed relative to the other stimuli. The second cluster (b) 
groups together arrays of DCs  infected with Influenza and exposed to UV-inactivated 
Influenza at 5 hours, and UV-inactivated Influenza at  18 hours, and also DCs exposed 
to Rhinovirus at 10,  18, and 24 hours. Again the gene expression profile of DC response 
to Rhinovirus is more similar to gene expression of DCs at early timepoints post-virus
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infection or exposure, rather than at later timepoints. This further supports the fact that 
Rhinovirus  exposure  leads  to  delayed  DC  maturation.  This  correlates  with  the  flow 
cytometry  data,  where  Rhinovirus-induced  DC  surface  upregulation  HLA-DR  and 
CD86 are not as great as those induced by Influenza and UV-inactivated Influenza. The 
presence of the array of DCs exposed to UV-inactivated  Influenza at  18  hours in this 
group  is  difficult to  explain,  and  is the  only  array to cluster aberrantly  in  the  whole 
study of 45 arrays.
The next cluster (c) groups together arrays of DCs responding to poly(I:C), from 5 to 
24 hours post exposure. This shows that DC responses to poly(I:C) are more similar to 
each  other,  across  time,  than  to  gene  expression  of  DCs  responding  to  the  virus 
treatments. Together, this  indicates that at later timepoints (10 to 24 hours after virus 
exposure  or  infection),  differential  responses  of  DCs  to  various  stimuli  are  easily 
recognisable. This is further supported by the next cluster (d), that groups together later 
timepoints of DCs responding to UV-inactivated Influenza (10 and 24 hours) and DCs 
infected with Influenza (10,  18, and 24 hours). Even though these 5 arrays are grouped 
in  one  cluster,  the  responses  to  Influenza  are  distinct  from  the  responses  to  UV- 
inactivated  Influenza.  Such  grouping  of Influenza  and  UV-inactivated  Influenza  DC 
arrays  may  also  reflect  transcriptional  effects  of  apoptosis  and  cell  death  in  DCs 
infected with Influenza and exposed to inactivated Influenza (Section 4.6, Table 4.1). In 
summary, we have shown that DCs can regulate differential transcriptional responses to 
virus stimuli, which contrasts and extends the general, stimulus-independent responses 
of DCs to LPS and poly(LC) for maturation, activation and differentiation.
Figure 4.11  Hierarchical clustering of virus- and dsRNA-stimulated DC arrays (next page)
Genes in the 27 virus- and dsRNA-stimulated DC arrays were filtered for genes that passed the 
SNR filter in all 27 arrays. The resulting 1713 genes and 27 arrays were clustered together with 
hierarchical clustering.  The dendrogram on the left represents the relationship between genes 
in  terms  of their  gene  expression  patterns.  Gene  expression  is  shown  as  a  pseudo-coloured 
representation of log2 expression ratio with red  being above and green  below the row/column 
median level of expression (set to 0) as shown by the scale. The coloured bars to the right mark 
the position of gene expression signatures which are particularly upregulated in DCs exposed to 
the indicated stimuli. These gene expression signatures are discussed in the following sections.
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4.7.3.1  Early virus-induced responses
Genes  involved  in  the  early  virus-induced  response  are  upregulated  between  2  and 
5 hours  after  DC  exposure  to  inactivated-Influenza,  Rhinovirus,  and  infection  with 
Influenza  (Figure  4.11,  4.12).  These  genes  are  largely  involved  with  intracellular 
transport:  in  the  transport  of  vesicles  (RAB5C,  vesicle  amine  transport  protein  1  
homolog,  hippocalcin-like  1, copine III), transport of proteins (endoplasmic reticulum 
glycoprotein,  solute  carrier  family  25  and  16,  KDEL  endoplasmic  reticulum  protein 
retention  receptor  1,  exportin  1),  transport  of  lipids  (sterol  carrier  protein  2),  and 
transport  of ions  that  participate  in  intracellular  signalling  (voltage-dependent  anion 
channel 1-3, ATPase, ATP synthase). There is also evidence of mobilisation of the actin 
cytoskeleton that facilitate these processes,  reflected  in the upregulation  of genes that 
encode  proteins  that  regulate  the  cytoskeleton  and  cellular  motility  (cofilin  1, 
calmodulin  3,  integrin  beta  4  binding  protein,  myosin,  tyrosine  3-
monooxygenase/tryptophan  5-monooxygenase  activation  protein).  Genes  involved  in 
signal  transduction  include  phosphodiesterase,  cAMP-dependent  protein  kinase  A, 
RAB5C,  protein  phosphatase  2,  tyrosine  3-monooxygenase/tryptophan  5-
monooxygenase  activation  protein,  and  protein  tyrosine  phosphatase  11.  This  cluster 
also  includes  genes  involved  in  nucleic  acid  metabolism  and  synthesis,  including 
guanine  monophosphate  synthetase,  dUTP  pyrophosphatase,  uridine  monophosphate 
kinase,  RNA  binding  proteins,  DNA  helicase,  and  genes  involved  in  transcription, 
including  activating  transcription  factor  7,  TAF12  RNA  polymerase  II  (TATA-box 
binding  protein-associated  factor),  LIM  domain  binding  1,  transcription  elongation 
factor B, and SET translocation.
This cluster of genes, upregulated at early timepoints after exposure to viruses, but not 
by dsRNA, demonstrates a specific virus-induced  response,  resulting  in  a coordinated 
upregulation  of  genes  involved  in  intracellular  transport  and  mobilisation  of  the
cytoskeleton.  There  is  also  upregulated  genes  involved  in nucleic  acid  metabolism,
suggesting  early  events  downstream  of virus  entry  stimulates  the  DCs  to  upregulate 
these genes to facilitate downstream virus replication.
Figure 4.12 Transcriptional signature of the early virus-induced gene cluster (next page)
This gene expression signature is enriched for genes involved in  intracellular transport (genes 
shown  in  red),  cytoskeleton regulation and cellular motility (genes shown  in  blue),  and  nucleic 
acid  metabolism  and  transcription  (genes  shown  in  green).  These  genes  are  most  strongly 
induced in DCs at early timepoints after exposure to virus.
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Mitochondrial ribosomal protein L3 
Guanine monophosphate synthetase 
Fanconi anemia, completemtation group G 
Lysosomal-associated mutispanning membrane protein-5 
Calmodulin 3 
Calmodulin 3
Integrin beta 4 binding protein
Myosin, light polypeptide 4, alkali; atrial, embryonic
KDEL endoplasmic reticulum (ER) protein retention receptor 1
Lysosomal-associated multispanning membrane protein-5
Cell division cycle 37 homolog
Cell division cycle 37 homolog
Cytochrome c
Transcription elongation factor 8 
Voltage dependent anion channel 1
Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein
Tyrosine 3-monoosygenase/tryptophan 5-monooxygenase activation protein
Protein phosphatase 2A regulatory subunit
Activating transcription factor 7
Cofilin 1
Cofilin 1
Thyroid autoantigen 70kD (Ku antigen)
Voltage dependent anion channel 2 
Hippocalcin-like 1  
Aldolase C, fructose-bisphosphate 
Aldolase C, fructose-bisphosphate 
Putative membrane protein 
15kDa selenoprotein 
15kDa selenoprotein
NADH dehydrogenase (ubiquinone) 1  alpha subcomplex 2
Voltage dependent anion channel 3 
Solute carrier family 25 (mitochondrial)
Solute carrier family 25 (mitochondrial)
Ribosomal protein L11  
Ribosomal protein L11  
RNA binding motif protein 10 
Acetylcholinesterase (YT blood group)
ATP synthase, H+ transporting, mitochondrial 
Vesicle amine transport protein 1  homolog 
Vesicle amine transport protein 1  homolog 
Protein kinase A, catalytic subunit 
Protein kinase A, catalytic subunit 
Eukaryotic translation initiation factor 3, subunit 7 
Eukaryotic translation initiation factor 3, subunit 7 
Member of RAS oncogene family 
Endoplasmic reticulum glycoprotein
FK506 binding protein 4. 59kDa 
PCTAIRE protein kinase 1
FK506 binding protein 4, 59kDa 
Eukaryotic translation initiation factor 4 
Eukaryotic translation initiation factor 4 
CD37 antigen
Suppressor of tumorigenicity 14 
Suppressor of tumorigenicity 14 
Thyroid autoantigen 70kD (Ku antigen)
Voltage dependent anion channel 2 
Suppressor of Ty5 homolog (S cerevisiae)
Suppressor of Ty5 homolog (S cerevisiae)
SET translocation (myeloid leukemia-associated)
SET translocation (myeloid leukemia-associated)
Uridine monophosphate kinase 
Spastic ataxia of Charlevoix-Saguenay (sacsin)
Solute carrier family 16 (monocarboxylic acid transporters) 
Protein tyrosine phosphatase, non-receptor type 11 
COMM domain containing 3 
COMM domain containing 3
NADH dehydrogenase (ubiquinone) 1  alpha subcomplex 2 
Spastic ataxia of Charlevoix-Saguenay (sacsin)
Serine hydroxymethyltransferase 1  (soluble)
Mediator of DNA damage checkpoint 1  
Uridine monophosphate kinase 
Exportin 1  (CRM1. yeast, homolog)
Vacuolar ATPase 
Vacuolar ATPase 
Similar to S. cerevisiae Sec6p 
Rho guanine nucleotide exchange factor (GEF) 1  
Rho guanine nucleotide exchange factor (GEF) 1  
EBNA1BP2 Nucleolar protein p40
PDE2A  Phosphodiesterase 2A
PDE2A  Phosphodiesterase 2A
EphB1  EPH receptor B1
TAF12  TATA box binding protein (TBP)-associated factor
LDB1  LIM domain binding 1
DAP  Death-associated protein
DAP  Death-associated protein
ATP6AP2  ATPase, H* transporting, lysosomal
ATP6AP2  ATPase, H+ transporting, lysosomal
SCP2  Sterol carrier protein 2
CPNE3  Copine III
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4.7.3.2  Antiviral response
The  induction  of this  cluster  of genes  is  a  common  response  in  DCs  to  dsRNA, 
Rhinovirus,  inactivated Influenza and live Influenza (Figure 4.13).  We define this here 
as the core antiviral response. A large number of genes upregulated in response to virus 
treatments  were  also  upregulated  in  DCs  as  part  of  the  core  maturation  response 
(Section  3.2.8).  These  genes  include  members  of the  STAT  family  of transcription 
factors (STAT1,  STAT3,  STAT5A), IRF-2,  immunoproteasome subunits, IFITM1  and 
IFITM2,  MyD88,  OAS1,  CD40,  BIRC2,  BAK1,  CFLAR,  SEMA4D,  and 
metallothioneins  (MT2A,  MT1L,  MT3).  A  highly  correlated  sub-cluster  (correlation 
coefficient 0.94)  comprise  a  subset of 5  genes  in  this  antiviral  response (indicated  in 
Figure 4.13). The  5  genes,  IFITM1  and IFITM2,  insulin-like growth  factor  1   receptor 
(IGF1R), ubiquitin conjugating enzyme E2L 6 (UBE2L6), and apolipoprotein B mRNA 
editing enzyme catalytic polypeptide-like 3B (APOBEC3B) are strongly co-expressed. 
While  IFITM1  and  IFITM2  are  integral  membrane  proteins  induced  by  alpha  and 
gamma  interferons,  and  IGF1R  is  induced  in  response  to  mitogenic  stimuli,  the 
inclusion  of APOBEC3B  and  UBE2L6  in  this  cluster  suggests their  role  in  antiviral 
immunity.
APOBEC3B  is  a  member  of the  apolipoprotein  B  (ApoB)  mRNA  editing  protein 
family.  The  prototype  member  APOBEC1  (for  “apoB  editing  catalytic  subunit  1”) 
functions as a cytidine deaminase by catalysing the conversion of cytidines to uracils. 
DNA  deamination  in  the  host  is  targeted  to  endogenous  immunoglobulin  loci  to 
generate  antibody  diversity  in  the  adaptive  immune  system.  However,  several  recent 
papers have shown that one mechanism of innate immunity to retroviruses is achieved 
by direct deamination of deoxycytidine to deoxyuracil in retroviral first (-)strand cDNA, 
resulting in guanine to adenine hypermutation of the (+)sense viral DNA, and leading to 
inactivation  of viral  functions (Harris et al., 2003;  Mangeat et al.,  2003; Zhang et al., 
2003a).  The  enzyme  APOBEC3G  is  packaged  in  virions  and,  during  reverse 
transcription,  deaminates viral  cDNA.  APOBEC3G has  been  shown to have  a role  in 
determining  HIV-1  infectivity  in  human  and  primate  cell  lines  (Sheehy  et  al.,  2002; 
Shindo et al., 2003). Most lentiviruses encounter the antiviral effects of APOBEC3G by 
virally  encoded  vif,  which  targets  APOBEC3G  for  ubiquitin-mediated  proteasomal 
degradation, thereby preventing its  incorporation  into virus particles (Yu et al., 2003). 
There  is  also  evidence  that  APOBEC3G  can  edit  DNA  and  affect  HBV  infectivity
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(Turelli et al., 2004). Another member of the family, APOBEC3F, has also been shown 
to  deaminate  deoxycytidine  to  deoxyuracil  during  HIV  (-)strand  cDNA  synthesis, 
thereby causing guanine to adenine mutations in the viral genome (Zheng et al., 2004). 
However,  APOBEC3B  has  not  been  characterised  to  have  immune  functions.  It  is 
attractive  to  speculate  that  the  induction  of  APOBEC3B  in  DCs  in  response  to 
Influenza,  Rhinovirus  and  dsRNA  reflects  an  antiviral  role  for  APOBEC3B  that 
represents an  interferon-inducible component of innate antiviral  defense,  and  as such, 
the function of members of the APOBEC family are a general  antiviral mechanism  in 
addition to defense against retroviruses.
The  presence  of UBE2L6  in  this  cluster also  suggests  an  interferon-induced  antiviral 
role.  Ubiquitination  is  a  process that  is  integral  to  protein  degradation,  and  involves 
three  classes  of enzymes:  El  ubiquitin-activating  enzymes,  E2  ubiquitin-conjugating 
enzymes,  and  E3  ubiquitin  protein  ligases.  Protein  degradation  involves  covalent 
attachment of the protein to ubiquitin, which  is a three-step process.  Ubiquitin  is first 
activated on the C-terminal glycine by El. Activated ubiquitin is then transferred by E2 
to a member of the E3 family, to which the protein is bound. E3 enzymes then catalyse 
the  covalent attachment of ubiquitin  to the target  protein.  After the  biosynthesis of a 
target protein-anchored polyubiquitin chain, the complex is bound to a ubiqutin receptor 
on  the  26S  proteasome,  allowing  degradation  of  the  target  protein  (Hershko  and 
Ciechanover,  1998).
The biological activites of the ubiquitin system include cell cycle regulation, activation 
or  degradation  of  transcription  factors,  and  antigen  presentation  (Hershko  and 
Ciechanover,  1998).  For example,  STAT1  is  inactivated  by  the  ubiquitin-proteasome 
pathway (Kim  and  Maniatis,  1996), whereas NF-kB  is activated  by the ubiquitination 
and degradation of its inhibitor IkB. Ubiquitination features heavily in the regulation of 
immune  functions  (Reinstein,  2004),  and  proteome  analysis  has  revealed  ubiquitin- 
conjugating enzymes UBE2E1, 2E2, and 2D1  to be upregulated by IFNa (Nyman et al., 
2000). The presence of UBE2L6  in the antiviral cluster  indicates that this E2  enzyme 
may also be involved in antiviral functions and be regulated by IFNa.
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Figure 4.13 Transcriptional signature of the core antiviral response (next page)
This  group  of genes  characterises  the  proposed  core  antiviral  response  that  DCs  induce  in 
response to the 3 different virus treatments and dsRNA. The genes shown in red are genes that 
were  similarly  upregulated  in  DCs  in  response  to  LPS  and  dsRNA  as  part  of  the  core 
maturation, activation and differentiation response  (Section 3.2.8). Genes in blue correspond to 
the highly correlated sub-cluster. The genes are very strongly correlated in their expression  in 
DCs in response to the different virus treatments (correlation coefficient 0.94).
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STAT3
Activated RNA polymerase II transcription cofactor 4 
Activated RNA polymerase II transcription cofactor 4 
Thioredoxin domain containing 4 (endoplasmic reticulum)
Proteasom e (prosome, macropain) subunit, beta type, 10 
sin3-assoclated polypeptide, 18kD
Chromosome 1 open reading frame 38 (basement membrane-induced gene 
Proteasome (prosome, macropain) subunit, beta type, 10
Transient receptor potential cation channel subfamily C member 4 associated protein 
Signal recognition particle 54kD
Eukaryotic translation initiation factor  2, subunit 2 (beta, 38kD)
Eukaryotic translation initiation factor  2, subunit 2 (beta, 38kD)
Sjogren syndrome antigen B 
Adrenomedullin
Proteasome (prosome, macropain) subunit, alpha type, 3 
Proteasome (prosome. macropain) subunit, alpha type, 3 
Methyl tetrahydrofolate dehydrogenase (NAD+ dependent)
Protein kinase C, delta 
Protein kinase C, delta 
Semaphorin 40
Baculoviral IAP repeat-containing 2 
Bacukwiral IAP repeat-containing 2 
HIR (histone cell cycle regulation defective homolog A)
TNF receptor-associated factor 2
G-rich RNA sequence binding factor 1
TNF receptor superfamily, member 5 (CD40)
Solute carrier family 20 (phosphate transporter), member 1 
Solute carrier family 20 (phosphate transporter), member 1 
FLN29 gene product 
Torsin family 1, member B 
FLN29 gene product
Myelord differentiation primary response gene (88)
Interferon induced transmembrane protein 1  (9-27kD)
Interferon induced transmembrane protein 2 (1-8kD)
Interferon induced transmembrane protein 2 (1-8kD)
Insulin-like growth factor 1  receptor
Insulin-like growth factor 1  receptor
Ubiquitin-conjugating enzyme E2L 6
Ubiquitin-conjugating enzyme E2L 6
ApoB mRNA editing enzyme, catalytic polypeptide-like 3B
Metallothionein 2A
Metallothionein 2A
Proteasome (prosome, macropain) activator subunit 2 (PA28 beta)
Proteasome (prosome, macropain) activator subunit 2 (PA28 beta)
Signal transducer and activator of transcription 1, 91 kO 
N-myc (and STAT) interactor 
t-complex-associated-testis-expressed 1 -like 1 
t-complex-associated-testis-expressed 1 -like 1 
ATP-binding cassette, subfamily B (MDR/TAP), member 2 
ATP-binding cassette, subfamily B (MDR/TAP), member 2 
TNF receptor superfamily, member 5 (CD40)
GTP cyclohydrolase 1  (dopa-responsive dystonia)
Interferon regulatory factor 2 
Interferon regulatory factor 2 
2,5-oligoadenylate synthetase 1  (40-46kD)
Lectin, galactoside-binding, soluble, 9 (galectln 9)
Signal transducer and activator of transcription 1, 91 kD 
N-ethytmaleimide-sensibve factor attachment protein, alpha 
N-ethylmaleimide-sensitive factor attachment protein, alpha 
DnaJ (Hsp40) homolog, subfamily A, member 1 
DnaJ (Hsp40) homolog, subfamily A, member 1 
KIAA0040 gene product
Metallothionein 3 (growth inhibitory factor (neurotrophic))
Metallothionein 3 (growth inhibitory factor (neurotrophic))
Metallothionein 1L
Interleukin 15 receptor, alpha
KIAA0040 gene product
HESB like domain containing 2
Carbohydrate (chondroitin 6/keratan) sulfotransferase 2
Carbohydrate (chondroitin 6/keratan) sulfotransferase 2
HESB like domain containing 2
Signal transducer and activator of transcription 5A
Putative eukaryotic translation initiation factor 3 subunit
Putative eukaryotic translation initiation factor 3 subunit
Transglutaminase 2
T ransglutaminase 2
Hypothetical protein DKFZp761G1923
Bcl2-antagonist/ killer 1
Bcl2-antagonist I killer 1
Bcl2-antagonist / kilter 1
Bcl2-antagonist / killer 1
Thrombospondin 2
TNF ligand superfamily, member 13B (BAFF, BLyS, TFfANK)
Ubiquitin-activatlng enzyme E1-like
Vaccinia related kinase 2
Novel RGD-containing protein
BTG family, member 3
Nijmegen breakage syndrome 1  (nibrin)
Nijmegen breakage syndrome 1 (nibrin)
Zinc finger, CW-type with coil-coil domain 3
Methyl tetrahydrofolate dehydrogenase (NAD+ dependent)
Cullin 1
CASP8 and FADCMike apoptosis regulator (FLIP)
CASP8 and FADD-like apoptosis regulator (FLIP)
Chemokine (C-C motif) ligand 8 (monocyte chemoattractant protein 2)
Chemokine (C-C motif) ligand 8 (monocyte chemoattractant protein 2)
HIR (histone cell cycle regulation defective homolog A)
Signal transducer and activator of transcription 3 (acute-phase response factor) 
Signal transducer and activator of transcription 3 (acute-phase response factor)
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4.7.3.3  Rhinovirus-specific responses
As shown  in  the  sample cluster dendogram  (Figure  4.10),  gene expression of DCs  in 
response to Rhinovirus exposure suggests a delayed activation relative to the response 
to  other  virus  and  dsRNA  stimuli.  This  is  demonstrated  by  the  positioning  of the 
Rhinovirus-specific cluster, sharing a higher branch point with DC samples at 5  hours 
after Influenza infection and 5  hours after inactivated Influenza exposure (branch b in 
Figure 4.10), and adjacent to DC samples at early timepoints (branch a in Figure 4.10). 
This indicates that the gene expression profile of DCs exposed to Rhinovirus at  10 to 
24 hours  is more similar to the gene expression profile of DCs exposed to inactivated 
Influenza  and  infected  with  Influenza  at  5  hours  after  virus  exposure.  Exposure  to 
Rhinovirus  may  therefore  affect  an  “intermediate”  activation  of DCs.  This  may  be  a 
specific strategy of Rhinovirus in escaping the  immune response by  inducing minimal 
phenotypic changes in DCs (Section 4.5) other than the core antiviral response (Section 
4.7.3.2). This intermediate transcriptional response may also result from an inability of 
Rhinovirus to replicate in DCs.
Matrix  metalloproteinase  2  (MMP2)  is  strongly  upregulated  in  DCs  exposed  to 
Rhinovirus,  especially  at  later  timepoints,  10  hours  to  24h  post-exposure.  This 
upregulation is not as marked in DCs responding to Influenza, inactivated Influenza, or 
dsRNA (Figure 4.14). MMP2  is a zinc-dependent enzyme involved  in the degradation 
of extracellular matrix, and is important in tumour invasion and cell migration. MMP2 
has also been  shown to be  important in the migration of Langerhans cells and dermal 
DCs  from  human  skin  (Ratzinger  et  al.,  2002).  The  induction  of MMP2  by  DCs 
responding  to  Rhinovirus,  which  contains  a  zinc-dependent  proteinase  (2Apro),  may 
indicate  an  interesting  interaction  between  the  virus  and  host  cell  in  utilising  zinc- 
dependent enzymes to facilitate virus replication and mobilise an immune response.
Protein  modification  enzymes  and  inhibiting  factors  are  heavily  represented  in  this 
cluster, with cathepsins, cystatins, ubiquitin conjugating enzymes and enzymes involved 
in  protein  biosynthesis  upregulated  by  DCs  responding  to  Rhinovirus  throughout the 
timecourse  (Figure  4.14).  Actin-binding  proteins  (thymosin  beta  10  and  beta  4,  and 
lymphocyte cytosolic protein  1), proteins involved in regulating the actin cytoskeleton, 
as  well  as  actin  and  vimentin  are  also  encoded  by  genes  represented  in  this  cluster. 
Again  there  are  genes  involved  in  signal  transduction  (RAP2A,  GDP  dissociation
195Plasticity of dendritic cell responses to antigen
inhibitor 1, tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, 
glucose  regulated  protein  GRP58,  FYN  tyrosine  kinase,  Bruton  agammaglobulinemia 
tyrosine  kinase),  cell  cycle  regulation  (microtubule-associated  protein  4,  soluble 
galactoside-binding  lectin  3),  transcription  factors  (GATA-binding  protein  6, 
transcription  elongation  factor  TCEB1)  and  translation  factors  (elF).  It  is  clear  that 
although  Rhinovirus  does  not  replicate  in  dendritic  cells,  there  is  significant 
transcriptional responses in DCs to the virus stimulus, probably reflecting downstream 
events triggered by Rhinovirus and dendritic cell  interactions via cellular receptors and 
endocytosis.
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ATPase, Clas V, type 10C 
ATPase, Clas V, type 10C 
Phospholipase 03
Lysosomal-associated membrane protein 1
Lysosomal-associated membrane protein 1
v-rel avian reticuloendotheliosls viral oncogene homolog A (p65)
v-rel avian reticuloendotheliosls viral oncogene homolog A (p65)
Glucose regulated protein, 58kD
Matrix metalloproteinase 2
Matrix metalloproteinase 2
Cathepsin L
Cathepsin L
FYN oncogene
FYN oncogene
Bruton agammaglobulinemia tyrosine kinase
Cathepsin C 
Actin, beta
Microsomal glutathione S-transferase 1 
Microsomal glutathione S-transferase 1 
Sialyltransferase 4C 
Sialyltransferase 4C
Mitogen-activated protein kinase 1 (ERK2) 
Thymosin, beta 10
cytochrome c oxidase subunit Vila polypeptide 2 
cytochrome c oxidase subunit Vila polypeptide 2 
Thymosin, beta 10
Major histocompatibility complex, class I, C 
GATA-bindlng protein 6 
Lymphocyte cytosolic protein 1 (L-plastin) 
Lymphocyte cytosolic protein 1 (L-plastin) 
Cystatln F (leukocystatin)
Cystatin F (leukocystatin)
GATA-blnding protein 6 
RAP2A, member of RAS oncogene family 
RAP2A, member of RAS oncogene family 
CD27-bind!ng (Siva) protein 
Thymosin, beta 4, X chromosome 
Vimentin 
Cathepsin B 
Cathepsin B
Transcription elongation factor B 
Tyrosine 3-monooxygenase 
Tyrosine 3-monooxygenase
SERPINE1  Serine (or cysteine) proteinase inhibitor, clade E, member 1
Cystatin B (stefin B)
Cystatin B (stefin B)
3-hydroxy-3-methytglutaryt-coenzyme A synthase 1 
3-hydroxy-3-methyiglutaryi-coenzyme A synthase 1 
Lectin, galactoside-binding, soluble, 3 
GDP dissociation inhibitor 1 
Calmodulin 1
Ubiquitin-conjugating enzyme E2D 3 
Calmodulin 1
Lectin, galactoside-binding, soluble, 3 
Eukaryotic translation initiation factor 5B 
Microtubule-associated protein 4
HS1  binding protein HAX1
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Figure 4.14 Transcriptional signature of DCs responding to Rhinovirus
This group of genes are more strongly upregulated in DCs responding to Rhinovirus compared 
to other virus treatments  (particularly genes shown  in  red).  However,  this profile also  includes 
genes that are upregulated  in DCs in response to early and later timepoints after Influenza and 
inactivated-lnfluenza  exposure.  This  upregulation  in  expression  is  generally  not  seen  in  DCs 
responding to dsRNA, similar to the early virus-induced responses (Section 4.7.3.1).
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4.7.3.4  Inactivated Influenza-specific responses
The  small  cluster  of strongly  upregulated  genes  in  DCs  exposed  to  UV-inactivated 
Influenza are mainly involved in the regulation of DNA transcription, especially linking 
the control of basal transcription to the cell cycle (Figure 4.15 A). Some of these genes 
are also strongly upregulated at  18 hours after infection with Influenza (Figure 4.15B). 
These  genes  encode proteins associated with  nuclear transcription.  This  shows that  a 
non-replicating  viral  stimulus  may  be  able  to  strongly  induce  dendritic  cells  to 
upregulate a transcriptional program, in the absence of viral replication. Therefore, the 
initial stimulus mediated by surface interactions between Influenza virus and dendritic 
cell and subsequent virus entry may be sufficient to trigger such downstream responses. 
This has been shown for HIV-1, where gpl20 (a glycoprotein present on the envelope 
of HIV-1) treatment of PBMCs and  macrophages  stimulates the  induction  of nuclear 
transcription factors and proteins associated with the actin cytoskeleton  (Cicala et al., 
2002).
Investigations of HeLa cells has also revealed replication-independent and replication- 
dependent  cellular  transcriptional  events  induced  by  Influenza  (Geiss  et  al.,  2001), 
though transcriptional changes on HeLa cells were distinct to that found in DCs in this 
study.  In  HeLa  cells,  Influenza  replication  was  necessary  to  induce  upregulation  of 
genes which encode cytokines and growth factor signalling receptors (e.g. IL-6, IL-15, 
insulin-like  growth  factor 2  receptor), transcription  factors  (STAT5,  NF-kB  p65) and 
proteins  involved  in  the  ubiquitin  pathway  (PSME2).  In  DCs,  such  genes  were 
upregulated  as part of the  proposed  antiviral  response,  regardless of virus replication 
(Figure 4.13). The disparity in transcriptional changes seen in  HeLa cells compared to 
DCs in response to live and  inactivated  Influenza further highlights the  importance of 
recognising certain transcriptional changes to be cell-type specific.
Figure 4.15 Transcriptional signature of DCs responding to UV-lnfluenza (next page)
This  group  of  genes  are  more  strongly  upregulated  in  DCs  responding  to  UV-inactivated 
Influenza  compared  to  other  virus  treatments.  A  shows  genes  that  are  more  strongly 
upregulated  in  DCs  in  response  inactivated  Influenza  compared  to  Influenza,  and  B  shows 
genes  that  are  more  similarly  upregulated  by  DCs  in  response  to  both  inactivated  and  live 
Influenza, at late timepoints. Genes involved in nuclear transcription are shown in red.
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24-dehydrocholesterol reductase 
Transcription elongation factor regulator 1 
Thymosin, beta 4, X chromosome
X-ray repair complementing defective repair in Chinese hamster cells 1 
KIAA0152  Integral membrane protein 
ZNF354A  Zinc finger protein 354A (transcription factor 17)
ADCY7  Adenylate cyclase 7
ATP6V0C  ATPase, H+ transporting, lysosomal 16KDa, VO subunit c 
RBM6  RNA binding motif protein 6 
NUP214  Nucleoporin 214kD
KIAA0101  gene product
Catenin (cadherin-associated protein), alpha-like 1 
Integrin, alpha M (complement component 3, alpha, also CD11 b) 
Integrin, alpha M (complement component 3, alpha, also CD11 b) 
Integrin, alpha M (complement component 3, alpha, also CD11 b)
ATP synthase, H+ transporting, mitochondrial F0 complex, subunit d 
Mitochondrial ribosomal protein L3 
v-myc avian myelocytomatosis viral oncogene 
FIAB5C, member of RAS oncogene family 
Glutamic-oxaloacetic transam inase 1, soluble 
Cyclln H
Lamin B receptor
Coagulation factor XII (Hageman factor)
Transcription factor 3 
Zinc finger protein (done 647)
General transcription factor II, i 
plm-2 oncogene 
Human clone 23826 mRNA sequence 
Human clone 23826 mRNA sequence 
RY1  Putative nudelc acid binding protein RY-1 
KIAA0317  KIAA0317 gene product
CREB1  cAMP responsive element binding protein 1 
BMP1  Bone morphogenetic protein 1
RAB3A  RAB3A, member of RAS oncogene family
STXBP1  Syntaxin binding protein 1
B4GALT3  UDP-Gal:betaGlcNAc beta 1,4-galactosyltransferase, polypeptide 3 
ARPP-19  Cyclinc AMP phosphoproteln, 19kD
CSTF3  Cleavage stimulation factor. 3' pre-RNA, subunit 3 ,77kO
TatD DNase domain containing 1 
2,4-dienoyl CoA reductase 1, mitochondrial 
Antigen identified by monoclonal antibody Ki-67 
v-myb avian myeloblastosis viral oncogene 
Transmembrane 9 superfamily member 2 
MLNS1  protein 
Lysyl oxidase-like 2
SMC4 (strudural maintenance of chromosome 4, yeast)-llke 1 
Integrin beta 3 binding protein 
Ubiquitin-conjugating enzyme E2C
Proteasome (prosome, macropain) 26S subunit, non-ATPase, 10 
RNA, U transporter 1 
ZMPSTE24  Zinc metalloproteinase, STE24 (yeast, homolog)
ILF1  Interleukin enhancer binding factor 1
ENSA  Endosulfine alpha
SRP19  Signal recognition particle, 19kDa
TIA1  TIA1 cytotoxic granule-associated RNA-binding protein
Homo sapiens pTM5 mariner-like transposon mRNA, partial sequence
LAP18  Leukemia-associated phosphoprotein p18 (oncoprotein 18)
CRY1  Cryptochrome 1  (photolyase-like)
IHSPC009  HSPC009 protein
ELAV (embryonic lethal, abnormal vision, Drosophila)-llke 1  (Hu antigen R) 
Nitrogen fixation 1
CDC23 (cell division cycle 23. yeast, homolog)
X-ray repair complementing defective repair in Chinese hamster cells 1 
Transcription factor Dp-2 (E2F dimerization partner 2)
Actin related protein 2/3 complex, subunit 4 (20 kD)
Serine/threonine kinase 16
High mobility group (nonhistone chromosomal) protein 4 
DEAH (Asp-Glu-Ala-Asp/His) box polypeptide 57 
MCG11349  Hypothetical protein MCG11349 
GRLF1  Glucocorticoid receptor DNA binding factor 1 
PRPSAP1  Phosphoribosyl pyrophosphate synthetase-associated protein 1 
Ems1  sequence
Cytochrome b-245, alpha polypeptide 
Replication protein A3 (14kD)
Interferon-related developmental regulator 2 
Myosin-binding protein H
Branched chain aminotransferase 2, mitochondrial 
Tumour necrosis factor, alpha-induced protein 1  (endothelial)
Diaphanous (Drosophila, homolog) 1
Glyceronephosphate O-acyltransferase 
Symplekin
Tumor susceptibility gene 101 
D123 gene product
Platelet/endothelial cell adhesion molecule 1 
Cydin D2
Protein tyrosine kinase 2 beta
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4.7.3.5  Influenza-specific responses
This group of genes encode proteins that are involved in cell growth, maintenance, and 
nucleic acid metabolism, which are strongly upregulated in late timepoints in Influenza- 
infected DCs and also at 24 hours after inactivated Influenza exposure  (Figure 4.16). 
The gene functions are similar to those observed in the cluster of upregulated genes by 
DCs  responding  to  inactivated  Influenza  (Figure  4.15).  Genes  involved  in  protein 
metabolism,  including  protein  processing  and  degradation  (PSMD10)  and 
ubiquitination (UBE2C), biosynthesis and phosphorylation, are also upregulated, which 
are  common  between  DC  responses  to  Influenza  and  inactivated  Influenza. 
Modification of the host response that involves protein synthesis and metabolism appear 
to be a general  feature of Influenza virus. The conflict between  Influenza modulating 
conditions  to  favour  the  translation  of viral  mRNAs  (de  la  Luna  et  al.,  1995)  and 
dendritic  cells’  increased  processing  activity  to  present  viral  antigens to  T  cells  may 
explain the upregulation of these genes in Influenza-exposed DCs.
In addition, this cluster also includes genes that are more strongly upregulated by DCs 
responding to Influenza infection. These genes are presumably dependent on replication 
events, such as THO complex 2,  involved in stabilising intermediate filament proteins 
as  part  of the  transcription/export  complex,  and  SWI/SNF  related  matrix  associated 
actin  dependent  regulator  of chromatin  (SMARCA2),  involved  in  regulating  DNA 
transcription.  These  genes  bind  to  chromatin,  to  alter  chromatin  structure  to  allow 
transcriptional activation of genes normally repressed by chromatin. Specific regulation 
of cellular transcription  is  affected  by  Influenza  replication,  whereas  upregulation  of 
genes involved in regulating basal transcription is more associated with DC responses to 
inactivated  Influenza  (Section  4.7.3.4).  A  further  influence  of  Influenza  in  DC 
transcription  include the upregulation of origin recognition complex ORC3L which  is 
necessary  for  the  initiation  of  DNA  replication,  and  nucleoporin  160kDa,  which 
regulates mRNA export from the nucleus. The latter may reflect a strategy of Influenza 
to  block  translation  of cellular  mRNAs  in  preference  to  viral  mRNAs  (Gale  et  al., 
2000).
The combination  of modulating genes which  encode  for protein  metabolism, together 
with selective transcriptional regulation of host cells, appear to be a distinctive effect of 
Influenza  infection  in  DCs.  Influenza  protein  NS1  functions  to  sequester  dsRNA
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thereby preventing PKR activation. The activation of PKR would result in a block to all 
protein  synthesis.  In addition to degrading cellular mRNAs  in  the nucleus  (Katze and 
Krug,  1984), Influenza has been shown to block nuclear export of cellular RNAs (Chen 
and  Krug,  2000),  whilst  favouring  viral  mRNA  translation.  This  serves  to  provide  a 
virus-specific  defence  mechanism  against  non-specific  inhibition  of  translation 
mediated by PKR.
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NFATC4  Nuclear factor of activated T cells, cytoplasmic, calcineurin-dependent 4 
LGMN  Legumain
ZFP36L1  Zinc finger protein 36. C3H type-like 1
RNF4  Ring finger protein 4
TM9SF2  T  ransmembrane 9 superfamlly member 2
FNTA  Famesyltransferase, CAAX box. alpha
SMARCA2 SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2
ORC3L  Origin recognition complex, subunit 3-like (yeast)
C14orf32  Chromosome 14 open reading frame 32
G3BP2  Ras-GTPase activating protein SH3 domain-binding protein 2
PCOLCE  Procollagan C-endopeptldase enhancer
RPIA  Rlbose 5-phosphate Isomerase A
VPS4B  Vacuolar protein sorting 4B (yeast)
XAP135  PHD zinc finger protein XAP135
PPP1CB  Protein phosphatase 1, catalytic subunit, beta isoform
PPP1CB  Protein phosphatase 1, catalytic subunit, beta isoform
HPRP8BP  U5 snRNP-specific 40kD protein
NDUFC1  NADH dehydrogenase (ubiquinone) 1, 6kDa
STAMBP  STAM binding protein
BAZ2A  Bromodomain adjacent to zinc finger domain, 2A
PPP1R10  Protein phosphatase 1. regulatory subunit 10
PPP1R10  Protein phosphatase 1, regulatory subunit 10
THOC2  THO complex 2
Rif1  Telomere-associated protein RIF1  homolog
NUP160  Nucleoporin 160kDa
NUP160  Nucleoporin 160kDa
DVRK1A  Dual-specificity tyrosine (Y)-phosphorylation regulated kinase 1A
NAB1  NGFI-A binding protein 1
NRIP1  Nuclear receptor interacting protein 1
DYRK1A  Dual-specificity tyrosine (Y)-phosphorylation regulated kinase 1A 
BAZ2A  Bromodomain adjacent to zinc finger domain, 2A
SOX12  SRY (sex determining region Y)-box 12
HOXA4  Homeobox A4
TRPM2  Transient receptor potential cation channel, subfamily M, member 2
R18517
NRlP1  Nudear receptor interacting protein 1
OAZ2  Ornithine decarboxylase antizyme 2
EPS15  Epidermal growth factor receptor pathway substrate  15
ZNF22  Zinc finger protein 22
PRKAA1  Protein kinase, AMP-activated, alpha 1 catalytic subunit
FCER1G  Fc fragment of IgE, high affinity I receptor, gamma polypeptide
CD81  CD81  antigen
CD81  CD81 antigen
USP34  Ubiquitin specific protease 34
MDN1  MDN1, midasin homolog (yeast)
TSN  Translin
CDKN1B  Cycli n-dependent kinase inhibitor 1B
R33463
DAG1  Dystroglycan 1
DAG1  Dystroglycan 1
Figure 4.16 Transcriptional signature of DCs responding to Influenza
This  group  of  genes  are  strongly  upregulated  in  Influenza-infected  DCs  at  late  timepoints, 
though  a  few  are  also  upregulated  by  DCs  at  late  timepoints  in  response  to  inactivated 
Influenza. Genes affecting nuclear transcription and chromatin remodelling are shown in red.
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4.7.3.6  dsRNA-specific responses
The dsRNA motif is one that is commonly found during virus replication (Jacobs and 
Langland,  1996).  Minute quantities of dsRNA,  as  little  as one  molecule per cell,  can 
have profound effects on cellular physiology (Marcus and Sekellick,  1977). For ssRNA 
viruses, the dsRNA motif can be found as the replicative intermediate in infected cells. 
The presence of both  positive-sense and negative-sense RNAs that are synthesized  in 
infected  cells  has  been  detected  for  a  number  of  viruses,  including 
encephalomyocarditis  virus (EMCV)  (Gribaudo et al.,  1991)  and  Rubella  (Lee  et  al., 
1994).  However,  virus-specific  RNA  molecules  that  contain  double-stranded  regions 
may  also  be  present  in  the  absence  of viral  replication.  The  ssRNA  genomes  of 
Influenza  and  Rhinovirus  contain  secondary  structures  that  may  be  recognised  as 
dsRNA. The negative strand ssRNA genome of Influenza contains panhandle structures 
in  the  terminal  noncoding  regions  that  are  partially  double-stranded.  This  structure 
serves to regulate  initiation and termination of viral transcription and polyadenylation 
(Desselberger et  al.,  1980;  Fodor et  al.,  1994;  Luo  et al.,  1991).  Rhinovirus  positive 
strand ssRNA genome contain cloverleaf structures that direct host proteins to regulate 
translation  or  replication  (Racaniello,  2001;  Mellits  et  al.,  1998;  Rohll  et  al.,  1994). 
Therefore  dsRNA  motifs  are  potentially  abundant  in  RNA  virus  genomes  and  life 
cycles.
In  addition  to  TLR3  that  detects  dsRNA,  the  cellular  proteins  PKR  and  2’,5’- 
oligoadenylate synthetase  1   (OAS1) can also bind specifically to dsRNA or RNA with 
secondary structures,  and be activated. PKR and OAS1  are found  in the cytoplasm as 
well as the nucleus (Jeffrey et al.,  1995; Rosenblum et al.,  1988), therefore dsRNA  in 
Influenza and Rhinovirus should both be detected. The activation of PKR leads to the 
phosphorylation of the a subunit of the protein  synthesis initiation  factor eIF2  (Levin 
and London,  1978) and IkB, which leads to IkB degradation and subsequent activation 
ofNF-icB (Kumar et al., 1994). Phosphorylation of eIF-2a by PKR is the mechanism by 
which interferon mediates the cessation of protein synthesis as part of controlling viral 
replication  in  virally-infected  cells  (Barber,  2001;  Der  and  Lau,  1995).  NF-kB  is 
important  in  the  initiation  of the  antiviral  response  by  activating  the  transcription  of 
IFNp  (Visvanathan  and  Goodboum,  1989),  in  addition  to  a range  of other cytokines, 
chemokines,  adhesion  molecules  and  MHC  molecules  (Baeuerle  and  Henkel,  1994). 
The  activation  of  OAS1  by  dsRNA  leads  to  ATP  polymerisation  to  2’,5’-linked
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oligoadenylates.  These  oligoadenylates  can  then  activate  a  ribonuclease  RNaseL  that 
cleaves  ssRNA  (Floyd-Smith  et  al.,  1981).  Both  negative  and  positive  sense 
picomaviral RNA have been found bound to OAS1  in EMCV-infected cells (Gribaudo 
et al.,  1991), and reduction of EMCV RNA shown to be mediated by RNaseL (Li et al., 
1998), consistent with the activation of this pathway in picornavirus-infected cells.
Genes upregulated by dendritic cells in response to dsRNA are distinct to DC responses 
to virus treatments (Figure 4.17). This dsRNA-specific response is initiated as soon as 
5 hours  after  stimulation,  and  the  poly(I:C)-stimulated  DC  samples  cluster  closely 
together from 5 to 24 hours post stimulation. These upregulated genes are largely a part 
of the core DC maturation response (Chapter 3). These include genes encoding proteins 
of the TNF  family (TRADD, TNFSF13), proteins that act downstream  of TNF (LPS- 
induced TNF factor), cytokine-mediated signal transduction pathways (STAM binding 
protein),  TGF{3  receptor  signalling  pathway  (famesyltransferase),  integrin-mediated 
signalling  pathway  (a  disintegrin  and  metalloproteinase  domain  11),  wnt  receptor 
signalling  pathway  (transcription  factor  7-like  2),  G-protein  coupled  receptor protein 
signaling pathway (endothelial differentiation, lysophosphatidic acid G-protein-coupled 
receptor  4),  BNIP  family  (Bcl2/adenovirus  E1B  19kDa  interacting  protein  3-like), 
intracellular signalling cascades (stathmin-like 2, autocrine motility factor receptor) and 
apoptosis regulation  (presenilin  1,  cold  autoinflammatory  syndrome  1,  cold  inducible 
RNA  binding  protein,  death-associated  protein  kinase  1).  Insulin-like  growth  factor 
binding protein 4 (IGFBP4) is also strongly upregulated, which functions to prolong the 
action of insulin-like growth factors.
Interestingly, this subset of genes is largely specific to dsRNA, and not shared between 
DC  responses  to  Rhinovirus  or  Influenza.  This  difference  could  be  a  result  of the 
differentiation of the  DC core maturation response (dsRNA and LPS) and  specifically 
virus-tailored responses. Another possibility for this difference is that viruses are able to 
downmodulate this activatory response in DCs, as these core genes are not upregulated 
in  DCs  responding to  Rhinovirus exposure  or  Influenza  infection.  However,  some  of 
these dsRNA-induced upregulated genes are also found in DC responses to inactivated 
Influenza,  like  IGFBP4,  TRADD,  cyclin  G2,  RBMS2  (RNA  binding  motif),  and 
complement  factor  C2  (Figure  4.17).  This  suggests that  the  dsRNA  motif as  part  of 
secondary  structures  in  inactivated  Influenza  genome  is  present  and  is  detected  by 
dendritic  cells.  In  contrast,  replication-competent  Influenza  does  not  cause  DCs  to
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upregulated these genes, suggesting that Influenza is able to suppress a range of the host 
immune  responses  to  dsRNA.  Interestingly,  although  there  is  no  evidence  that 
Rhinovirus  can  replicate  in  DCs  in  this  system,  DC  responses  to  non-replicating 
Rhinovirus  is distinct to DC responses to  inactivated  Influenza.  This  further suggests 
that DC responses are virus-specific, in addition responses dependent on the replicative 
ability of the virus.
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Tight junction protein 1  (zona occludens 1)
Ubiquitln protein ligase E3C
Catenin (cadherin-associated protein), alpha 2
Mitogen-activated kinase associated protein 1
KIAA0494 gene product
Erythrocyte membrane protein band 4.1-like 3
Erythrocyte membrane protein band 4.1-like 3
Phosphorylase, glycogen; brain
FERM, RhoGEF (ARFIGEF) and pleckslrin domain protein 1  (chondrocyte derived)
Bcl2/adenovirus E1B 19kDa interacting protein 3-like
Cold inducible RNA binding protein
Protein phosphatase 6, catalytic subunit
Nucleotide binding protein 1  (MinD homolog, E.coli)
Acyioxyacyl hydrolase (neutrophil)
Transcription factor binding to IGHM enhancer 3 
CD209 antigen (DC-SIGN)
Cyclln-dependent kinase inhibitor 1B (p27, Kip1)
STAM binding protein 
Intersectin 1  (SH3 domain protein)
Seven in absentia homolog 1  (Drosophila)
Seven in absentia homolog 1  (Drosophila)
Cydin G2
Farnesyltransferase, CAAX box, alpha 
Plexin C1
Component of oligomeric golgi complex 5
RNA binding motif, single stranded interacting protein 2
Stalhmin-like 2
Tumour necrosis factor (ligand) superfamily, member 13
Homo sapiens cDNA FU20722 fls, clone HEP15411, mRNA sequence
Vam6/Vps39-like
Tumour necrosis factor (ligand) superfamily, member 13 
Acyioxyacyl hydrolase (neutrophil)
Phosphatidic acid phosphatase type 2B 
Presenilln 1  (Alzheimer disease 3)
Vitiligo-associated protein 
Slalytransferase
CD36 antigen (collagen type I receptor, thrombospondin receptor)
Neuregulin 1
Complement component 2
Insulin-like growth factor binding protein 4
Cathepsin Z
TNFRSFIA-associated via death domain 
UV radiation resistance associated gene 
Mannosidase, beta A, lysosomal
Veside-associated membrane protein 2 (synaptobrevin 2)
Chromosome 14 open reading frame 32 
MDN1, midasin homolog (yeast)
Phosphatidylserine decarboxylase
Phosphoinositide-3-kinase, regulatory subunit, polypeptide 1  (p85 alpha)
Helicase with SNF2 domain 1 
Autocrine mobility factor receptor
HIV-1  inducer of short transcripts binding protein; lymphoma related fador 
A disintegrin and metalloproteinase domain 11 
DnaJ (Hsp40) homolog, subfamily B, member 2 
ProSAPiP2 protein (TBK1-b!ndlng protein 1)
Endothelial differentiation, lysophosphatidic acid-G-protein-coupled receptor, 4 
Thyroid hormone receptor interactor 6 
Fibronectin 1
Ribosomal protein S6 kinase, 70kDa, polypeptide 2
Cold autoinflammatory syndrome 1
Protein tyrosine phosphatase, receptor type, O
Death-associated protein kinase 1
Fc fragment of IgG binding protein
Grancalcin, EF-hand calcium binding protein
LPS-induced TNF-alpha factor
Transcription factor 7-like 2 (T-cell specific, HMB-box)
Insulin-like growth factor 2 receptor 
Insulin-like growth factor 2 receptor 
Phosphatidytinositol 4-kinase type II
Colony stimulating factor 2 receptor, alpha, tow-affirxty (granulocyte-macrophage) 
LIM domain only 7
Figure 4.17 Transcriptional signature of DCs responding to dsRNA
This  group  of  genes  are  strongly  upregulated  by  DCs  responding  to  dsRNA,  compared  to 
Rhinovirus and  Influenza. These genes reflect a subset of the core maturation program in DCs 
responding  to  LPS and  dsRNA,  and  are not upregulated  in  DCs  responding to viruses.  There 
are  genes  that  are  similarly  upregulated  by  DCs  in  response  to  dsRNA  and  inactivated 
Influenza (genes shown in red).
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4.7.3.7  NF-kB response
This  group  of genes  are  involved  in  the  induction  and  maintenance  of the  NF-kB 
response  (Figure  4.18).  These  genes  are  strongly  upregulated  in  DCs  responding  to 
dsRNA.  This  is  consistent  with  the  results  from  Chapter  3  where  these  genes  were 
classified  as  part  of  the  core  DC  activation  and  differentiation  response,  as  the 
activation  of  numerous  intracellular  signalling  pathways  downstream  of  TLR3 
culminates  in  the  activation  of NF-kB.  These  genes  are  also  upregulated  in  DCs 
responding to live Influenza and inactivated Influenza. A smaller subset of the NF-kB 
response genes are also upregulated in DCs responding to Rhinovirus. Activation of this 
transcriptional  program  may  be  a  result  of TLR  signalling  or  PKR  activation  as  a 
response  to  dsRNA,  as  well  as  other  virus-stimulated  receptors  that  induce  NF-kB 
activation.  The  ability  of viruses  to  activate  NF-kB  suggests  the  importance  of this 
transcription factor in the life cycle of viruses (Pahl,  1999; Santoro et al., 2003). Many 
viruses are known to induce NF-kB responses, including Influenza and Rhinovirus.
Influenza’s ability to activate NF-kB  as reported  in the  literature varies depending on 
the cell type in which the experiments were carried out. Where Influenza A infection of 
lung  epithelial  cells  (Ronni  et  al.,  1997)  and  macrophages  (Matikainen  et  al.,  2000) 
showed  activation  of  NF-kB,  Influenza  infection  in  mouse  embryonic  fibroblasts 
(MEFs)  showed  that this was  inhibited by the viral NS1  protein  (Wang  et al.,  2000). 
This further emphasises the importance of cell-type specific responses. Transcriptional 
profiling  of  lung  epithelial  cells  infected  with  Influenza  also  showed  a  significant 
induction  of genes  involved  in the  IFN and NF-kB  pathway; and deletion of the viral 
NS1  gene further increased the number and magnitude of expression of cellular genes 
implicated  in these pathways (Geiss et al., 2002).  Susceptibility of Influenza infection 
has  been  shown  to  vary  in  cells  which  relate  to  their  ability  to  activate  the  NF-kB 
pathway  (Nimmerjahn  et  al.,  2004).  Results  here  indicate  that  in  addition  to 
susceptibility to Influenza infection (Section 4.3.2), which may relate to increased NF- 
kB  activities and  proteins  in  DCs (Granelli-Pipemo et al.,  1995) (Introduction Section
1.2.3.1),  Influenza  infection  of DCs results  in the transcriptional  activation  of NF-kB 
(Figure 4.18). As inactivated Influenza exposure to DCs also transcriptionally activates 
this cluster of genes, active Influenza replication  is not required for NF-kB  activation. 
Binding  of the  viral  particle  to  its  receptor  may  be  sufficient  to  trigger  membrane-
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proximal  signalling  cascades that activate  NF-kB,  and  entry  of inactivated  Influenza, 
and  detection  of  Influenza  dsRNA  by  PKR  and  TLR3  also  activates  NF-kB 
(Alexopoulou et al., 2001; Kumar et al.,  1994).
Rhinovirus is able to activate NF-kB in a range of respiratory epithelial cells, resulting 
in  the  induction  of  various  cytokine  (IL-6)  and  chemokine  (CXCL8)  transcripts 
(Funkhouser et al., 2004; Kim et al., 2000; Zhu et al.,  1996) and upregulation of surface 
expression of ICAM1  (Papi and Johnston,  1999). Rhinovirus exposure in DCs however, 
results in the induction of a small subset of the NF-kB response genes (Figure 4.18).
In  addition  to  activating  core  immune  response  genes  which  include  cytokines  and 
chemokines, regulators of motility, migration and cell adhesion, and antigen presenting 
functions  (Chapter  3),  NF-kB  also  activates  genes  involved  in  apoptosis  regulation. 
These genes include proapoptotic genes caspase 4, tumour protein p53  binding protein 
2,  serine/threonine  kinase  17b,  and  anti-apoptotic  genes  growth  arrest  and  DNA- 
damage-inducible  beta  (GADD45(3),  TNF  alpha-induced  protein  3  (TNFAIP3),  and 
baculoviral  IAP  repeat-containing  3  (BIRC3).  The  activation  of  such  apoptosis 
regulatory genes downstream of NF-kB clearly make the regulation and timing of NF- 
kB  activation  important  in  determining  whether the  virus-infected  cells are  protected 
from or undergo apoptosis (Bose et al., 2003). The regulation of apoptosis may also be 
important for DC responses to Influenza as the induction of apoptosis by Influenza is an 
important  mechanism  of  Influenza-induced  cell  death  (Hinshaw  et  al.,  1994).  In 
addition to activating NF-kB and downstream pro-apoptotic genes, PKR also mediates 
apoptosis via eIF-2a (Gil et al.,  1999; Srivastava et al.,  1998) by  inhibiting translation 
of cellular  proteins.  As  Influenza  antagonises  the  activity  of  PKR  by  sequestering 
dsRNA, the virus may also indirectly regulate apoptosis mediated by PKR activity. The 
mechanisms  by  which  Influenza  induces  apoptosis  in  cells  are  ill  defined,  and  cell- 
specific  considerations  make  data  from  experiments  performed  in  various  cell  types 
difficult to extrapolate. In DCs, cell viability experiments clearly showed that Influenza 
infection  induced  a  significant  amount  of cell  death  (Section  4.6)  (Oh  et  al.,  2000) 
compared to DC  exposure to  inactivated  Influenza and  Rhinovirus. Together with the 
marked  induction  of  apoptosis-regulating  genes,  this  suggests  that  transcriptional 
regulation  of NF-kB  and  therefore  its  downstream  genes  by  Influenza-infected  DCs 
may be a mechanism by which Influenza mediates its apoptotic effects.
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So far, the upregulation of NF-kB responsive genes (Figure 4.18) mediated by DCs in 
response to Influenza infection in particular has been  interpreted as a response to viral 
infection,  as  these  genes  have  important  immune  functions  (cytokines,  chemokines, 
apoptosis regulation,  and antigen presentation).  However,  a target for PKR  is eIF-2a, 
and  phosphorylation  of the  a  subunit  results  in  the  inhibition  of cellular  translation 
initiation.  The  upregulation  of such  NF-kB  response  genes  may  be  a  reflection  of 
transcript  accumulation  of such  induced  genes  as  translation  is  inhibited.  Therefore, 
gene  expression  data  should  be  interpreted  within  the  confines  of  transcriptional 
activity, and that this does not necessarily translate to protein activity.
Figure 4.18 Transcriptional signature of the NF-kB response (next page)
This cluster shows a number of genes that are thought to be regulated by NF-kB. These genes 
are  upregulated  by  DCs  most strongly  in  response to  dsRNA,  as  demonstrated  in  Chapter 3 
(Section  3.2.8)  as  part  of the  core  DC  maturation  program.  However,  Influenza-infected  DCs 
also  seem  to  upregulate  the  transcripts  of  NF-kB  genes  (shown  in  red),  suggesting  that 
Influenza also activates NF-kB as part of its replication cycle in DCs.
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Discussion
The theme of DC plasticity to antigens was further explored  in this chapter. LPS- and 
dsRNA-specific responses from the core activation and differentiation program alluded 
to antigen-specific responses that were subtle and difficult to interpret. The use of more 
complex antigens in the form of whole viruses allowed DC plasticity to be seen more 
clearly.  Both  live  and  inactivated  forms  of  Influenza  and  Rhinovirus  induced 
differential phenotypic responses in DCs at the level of surface expression of a range of 
relevant markers. Exposure to viruses also differentially affected DC viability. This was 
supported by the observed transcriptional  plasticity  in  DC  responses to different virus 
treatments.
Currently there are no studies of the global transcriptional effects of different viruses on 
DCs. DC responses to different viruses are usually investigated within a particular facet 
of the  DC  response  (Lopez  et  al.,  2003),  whereas  global  changes  affected  by  virus 
infections are usually investigated in stromal cell  lines (Geiss et al., 2001; Geiss et al., 
2002).  In  particular,  effects  of  Influenza  and  Rhinovirus  infections  have  been 
investigated  in  lung and bronchial  epithelial  cells,  as both  are  respiratory  viruses that 
cause pathogenesis in the lung.
A number of microarray studies have addressed the effects of Influenza A infection  in 
cells,  in  particular  the  effects  of viral  NS1  and  active  replication  in  mediating  host 
antiviral responses.  Effects of NS1  in cell lines include targeting of PKR to counteract 
replication  inhibition  (Bergmann et al., 2000) and translation  shutoff (Salvatore et al., 
2002),  inhibiting the activation of NF-kB  and  IFNa/p (Wang et  al.,  2000),  inhibiting 
the activation of IRF-3 (Talon et al., 2000), and inhibition of JNK and API transcription 
factors (Ludwig et al., 2002). Anti-Influenza responses mediated by different cell-types 
are  largely  cell-type  specific,  as  seen  by  differential  NF-kB  activation  induced  by 
Influenza  in  different cell  types (Section  4.7.3.7). The effect of Influenza  infection  in 
respiratory  epithelial  cells  are  important  in  the  in  vivo  infective  context  and  in 
considering  the  pathogenesis  of Influenza,  as  stromal  cell  detection  and  responses to 
viruses  contribute to antiviral  immunity  (Sato and  Iwasaki,  2004).  However,  DCs are 
also  targeted  and  are  susceptible to  Influenza  infection.  Downstream  consequences of 
Influenza-infected  DCs shape the adaptive immune response, making DC  responses to 
Influenza important to understand.
210Plasticity of dendritic cell responses to antigen
Immune responses to Rhinovirus have been  investigated  particularly  in the context of 
asthma exacerbation in atopic patients (Papadopoulos et al., 2004) and the contribution 
to chemokine  induction in the airways to affect immunopathology (Gern et al., 2003). 
Rhinovirus does not seem to induce a clearly polarised T cell response (Papadopoulos et 
al.,  2002).  Interaction  with  monocytes  results  in  a  broad  non-specific  activation  of 
lymphocytes (Gem et al.,  1996c) and inhibition of antigen-specific T cell proliferation 
(Gem  et  al.,  1996b;  Stockl  et  al.,  1999).  The  lack  of DC  stimulation  by  Rhinovirus 
relative to Influenza observed here may also be linked to the lack of T cell responses to 
Rhinovirus.  The  inability  to  establish  productive  infection  in  monocytes  and 
macrophages (Gem et al.,  1996a) and  DCs (Kirchberger et al.,  2003)  is  in  agreement 
with the finding here that Rhinovirus particles were not detected in Rhinovirus-exposed 
DCs.
Transcriptional profiling analysis has revealed that DCs are plastic in their responses to 
live  and  inactivated  Influenza  and  Rhinovirus,  and  DCs  are  able  to  regulate  specific 
responses to  each  virus  treatment.  In  addition  to virus-specific  regulation,  subsets  of 
genes  appear  to  be  commonly  regulated.  The  early  virus-induced  response  (Section
4.7.3.1)  is seen at early timepoints after virus exposure.  These responses are not shared 
by DCs responding to dsRNA. The genes in this cluster encode proteins that function in 
intracellular transport, which may be mediated specifically by viruses in the process of 
viral entry and uncoating.
In contrast, the late antiviral response (Section 4.7.3.2) is induced in DCs responding to 
all  three  virus  treatments as well  as dsRNA. This  suggests that the  antiviral  response 
shares  similarity  to  the  core  activation  and  differentiation  response  of DCs,  possibly 
mediated  by  IRF-3,  the transcription  factor that participates  in  mediating the antiviral 
program (Doyle et al., 2002). However, even within the common antiviral cluster, genes 
are  differentially  regulated  by  DCs  responding  to  different  viruses,  in  particular  the 
lower  transcript  levels  of the  antiviral  genes  expressed  by  Influenza-infected  DCs 
(Figure 4.13), suggesting the ability of live Influenza to downmodulate this host defence 
mechanism.
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The  lack  of evidence  for  Rhinovirus  replication  in  DCs  suggests  that  downstream 
transcriptional  events  specific  to  Rhinovirus-exposed  DCs  are  a  result  of Rhinovirus 
interaction  with  ICAM1  or  other  receptors  on  DCs,  and  possibly  viral  entry  by 
endocytosis.  Upregulated  genes  include  MMP2,  cathepsins  associated  with  antigen 
processing,  and  HLA-C  upregulated  for  antigen  presentation  (Figure  4.14).  Genes 
associated  with  actin  remodelling  (LCP1,  ACTB)  are  also  upregulated.  Such  genes 
induced at late timepoints in Rhinovirus-exposed DCs suggests that Rhinovirus induces 
a delayed activation response in DCs.
Influenza  infection  of  DCs  results  in  a  markedly  distinct  transcriptional  program 
compared  to  treatment  of  DCs  with  inactivated  Influenza.  This  illustrates  the 
importance of active viral modulation of host responses, and that Influenza virus is very 
active  at  downmodulating  host  immune  responses.  Whereas  previous  literature  have 
attributed  the  immunomodulatory  NS1  viral  protein  as  responsible  for  counteracting 
host anti-influenza defences, results here suggest the additional involvement of proteins 
involved in the process of Influenza replication.
Transcriptional  plasticity  mediated  by  DCs  in  response  to  different  virus  treatments 
demonstrates that DCs are able to distinguish and regulate responses between different 
viruses,  at  the  level  of  specific  virus  and  dendritic  cell  interactions  (comparing 
inactivated  Influenza-  and  Rhinovirus-induced  responses)  and  replication-dependent 
events (comparing inactivated and live Influenza-induced responses).
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Chapter 5 
Pathogen-specific dendritic cell effector functions 
Introduction
In  the  previous  chapter,  hierarchical  clustering  analysis of virus-treated  dendritic  cell 
microarrays resulted  in a sample dendogram that was  broadly ordered  in time, within 
which  virus-specific  responses  could  be  identified.  This  suggested  that  DCs  are 
transcriptionally  plastic  to  different  antigens.  Statistical  methods  for  identifying 
differentially regulated  genes do not easily apply to time-dependent data,  unless there 
are multiple repeat arrays as in Chapter 3.  We therefore needed to find a new filtering 
method that captured  the time-dependent nature of the experiments,  without the  need 
for over-sampling at multiple timepoints. There  is much evidence in the  literature that 
emphasise the need for further development of statistical tools and analysis methods for 
time series microarray data (Bar-Joseph, 2004; Slonim, 2002). Currently, the prototype 
time-series analysis of microarray data involves using Fourier transformations to test for 
periodicity,  phase  shift and  cyclical  patterns  in  the gene expression monitored during 
the yeast cell cycle (Spellman et al.,  1998). However, this is not applicable to dendritic 
cells, as the cells respond to stimuli and antigens by maturation and differentiation, and 
not  simply  cell  cycling  resulting  in  a  return  to  the  resting  state.  Mature  and 
differentiated DCs have a very different phenotype compared to immature DCs, so the 
very nature of the biological event being a change and transition in state requires a new 
method of analysis for differential gene expression over time.
A  novel  analysis  method  based  on  vector  algebra  was  devised  that  involved  the 
modelling  of gene  expression  profiles  as  gene  expression  vectors which  incorporated 
temporal  relationships  between  samples.  Basic  concepts  of  vector  algebra  and  its 
applicability  to  microarray  analysis  were  confirmed,  and  this  new  method  was 
compared  to  hierarchical  clustering  by  investigating  the  genes  commonly  and 
differentially  regulated  as  identified  by  the  two  methods.  Overall,  the  new  method 
allowed the temporal  relationship of the dendritic cell  samples to be  incorporated  into 
the  gene  expression  vectors.  The  comparison  of such  expression  vectors  in  dendritic 
cells  responding  to  different  viruses  allowed  the  capturing  of the  complex  temporal 
aspects of the evolution of DC responses to antigen. Candidate genes that contributed to
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the common  and  differential  responses were  selected  for further investigation,  on  the 
transcript and protein level.
Results 
5.1 Criteria for differential gene expression
In order to  identify genes that fit certain  criteria, the criteria first  need to be defined. 
One criterion is to identify genes that were differentially regulated in DCs in response to 
different stimuli, for example gene X in Figure 5.1  that is differentially regulated in DCs 
responding to Influenza, inactivated-Influenza, and Rhinovirus. The second criterion  is 
to  identify  genes that were  induced  or suppressed  in  time,  in  order to  filter out non­
changing genes, for example gene X regulated by Influenza-infected DCs in Figure 5.1. 
Hierarchical clustering and Treeview offer a global view of these results as a pseudo­
coloured representation of log2 expression ratios, allowing a quick visualisation of the 
overall  results.  However,  the  ability to  accurately  partition the data based  on  defined 
conditions is difficult. In Chapter 3, the extensive over-sampling of different timepoints 
and  the  defined  temporal  ordering  throughout  the  core  maturation  process  made  it 
possible to use statistical methods to identify differentially regulated genes.  However, 
because  the  temporal  ordering  of  different  virus  responses  were  more  complex 
(compare  Figure  3.8  to  Figure  4.10),  statistical  methods  are  not  easily  applicable. 
Therefore,  using two criteria defined above,  a method  adapted  from vector algebraic- 
based global gene expression analysis was devised to allow genes that fit the criteria to 
be identified from two calculations.
5.2 Vector analysis
The concepts of vector algebra, including vector angle (the angle between two vectors) 
and the magnitude of vectors, have natural and powerful  interpretations in the analysis 
of microarray data (Kuruvilla et al., 2002). Vector angles in particular offer a rigorous 
method for identifying “similarity” and “dissimilarity” in gene expression patterns. The 
layout  of microarray  data as  a matrix of log2 expression  ratios,  where  rows  represent 
gene elements (n) and columns represent experiments or transcription profiles {p), make 
the complementary concepts of gene vectors (variation of gene expression ratios over p 
experiments)  and  experiment  vectors  (experimental  variation  over  n  genes)  intuitive,
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and the generation of these vectors a natural operation. The nature of timecourse array 
data naturally lends itself to this type of analysis, by the modelling of gene expression 
ratios as gene vectors, defined by coordinates which are the expression  ratios in each 
experimental timepoint. The temporal nature of the data then becomes inherent  in the 
definition of the gene vectors. For example, the expression of gene X in DCs exposed to 
different  virus  treatments  (Figure  5.1 A)  can  be  visualised  as  a  two-dimensional  line 
graph  of the  variation  of log2  gene  expression  ratios  across  the  experiments  (Figure 
5.IB). Alternatively, the log2 expression ratios of genes can be visualised as vectors in 
experimental space, where each dimension of the vector is the gene expression ratio at a 
given experimental timepoint (Figure 5.1C, first three dimensions shown). Importantly, 
the  fundamental  basis  of three-dimensional  Euclidean  space  can  be  extended  to  n- 
dimensional  space,  and  therefore  the  number  of  dimensions  corresponding  to  the 
number  of experiments  can  be  extended.  This  makes  it  possible  to  determine  vector 
angles between  the  ^-dimensional  vectors of each  gene  in  the  different dendritic  cell 
treatments.
Figure 5.1 Transformation of gene expression to gene vectors (next page)
A Example of a data matrix table of a gene X as expressed in DCs treated with Influenza, UV- 
Influenza,  and Rhinovirus,  and the corresponding log2 gene expression ratios in 6 experiments 
across  a  24  hour  timecourse.  Gene  vectors  then  correspond  to  the  variation  in  log2  gene 
expression ratios over time, where each element in the vector is the log2 gene expression ratio 
in one experiment.
B  A  line  graph  of  log2  gene  expression  ratios  for  gene  X  in  the  3  conditions  across  6 
experiments corresponding to the variation in expression over time.
C  The  corresponding  3  gene  vectors  (first  three  dimensions  shown)  transformed  from  log2 
expression ratios plotted in 3-dimensional (experimental) space.
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(t=5)
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(t=18)
Expt 6 
(t=24)
Influenza 0.52 0.69 0.57 0.44 0.42 0.51
UV-lnfluenza -0.62 0.92 3.12 5.64 4.23 3.78
Rhinovirus 2.15 2.03 1.42 0.67 -0.94 -0.77
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5.2.1  Vector angle and its counterpart
Hierarchical clustering of microarray data was originally devised to cluster correlation 
matrices  (Eisen  et  al.,  1998),  and  has  become  a  popular  method  for microarray  data 
analysis  (Quackenbush,  2001;  Slonim,  2002).  The  measure  of  similarity  used  in 
hierarchical clustering is the Pearson correlation coefficient (r), which is generated for 
all the pair-wise comparisons between genes or experiments and used in the subsequent 
production of experimental and gene dendograms (Section  1.4.4.3,  Chapters 3  and 4). 
The complementary measure of correlation in the analysis of vectors is the concept of 
the vector angle (0). If two vectors are pointing in the same direction in space they are 
highly  correlated,  and  the  corresponding  angle  between  the  vectors  will  be  small. 
Therefore,  high  correlation  between  genes will  give vectors with  a small  angle  (r«l, 
0«O°). Uncorrelated vectors will be orthogonal (r«0, 0«9O°), and anti-correlated vectors 
will  point  in  opposite  directions  (rwl,  0^180°)  (Figure  5.2).  The  similarity  in  the 
relationship  between  the  Pearson  correlation  coefficient  and  the  vector  angle  can  be 
seen  from  their  definitions,  where  cov(,)  is  the  covariance  between  gene  expression 
ratios, and  (,)  represents an inner or dot product:
It is clear that r and inverse cosine function are identical, except that covariance and dot 
product are interchanged. However, the advantage of using vector angles is the ultimate 
application of vector algebra in modelling microarray data. Advantages of this method 
include  modelling  experimental  vectors  in  addition  to  gene  vectors  utilised  in  this 
chapter.  Experimental  vectors  become  one  point  in  a  much  higher-dimensional  gene 
space  (dimensions  correlate  to  the  number  of genes  monitored),  compared  to  gene 
vectors  which  reside  in  experimental  space.  Addition  of new  experimental  profiles 
means the addition of points where the dimension of gene space remains fixed (by gene 
number), and relationships between experimental profiles become much more apparent. 
Therefore, the advantage of vector analyses lies in the scalability of concepts to higher 
dimensions that captures microarray data effectively.
jco\(x,x)»co\(y,y)
co\(x,y)
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Figure 5.2 Function of cosine0 and its relationship to vector angles
The  blue  and  orange  arrows  represent  simplified  pairs  of  2-dimensional  gene  vectors.  The 
relationship  between  gene  vectors  and  the  corresponding  vector  angle  between  the  vectors 
relates  to  the  cosine  function,  where  small  vector  angles  correspond  to  cos0  «  1,  and  large 
vector  angles  showing  no  correlation  (90°,  270°)  and  anti-correlation  (180°)  correspond  to 
cos0 * 0 and cos© * -1  respectively. This directly relates to the Pearson correlation coefficient r.
5.2.2  Transforming gene expression data into vectors
The data matrix generated from Cluster gives filtered normalised log2 expression ratios. 
The  27  arrays  used  for  this  analysis  were  the  18  virus-stimulated  and  9  poly(I:C)- 
stimulated DC samples over 24 hours. Filtered for genes that passed the signal-to-noise 
ratio cut-off of the negative genes for all 27 arrays, this produced  1713  gene elements 
for  vector  analysis.  The  data  matrix  was  partitioned  into  the  four  conditions  to  be 
compared, and 6 pairwise comparisons for vector analysis were undertaken (Table 5.1).
To illustrate the transformation of gene expression ratios into gene vectors, let P and Q 
be two gene vectors,  with three coordinates each.  These  Cartesian vectors are defined 
by P = (P1, P2, P3); Q = (Q1, Q2, Q3). The magnitude of a Cartesian vector is represented 
by the Cartesian scalar |P|  and \Q\, where:
|p|  = [(P')2+(P2)2+(P3)2f ,  |g|  = [(Q‘)2+(Q2)2+(Q3)2],/‘
The inner product (P,Q) is defined by:
(^ e )= |/1 le|co se
Proof for the  inner product is  derived  from the  law of cosines.  Rearrangement of the 
above formula will give the angle between vectors P and Q:
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  s(fJ _ (P'Q)_______________ p 'q '  + p 2q 2   + p 3q 3______________
W   Vk/ ” )2+(/>2)2+(/>3)2][(e')2+ (g 2)j + (e 3)2]
Extending this to microarray data, with 6 timepoints, the vector angle 0 between gene 
vectors A and B, where A=(A°, A2, A5, A10, A18, A24); B=(B°, B2, B5, B10, B18, B24), can 
be calculated as below:
A°B° + A2 B2   +  A5 B5   +  AW B‘° +A'*B1 8  + A2 4 B2 4  
cos Q   =   ■ ,                  ■   - ............................................  -.......................................................................................
J[(A0)2  +(A2)2  +(A5)2  +(A'0)2  +(A'*)2  +(A2 4 )2][{B0)2  +(B2)2  +(B5)2  +(B'0)2  +(B'8)2  +(B2 4 )2]
If gene vector A represents the log2  expression ratio of a particular gene  in  dendritic 
cells  responding  to  Influenza  over  time,  and  gene  vector  B  represents  the  log2 
expression ratio of the same gene in dendritic cells responding to inactivated Influenza 
over time,  then the cos0  values generated would represent similarity  in  expression  of 
that gene in DCs responding to Influenza and inactivated Influenza.
In  practice,  the  vector angle of 45°  was used as a cut-off for correlation; two  vectors 
where  the  vector  angle  was  smaller than  45°  were  deemed  correlated  and  therefore 
similarly  regulated  by  DCs  responding  to  the  different  stimuli  (criteria  to  filter  at 
COS0  and two vectors where the vector angle was larger than  45°  were deemed
differentially regulated.
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5.2.3  Standard deviation of gene expression
A  simple  way  of identifying  genes  that  change  their  level  of expression  over  time 
(across experiments) is to plot log2 expression ratios of n genes over time, as defined by 
the  experiments.  Genes that vary in time will have a larger standard deviation of log2 
gene expression ratio over time, whereas non-changing genes will have a small standard 
deviation.
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Figure 5.3 Expression ratios of two genes over time
An example of the change in expression ratios of two genes over time. The expression of gene 
A (blue) is non-changing, whereas gene B  (orange) changes significantly. Accordingly,  gene A 
will have a small standard deviation, and gene B a large standard deviation.
The  definition  of  standard  deviation  is  correlated  to  a  second  metric  derived  from 
treating  gene  expression  as  vectors,  which  is  the  ratio  of magnitudes.  Genes  that  are 
highly  correlated,  i.e.  small  vector  angle  between  the  vectors,  may  have  different 
magnitudes.  For  example,  two  vectors  defined  by  three  coordinates  (2,4,7)  and 
(6,12,20) will have a small vector angle (cosO « 0.99), but they are clearly of different 
magnitudes.  If only  correlation  coefficients  were  used,  as  is  the  case  for hierarchical 
clustering,  this  property  of magnitude  would  be  obscured.  This  information  can  be 
captured by the ratio of magnitudes (a) between vectors, namely the square root of the 
quotient of the scalar components of two vectors:
M =   |[(Q°)2 +(Q2)2  +(Q5)2  +(Q'°)2  +(Q18)2  +(Q24)2F
vM   v  [(p0)2 + (p 2)2 +(p5)2 + (p10)2+ (p18)2+ (p24)2f
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This  ratio  of magnitude  (a)  is  an  additional  metric  in  cases  where  vector angles  are 
small  (close to 0°),  in order to differentiate between the  magnitude  of the vectors.  To 
confirm the relationship between a and standard deviation, 761  vector pairs with small 
vector  angles  (761  genes  that  were  commonly  regulated  between  different  virus 
conditions,  i.e.  the  sum of commonly regulated genes  in the  comparisons  from Table
5.1), were compared to standard deviation values generated for the same gene vectors. 
There is a clear correlation between the standard deviations computed and the ratio of 
magnitudes a between the commonly regulated genes (Figure 5.4).
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Figure 5.4 Relationship between standard deviations and ratio of magnitudes alpha
Standard  deviations  (SD)  of  expression  ratios  over  time  of  similarly  regulated  genes  were 
calculated  for genes  that are commonly  regulated  between  virus treatments.  The quotients  of 
SDs between vector pairs were plotted on the y-axis,  against the  ratio of magnitudes a of the 
corresponding vector pairs on the x-axis. The correlation coefficient (r) between the quotients of 
SDs and a between the vector pairs was 0.957 (to 3 significant figures).
This  shows  that  by  defining  standard  deviations  for  gene  vectors,  the  magnitude 
component  of the  gene  vectors  is  also  captured.  However,  the  advantage  of standard 
deviations  is  that  non-changing  genes  can  be  filtered  out,  as  each  gene  vector  has  a 
standard deviation value, compared to the ratio of magnitude which is defined for vector 
pairs. Therefore to identify differentially regulated genes between virus treatments over 
time, pairwise  gene vector angles and standard deviations were calculated and filtered 
according to cos0 < 2'/2  and standard deviation of 1.5. Commonly regulated genes were 
filtered at a vector angle criteria of cos0 > 2'/2.
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5.2.4 Analysis of virus-stimulated and dsRNA-stimulated DCs
An  Excel  workbook  was  designed  to  incorporate  the  filtered  and  normalised  gene 
expression  data from  Cluster and transform these  into gene vectors,  and calculate the 
filtering parameters of vector angles and standard deviation. Considering the 4 different 
stimuli  within  these  27 arrays,  6  different binary  comparisons were  made to  identify 
genes that were commonly and differentially regulated  by dendritic cells over time in 
response to different stimuli (Table 5.1). This identified an average of 128 commonly 
regulated  genes  (n  =  6,  range  =  45)  in  DCs  responding  to  the  different  viruses  and 
dsRNA  treatment,  and  an  average  of  670  genes  (n  =  6,  range  =  501)  that  are 
differentially  regulated  in  DCs  responding  to  different  virus  and  dsRNA  treatments 
(Table 5.1).
Table  5.1  Commonly and differentially regulated genes  in  dendritic cells  responding to 
different virus treatments
Commonly regulated T Differentially regulated1
Influenza v Rhinovirus 100 686
UV-lnfluenza v Rhinovirus 145 794
UV-lnfluenza v Influenza 135 716
Poly(l:C) v Influenza 127 652
Poly(l:C) v UV-lnfluenza 124 841
Poly(l:C) v Rhinovirus 130 339
tCommonly and ^differentially regulated genes for the various binary comparisons are listed in 
Appendices 1-6 and 7-12 respectively (attached disk).
Vector  analysis  of  gene  expression  ratios  in  DCs  responding  to  the  three  virus 
treatments  revealed  genes that  are  commonly  regulated  in  response to  all  three  virus 
treatments  (blue  area  in  Venn  diagram  in  Figure  5.5).  Genes  are  also  commonly 
regulated between pairs of virus treatments analysed, which indicate similarity between 
DC  responses  to  different  viruses.  The  two  virus  treatments  with  the  most  genes 
commonly  regulated  and most genes differentially  regulated  are  inactivated  Influenza 
and Rhinovirus, followed by inactivated Influenza and Influenza infection. Comparison 
between Influenza and Rhinovirus resulted  in the least number of commonly regulated 
and differentially regulated genes. This may reflect on the absolute number of regulated 
genes by DCs in response to different virus treatments, where treatment with inactivated 
Influenza  induces  change  in  the  largest  number  of genes  in  DCs,  and  infection  with
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Influenza induces change in the least number of genes. There are also genes that seem 
virus-specific,  which  are  identified  as  differentially  regulated  for  a  particular  virus 
treatment within the comparisons (e.g.  359  Influenza-specific genes that are common 
between  686  differentially  regulated  genes  in  DCs  responding  to  Influenza  and 
Rhinovirus, and 716 differentially regulated genes in DCs responding to Influenza and 
inactivated Influenza) (Figure 5.5).
Inactivated  Influenza  as  a  superior  antigen  compared  to  live  Influenza  was  seen  in 
phenotypic  changes  (Section  4.5,  Table  4.2)  and  transcriptional  responses  in  DCs 
(Section  4.7).  Transcriptional  regulation  in  lung  epithelial  cells  responding  to  live 
Influenza and NS1-deleted Influenza (Geiss et al., 2002) also showed that live Influenza 
perturbed  the  expression  of fewer  number  of cellular  genes  (84  genes  significantly 
regulated,  corresponding to *0.5-1% of all the cellular genes monitored on the array) 
compared  to  a  NS1-deleted  Influenza  strain  which  resulted  in  the  regulation  of 115 
cellular genes  (corresponding to *0.7-1.4% of all the cellular genes monitored on the 
array).  Results here  show  much  larger numbers of regulated  genes,  for example  DCs 
regulate  a  total  of 719  genes  in  response  to  inactivated  Influenza,  which  represents 
approximately 42% of genes that are analysed. As discussed in Chapter 4, comparison 
of DC responses to HeLa cell responses to live and inactivated Influenza (Geiss et al., 
2001)  show  that  genes  regulated  in  DCs  responding  to  inactivated  Influenza  are  not 
regulated in HeLa cells, where in the latter, regulation of the same genes are dependent 
on Influenza replication. Both these comparisons indicate that DCs are more sensitive to 
antigenic stimuli, transcriptionally regulating larger numbers of genes to similar stimuli, 
and have a lower threshold of “activation” in that certain virus replication events are not 
required for the regulation of host genes.
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Figure 5.5 Distribution of regulated genes in dendritic cells responding to viruses
Log2  expression  ratios  were  compared  using  vector  and  standard  deviation  analyses,  and 
commonly  and  differentially  regulated  genes  were  identified,  giving  rise  to  intersections  of 
common  response  genes  and  virus-specific  dendritic  cell  responses.  Commonly  regulated 
genes  correspond  to  figures  in  Table  5.1,  virus-specific  genes  derived  from  comparing 
differentially regulated genes between virus pairs.
5.3  Commonly regulated core antiviral response
A group of 15 genes was identified to be very closely correlated in terms of small vector 
angles  in  DC  responses  to  all  three  virus  stimuli  (Figure  5.5).  Of these  15  genes,  10 
genes  are  commonly  upregulated  (Table  5.2,  Figure  5.6),  and  5  are  commonly 
downregulated.  All  10  upregulated genes  are  within the  subset of the  proposed “core 
antiviral response” identified by hierarchical clustering (Section 4.7.3.2, Figure 5.7). Of 
this group of 26 genes identified as commonly regulated by hierarchical clustering, over 
half of the  genes  (16  genes  out of 26)  are  not defined as  commonly regulated by the 
criteria of vector angles.  This  is because  some of the genes  (for example  STAT1  and 
OAS1)  are  clearly  downregulated  by  Influenza-infected  DCs  at  late  timepoints,  and 
other genes (for example TOR IB and FLN29) are not upregulated by DCs in response 
to  Rhinovirus  (Figure  5.7).  This  illustrates  the  sensitivity  of vector angles  to  identify 
more precisely co-expressed genes.  The  10  genes identified as commonly upregulated 
as defined by the criteria of vector angles (cos0 > 2V l) are shown in Figure 5.6.
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Table 5.2 Genes commonly upregulated by dendritic cells in response to viruses
Gene Name  Gene Symbol  Genbank
Transporter 1, ATP-binding cassette,  subfamily B (MDR/TAP) TAP1 H23432
Apolipoprotein B mRNA editing enzym e, catalytic polypeptide-like 3B APOBEC3B T71211
Metallothionein 3 MT3 AI418147
Ubiquitin-conjugating enzym e E2L 6 UBE2L6 H93314
Tumour necrosis factor receptor subfamily, m em ber 5 (CD40 antigen) TNFRSF5 R49883
Interferon induced transm em brane protein  1  (9-27) IFITM1 H00943
Interferon induced transm em brane protein 2 (1-8D) IFITM2 W 37877
Proteasom e activator subunit 2 PSME2 AA029750
Insulin-like growth factor 1  receptor IGF1R H00849
DnaJ (Hsp40) homolog, subfamily A,  m em ber 1 DNAJA1 H06531
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IFITM1
IFITM2
IFITM2
IGF1R
IGF1R
UBE2L6
UBE2L6
APOBEC3B
PSME2
PSME2
ITAP1
TAP1
TNFRSF5
DNAJA1
DNAJA1
MT3
MT3
Interferon induced transmembrane protein 1   (9-27kD)
Interferon induced transmembrane protein 2 (1-8kD)
Interferon induced transmembrane protein 2 (1-8kD)
Insulin-like growth factor 1   receptor 
Insulin-like growth factor 1   receptor 
Ubiquitin-conjugating enzyme E2L 6 
Ubiquitin-conjugating enzyme E2L 6 
APOBEC3B  ApoB mRNA editing enzyme, catalytic polypeptide-like 3B
Proteasome (prosome, macropain) activator subunit 2 (PA28 beta) 
Proteasome (prosome, macropain) activator subunit 2 (PA28 beta) 
ATP-binding cassette, subfamily B (MDR/TAP), member 2 
ATP-binding cassette, subfamily B (MDR/TAP), member 2 
TNF receptor superfamily, member 5 (CD40)
DnaJ (Hsp40) homolog, subfamily A, member 1  
DnaJ (Hsp40) homolog, subfamily A, member 1  
Metallothionein 3 (growth inhibitory factor (neurotrophic)) 
Metallothionein 3 (growth inhibitory factor (neurotrophic))
-4  -2 + 2  +4
Figure 5.6 Commonly upregulated genes by DCs in response to viruses
Treeview  visualisation  of  the  10  genes  identified  by  vector  analysis  as  being  commonly 
upregulated in DCs responding to different virus treatments. This group of genes are within the 
proposed antiviral cluster identified in Section 4.7.3.2 (and shown in Figure 5.7).
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Figure 5.7 Genes comprising the proposed core “antiviral cluster”
Cluster  of  genes  commonly  upregulated  by  DCs  in  response  to  Influenza,  Rhinovirus  and 
dsRNA treatment.  Blue dots indicate the  10 genes commonly upregulated  by DCs responding 
to  all three virus treatments (Figure 5.6) as identified  by vector analysis.  Orange dots  indicate 
known interferon-response genes (see Section 5.3.2).
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The  10  commonly  upregulated  genes  showing  a common  expression  pattern  may be 
induced  by  a  cytokine  that  is  secreted  by  DCs  in  response  to  the  virus  treatments, 
resulting  in  the  activation  of  common  transcription  factors,  and  the  coordinated 
transcriptional  upregulation  of  these  genes  (Figure  5.7).  These  possibilities  were 
explored by examining the promoter regions of these genes to identify the presence of 
common  promoter  regions  where  transcription  factors  may  bind,  and  measuring  DC 
culture  supernatants  for  secreted  type  I  interferon,  a known  cytokine  for modulating 
some of these genes as part of the antiviral response.
5.3.1  Genome analysis of commonly upregulated genes
Genes that are co-expressed may be co-regulated by the same transcription factor(s). To 
explore this possibility, DNA sequences of regions  1000 base pairs (bp) 5’ upstream of 
the  10  commonly  upregulated  genes  in  Table  5.2  were  extracted  from  the  human 
genome and  input to the Transcription  Element Search  Software (TESS) to search  for 
transcription factor binding sites (TESS: http://www.cbil.upenn.edu/tess). In particular, 
the  presence  of  DNA  sequences  to  which  transcription  factors  IRF-1  (interferon 
regulatory  factor-1),  ISGF-3  (interferon-stimulated  gene  factor-3),  and  NF-kB  bind 
were  noted  (Figure  5.8),  as  these  are  probably  most  relevant  in  dendritic  cells 
orchestrating a common response to various virus treatments.
IRF-1  functions to  activate the  IFN(3 promoter and  other  interferon-stimulated  genes, 
but is not a primary transcriptional activator of either, as it has only weak transcriptional 
activity (Pine et al.,  1990; Reis et al.,  1992). Known targets of IRF-1  include TAPI  and 
PSME2, as well as IFNp. ISGF-3 comprises IRF-9, STAT1  and STAT2 (Qureshi et al., 
1995), and functions to mediate downstream effects of IFN signalling and activates the 
interferon-stimulated genes (ISGs) (Kessler et al.,  1990; Schindler et al.,  1992). STATI 
itself has a binding site for ISGF-3 in its promoter sequence to enable positive feedback 
for  interferon  signalling.  Although  STAT1  was  identified  as  part  of the  proposed 
antiviral  cluster  (Section  4.7.3.2),  STAT1  is  not  further  upregulated  by  Influenza- 
infected  DCs  at  later  timepoints  (10  to  24  hours  after  virus  infection),  and  was  not 
identified by vector and standard deviation analyses as commonly upregulated by DCs 
(Figure  5.6).  NF-kB  activates  numerous  immune  response  genes,  as  discussed  in the 
context of the  DC  core activation  and differentiation  program,  and  is also involved  in
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mediating  the  antiviral  effects  of  interferon  as  well  as  participate  in  IFN(3  gene 
regulation (Hiscott et al., 2003; Lenardo et al.,  1989).
Of the  10 genes commonly upregulated by dendritic cells, 8 genes had DNA sequences 
in their promoter regions to which transcription factors IRF-1, ISGF-3, and NF-kB can 
bind  (Figure  5.8).  The  two  genes which  did  not  have  consensus  sequences  for these 
transcription  factors  in  their  promoter  regions  are  IGF1R  and  IFITM2.  No  one 
transcription factor binding site is present in all of the 8 genes. Five out of 8 genes share 
consensus sequences for NF-kB, and 4 share consensus sequences for interferon-related 
transcription factors IRF-1  and ISGF-3. TAPI  and UBE2L6 share consensus sequences 
for both NF-kB and IRF-1.
To explore the  possibility  of the  role  of IRF-3  and  IRF-7  in  the  activation  of the  10 
commonly  upregulated  genes,  consensus  sequences  that  matched  IRF-3  and  IRF-7 
binding sites were also searched in the promoter regions (Yan et al., 2004). These two 
IRF  transcription  factors  is  believed  to  be  activated  independently  of  interferon 
signalling,  and  IRF-3  activation  directly  downstream  of  virus  entry  has  been 
demonstrated  (Bose  and  Banerjee,  2003;  Hiscott  et  al.,  1999;  Servant  et  al.,  2002), 
resulting  in  the  production  of  IFN(3.  The  production  of  IFNp  results  in  autocrine 
signalling via interferon  receptors,  and downstream  signalling results in the activation 
of IRF-7, and the transcription of IFNa and  further activation of IFN(3 (Nakaya et al., 
2001;  Sato  et  al.,  1998;  Yang  et  al.,  2004).  However,  only  the  promoter  regions  of 
TAPI  and IFITM1  had consensus sequences for IRF-3  and IRF-7 respectively (Figure 
5.8).
This analysis  shows that the promoter regions  for  10  genes commonly  upregulated  in 
dendritic  cells  do  not  share  common  transcription  factors.  There  are  several  possible 
reasons for this. Firstly, it is possible that with the current state of knowledge, these 10 
genes  do  share  a  common  transcription  factor  that  is  not  yet  represented  in  the 
TRANSFAC  database,  or a transcription  factor that  is  still  unknown.  Secondly,  gene 
regulation  is  multiplex,  and  individual  genes  are  regulated  by  multiple  transcription 
factors, which together enhance or suppress transcription. Therefore, genes may be co­
expressed  as a result of a combination  of effects of multiple transcription  factors that 
need  not  be  shared  across  all  genes.  Furthermore,  transcription  factors  that  bind  to
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enhancer regions may be more than  1000 bp upstream of the genes they regulate, which 
were not taken  into account in this analysis. Cross-species promoter analysis may also 
improve promoter prediction by incorporating information about promoter sites that are 
conserved across other mammalian species,  increasing the likelihood of such promoter 
sites being functional in vivo (Frazer et al., 2003;  Sandelin et al.,  2004). However, the 
presence of interferon-regulated transcription  factors and NF-kB  in the  10 upregulated 
genes  strongly  suggest  that  these  genes  are  co-regulated.  NF-kB  can  induce  the 
transcription  of  IFNp  (Lenardo  et  al.,  1989),  and  signalling  downstream  of  the 
interferon  receptor  also  results  in  the  activation  of  NF-kB  (Hoebe  et  al.,  2003b). 
Therefore,  the  possibility  of  secreted  interferon  acting  in  an  autocrine  manner  to 
mediate  the  induction  of the  10  commonly  upregulated  genes  in  DCs  responding  to 
different virus treatments was investigated.
Figure 5.8 Promoter analysis of the commonly upregulated genes in DCs responding to 
different virus treatments (next page)
Nucleotide  sequences  1000  base  pairs  5’  upstream  of the  10  commonly  upregulated  genes 
derived  from  Ensembl  (www.ensembl.org)  were  searched  for  consensus  binding  sites  for 
transcription  factors  NF-kB,  IRF-1,  ISGF-3  in  Transcription  Element  Search  Software  (TESS) 
Transfac  database  (http://www.cbil.upenn.edu/tess/).  Binding  sites  for  IRF-3  and  IRF-7  were 
analysed  individually with  sequences  from  (Yan  et  al.,  2004).  The  8  genes whose  upstream 
regions  contained  binding  sites  for  the  above  transcription  factors  are  shown.  Degenerate 
nucleotides indicated are as follows: W=A/T, N=A/C/G/T, S=C/G, Y=C/T.
229AP0BEC3B
MT3
UBE2L6
TNFRSF5
IFITM1
PSME2
DNAJA1
Consensus sequences
•   NF-kB  m   IRF1  IRF3/7  m   ISGF1/3
GGGAMTNYCC  CTTTCTCTTT  GAAASSGAAANY  CTTTCAGTTT
GAAWNYGAAANY  GCTTCAGTTT
TAP1 (-290)
(-943)
(-605)
(-607)
GGGGaAAGTCCC (R) 
GgAAAGTCCCC (R)
AAAGaGAAAG (R) 
GAAASSGAAANY
APOBEC3B (-263)
(-269)
CTTTCTCTTT
CTTTCTCTTT
MT3 (-95) AAACtGAAAG (R)
UBE2L6 (-500)
(-393)
TgGGGGCTTCCCC
AAAGAGAAAG (R)
CD40 (-106)
(-392)
(-500)
GGGAATtTTC
GGGAAtTTCC
GGGAATTTCC
IFITM1 (-519)
(-171)
(-135)
(-137)
GGGAATtTTC (R) 
GGAAANtGAAACT 
AAACTGAAAg (R) 
GAAWNYGAAANY
PSME2 (-13) CTTTCTcTTT
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5.3.2 Type I Interferon production by DCs
Type  I  interferons  (IFNa/p)  are  produced  in  large  quantities  upon  viral  infection  in 
many  different  cell  types,  and  directly  exert their  antiviral  functions  in  two  ways:  to 
induce antiviral activity in uninfected cells, and to induce apoptosis in infected cells. In 
this way, the  inhibition of viral replication and the selective  induction  of apoptosis  in 
virally  infected  cells constitute the first line of defence of the  immune  system  against 
viruses.  During  viral  infection,  transcriptional  induction  of  the  IFNa/p  genes  is 
achieved through the activation of two transcription factors of the interferon-regulatory 
factor  (IRF) family,  IRF-3 and IRF-7 (Lin et al.,  1998b; Sato et al.,  1998). The virus- 
induced  production  of  IFNa/p  transmits  signals  to  induce  numerous  target  genes, 
termed the IFN-inducible genes (or IFN-stimulated genes ISGs). This elicits an antiviral 
response  in  both  an  autocrine  and  paracrine  manner  (Stark  et  al.,  1998).  The 
mechanisms of transcriptional activation of the IFN-inducible genes have been studied 
extensively (Stark et al., 1998).
Dendritic  cells  have  been  heavily  investigated  in  terms  of their  ability  to  produce 
interferons,  their  responses  to  interferons,  and  the  variety  of  stimuli  for  interferon 
production  (Diebold  et  al.,  2003;  Tough,  2004).  Global  gene  expression  analysis has 
also identified genes that are induced in response to interferons in a variety of cell types, 
for example  in  epithelial  cells (Geiss et al.,  2003). The subset of 10  genes within the 
core  antiviral  response  identified  by  vector analysis  indicate the  possibility  that their 
transcriptional  induction  is  a result  of secreted  interferon  because  of the  presence  of 
interferon-related  transcription  elements  such  as  the  interferon-stimulated  response 
element (ISRE)  in the promoter regions of these  genes (Figure  5.8).  Furthermore, the 
transcription  factors  IRF-1,  ISGF-3  and  NF-kB  have  been  shown  to  be  induced  by 
interferons (Kessler et al.,  1990;  Sims et al.,  1993;  Yang et al.,  2000).  Therefore,  we 
assayed virus-treated DC culture supernatants over 24 hours for the presence of type I 
interferons.
Culture  supernatants  from  DCs  infected  with  Influenza,  exposed  to  inactivated 
Influenza,  Rhinovirus, and  inactivated Rhinovirus, were collected at 5 timepoints after 
virus  exposure.  Immunoassays  for  IFN(3  and  IFNa  (13  subtypes)  clearly  showed 
differential IFN production in DCs that is dependent on the virus stimulus (Figure 5.9).
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The  highest  levels  of  both  IFNa  and  IFNp  was  produced  by  DCs  responding  to 
inactivated  Influenza,  and  the  kinetics  of production  are  such  that  the  peak  of IFNp 
production  is  at  10  hours,  in  contrast  to  the  levels  of IFNa  which  steadily  increased 
over 24 hours.
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Figure 5.9 Production of IFNa and IFNp in DCs responding to different virus treatments
Type I  IFN was measured by two sandwich immunoassays, to detect 13 subspecies of IFNa (A) 
and  IFNp  (B).  DC  culture  supernatants  were  harvested  at  5  timepoints  after  virus  or  mock- 
stimulation  (2,  5,  10,  18,  24  hours).  Bars indicate the levels of IFN  (pg/ml) detected.  Error bars 
were derived from the standard deviations of triplicates performed in the assay.
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The  results  of the  type  I  Interferon  immunoassay  suggests  that  DCs  exposed  to  the 
different virus treatments do not all produce interferons to the same extent. DCs treated 
with  inactivated  Influenza  produce  the  most  IFNa;  the  levels  of IFNa  produced  are 
almost  7 times higher than the  levels produced  by  DCs exposed  to  Rhinovirus by  24 
hours. DCs exposed to the other virus treatments, Influenza and inactivated Rhinovirus, 
do  not  produce  significant  amounts  of IFNa  relative  to  control  mock-infected  DCs. 
Interferon-p  is  also  produced  to  the  highest  levels  in  DCs  exposed  to  inactivated 
Influenza, and the levels of IFNp reach maximum at  10 hours after virus exposure. In 
contrast,  DCs  exposed  to  other  virus treatments  do  not  produce  significant  levels  of 
IFNp.
Given that DCs exposed to the different virus treatments commonly upregulated the  10 
putative “antiviral” genes, the lack of correlation between levels of IFN production and 
the DC transcriptional  responses to viruses suggests the transcriptional  response to be 
independent  of secreted  type  I  IFN.  The  averaged  log2  expression  ratios  of the  10 
commonly  upregulated  genes  show  the  kinetics  of induction  of these  genes  in  DCs 
responding to Influenza and inactivated Influenza up to 5 hours after virus exposure are 
very  similar;  however,  the  induction  is  slower  for  DCs  responding  to  Rhinovirus 
(Figure 5.10A). This supports the hypothesis that the induction of these genes is specific 
to virus exposure,  rather than  dependent on  downstream  IFN  signalling as a result of 
secreted IFN from DCs. The induction of such antiviral genes may be a result of early 
events  in  virus  entry  that  activates  IRF-3,  which  has  been  shown  in  lung  Fibroblasts 
responding to a diverse range of enveloped viruses (Collins et al., 2004).
However, the data also suggest that whereas initial transcript induction (between 0 and 
5 hours) is independent of released IFN, the maintenance of gene expression (between 5 
and 24 hours) is related to released IFN (Figure 5.10A), and more specifically to IFNa. 
For example, DCs exposed to inactivated Influenza and Rhinovirus both produce IFNa, 
and  these  DCs  maintain  a  higher  level  of transcript  expression  of the  10  commonly 
upregulated  genes,  possibly  as  a  result  of IFN  autocrine  feedback  and  downstream 
signalling.  DCs  infected  with  Influenza  do  not  secrete  IFNa,  and  there  is  no  further 
upregulation of these transcripts after 5 hours.
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The  hypothesis of IFN  signalling  functioning at  later timepoints  may  be  illustrated  in 
the expression kinetics of known interferon-response genes that are clustered within the 
proposed  antiviral  cluster  (orange  dots  in  Figure  5.7).  These  genes  include  STAT1, 
IRF2,  2’5’-oligoadenylate  synthetase  1   (OAS1),  and  N-myc  and  STAT  interactor 
(NMI). These have all  been  shown to be induced by type I  interferons (Benech et al., 
1987; Lebrun et al.,  1998; Shuai et al.,  1994; Zhou et al., 2000). While the induction of 
the transcripts (between 0 and 5 hours) of interferon response genes is similar to the 10 
commonly upregulated genes, being rapid for DCs exposed to Influenza and inactivated 
Influenza,  but delayed  for Rhinovirus,  the  levels of IFN-response  genes after 5  hours 
show  the  same  interferon-dependency  seen  for the  10  commonly  upregulated  genes. 
The  effects of IFN  signalling  can  be  seen  in  the  higher  levels of expression  of IFN- 
response  genes  in  DCs  treated  with  UV-lnfluenza  at  5  hours  to  10  hours.  These 
transcripts  steadily  increase  over  24  hours,  reflecting  increasing  amounts  of  IFNa 
detected in culture supernatants samples of DCs exposed to inactivated-Influenza. In the 
case of replication-competent Influenza, the initial burst of transcript induction of IFN- 
response genes is not maintained. Finally, for DCs exposed to Rhinovirus, after a delay 
in transcript induction, the level of expression is maintained at later timepoints.
Taken  together,  the  data  suggests  that  induction  of this  proposed  antiviral  response, 
including upregulation of the 10 commonly upregulated genes in DCs responding to all 
three virus treatments, is downstream of early events of virus exposure and virus entry, 
and  is  not  induced  as  a  result  of IFN  feedback  signalling.  However,  secreted  type  I 
interferons  may  play  a role  in  the  maintenance  of this  antiviral  response,  where  IFN 
feedback signalling functions to sustain and amplify the transcript levels of these genes.
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Figure 5.10 Transcript expression of IFN-independent and IFN-dependent genes
Normalised  log2  expression  ratios  of  (A)  the  10  commonly  upregulated  genes,  and  (B)  four 
characterised  interferon-response  genes  (indicated  in  Figure  5.7)  were  averaged  and  plotted 
over  time  to  show  their  expression  in  DCs  responding  to  Influenza  infection  (orange  ♦), 
inactivated Influenza (pink ■) and Rhinovirus (grey  A) exposure.
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The kinetics of induction of the proposed antiviral genes suggest that even though this is 
classified as a core antiviral response, there are still  subtle variations dependent on the 
initial  virus  stimulus.  The  similarity  in  the  antiviral  transcript  induction  in  DCs 
responding  to  Influenza  and  inactivated  Influenza,  compared  to  the  delayed  antiviral 
transcript  induction  in  DCs  responding  to  Rhinovirus,  suggests  that  this  is  a  virus- 
dependent effect. The delay is evident and consistent for all the genes in this antiviral 
cluster. Rhinovirus-exposed DCs also secrete lower levels of IFNa. This may suggest 
that  downstream  events  triggered  in  DCs  by  Rhinovirus  binding  and  subsequent 
endocytosis  is  slower  in  DCs,  and/or  induces  a  less  vigorous  antiviral  response 
compared to Influenza. It is still unclear whether Rhinovirus is capable of establishing a 
productive  infection  in  our  DC  system;  though  Rhinovirus  particles  could  not  be 
detected in DCs, there is still the possibility that Rhinovirus particles are produced but 
not  detected  by  the  antiserum  used.  Alternatively,  a  slower  induction  of  antiviral 
transcripts  may  suggest  a  slow  replication  cycle,  and  that  later timepoints  should  be 
investigated for detecting Rhinovirus replication in DCs.
In contrast, the absence of IFNa/p from culture supernatants of DCs infected with live 
Influenza  compared  to  treatment  with  inactivated  Influenza  suggests  that  virus 
replication events are responsible for suppressing IFN production or release from DCs. 
Measuring DC responses to Influenza and  inactivated Influenza over time has allowed 
replication-dependent  effects  to  be  detected.  As  differences  in  levels  of  antiviral 
transcript  expression  of the  10 commonly  upregulated  genes between  inactivated  and 
live Influenza only manifest after 5 hours, this suggests that Influenza replication events 
may be responsible for suppressing the production or release of IFN from DCs.
The microarray study of the Influenza- and  Influenza NS1  mutant-mediated effects on 
lung epithelial cells showed that mutations in the NS1  gene lead to enhanced antiviral 
gene  expression  of IFN  and  NF-icB-regulated  genes  during  Influenza  virus  infection 
(Geiss et al., 2002). This is in agreement with our results which showed marked type I 
IFN production and greater expression levels of IFN-response genes in DCs exposed to 
inactivated  Influenza compared  to  Influenza-infected  DCs.  This may  be explained  by 
the  ability  of NS1  to  inhibit  the  activation  of IRF-3  (Talon  et  al.,  2000),  and  PKR 
(Bergmann  et al.,  2000) by  sequestering dsRNA,  and  also  inhibit downstream NF-kB 
activation and type I IFN induction (Wang et al., 2000).
236Pathogen-specific dendritic cell effector functions
5.4  Differentially regulated genes
Even  in the core antiviral  response,  differential  transcriptional  regulation  of genes by 
DCs  responding  to  the  three  virus  treatments  was  already  evident.  This  strongly 
suggests that DCs are able to differentiate between virus stimuli. Analysis of genes that 
are classified  as differentially expressed  revealed TNFa  to  be  differentially regulated 
between DC responses to Influenza and Rhinovirus, and between responses to Influenza 
and inactivated Influenza (Appendices 7-9, see attached disk). TNFa is thought to have 
antiviral functions by synergising with interferons to mediate an antiviral state (Seo and 
Webster, 2002). It is also one of the key mediators in the immunopathology associated 
with Influenza infection (Cheung et al., 2002). Viruses that encode factors which target 
TNF-dependent activities, for example poxviruses that encode soluble versions of TNF 
receptors (Introduction  Section  1.2.3.2),  and a viral TNFR  gene encoded  by  myxoma 
virus  (Schreiber  et  al.,  1996),  also  supports  an  antiviral  role  for  TNFa.  Models  of 
adenovirus infection in mice have also indicated the importance of TNFa in mediating 
early DC maturation and the activation of the ThI  pathway (Trevejo et al., 2001).
TNFa is found in a cluster with NF-kB responsive genes identified in  Section 4.7.3.7 
(Figure  5.11).  There  are  many  known  inducers  of NF-kB  activity,  including  TNFa 
itself, IL-1  and TLRs (Introduction Section  1.1.4). The clustering of TNFa and NF-kB, 
additional  components downstream  of the TNFa  and NF-kB  signalling pathway  (e.g. 
TANK,  TRAF1),  and  NF-KB-activated  genes  (e.g.  BIRC3,  CD83,  ICAM-1),  suggest 
that this  cluster may  represent the TNFa  signalling  pathway  leading  to  activation  of 
NF-kB  and downstream  responses.  However,  Influenza,  Rhinovirus,  and dsRNA  may 
also induce NF-kB activity independently of TNFa (Alexopoulou et al., 2001; Ronni et 
al.,  1997;  Zhu  et  al.,  1996).  Vector  analysis  also  showed  NF-kB  to  be  differentially 
regulated  in  DCs  exposed  to  different  viruses  (Appendices  7-9,  see  attached  disk). 
Therefore, TNFa transcript expression and production in DCs exposed to different virus 
treatments  was  investigated  by  real-time  RT-PCR  and  TNFa  immunoassay 
respectively.
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Figure 5.11 Virus-specific gene regulation in the NF-kB gene cluster
Cluster  of  genes  in  the  NF-kB  cluster,  strongly  upregulated  by  DCs  exposed  to  dsRNA  and 
Influenza,  variably  upregulated  by  DCs  exposed  to  inactivated  Influenenza,  and  showing 
minimal change in expression in DCs exposed to Rhinovirus. Genes in blue are associated with 
NF-kB signalling and NF-KB-induced genes
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5.4.1  Production of TNFa by DCs
To measure the transcript levels of TNFa, real-time RT-PCR was performed using the 
Taqman  system. The correlation between TNFa transcript  levels as  seen  by real-time 
RT-PCR  and  microarrays  is  shown  in  Figure  5.12,  comparing  raw  background- 
corrected signal intensities of sample (Cy5) TNFa from the microarrays to fold changes 
in TNFa transcript compared to timepoint zero by RT-PCR. It should be noted that the 
signal intensities for the TNFa duplicate spots for the array of Influenza-infected DCs 
at  10 hours post-infection (t=l 0) are not consistent, indicative of a noisy spot in one of 
the duplicate spots (circled in Figure  5.12C,  5.13). However, this  inconsistency  is not 
seen in the other virus arrays, as the signal intensities for the TNFa duplicate spots are 
all  in  good  agreement  (Figure  5.12C).  When  this  discrepancy  is  taken  into 
consideration, the raw Cy5  signal  intensities for TNFa  in the virus arrays shows high 
correlation between microarray and real-time RT-PCR results for the TNFa transcripts 
(Figure  5.13).  DCs  infected  with  Influenza  accumulate  the  most  TNFa  transcript 
between  0  and  2  hours,  which  then  decreases.  DCs  exposed  to  inactivated  Influenza 
accumulate the most TNFa transcript between 2 and 5 hours, which then also decreases. 
There is lower TNFa expression in DCs exposed to Rhinovirus, as shown by lower Cy5 
signal intensities and RT PCR transcript levels, although the relative levels are less well 
correlated.
The difference  in the “absolute”  levels of TNFa transcript  measured,  either as  signal 
intensities  by  microarrays  or calculated  fold  changes  compared  to  timepoint zero  by 
real-time  RT-PCR  may  reflect  the  larger  dynamic  range  of  real-time  RT-PCR  in 
measuring  transcript  levels.  However,  comparison  of the  kinetics  of TNFa  transcript 
accumulation  in  DCs  exposed  to  different  virus  treatments  over  time  show  much 
similarity between microarray results and real-time RT-PCR (Figure  5.13). The  levels 
of TNFa  protein were also determined by a sandwich  immunoassay (Methods Section
2.7.1)  which correlated with real-time RT-PCR results (Figure 5.14).
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Figure 5.12 Microarray data for TNFa
A  TreeView  visualisation  of  normalised  log2  expression  ratios  for  duplicate  copies  of  TNFa 
across  18 virus arrays,  showing  pseudocoloured  representation of up- (red) and  down- (green) 
regulation of TNFa in DCs responding to different viruses over 24 hours.
B  Corresponding  line  graphs  of  the  averaged  normalised  log2  expression  ratios  for  TNFa 
across  virus  arrays,  showing  expression  of  TNFa  in  Influenza-infected  DCs  (orange), 
inactivated  Influenza-exposed DCs (pink), and Rhinovirus-exposed DCs (grey).
C  Corresponding  raw  signal  intensity  values  for  Cy5  (sample)  values  of  TNFa  of  the  virus 
arrays.  Raw  signal  intensity  values  for  Cy5  (the  fluorophore  with  which  the  sample  RNA  is 
labelled)  TNFa  were  plotted  for  each  of  the  duplicate  spots,  in  virus-treated  DC  arrays 
(Influenza  -   orange,  inactivated  Influenza  -   pink,  Rhinovirus  -   grey).  Comparison  between 
signal  intensity  of the  duplicate  spots  indicates  the  duplicate  spot  correlation  or  background 
noise associated  with the  particular spot.  The  red  circle indicates the lack of correlation  in the 
duplicate spots for TNFa in the array hybridised with Influenza-infected DCs at 10 hours.
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Figure 5.13 Comparison between microarray and real-time RT PCR data for TNFa
The sample raw Cy5 intensity values for the  18 virus-treated  DC arrays from  Figure 5.12C are 
shown on the left, compared to real-time Taqman results for TNFa on the right. This shows the 
transcript expression of TNFa in virus-treated DCs over time in response to Influenza (orange), 
inactivated  Influenza (pink), and Rhinovirus (grey) as measured by microarrays and by real-time 
RT-PCR. Transcript levels for TNFa from real-time RT PCR results are derived from calculated 
fold-changes in TNFa transcript compared to levels of TNFa at 0 hours in corresponding virus- 
treated DCs.
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5.4.1.1  Production of TNFa by DCs exposed to Influenza
At  the  transcript  and  protein  level,  both  live  Influenza  and  inactivated  Influenza 
stimulate DCs to upregulate TNFa transcript which results in the release and detection 
of TNFa  in DC culture supernatant (Figure 5.14). The kinetics of transcript induction 
and the absolute levels of TNFa transcript between Influenza and inactivated Influenza 
treatment differ. Inactivated Influenza triggers a slower induction of TNFa transcript in 
DCs,  which  reaches peak  levels at  5  hours post-exposure.  In  contrast,  live  Influenza 
rapidly  induces  TNFa  transcript  in  DCs  reaching  a  maximum  level  2  hours  post­
infection (Figure 5.14A). DCs exposed to inactivated Influenza induce higher levels of 
TNFa transcript, almost 2-fold more than DCs infected with Influenza. This difference 
in  levels  of TNFa  transcript  translates to  levels  of TNFa  protein  production  that  is 
detected in culture supernatants. DCs exposed to inactivated Influenza produce almost 
2.5 times more TNFa compared to DCs infected with Influenza. In contrast to different 
transcript  induction,  the  kinetics  of TNFa  protein  production  is  very  similar  in  DCs 
exposed to live and inactivated Influenza, where peak levels of TNFa are detected at 10 
hours  post-virus  exposure.  However,  at all  times,  inactivated  Influenza exposed  DCs 
produced more TNFa protein (Figure 5.14B). The lower levels of TNFa transcript and 
protein  in  Influenza-infected  DCs  is  consistent  with  Influenza  downregulating  host 
cellular  responses  including  TNFa  secretion,  thereby  downmodulating  its  antiviral 
activity. The lower levels of TNFa production in Influenza-infected DCs compared to 
inactivated Influenza support the antiviral role of TNFa, over its role in contributing to 
Influenza  pathogenesis  (Nain  et  al.,  1990;  Seo  and  Webster,  2002).  However,  lower 
levels of IFNa/(3 production are also observed in Influenza-infected DCs. Whether this 
is a specific inhibition of the release of antiviral cytokines such as type I interferons and 
TNFa mediated by Influenza, or whether it is a broad response of Influenza to inhibit 
translation of cellular mRNAs in favour of translating viral mRNAs, is unclear from this 
data.
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5.4.1.2  Production of TNFa by DCs exposed to Rhinovirus
DCs  exposed  to  Rhinovirus  and  inactivated  Rhinovirus  also  induce  some  TNFa 
transcript, but to a much lower level (Figure 5.14A). Similar to the production of IFNa, 
DCs exposed to Rhinovirus  induce TNFa  transcript and  protein  with  slower kinetics 
compared to Influenza-infected and inactivated Influenza-exposed DCs. This transcript 
induction  of TNFa  in  Rhinovirus-exposed  DCs  translates  to  small  levels  of TNFa 
production  in  culture  supernatants,  which  reaches  peak  levels  at  10  hours  post-virus 
exposure (Figure 5.14B). The delayed kinetics is evident, as Rhinovirus-exposed DCs 
produce the most TNFa between  5  to  10 hours, compared to Influenza-exposed DCs 
which  produce  the  most  TNFa  between  2  to  5  hours  (Figure  5.14B).  The  initial 
induction  of TNFa  transcript  in  DCs  exposed  to  inactivated  Rhinovirus  does  not 
translate to TNFa protein production, with TNFa levels similar to control unstimulated 
DC culture supernatants.
Overall,  it  is  clear that  in  DCs  exposed  to  purified  virus  preparations,  the  levels  of 
TNFa transcript and protein are differentially regulated. Considering both the reduction 
of TNFa  production  and  the  lack  of IFNa/p  production  in  Influenza-infected  DCs 
compared to inactivated Influenza, this suggests a hierarchy  in the relative importance 
of suppressing  functions  of particular  cytokines  in  order  for  Influenza  to  establish 
infection. There is a complete suppression of IFNa/p production, while levels of TNFa 
are  reduced  in  Influenza-infected  DCs  compared  to  DCs  exposed  to  inactivated 
Influenza. The Influenza NS1  protein can sequester dsRNA and inhibit the activation of 
IRF-3  (Talon  et  al.,  2000),  PKR  (Bergmann  et  al.,  2000)  and  NF-kB  (Wang  et  al., 
2000), thereby preventing IFNa/p production. However, other aspects of the virus entry 
and  infection process may trigger activation of DCs and the subsequent production of 
TNFa  independently  of dsRNA.  The  absolute  levels  of TNFa  production,  higher  in 
DCs  exposed  to  inactivated  Influenza  compared  to  live  Influenza,  may  suggest  that 
Influenza broadly downmodulates host production of TNFa.
DCs  exposed  to  Rhinovirus  induced  TNFa  transcript  with  slower  kinetics.  This  is 
similar to the induction of the core antiviral genes and IFNa production. However, the 
production  of IFNa  and  TNFa  in  DCs  exposed  to  Rhinovirus  show  that  Rhinovirus 
does have a direct effect on DCs.
243Pathogen-specific dendritic cell effector functions
A
200
180
160
140
120
100
80
60
40
20
0 
0
TNFa
B
TNFa
pg/ml
1500
1000
500  -
0     ---
2  24
I j
Control  Influenza  UV-lnfluenza  Rhinovirus  UV-Rhinovirus
Figure 5.14 Transcript and protein measurement of TNFa 
A TNFa transcript levels as measured by real-time RT PCR
Buffy  coat  DCs  were  stimulated  with  the  different  virus  treatments,  or  mock-stimulated  with 
medium. At the indicated timepoints (0,  2,  5,  10,  18,  24 hours) following infection or exposure, 
DCs  were  harvested,  RNA  extracted,  and  reverse  transcribed  to  cDNA.  This  was  used  as 
template  cDNA  (50ng) for TaqMan  RT-PCR,  with  commercially  available Assays-On-Demand 
TNFa  primers  and  FAM-labelled  probe  (Materials  and  Methods  Section  2.6.2).  The  y-axis 
shows  fold  induction  of  TNFa  mRNA  compared  to  time  zero  for  each  virus  condition.  The 
colours correspond to the stimuli as indicated in B: control - blue, Influenza - orange, inactivated 
Influenza - pink, Rhinovirus - grey, inactivated Rhinovirus - purple.
B TNFa protein production as measured by ELISA
Culture  supernatants  from  DCs  stimulated  with  the  different  virus  treatments,  or  mock- 
stimulated, were harvested at the indicated timepoints (2, 5,  10,  18, 24 hours) following infection 
or  exposure.  TNFa  sandwich  immunoassay  was  used  to  detect  TNFa  (pg/ml)  in  the  culture 
supernatants.
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5.4.2  Differential production of chemokines and cytokines
Chemokines  and  cytokines  play  an  important  role  in  host  defense  against  virus 
infections.  Transcriptional  studies  of the  core  maturation  response  of dendritic  cells 
highlighted  the  importance  of the  regulation  of such  proteins  (Section  3.2.8.3)  for 
coordinating  the  downstream  immune  response.  The  transcriptional  regulation  of 
cytokines  and  chemokines  involve  a  large  number  of different  transcription  factors, 
including NF-kB (Pahl,  1999). Activation of DCs also leads to MAPK pathway activity, 
resulting in the formation of AP-1  (activating protein  1) transcription factor, consisting 
of Jun  and  Fos  homo-  and  heterodimers  (Curran  and  Franza,  1988).  Inflammatory 
cytokines such as TNFa and IL-6 also function  in an autocrine and paracrine fashion, 
resulting in downstream activation of NF-kB and transcription factors responsive to IL- 
6 (e.g. NF-IL-6 (also known as C/EBP(3) that binds to IL-6 response elements) (Akira et 
al., 1992).
A large number of chemokines and cytokines are target genes of NF-kB, AP-1, and NF- 
IL-6.  These  include  chemokine  (C-X-C  motif)  ligand  8  (CXCL8,  formerly known  as 
interleukin-8),  interleukin-6 (IL-6),  chemokine (C-C  motif)  ligand 2  (CCL2,  formerly 
known  as  monocyte  chemoattractant protein-1),  and  chemokine  (C-C  motif)  ligand  5 
(CCL5, also known as RANTES). Genome analysis of CXCL8, IL-6, CCL2 and CCL5 
reveal the presence of binding sites for NF-kB, AP-1  and NF-IL-6 transcription factors 
(Figure 5.15). As NF-kB was also differentially regulated by DCs (identified by vector 
analysis,  Appendices  7-9,  attached  disk)  in  response  to  the  virus  treatments,  the 
production of these NF-KB-downstream cytokines and chemokines were investigated
The FAST®Quant MicroSpot ELISA (Schleicher & Schuell BioScience, Germany) is a 
high  throughput  system  for  multiplex  cytokine  quantification.  The  FAST®Quant 
Human II  system  allows the detection  of 10 different cytokines:  CXCL8  (IL-8),  GM- 
CSF, IL-10, IL-lp, IL-12p70, IL-2, CCL2 (or MCP-1), IL-4, CCL5 (or RANTES), and 
IL-6. The 10 cytokines are spotted in triplicate, along with 6 “dummy” controls, making 
36  spots  per  reaction  pad.  Each  assay  consists  of 4  slides  containing  16  pads  each, 
making up a total of 64 pads. This allows the assay of 56 individual samples along with 
8 control samples (used to produce standard curves) allowing the simultaneous assay of 
10 different cytokines in triplicate (Materials and Methods Section 2.7.2).
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Of the  10 cytokines measured in the DC culture supernatants by this array system, the 
levels of GM-CSF and IL-4 detected were all above the maximum detection limit. This 
is due to the presence of GM-CSF and IL-4 in the culture medium of DCs. The results 
for  IL-lp,  IL-2,  IL-10  and  IL-12p70  were  equivocal  and  difficult  to  interpret.  In 
contrast,  Influenza  and  Rhinovirus  treatment  of  DCs  both  result  in  significant 
production of CXCL8, IL-6, CCL2 and CCL5.
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^   NF-kB 
GGGAMTNYCC
NF-IL-6
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TGASTMA
CXCL8 (-80) gGGAATTTCC
(-853) CTGGAA
(-752) CTGGAA
(-170) TTTCGTCA
IL-6 (-73) GGGAcTTTCC
(-762) CTGGGA
(-432) CTGGAA
(-745) GGGTCA
(-540) AGATGACT
(-284) CTGAGTCA
(-133) CCAATCA
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(-137) CTGGAA
(-953) TAACTCA
CCL5 (-590) AgGAAATTCC
(-53) GGAAAtTCCC
(-254) CTGGAA
(-361) TGACTCA
(-353) TGAGTAA
Figure 5.15 Promoter analysis of CXCL8, IL-6, CCL2, and CCL5
Nucleotide sequences 1000 bp 5’-upstream of the start codons (promoter regions) for the genes 
CXCL8,  IL-6,  CCL2 and  CCL5 were derived from  Ensembl  (www.ensembl.org) were searched 
for consensus  binding  sites  for transcription  factors  NF-kB,  NF-IL6  and  AP-1  in  Transcription 
Element Search Software (TESS) Transfac database.
The degenerate nucleotides indicated: M=A/C, N=A/C/G/T, S=C/G, Y=C/T.
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lnterleukin-1 p
Virus-exposed DCs do not seem to produce significant amounts of IL-lp compared to 
mock-infected DCs (Figure 5.16A). Studies in human monocytes show that stimulation 
with LPS results in the production of up to 3000 pg/ml of IL-lp between 4 and 8 hours 
post-stimulation (Kwak et al., 2000). Monocyte-derived DCs have also been shown to 
be  able  to  secrete  large  amounts  of IL-lp  (Ruppert  and  Peters,  1991),  both  at  basal 
levels and after stimulation with LPS  (Luft et al., 2002). The levels of IL-lp detected 
with  the  FAST®Quant  assay  system  in  all  DC  samples,  including  post  LPS-  and 
poly(I:C)-stimulation (data not shown), are much lower, only up to 80 pg/ml (Influenza- 
infected  DC  at 24h,  Figure  5.16A).  This result may reflect a limitation of the protein 
cytokine  assay  in  measuring  IL-lp.  It would therefore be  useful to verily this with  a 
traditional  immunoassy  for  IL-lp.  IL-lp  contributes  to  Langerhan  cell  migration 
(Cumberbatch  et  al.,  1997)  and  is  secreted  by  DCs  as  an  inflammatory  cytokine  in 
response to antigenic stimuli (Luft et al., 2002).
Interleukin-2
The  levels  of IL-2  production  in  the  dendritic  cell  supernatants  in  both  the  mock- 
infected  and  virus  treated  DCs  are  very  low,  and  IL-2  levels  cannot  be  consistently 
detected  above  background  levels.  The  low  levels  of  IL-2  measured  in  these  DC 
supernatants  may  also  be  attributed  to  a  limitation  of  the  assay,  similar  to  the 
measurement of IL-lp.
Recent microarray studies have identified strictly defined kinetics of IL-2 production in 
murine DCs in response to bacterial encounter (Granucci et al., 2001a), where early IL- 
2 transcript expression between 2 to 8 hours after bacterial encounter helps sustain the 
growth  of T,  B  and  NK  cells,  and  expression  during  the  late  phase  contributes  to 
regulation  of the  cell-mediated  response  by  promoting  activation-induced  cell  death 
(AICD)  of effector T  cells  (Granucci  et  al.,  2003b;  Van  Parijs  et  al.,  1999).  On  the 
protein  level,  peak  levels  of IL-2  between  4  and  10  hours  after  bacterial  encounter 
reached 200 pg/ml (Granucci et al., 2001a). The data here may also suggest a biphasic 
mode of IL-2 production in virus-exposed human DCs, but needs to be interpreted with 
caution.
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Figure 5.16 Production of IL-ip and IL-2 by DCs stimulated with viruses
DCs were  exposed  to  different viruses or mock-stimulated,  and the  culture  supernatants were 
collected  at  5  different  timepoints  (2,  5,  10,  18,  24  hours)  after  virus  stimulation.  Culture 
supernatants  were  assayed  for  (A)  IL-1 p  and  (B)  IL-2  production  by the  FAST®Quant  ELISA 
array system. The error bars indicate standard deviation from triplicate results.
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lnterleukin-10
The results for IL-10 production are difficult to  interpret for DCs exposed to live and 
inactivated Influenza, largely because of the large fluctuations at 24 hours and 10 hours 
post-virus  exposure respectively  (Figure  5.17A).  DCs  exposed to Rhinovirus  seem to 
actively downregulate IL-10 production, as there are significantly lower levels of IL-10 
in  Rhinovirus-exposed  DCs  compared  to  mock-infected  DCs  at  24  hours  (p=0.017, 
Figure  5.17A).  In  contrast,  DCs  exposed  to  inactivated  Rhinovirus  produce  higher 
levels of IL-10 at 24 hours post-virus exposure (p=0.021, Figure 5.17A). The difference 
in  IL-10  production  in  DCs  exposed  to  live  and  inactivated  Rhinovirus  supports 
differential  phenotypic  changes in  DCs responding to  live  and  inactivated Rhinovirus 
from Chapter 4. This suggests that even though there is no evidence that Rhinovirus is 
capable  of replication  in  DCs,  there  is  still  a  difference  in  DC  responses to  live  and 
inactivated Rhinovirus preparations.
IL-10 functions to sustain humoral  immunity by  inducing the production of the B cell 
chemoattractant CXCL13  in both myeloid and plasmacytoid DCs (Perrier et al., 2004), 
amplifying B cell recruitment in the initiation of an adaptive immune response. As DCs 
exposed  to  inactivated  Rhinovirus produce higher levels of IL-10 compared to mock- 
stimulated DCs, this suggests the difference between live and inactivated Rhinovirus is 
an ability to modulate subtle differences in IL-10 production.
Interleukin-12
The results for IL-12p70 are also difficult to interpret (Figure 5.17B). DCs exposed to 
the different virus treatments do not seem to produce much  IL-12 compared to mock- 
stimulated  control  DCs.  IL-12p70  is  an  important  cytokine  for  modulating  adaptive 
immune responses. IL-12 activates NK cells, induces the production of IFNy, promotes 
the  differentiation  of TH1   CD4+  T  cells,  and  is  therefore  a  critical  factor  in  viral 
immunity.  IL-12  is  secreted  by  dendritic  cells  and  macrophages  in  response  to 
pathogens. In the in vivo context, however, IL-12 production is enhanced by T cells due 
to the production of T cell-derived cytokines (IFNy and IL-4) as well as CD40L-CD40 
interactions (Trinchieri, 2003). The  lack of secondary  signals in this system may be a 
reason for the low levels of IL-12p70 detected.
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Figure 5.17 Production of IL-10 and IL-12 by DCs stimulated with viruses
DCs were  exposed  to different viruses or mock-stimulated,  and the culture supernatants were 
collected  at  5  different  timepoints  (2,  5,  10,  18,  24  hours)  after  virus  stimulation.  Culture 
supernatants  were  assayed  for  (A)  IL-10  and  (B)  IL-12p70  production  by  the  FAST^Quant 
ELISA  array  system.  The  error  bars  indicate  standard  deviation  from  triplicate  results.  Black 
asterixes indicate significance at p<0.021  compared to matching timepoints in mock-stimulated 
DC supernatants. P-values were calculated by the standard Student’s paired f-test.
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Chemokine (C-X-C motif) ligand 8
Virus-exposed  DCs produce significantly higher levels of CXCL8 compared to mock- 
infected DCs (Figure 5.18A). The detection  limit of the assay at 6000 pg/ml makes it 
difficult to distinguish between a plateau in levels of CXCL8 or whether production of 
CXCL8 still  increases. Evidence in the literature suggests that CXCL8 production still 
increases  after  24  hours  in  pulmonary  epithelial  cells  infected  with  Rhinovirus 
(Johnston et al.,  1998; Papadopoulos et al., 2001) and Influenza (Arndt et al., 2002).
The robust production of CXCL8 in DCs in response to Influenza and Rhinovirus seems 
likely to be a core response induced by virus contact and virus entry, and the similarity 
in  CXCL8  production  by  DCs  responding  to  live  and  inactivated  virus  preparations 
suggests  that  CXCL8  production  is  independent  of virus  replication.  CXCL8  is  also 
produced  by  DCs  stimulated  with  LPS  and  dsRNA  (Chapter  3,  Figure  3.18).  This 
suggests  that  production  of CXCL8  is  a  broad  acute  response  as  a  result  of  DC 
stimulation by pathogen components and viruses, via the activation of NF-kB and AP-1 
or NF-IL-6 transcription factors (Figure 5.15).
CXCL8  was  first  described  as  a  potent  neutrophil  chemotactic  factor,  promoting 
neutrophil  migration  across  endothelium  (Smith  et  al.,  1991b),  pulmonary  epithelium 
(Smart and Casale,  1993), and activates neutrophil degranulation and respiratory burst 
(Walz et al.,  1991). CXCL8 also activates basophils (Tanimoto et al.,  1992) and T cells 
(Lippert  et  al.,  2000).  CXCL8  can  be  produced  by  immune  cells  (monocytes,  DCs, 
macrophages, and neutrophils) (Badolato et al.,  1997; Kienast et al.,  1996; Konig et al., 
1996;  Verhasselt  et  al.,  1998)  and  stromal  cells  (endothelial  cells,  fibroblasts,  and 
epithelial cells) (Mauviel et al.,  1992;  Smart and Casale,  1993). CXCL8 production is 
induced  by  pro-inflammatory  cytokines  such  as  TNFa  and  IL-1  (Matsushima  et  al., 
1989), as well as by bacteria and viruses, including Rhinovirus and Influenza (Aihara et 
al.,  1997;  Johnston  et  al.,  1998;  Johnston  et  al.,  1997;  Matsukura  et  al.,  1996; 
Murayama et al.,  1997). The accumulation of CXCL8  at the  site of antigen encounter 
functions to recruit immune cells to this site and focuses the immune response.
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lnterleukin-6
Virus-exposed  DCs  produce  significantly  higher  levels  of interleukin-6  compared  to 
mock-infected  DCs  (Figure  5.18B).  Comparison  between  DCs  exposed  to  live  and 
inactivated Influenza suggest that live Influenza downmodulates the production of IL-6 
in  DCs.  The  levels  of IL-6  produced  from  DCs  exposed  to  inactivated  Influenza  are 
significantly  higher compared to  Influenza-infected  DCs.  This pattern  is also  seen  in 
DCs exposed to  Rhinovirus, where there are higher levels of IL-6 production  in DCs 
exposed to inactivated Rhinovirus compared to live Rhinovirus. The peak levels of IL-6 
produced at  10 hours in DCs exposed to live and inactivated Rhinovirus are higher than 
Influenza-infected  DCs, yet lower than  in  DCs exposed to  inactivated  Influenza. This 
suggests  that  live  Rhinovirus  in  DCs  does  not  vigorously  downmodulate  the  host 
response  to  IL-6  production  compared  to  live  Influenza,  and  that  both  live  and 
inactivated  Rhinovirus  may  not  be  as  immunogenic  as  inactivated  Influenza  in 
stimulating IL-6 production in DCs.
Interleukin-6  is  a pro-inflammatory cytokine that  plays  a central  role  in  host defence 
due  to  its  wide  range  of immune  and  haematopoietic  activities,  as well  as  its  potent 
ability to  induce the acute phase response (Poli  and Cortese,  1989).  Its broad-ranging 
effects reflect the key function of IL-6 as a systemic alarm  signal that recruits diverse 
host defence mechanisms in order to limit tissue injury. Here, IL-6 production by DCs 
in response to viruses is varied, depending on virus type.
IL-6 has been shown to be produced in lung fibroblasts infected with Rhinovirus (Zhu 
et al.,  1996), though this study found that UV-inactivated Rhinovirus did not induce IL- 
6 production  in lung fibroblasts. Details of UV-inactivation procedures are relevant, as 
prolonged exposure to UV-light destroys virus particles and their ability to bind to their 
cognate  receptors.  Extracellular  binding  assays  (Section  4.2.2)  show  that  Rhinovirus 
exposed  to  UV-light  for  20 minutes  are  unable  to  bind  to  DCs,  whereas  Rhinovirus 
exposed to UV-light for 2 minutes are able to bind to DCs, even though the titre is still 
effectively reduced by 6 logs (data not shown). Therefore, the lack of response reported 
in the literature for inactivated virus that infers cytokine secretion as dependent on virus 
replication should be interpreted in light of the inactivation procedure.
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Figure 5.18 Production of CXCL8 and IL-6 by DCs stimulated with viruses
DCs were exposed to viruses or mock-stimulated, and the culture supernatants were collected 
at  5  different  timepoints  after  (2,  5,  10,  18,  24  hours)  virus  stimulation.  Culture  supernatants 
were assayed for (A) CXCL8 and  (B)  IL-6 production by the FAST^Quant ELISA array system. 
The  error  bars  indicate  standard  deviation  from  triplicate  results.  Black  asterixes  indicate 
significance at p<0.001  compared to matching timepoints in mock-stimulated DC supernatants. 
Blue  asterixes  indicate  significance  at  p<0.0005  between  virus-treated  DCs  at  matching 
timepoints. P-values were calculated by the standard Student’s paired f-test.
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Chemokine (C-C motif) ligand 2
Production of CCL2 in DCs seem much more dependent on specific virus exposure than 
CXCL8 and IL-6. The levels of CCL2 produced in DCs exposed to live and inactivated 
Rhinovirus  are  twice  as  high  as  CCL2  produced  in  Influenza  exposed  DCs  (Figure 
5.19A).  DCs exposed  to  inactivated  Influenza  also  produce higher amounts of CCL2 
compared  to  Influenza-infected  DCs,  which  may  represent  an  active  process  of live 
Influenza  downmodulating  a  host  immune  response.  DCs  exposed  to  Rhinovirus 
produce higher levels of CCL2, and this response seems specific to Rhinovirus, and is 
not  necessarily  related  to  whether the  virus  is  live  or  inactivated.  This  link  between 
CCL2 production in DCs exposed to Rhinovirus has not been previously reported.
Formerly  known  as  monocyte  chemoattractant  protein  1   (MCP-1),  CCL2  specifically 
attracts  monocytes  and  memory  T  cells,  and  its  expression  occurs  in  a  variety  of 
diseases characterised by mononuclear cell infiltration such as atherosclerosis, multiple 
sclerosis and rheumatoid arthritis (Gu et al.,  1997). Its role in modulating the immune 
response is as yet unclear.  Phenotypes of CCL2 and  its corresponding receptor CCR2 
knockout  mice  are  disparate  in  adaptive  immunity,  where  CCL2  stimulates  Th2 
polarisation, and CCR2 activation stimulates ThI  polarisation (Daly and Rollins, 2003; 
Sato et al., 2000b). This may suggest a dose-response effect in that low levels of CCL2 
activating CCR2  may polarise a ThI  response, but high  levels of CCL2 may result in 
receptor desensitisation or saturation, and a resulting Th2 response. The production of 
CCL2  by  basal  epithelial  cells  also  recruits  immature  DCs  to  peripheral  tissue  sites 
(Vanbervliet et al., 2002), and its production at the site of pathogen encounter by DCs 
may  serve to further recruit immature DCs,  monocytes and  memory T cells from the 
blood  into  these  sites  to  amplify  the  immune  response.  CCL2  is  produced  to 
significantly  higher  levels  in  DCs  responding  to  Rhinovirus  compared  to  Influenza, 
which may suggest CCL2 to have a specific function in the interaction of host response 
and Rhinovirus.
Chemokine (C-C motif) ligand 5
Virus-exposed  DCs  secrete  significant amounts of CCL5.  DCs exposed to  inactivated 
Influenza  produce  more  CCL5  more  rapidly  compared  to  Influenza-infected  DCs 
(Figure  5.19B).  The  rate  of CCL5  production  in  Rhinovirus-exposed  DCs  is  slower 
compared to Influenza-exposed DCs. This is another indicator of the slower replication
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or  infectious  program  mediated  by  Rhinovirus  compared  to  Influenza  in  DCs,  and 
suggests  that  CCL5  production  in  live  and  inactivated  Rhinovirus-exposed  DCs  will 
continue  after 24  hours.  Rhinovirus  infection  of respiratory  epithelial  cells  show that 
CCL5 continues to be produced between 24 and 48 hours after infection (Papadopoulos 
et al., 2001).
Influenza- and Rhinovirus-exposure in DCs clearly result in the differential production 
of CCL5.  This  indicates  that  in  addition  to  its  role  in  the  core  maturation  response 
(Section  3.2.8.3),  CCL5  may  have  an  important  antiviral  role.  Influenza  actively 
downmodulates  this  host  response  by  decreased  CCL5  production  compared  to 
inactivated Influenza, which is not seen in the comparison between live and inactivated 
Rhinovirus. The trigger for CCL5 production may also be different, where the binding 
and  entry  of  Influenza  stimulates  vigorous  CCL5  production  (DCs  responding  to 
inactivated Influenza), whereas this occurs later in DCs responding to Rhinovirus.
CCL5  recruits memory Th cells,  eosinophils and monocytes (Schall et al.,  1990),  and 
has  been  demonstrated  to  be  involved  in  immune  responses  associated  with  viral 
diseases  (Gross  et al.,  2003;  Melchjorsen  and  Paludan,  2003).  There  is  evidence that 
type I IFN and TNFa may also induce CCL5 production (Cremer et al., 2002; Lane et 
al.,  1999), and the involvement of IRFs that bind to promoter regions of CCL5 (Casola 
et  al.,  2001;  Genin  et  al.,  2000)  further  support the  importance  of CCL5  in  antiviral 
immunity.  Both  Influenza and  Rhinovirus  infection  have  been  shown  to cause CCL5 
production  in  airway  epithelial  cells  (Kujime  et  al.,  2000;  Matsukura  et  al.,  1998; 
Schroth  et  al.,  1999),  and  bronchial  epithelial  cells  incubated  with  UV-inactivated 
Rhinovirus secreted significant amounts of CCL5 (Schroth et al.,  1999). Though CCL5 
contributes to antiviral immunity, in atopic patients with allergic airway disease, CCL5 
may exacerbate allergic  symptoms (Elliott et al.,  2004; John et al.,  2003; Tekkanat et 
al., 2002).
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Figure 5.19 Production of CCL2 and CCL5 by DCs stimulated with viruses
DCs were exposed to viruses or mock-stimulated, and the culture supernatants were collected 
at 5 different timepoints (2, 5,  10,  18, 24 hours) after virus stimulation. The culture supernatants 
were assayed for (A) CCL2 and (B) CCL5 production by the FAST®Quant ELISA array system. 
The  error  bars  indicate  standard  deviation  from triplicate  results.  The  black asterixes  indicate 
significance at p<0.001  compared to matching timepoints in mock-stimulated DC supernatants. 
The  blue  asterixes  indicate  significance  at  p<0.001  between  virus-treated  DCs  at  matching 
timepoints. P-values were calculated by the standard Student’s paired f-test.
256Pathogen-specific dendritic cell effector functions
Chemokines as effectors of dendritic cell responses to viruses
The  levels  of CXCL8,  IL-6,  CCL2  and  CCL5  production,  together with  IFNa/p and 
TNFa, suggest that upon  infection of DCs,  Influenza actively downmodulates the host 
response by consistently  suppressing the secretion of these cytokines and  chemokines 
(Table 5.3).  In comparison, DCs exposed to inactivated Influenza are able to mount a 
full robust immune response in secreting high  levels of IFNa/p, TNFa, CXCL8, IL-6, 
CCL2 and CCL5, without “interference” from replication-dependent events (Table 5.3). 
Studies have shown that Influenza virus NS1  protein is able to inhibit the activation of 
AP-1, NF-kB, IRF-3 and IRF-7 transcription factors (Ludwig et al., 2002; Talon et al., 
2000;  Wang  et al.,  2000).  These  results  suggest that replication-dependent events are 
responsible  for  a  dampened  cytokine  and  chemokine  response  in  DCs  infected  with 
Influenza compared to DCs exposed to inactivated Influenza. As shown in Figure 5.15, 
promoter regions of CXCL8, IL-6, CCL2 and CCL5  share NF-kB, AP-1  and NF-IL-6 
binding sites. Though  inactivated Influenza should still contain NS1  protein, Influenza 
replication results in much increased production ofNSl, which may explain differences 
in the levels of IL-6,  CCL2,  CCL5, TNFa,  and IFNa/p produced  between  Influenza- 
infected and inactivated Influenza-exposed DCs.
Both live and  inactivated Rhinovirus exposure in DCs result in DC activation in terms 
of cytokine secretion (Table 5.3) and cell surface phenotype (Table 4.2). Rhinovirus has 
been shown to activate transcription factors AP-1  and NF-kB, leading to production of 
CXCL8 in bronchial epithelial cells and the upregulation of ICAM-1  surface expression 
(Funkhouser et al., 2004; Papi and Johnston,  1999). Even though there is no evidence of 
Rhinovirus replication in DCs, differences between live and inactivated Rhinovirus are 
observed as varied DC responses. These differences can be a direct result of replication 
of Rhinovirus  in  DCs  causing  modulation  of host  responses,  where the  replication  is 
abortive or undetectable by the assays used here.
In  studies  involving Rhinovirus  infection  in  bronchial  epithelial  cells,  sampling  at 24 
and  48  hours  after  infection  showed  that  levels  of CXCL8  and  CCL5  continued  to 
increase after 24 hours following virus exposure (Papadopoulos et al., 2001; Schroth et 
al.,  1999). However, the levels of CXCL8 and CCL5 after incubation with RV16 for 48 
hours reported  in these studies were lower than the levels that DCs produced 24 hours 
following  virus  exposure.  Therefore,  the  differences  in  DC  responses  in  terms  of
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cytokine and chemokine production over 24 hours are probably indicative of early DC 
responses to live and inactivated Rhinovirus exposure, and the roles of CCL5 and CCL2 
in mediating host immune responses to Rhinovirus warrant further investigation.
Chemokines CXCL8, CCL2 and CCL5 have been shown to be important in mediating 
immunopathology in relation to pulmonary diseases (Maus et al., 2003; Mukaida, 2003; 
Rose  et  al.,  2003).  This  is  largely  due  to  their  chemotactic  properties  in  recruiting 
neutrophils (CXCL8), monocytes and T helper cells (CCL2 and CCL5) and eosinphils 
(CCL5),  leading  to  pathological  situations  characterised  by  chronic  inflammation. 
However, these studies focus on responses of stromal cells to infection and pathology. 
Dendritic cells also  secrete  large numbers of chemokines,  and the role of DCs  in the 
initiation  and  shaping  of the  adaptive  immune  response  make  chemokines  crucial 
effectors. The varied responses of DCs  in the production  of IFNa/p,  TNFa, CXCL8, 
IL-6, CCL2 and CCL5  demonstrate that DCs are also plastic  in their responses at the 
level of protein production that is tailored to the viral antigen (Table 5.3).
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Discussion
Transcriptional  plasticity  of dendritic  cell  responses  to  different  virus  stimuli  were 
further investigated. Initial hierarchical clustering analysis of DC responses to Influenza 
and  Rhinovirus,  inactivated  Influenza  and  dsRNA  suggest  that  DCs  are  able  to 
modulate  differential  gene  responses  depending  on  virus  stimuli.  Vector  analysis 
robustly identified subsets of differentially and commonly regulated genes. These genes 
were further explored by promoter analysis and investigated at the transcript and protein 
level.
Novel gene expression analysis method
Time-series analysis applied to microarray  data is an  area that has received  relatively 
little specific attention. Whereas statistical analysis methods for identifying differential 
expression  in  straightforward  binary  comparisons  are  plentiful,  including  SAM  and 
Mann-Whitney  U  methods  described  in  Chapter  3,  these  methods  do  not  take  into 
consideration  the  temporal  relationships  between  experimental  samples.  From  the 
microarray analysis of the dendritic cell “maturation” response, it is clear that temporal 
relationships  are  an  inherent  part of DC  function,  which  make  the  temporal  element 
crucial to analysing DC responses.
Hierarchical clustering of dendritic cell responses to different virus treatments revealed 
differential  responses  modulated  by  DCs  that  suggest  virus-specificity.  Though 
clustering  analysis  has  provided  potentially  meaningful  clusters  that  can  be  further 
explored,  the  limitations  of this  method  for  identifying  commonly  and  differentially 
regulated  genes means only a broad overview through pattern  finding  is achieved. To 
further identify genes that may be important in differentially regulating DC responses to 
viruses,  a  method  that  incorporates  the  temporal  relationship  between  experimental 
samples was developed.
Commonly and differentially regulated responses were identified using a novel analysis 
method  that  involved  modelling  gene  expression  changes  over  time  as  multi­
dimensional  gene  vectors.  The  number  of dimensions  correlates  to  the  number  of 
timepoints  per  virus  treatment  (i.e.  6  timepoints  over  24  hours  transforms  into  a  6- 
dimensional  gene  vector).  As  each  timepoint  is  a  dimension  of the  gene  vector,  this
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allows  the  temporal  relationship  between  experimental  samples  that  relate  to  gene 
expression changes to be considered as an inherent property of the gene vector (i.e. gene 
expression),  so  that  the  temporal  aspect  of  the  data  is  retained.  Modelling  gene 
expression  ratios  as  vectors  is  advantageous  because  it  offers  flexibility  in  the 
dimension of vectors that is analysed  (no  limitations on timepoints),  and  allows user- 
defined  filtering criteria (vector angles and vector magnitudes). However,  a drawback 
of this  analysis  method  is  that  aberrantly  variable  data  points  (from  inconsistent 
microarray  signal  measurements)  would  result  in  a  vector  which  when  compared  to 
other vectors may give a falsely large vector angles. Vector magnitude is analogous to 
the  standard  deviation  measurement  used  here,  though  this  measurement  is  also 
sensitive to poor quality microarray spots. This indicates the importance of confirming 
original microarray data (Figure 5.12).
The scalability of this vector analysis method in its ability to capture high dimensional 
data  also  offers  the  option  of modelling  experimental  vectors  in  addition  to  gene 
vectors.  An  experimental  vector  captures  the  same  information  contained  in  a 
scatterplot of gene vectors, and is subsequently of higher dimension. As experimental 
profiles are added to a microarray dataset, where the number of genes remains fixed, 
plotting  experimental  vectors  allows  more  effective  visualisation  of the  relationship 
between experiments.
Vector  modelling  allowed  the  use  of vector  angles  as  a  metric  for  gene  expression 
correlation  over time, and the magnitude of gene expression  changes over time to be 
assessed  by  standard  deviations.  This  method  is  robust  in  that  commonly  correlated 
genes with  small vector angles are identified that correlate to genes that are clustered 
together with high correlation coefficients by hierarchical  clustering  in  Chapter 4. An 
additional advantage of this vector method of analysis is that it allows flexibility in the 
subsets of genes that are identified as commonly and differentially regulated, based on 
the criteria of vector angles. If a cut-off for common regulation  is less stringent,  i.e. a 
larger vector angle  is considered,  then the  subset of genes  identified  as  co-expressed 
will  be  larger,  though  this  may  incorporate  more  “noise”  in  the  common  regulation 
profile.  Conversely,  the  subset  of differentially  regulated  genes  will  be  smaller,  and 
more  robust.  This  flexibility  of vector  angles  allows  tailoring  a  cut-off value that  is 
suitable for the analysis. In addition, standard deviation filtering allows the selection of 
genes that change expression significantly with time. The measure of standard deviation
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is  an  extension  from the  magnitude metric that  is  also considered  in  modelling  gene 
expression as vectors, but allows the measure of magnitudes to relate to individual gene 
vectors and not the relationship between two vectors.
Differential production of cytokines and chemokines
Vector  analysis  identified  a  set  of  10  genes  that  are  commonly  upregulated  on  the 
transcript  level  in  DCs  in response to  all  three  different  virus treatments -  Influenza 
infection,  inactivated Influenza exposure, and Rhinovirus exposure. These genes were 
also clustered together in the proposed antiviral cluster identified in Section 4.7.3.2. Co­
expression  of  genes  suggest  co-regulation  by  common  transcription  factors,  and 
promoter  analysis  showed  the  presence  of NF-kB,  IRF-1,  IRF-3,  IRF-7  and  ISGF-3 
binding sites that are probably most relevant to modulating the antiviral response (Katze 
et al., 2002;  Li and Verma, 2002; Pfeffer et al., 2004; Taniguchi et al., 2001). Type I 
interferons are known to activate these transcription factors, and the hypothesis of IFNs 
mediating  the  activation  of common  transcription  factors  which  upregulated  the  10 
commonly upregulated genes was tested. This was shown to be incorrect, as the levels 
of IFNa/p detected  from  dendritic cells exposed to viruses were variable and did not 
correlate  to  the  common  transcriptional  upregulation  of the  10  genes.  IFNa/p  levels 
may, however, be involved in the maintenance of the antiviral response. This strongly 
suggests that this core response is most likely independent of de novo protein synthesis, 
and  its induction a response to core viral motifs that are recognised by dendritic cells 
and commonly triggered by viruses.
A large number of differentially responsive genes were identified, including TNFa and 
NF-kB. TNFa has been shown to be critical in affecting DC maturation in response to 
virus infection and downstream activation of adaptive immunity (Trevejo et al., 2001). 
Other cytokines and chemokines activated by NF-kB were also investigated. Influenza 
seems to commonly  modulate a downregulation  in cytokine production  from  DCs,  in 
contrast to the vigorous  response stimulated by  inactivated  Influenza.  This difference 
between  live  and  inactivated  virus  exposure  is  less  clear  for  Rhinovirus.  However, 
responses  of DCs  to  Rhinovirus  are  clearly  different  to  those  induced  by  Influenza, 
including  the  absolute  levels  of cytokines  produced  and  rate  of cytokine  production. 
This temporal delay of induction of DC responses to Rhinovirus should be addressed by
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monitoring cytokine production at later timepoints, in order to allow for delayed effects. 
The  possibility  of Rhinovirus  replication  in  DCs  should  not  be  excluded,  as there  is 
clearly a robust response to Rhinovirus exposure, and further investigations are needed 
to  determine  Rhinovirus  replicative  capacity  in  DCs,  or  if Rhinovirus  establishes  an 
abortive infection in DCs.
Both  live  and  inactivated  Rhinovirus-exposed  DCs  produce  high  levels  of  CCL2, 
significantly  higher  than  the  levels  produced  by  Influenza-infected  and  inactivated 
Influenza-exposed  DCs.  The  production  of CCL2  from  DCs  has  not been  previously 
reported, and suggests a mechanism for monocyte and DC recruitment from the blood 
to the site of Rhinovirus encounter to further amplify the immune response. Additional 
downstream  effects  of  CCL2  should  also  be  further  investigated,  as  it  may  have 
important implications for shaping downstream adaptive immunity. Rhinovirus-exposed 
DCs  also  produce  high  levels  of  CXCL8,  IL-6  and  CCL5.  In  contrast  to  other 
respiratory viruses (e.g. Influenza and adenovirus), it is believed that the manifestations 
of  Rhinovirus-induced  pathogenesis  are  the  result  of  virus-induced  mediators  of 
inflammation  (Zhu  et  al.,  1996)  rather than  direct  cytotoxic  effects  (Johnston  et  al., 
1993).
Rhinovirus  infection  account  for  80%  of acute  asthma  exacerbations  in  school-aged 
children  and  half of all  asthma  exacerbations  in  adults  (Yamaya  and  Sasaki,  2003). 
Numerous reports in the literature have shown that cytokines are produced in abundance 
in  Rhinovirus-infected  bronchial  and  pulmonary  epithelial  cells,  and  the  resulting 
recruitment  and  activation  of  effector  cells  such  as  neutrophils,  eosinophils  and 
basophils to the airway mucosa is thought to contribute to the exacerbation of asthma 
(Papadopoulos et al., 2004). Interestingly, CCL2 is elevated in the airways of asthmatics 
(Sousa et al.,  1994), and is thought to be involved in the chain of inflammatory events 
that promotes airway remodelling in asthma. Rhinovirus infection of asthmatic patients 
probably exacerbates the already present hyperreactivity and  inflammatory response in 
asthmatic  airways,  and  acts  as  a  trigger  in  susceptible  patients.  Whether the  asthma 
exacerbation  is  primarily  caused  by  the  viral  infection  resulting  in  the  heightened 
inflammatory environment  in the airways,  or is secondary to the delayed clearance of 
the viral  infection as a result of the Tn2-bias of the immune response of atopic patients 
is unknown.
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Further investigations into functional DC plasticity in recognising different viruses, and 
how  viruses  interact  with  DCs,  will  allow  insight  into  differential  adaptive  immune 
responses  that  are  initiated  by  DCs  in  response  to  viral  pathogens.  Cytokines  and 
chemokines  are a  link  between  cells of the  innate  and  adaptive  immune  system,  and 
have wide-ranging effects. Understanding how they are differentially regulated by DCs 
may provide an avenue for their modulation in therapeutics in order to affect clearance 
of viral infections.
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Chapter 6 
Summary and directions for future research
In this thesis I  have used DNA arrays to explore transcriptional  plasticity in dendritic 
cell  responses to  simple and complex antigens. The antigens used ranged from  single 
pathogen  components  to  two  different  RNA  viruses  which  differ  in  their  virion 
architecture and their capacity to establish infection in DCs.
The in vitro response of dendritic cells to antigens can be extrapolated to reflect the in 
vivo  initiation  of the  wider  immune  response.  The  complexity  of this  response,  the 
nature of which is dependent on the specific antigenic stimulus and the context in which 
the  antigenic  stimulus  is  met,  is  in  part  revealed  by  transcriptional  profiling. 
Furthermore, sampling DC maturation at discrete timepoints can elucidate the temporal 
aspects of the evolution of the immune response to antigen. Consequently, to achieve a 
more  complete  model,  consideration  of the  temporal  and  environmental  context  is 
necessary for the understanding of dendritic cell function.
6.1  Transcriptional states reflect biological function
Dendritic  cell  responses  to  component  antigens  LPS  and  dsRNA  showed  distinct 
cascades of transcriptional regulation, which corresponded to temporally distinct stages 
of dendritic  cell  maturation  comprising  of activation  and  differentiation,  as  well  as 
dendritic cell specific functions (Figure 3.31). The various stages of DC maturation also 
reflect  their  migration  from  the  periphery  where  the  antigens  are  first  encountered, 
initial  DC  effector  responses  which  further  recruit  innate  cells  to  the  site  of antigen 
encounter,  and entry  into draining lymph nodes where adaptive immune responses are 
initiated.  Transcriptional  states  of  maturing  dendritic  cells  therefore  reflect  the 
generation of the innate and adaptive immune response both  in time and place (Figure 
6.1).  The  contribution  of  the  temporal  and  spatial  context  to  the  dendritic  cell 
maturation response is therefore inherent in the consideration of the downstream effects 
of dendritic cells to initiate the adaptive immune response. However, questions remain 
as to how  much  of this process of activation  and differentiation  is pre-programmed  in 
DC biology and function, and how much is influenced by the type of antigenic stimuli
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encountered,  and  the  context within  which  such  an  immune  response  is  initiated? In 
other words, are differences seen when different maturation stimuli are used?
6.2  Relevance of maturation stimuli
Culture systems that generate mature DCs from  immature precursors generally induce 
maturation by the addition of TNFa, CD40 ligand (CD40L, or TNFSF5), a combination 
of inflammatory  cytokines,  or  conditioned  medium  (Kato  et  al.,  2001;  Reddy  et  al., 
1997).  CD40  ligand  is  expressed  on  T  cells,  and  its  interaction  with  CD40  on  DCs 
functions to enhance the DCs’  capacity to stimulate T cells via the upregulation of co­
stimulatory molecules and cytokine secretion  (Celia et al.,  1996;  Schulz et al., 2000). 
However,  CD40  ligation  in  immature  DCs  in the  absence of priming  from  microbial 
stimuli does not determine the type of DC responses (Edwards et al., 2002), and the role 
of CD40L is probably limited to amplifying innate DC responses that are determined by 
the microbial signal. In addition, DCs do not generally undergo CD40 ligation until they 
are  in  draining  lymph  nodes  and  interacting  with  T  cells,  which  questions  the 
appropriateness of CD40L as a maturation stimulus for DCs.
TNFa  stimulation  of immature  DCs  does  not  result  in  terminal  DC  maturation,  but 
induces  only  a  transient  activated  state  (Nelson  et  al.,  1999).  This  demonstrates that 
inflammatory  cytokines  may  not  necessarily  cause  DCs  to  differentiate  into  mature 
antigen presenting cells, and the appropriateness of maturation stimuli also needs to be 
considered.  The  concept  of conditioned  medium  is  interesting,  as  it  considers  the 
context  in  which  DCs  reside  and  are  stimulated,  implying  the  factors  in  such 
conditioned  medium  derived  from  various  immune  cells  should  more  closely  mimic 
physiological  states.  However,  the  difficulty  in  knowing  the  precise  composition  of 
conditioned  media  and  issues  with  consistency  currently  limit  the  value  of such  an 
approach.
The  relevance  of maturation  stimuli  is  of central  importance,  as  DCs  stimulated  to 
mature with cocktails of inflammatory cytokines in the absence of pathogenic  stimuli 
may actually mimic a detrimental maladaptive immune response similar to that seen in 
autoimmunity.  In  multiple  sclerosis,  IFNp therapy has been  shown to be beneficial  in 
ameliorating  the  detrimental  ThI-biased  responses that  results  in  the  immune  system
265Summary and directions for future research
targeting oligodendrocytes in the central nervous system. This is in contrast to IFN(3’s 
well-recognised role in inducing ThI-biased antiviral immunity. This paradoxical effect 
is  linked to the timing of IFN(3 exposure,  where the presence of IFN(3 during TNFa- 
induced  DC  maturation  strongly  augments  ThI-differentiation  of  naive  Th  cells, 
whereas the presence of IFN(3 during mature DC-mediated primary stimulation of naive 
Th  cells has the  opposite effect  of inhibiting ThI  cell  polarisation  and  promoting the 
generation of a IL-10-secreting T cell subset (Nagai et al., 2003). This study emphasises 
the importance of the timing in which immune cells are exposed to cytokines within the 
framework  of the  generation  of the  immune  response,  where  cytokines  may  have 
conflicting  polarising  effects  that  may  not  be  obvious  if temporal  aspects  are  not 
considered.
Figure 6.1  Schematic representation of the dendritic cell response to antigen
1)  Bone  marrow  progenitors  giving  rise  to  DC  precursors  migrate  from  the  bone  marrow  to 
peripheral sites such as the skin or mucosa.  Here,  precursors differentiate into immature DCs, 
their  properties  and  location  optimised for antigen  capture.  2) Antigens  such  as  viruses  may 
enter the body at breaches in barrier sites such as mucosae.  DCs at such sites can capture the 
viruses,  and  may  be  susceptible to  virus  infection.  3)  Soon  after  activation  by  viruses,  either 
viral  infection  or  surface  interaction  with  viruses,  early  activated  DCs  secrete  a  variety  of 
effector cytokines such as TNFa,  CXCL1  and CXCL2,  and CXCL8. These early activated DCs 
also modulate expression of cytoskeletal genes to begin their migration out of the periphery. 4) 
The secreted cytokines serve to further recruit additional innate cells from the blood to the site 
of antigen encounter.  5) Transitional DCs further secrete additional cytokines and chemokines, 
which  may signal  in  autocrine and  paracrine ways to amplify signalling  pathways and activate 
transcription factors that contribute to  DC  differentiation  and  maturation,  and further influence 
the surroundings e.g. establishing an antiviral state through the action of IFNa/p. 6) Mature DCs 
finally reach the draining lymph nodes, and are fully differentiated and optimised to interact with 
T cells to initiate the adaptive immune response.
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6.3  Transcriptional regulation of signalling pathways
Components  of the  mitogen-activated  protein  kinase  (MAPK)  cascade,  an  important 
signal transduction pathway affecting dendritic cell activation and differentiation, were 
differentially  regulated  during  dendritic  cell  maturation.  p38  is  clearly  involved  in 
aspects  of DC  activation  and  maturation,  including  activation  of transcription  factors 
and  upregulation  of surface  expression  of co-stimulatory  molecules  (Ardeshna et  al., 
2000; Arrighi et al., 2001). It has also been shown that p38 modifies chromatin structure 
by phosphorylation of histone H3, and regulating NF-kB recruitment to selected targets 
including  inflammatory  and  immune  response  genes  (Saccani  et  al.,  2002). 
Furthermore,  transcriptional  downregulation of the p38 pathway  at the  later stages of 
DC  maturation  implies that there  is a specific window of time where enhancement of 
NF-kB recruitment to inflammatory genes is required, namely the early activation stage. 
Modification of the chromatin environment of specific genes by p38 adds an additional 
regulatory  level  to  transcriptional  activation  of inflammatory  and  immune  response 
genes that needs to be tightly regulated.
It may be interesting to speculate that other members of the MAPK family that are co- 
ordinately  activated  downstream  of  microbial  and  inflammatory  stimuli  may  also 
function  to  modify  chromatin  structure  and  regulate  transcription  of specific  genes. 
Inhibitors of p38 and ERK could be used in conjunction with microarrays to map such 
genes  that  undergo  chromatin  modification  allowing  transcription  factor  recruitment. 
That  different  TLR  agonists  “instruct”  DCs  to  induce  distinct  Theiper  responses  via 
differential  modulation  of MAPK  family members (Agrawal  et al.,  2003) may be the 
result  of selective  recruitment  of different  gene  sets  for  transcriptional  induction  by 
ERK  and  p38.  Blockade  of  the  ERK  pathway  did  not  inhibit  LPS-induced  H3 
phosphorylation,  which  was  reduced  by  over 90%  by  a p38  inhibitor  (Saccani  et  al., 
2002).  In  contrast,  RSK-2,  the  kinase  downstream  of ERK,  is required  for epidermal 
growth factor (EGF)-activated phosphorylation of H3 (Sassone-Corsi et al.,  1999). This 
suggests that both the p38 and  ERK pathways are  involved  in chromatin remodelling, 
modifying  the  transcription  of  specific  genes  dependent  on  the  initial  activating 
stimulus.
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Overall,  the  transcriptional  regulation  of  signalling  pathways  further  supports  the 
importance of the temporal regulation of DC maturation, and their innate and adaptive 
functions including secretion of inflammatory and polarising cytokines.
6.4  Dendritic cell plasticity to antigens
An  understanding  of the  core  dendritic  cell  activation  and  differentiation  response 
formed  the  basis  for  further  investigation  of DC  transcriptional  responses  to  more 
complex antigens,  whole viruses. Array results showed that although there was still  a 
temporal  ordering  and  presence  of the  core  maturation  response,  these  were  within 
pathogen-specific  transcriptional  responses.  This  specificity  depended  on  the  type  of 
virus and the capacity of the virus to replicate. Transcriptional plasticity demonstrated 
by  dendritic  cell  responses  to  viruses  was  also  evident  on  the  protein  level.  Further 
characterisation  of virally-challenged  DC  gene  expression  programmes,  including  the 
regulation of signalling pathways, transcription factors and innate and adaptive effector 
functions  of  DCs  will  facilitate  understanding  of  how  antiviral  and  virus-specific 
responses are modulated.
The  presence  of  a  core  and  pathogen-specific  transcription  programmes  raises  the 
question of how and when such plasticity is manifested in DC phenotype and function. 
The differences between the core DC transcriptional responses to pathogen components 
(LPS  and  dsRNA)  and  the  virus-specific  DC  responses can  be  illustrated  by the  data 
visualisation technique of spring embedding. Spring embedding allows the visualisation 
of the relationships between all genes on each array to be examined by the strength of 
associations  (“springs”)  based  on  gene  expression  profile  correlation,  a form  of non­
linear principal component analysis. This in effect collapses high-dimensional data (45 
arrays,  approximately  2000  genes)  into  a  2-dimensional  output,  the  dimensions 
encompassing  the  largest  variance  in  gene  expression  (Spring  embedding  (SE)1  and 
SE2  in Figure 6.2). Figure 6.2 shows the relationship between DC responses to the two 
pathogen components and the three virus treatments. The correlation between the arrays 
is represented by the distance between the arrays. There are three major conclusions that 
can be drawn from this. Firstly, the control mock-stimulated DCs and time zero arrays 
of stimulated DCs all cluster together,  i.e. the gene expression of DCs at the beginning 
of the timecourse, and DCs that are mock-stimulated over 24 hours, are essentially the 
same. This  is  supported  by  hierarchical  clustering  in Chapter 3  and 4 which clustered
269Summary and directions for future research
together  mock-stimulated  DCs  and  DCs  at  time  zero.  Secondly,  by  24  hours,  gene 
expression of mature DCs are also very similar, suggesting the common phenotype of a 
potent antigen presenting cell. Thirdly, core maturation and virus-stimulation results in 
markedly  different gene expression  changes,  where  LPS- and  dsRNA-stimulated  DCs 
respond  by  progressing  in  one  direction  (green  arrow),  and  virus-stimulated  DCs 
respond  by  progressing  in  a  different  direction  (red  arrow).  This  suggests  that  DCs 
activate and respond in very divergent paths to core pathogen components and viruses, 
and  this  difference  is  evident  by  2  hours  post-stimulation.  Such  paths  then  seem  to 
converge,  resulting  in  a mature  antigen  presenting cell  by  24 hours  after stimulation. 
This  suggests  that  mature  DCs  induce  certain  characteristics  that  define  an  effective 
antigen  presenting  cell,  but  the  way  such  characteristics  are  acquired  are  plastic, 
dependent on the stimulus.
Figure 6.2 Dendritic cell core and virus-specific maturation
Spring Embedding showing relationship between DC responses to LPS, dsRNA, Influenza, UV- 
inactivated  Influenza,  Rhinovirus,  and  control  mock-stimulation.  The two dimensions  SE1  and 
SE2 refer to the dimensions that capture the two largest variations in gene expression profiles 
of the 45 arrays.  (Figure courtesy of Tim Ebbels,  Department of Computer Science, University 
College London)
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However, Figure 6.2 does not clearly demonstrate DCs’  ability to induce differential T 
cell responses, namely ThI  and Th2. This may be a result of the similarity in the range 
of  antigens  used,  in  that  both  LPS,  dsRNA,  and  the  two  RNA  viruses  generally 
stimulate ThI  responses in DCs. A natural continuation of this work would be to profile 
DC responses to a wider range of antigens, from DNA viruses to bacteria and parasites. 
It would be interesting to compare DC transcriptional responses to defined ThI  and Th2 
polarising  antigens.  We  hypothesise  that  the  TH2  “end-state”  at  24  hours  after 
stimulation will be distinct from the ThI  “end-state”, and that similar alternative paths 
to  the  Th2  state  will  be  determined  (Figure  6.3).  The  work  here  may  have  defined 
subtler  plasticity  within  a  ThI  “subspace”,  reflected  in  divergent  gene  expression 
profiles of the progression of maturation in response to different ThI-inducing stimuli.
In summary, it can be seen that DCs have two potential plastic states, at the periphery in 
shaping  the  innate  immune  response,  and  centrally  in  shaping  the  adaptive  immune 
response  (Figure  6.3).  DNA  microarrays  have  allowed  a  detailed  profiling  of the 
evolution of the immune response from the perspective of the dendritic cell. Expanding 
the  repertoire  stimuli  will  help  elucidate  the  various  mechanisms  that  determine  the 
outcome of host-pathogen interactions.
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Figure 6.3 Proposed plasticity model for DC activation and differentiation
This  is  an  extrapolated  version  of  Figure  6.2  that  includes  hypothesised  DC  gene  expression 
changes  in  response  to TH 2-inducing  stimuli,  for example  parasitic antigens.  As  DCs  undergo 
the  process  of activation  and  differentiation  in  response to various stimuli,  there  is plasticity at 
the  various  stages  of  maturation.  The  activation  of  DCs  depends  on  the  initial  stimuli  and 
environmental  context,  which  affects  downstream  effector cytokines  that  are  secreted.  These 
transitional  DCs  then  differentiate  into  mature  antigen  presenting  cells  that  can  induce  either 
Th1  or Th2 responses depending on the stimuli. The subtleties in transcriptional plasticity at the 
various  stages  are  demonstrated  by  gene  expression  profiling  of  DC  responses  throughout 
maturation,  giving  rise  to  functional  plasticity  affecting  differential  host-pathogen  immune 
responses.
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